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Summary 
The principle of microscopic reversibility serves as the basis of a novel screening method for 
the evaluation of chiral catalysts within asymmetric allylic substitution reactions. Monitoring 
the back reaction of quasienantiomeric products 142a and 142b by electrospray ionisation 
mass spectrometry (ESI-MS) reveals the intrinsic enantioselectivity of palladium catalysts in 
the nucleophilic addition step and thus in the overall substitution process.  
 
 
In this manner, an equimolar mixture of mass-labelled quasienantiomers 142a and 142b was 
subjected to typical reaction conditions and the ratio of the resulting cationic allyl-palladium 
complexes A and B, which are the only species visible in the mass spectrum, was determined 
with high accuracy. 
A series of linear diaryl allylation products with commonly used nucleophiles as leaving 
groups were initially analysed with respect to their leaving group ability, which correlates 
well with the pKa values of the respective nucleophiles. Based on these results, screening 
procedures for allylic alkylations and aminations using substrates derived from acetyl acetone 
and phthalimide were developed. In both cases, the ratios of allyl intermediates A/B closely 
match with the enantiomeric product ratios of corresponding preparative reactions as 
determined by HPLC analysis of the products. The methodology is fast, reliable, and enables 
the simultaneous screening of catalyst mixtures, as long as the catalysts possess different 
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molecular masses. Three palladium complexes were tested in a single reaction vessel and the 
most powerful derivative was readily identified. 
After having established a protocol for the evaluation of chiral palladium catalysts in allylic 
substitutions of linear diaryl substrates, the methodology was extended to the more 
demanding carbocyclic substrates. An efficient screening for the kinetic resolution of 
cyclohexenyl benzoate was developed by the use of cyclic allyl esters 65a and 65b. 
Moreover, analysis of the back reaction starting from the allylation products 90a and 90b 
allowed for determining the efficiency of the catalysts in the overall substitution process. The 
observed data were in good agreement with the corresponding preparative reactions. 
 
 
In an additional project, new pyridyl-phosphite 208, bis(N-sulfonylamino)phosphine 209, and 
phosphinooxazoline ligands 133 were successfully synthesised and evaluated by the ESI-MS 
procedures and conventional preparative catalytic reactions.  
 
 
The back reaction screening method was further extended to the mass spectrometric 
evaluation of racemic catalysts. Using a scalemic mixture of quasienantiomers 142a and 142b 
enabled to determine the enantioselectivities of chiral catalysts by testing their racemates. 
This approach was used to study phosphinooxazoline ligands 143, which possess a 
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stereogenic phosphorus atom as the only source of chirality, because the synthesis of the 
enantiomerically pure compounds is not straightforward.  
 
 
A series of derivatives was synthesised and evaluated by ESI-MS. Conventional preparative 
reactions of the separated enantiomers were performed as well. Ligands derived from dialkyl, 
alkylaryl, and diaryl phosphines induced only low to moderate selectivities in allylic 
substitutions and the results are not competitive with the established phox ligands derived 
from chiral aminoalcohols. The screening methodology was successfully used to determine 
these selectivities without the time-consuming preparation of the enantiomerically pure 
compounds.  
Finally, the ESI-MS analysis of iridium-catalysed allylic substitution reactions proved the 
actual existence of a previously postulated allyl-iridium intermediate. Preliminary results are 
promising and provide information which is in accordance with the suggested reaction 
mechanism.
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1 Introduction 
Asymmetric catalysis is one of the most important methods for the synthesis of 
enantiomerically enriched compounds.[1-3] The development and fine-tuning of chiral 
catalysts, which provide efficient asymmetric induction for a specific transformation, is often 
a labour-intensive, costly, and time-consuming process. Therefore, screening methods that 
accelerate the identification and optimisation of new ligands are of considerable importance 
and increasing amount of research has been devoted to the development of high-throughput 
techniques in the last few years.[4, 5]  
The enantioselectivity of a chiral catalyst is usually determined by measuring the 
enantiomeric excess of the reaction product it produces. However, the value obtained in this 
fashion does not necessarily reflect the intrinsic enantioselectivity of the respective catalyst. A 
competing unselective background reaction, catalytically active impurities, or the dissociation 
of a chiral ligand from the metal centre might lead to low enantiomeric purity of the product, 
despite the high selectivity of the catalyst itself.  
In our group, a method based on quasienantiomeric substrates and electrospray ionisation 
mass spectrometry (ESI-MS) was developed, allowing for the determination of a catalyst´s 
intrinsic enantioselectivity.[6] This approach relies on the quantification of charged reaction 
intermediates and does not require product analysis. As a first application, the kinetic 
resolution of racemic allyl esters by palladium-catalysed allylic substitution was studied. 
 
 
1.1 Electrospray Ionisation Mass Spectrometry  
Electrospray ionisation (ESI), which originated in the paint and coatings industry, was first 
applied to mass spectrometry in the late 1960’s. Dole realised that electrospraying of a 
polymer solution into an evaporation chamber resulted in the formation of intact macroions in 
the gas phase.[7] The method was considerably improved by Fenn, who coupled an 
electrospray source to a quadrupole mass analyser, thus enabling the mass spectrometric 
analysis of thermally fragile polar molecules such as proteins and peptides.[8-10] For this 
contribution Fenn was awarded the Nobel Prize for Chemistry in 2002, along with Tanaka, 
who introduced matrix assisted laser desorption (MALDI) in mass spectrometry.[11, 12] 
Electrospay ionisation (ESI) is a mild technique that allows for transfer of intact molecular 
ions from a dilute solution directly into the gas phase.[13-15] The charged compounds being 
analysed can either be transient species, or protonated/deprotonated forms or ion adducts of 
neutral species.  
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The spraying process can be described with relative simplicity.[16] The solution containing the 
analyte is pumped through a charged capillary. The high voltage generates a mist of charged 
droplets (nebulisation), which pass through a potential and pressure gradient towards the 
analyser of the mass spectrometer.[17] The solvent in these droplets is evaporated by a warm 
flow of drying gas, usually nitrogen. As a consequence, the charge density increases to a point 
at which electrostatic repulsion becomes of the same order of magnitude as the surface 
tension.[18] At this point the droplet fragments in what is termed a ‘Coulomb explosion’, 
producing many daughter droplets, which in turn undergo the same process.[19] Whether or not 
this iterative process finally produces the bare analyte ions is still a subject of debate. 
Alternatively ions can ‘evaporate’ from the droplet’s surface.[20] Whatever the exact 
mechanism might be, electrospray ionisation is a very ‘soft’ means of ionisation, that causes 
little or no fragmentation of the analyte. Proteins can be ionised without denaturation and 
noncovalent receptor-ligand complexes remain intact. The method can even be used for the 
examination of charged non-covalent and non-volatile organometallic complexes, which are 
usually not compatible with most ionisation techniques.[21]  
 
 
1.2 Mass Spectrometric Detection of Reaction Intermediates 
Electrospray ionisation as a tool for the analysis of ionic transition metal complexes was first 
described by Chait for bipyridyl (bpy) and 1,10-phenanthroline complexes of ruthenium in 
1990.[22] A dilute solution of [Ru(II)(bpy)3]2+ in acetonitrile was analysed and the signal for 
the intact cation detected. The collision energy was found to be an adjustable parameter, 
which controls the extent of desolvation and fragmentation. Under mild conditions, the mass 
spectrum exhibited additional peaks resulting from the attachment of one to four acetonitrile 
molecules to the ruthenium centre, whereas at higher energies the doubly charged ion 
dissociated and signals for the fragments [Ru(II)(bpy)2]2+and [Ru(II)(bpy)]2+ were observed. 
Fragmentation of the complex by collisional activation is a characteristic feature for mass 
spectra of coordination compounds.[23] Typically, the loss of an intact ligand occurs rather 
than its fragmentation. This is particularly helpful for the identification and structural 
assignment of signals in the mass spectra and can be used for the characterisation of 
organometallic complexes.[21] 
During the last two decades there has been considerable growth in the applications of 
electrospray ionisation mass spectrometry as a tool for mechanistic investigations, especially 
for homogeneous transition metal-catalysed reactions.[24-26] The great utility of ESI-MS can be 
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ascribed to its ability to transfer ions of many different types, charges, and broad mass ranges 
from the reaction solution directly to the gas phase and to characterise these ions quickly, 
sensitively, and selectively. The gentle ion transfer ensures a close relation between the 
detected gas-phase ion and the actual species in solution.[24] The opportunity to directly 
analyse dilute solutions is a major advantage, as catalytically active species often exist only 
under these conditions and can not be isolated as pure compounds. The optimal concentration 
range (0.001-10 mM) for ESI-MS corresponds to typical catalyst concentrations of many 
reactions. The ability of ESI-MS to selectively ‘fish’ for ionic species[27] allows to analyse the 
course of various transformations by interception, characterisation, and reactivity 
investigations of charged intermediates.  
Pioneering work in this field was accomplished by Chen, who also advanced ESI-MS as a 
tool for the mechanistic investigation of transition metal-catalysed reactions by the 
development of more sophisticated instruments. The interests of Chen’s group have included 
catalytic hydrogenations with rhodium,[28] iridium,[29] and ruthenium complexes,[30, 31] C-H 
activation reactions with iridium(III),[32, 33] and platinum(II),[34-36] olefin metatheses,[37-41] 
Ziegler-Natta polymerisations using zirconocene catalysts,[42, 43] the olefination of aldehydes 
with high-valent rhenium compounds,[44] and the palladium-catalysed polymerisation of 
ethene.[45, 46] 
Furthermore, ESI-MS has been applied by other groups to study additional palladium-
catalysed transformations such as Heck,[47] Suzuki,[48, 49] and Stille reactions,[50] the oxidative 
homocoupling of arylboronic acids,[51] and allylic substitution reactions.[52, 53] Its usefulness 
for studying reactions involving other metal ions has been demonstrated for nickel-catalysed 
C-C couplings,[54] catalytic epoxidations with oxomanganese(V) complexes,[55, 56] iridium-
catalysed hydrosilylations of terminal alkynes,[57] and cobalt-mediated Pauson-Khand 
reactions.[58]  
Along with a variety of transition metal-catalysed reactions, ESI-MS has become a major tool 
for the detection of reaction intermediates in organocatalytic transformations. These species 
are mostly either charged (e.g. iminium ions) or can be easily protonated by protic solvents. 
The first study in this field was reported by Eberlin, who investigated the Baylis-Hillman 
reaction catalysed by 1,4-diazabicyclo[2,2,2]octane (DABCO).[59] More recently, the analysis 
of direct Mannich-type α-methylenation of ketoesters was described.[60] Metzger used ESI-
MS as an analytical tool to study the respective reaction mechanisms for electron transfer-
initiated Diels-Alder reactions,[61] proline-catalysed aldol reactions,[62] and the direct 
organocatalytic α-halogenation of aldehydes.[63] 
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The variety of transformations analysed by ESI-MS to date demonstrates the enormous 
potential of this method for mechanistic studies. Beyond this, several applications in reactivity 
screenings for the discovery and development of catalysts were described.[24]  
An elegant evaluation of different Brookhard-type catalysts was reported by Chen.[45] The 
polymerisation of ethene was carried out in the presence of a simultaneously synthesised 
mixture of eight different precatalysts.  
 
Scheme 1. Polymerisation of ethene using eight different Brookhard-type catalysts in one pot.  
The ESI-MS analysis of the reaction mixture after the addition of dimethylsulfoxide provided 
a complex spectrum. Several overlapping series of oligo- and polymeric ions corresponded to 
each catalyst with zero to hundred attached ethylene units. The most efficient catalyst, 
carrying the longest polymer chain, was identified by a collision induced dissociation (CID) 
experiment. A series of intermediates with m/z > 2200 was filtered out and fragmented by 
xenon collision. The β-hydride elimination of the hydrocarbon chain, induced in this manner, 
generated a palladium hydride, which allowed for identification of the most effective catalyst. 
 
NR1
R1 N
R2 R2
R3
R2
R3
R2
Pd
OTf
Me
mixture of 
eight precatalysts
H2C CH2
1 h, −10 °C
NR1
R1 N
R2 R2
R3
R2
R3
R2
Pd
OTf
CnH2n+1
DMSO
NR1
R1 N
R2 R2
R3
R2
R3
R2
Pd
O
CnH2n+1
SMe2
−OTf
ESI-MS analysisintermediate
INTRODUCTION 
 5 
mass filter
Xe-collisionNR1
R1 N
R2 R2
R3
R2
R3
R2
Pd CnH2n+1
NMe
Me N
iPr iPr
iPr iPr
Pd H
− Pd
 
Figure 1. Mass spectrometric screening for reactivity.  
 
 
1.3 Quasienantiomers in Mass Spectrometry 
Mass spectrometry is an attractive analytical method for high-throughput applications due to 
its wide scope (many types of molecules can be detected), sensitivity, tolerance of impurities 
(peaks other than the masses of interest can be ignored), and speed. However no stereo 
information is provided by this technique, because enantio- or diastereomeric compounds can 
not be distinguished as they have the same mass.  
In the last two decades several methods for distinction of stereoisomers by mass spectrometry 
have been developed,[64] including the kinetic method based on the dissociation of cluster 
ions,[65-67] the formation of diastereomeric host guest adducts, [68-71] and the collision-induced 
dissociation (CID) of diastereomeric adducts of the analyte and a chiral reference in a MS/MS 
experiment.[72] 
An elegant method, introduced by Horeau in 1990, is based on the use of mass labels to 
determine the absolute configuration of secondary alcohols by mass spectrometry.[73] 
An equimolar mixture of chiral anhydrides 1a and 1b was used for the acylation of an 
enantiomerically pure secondary alcohol of unknown configuration (Scheme 2). The 
transformation proceeds by kinetic resolution to give the diastereoisomeric esters 2a and 2b. 
The anhydrides 1a and 1b differed not only in their absolute configuration but also in mass. 
By the introduction of a deuterium label, the resulting esters 2a and 2b could be distinguished 
through mass spectrometry. After the reaction mixture had been subjected to electron impact 
ionisation spectrometry, the relative peak intensities of species 3a and 3b, formed by 
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fragmentation, were compared. Based on the more abundant species, the absolute 
configuration could be unambiguously assigned.  
 
Scheme 2. Assignment of the absolute configuration of secondary alcohols according to Horeau.  
An extension of this methodology to determine the enantiomeric excess of secondary alcohols 
was described by Finn.[74] The approach uses chiral mass-labelled N-acylprolines as the 
acylating agents, which differ in a substituent remote to the stereogenic centre. The validation 
of this so-called ‘mass spectrometry enantiomeric excess determination’ (MSEED) analytical 
method was performed by screening a family of chiral phosphite P,N-ligands for the rhodium-
catalysed asymmetric hydrosilylations of ketones.[75] The catalysts were tested in the 
reduction of several substrates (Scheme 3). The obtained silyl ethers 5 were reacted with 
mass-labelled acylprolines 6a and 6b to give a mixture of diastereomeric esters 7a and 7b, 
which could then be distinguished by mass spectrometry. Based on the ratio of these 
derivatives the enantiomeric excesses of the hydrosilylation products were estimated. For 
comparison aliquots of the silyl ethers 5 were hydrolysed to the corresponding alcohols 8, 
which were then analysed by HPLC on a chiral column. The values obtained from both 
methods were quite similar (within ± 10% ee for all examples). Phosphite 9 was identified as 
the most selective ligand in this screening with enantioselectivities of up to 94%.  
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Scheme 3. Method for examining the enantiomeric excesses of hydrosilylation products 8.  
Another approach based on mass-labelled enantiomers for the determination of enantiomeric 
excesses was developed by Reetz (Scheme 4) .[76]  
 
Scheme 4. Mass spectrometric investigations of kinetic resolutions and desymmetrisations.  
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The lipase-catalysed kinetic resolution of 1-phenylethyl acetate 10a was studied. Through 
deuterium labelling, the sodium adducts of both substrate enantiomers (S)-10a and (R)-10b 
appeared at different m/z values in the mass spectrum and the enantiomeric excess of the 
remaining substrate could be calculated by simple integration of these two signals. In 
addition, the desymmetrisation of prochiral substrates, such as cis-1,4-diacetoxycyclopentene 
12 was analysed in a similar manner by mass spectrometric monitoring of products 13a and 
13b.  
Mass-labelled enantiomers, which were introduced by Horeau, are known as 
quasienantiomers. The terms ‘pseudoenantiomers’ and ‘pseudoracemate’, often used instead, 
should be avoided, since the latter has a well-established different meaning in crystallography. 
[77, 78] It refers to one of the three possible crystalline forms of true racemates and therefore 
should be reserved for this purpose. Several applications of mass-labelled quasienantiomers 
have been described recently in a review by Curran.[77] 
Quasienantiomeric substrates were also used in our group for measuring the intrinsic 
selectivities of chiral catalysts by mass spectrometric monitoring of the respective reaction 
intermediates. This methododology was successfully applied to the kinetic resolution of 
racemic allyl esters by palladium-catalysed allylic substitution (Section 1.4.2) and the 
enantioselective Diels-Alder reaction.[6, 79] 
 
 
1.4 Palladium-Catalysed Allylic Substitutions 
1.4.1 Reaction Mechanism 
Asymmetric palladium-catalysed allylic substitution is a powerful method for the construction 
of carbon-carbon and carbon-heteroatom bonds.[80, 81] The most important of these 
transformations involve reactions with ‘soft’ nucleophiles such as stabilised carbanions or 
amines. The reaction mechanism has been intensely investigated and elucidated in detail 
(Scheme 5). An allylic substrate 14, typically an acetate, reacts with the catalyst, which enters 
the catalytic cycle on the palladium(0) oxidation level. The transformation is initiated by the 
formation of a π-complex 15, which eliminates the leaving group X− to generate a cationic η3-
allyl-palladium(II) complex 16 by oxidative addition. The resulting anion X− can then 
coordinate to the palladium centre in an equilibrium resulting in a neutral species depending 
on the structure of the ligand, the solvent, and the anion. With bidentate ligands the cationic 
complex 16 usually predominates.  
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Scheme 5. Mechanism of palladium-catalysed allylic substitutions.  
The electrophilic palladium(II) centre activates the allylic system for nucleophilic attack, 
which can occur at either terminus of the fragment. Various chiral ligands can control this 
addition through steric or electronic effects. A rather unstable palladium(0) olefin complex 17 
is formed, which rapidly releases the product 18 and the catalyst. Both the oxidative addition 
and the subsequent nucleophilic attack proceed with inversion of the configuration at the 
reacting allyl carbon atom, which results in an overall retention of stereochemistry.   
The formation of allyl intermediate 16 is fast, while the nucleophilic addition to the allyl 
system is slower and the rate-limiting step. The cationic intermediate 16, the only charged 
species of the catalytic cycle represents the resting state of the reaction. In the absence of a 
suitable nucleophile it is stable and can be isolated. It exists in a sufficiently high 
concentration in the reaction mixture to be detectable by ESI-MS under typical conditions. 
This attractive feature allowed for the development of a mass spectrometric screening 
protocol for the evaluation of chiral ligands in the kinetic resolution of allylic esters by 
palladium-catalysed allylic substitution.[6] 
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1.4.2 Screening of Chiral Catalysts in the Kinetic Resolution of Allyl Esters  
In 2004, Markert and Pfaltz developed a protocol for determining the intrinsic 
enantioselectivities of chiral catalysts based on quasienantiomeric substrates and electrospray 
ionisation mass spectrometry (ESI-MS) as an analytical tool.[6] In contrast to previously 
developed screening methods for asymmetric reactions, which also make use of 
quasienantiomeric substrates (Section 1.3), this method relies on the quantification of catalytic 
intermediates rather than product analysis. 
As a first application the kinetic resolution of racemic allyl esters by palladium-catalysed 
allylic substitution was studied using an equimolar mixture of quasienantiomeric substrates 
(S)-19a and (R)-19b (Figure 2). The benzoates bear mass labels at the para-position of one 
aryl group, allowing for the mass spectrometric differentiation of allyl intermediates 20a and 
20b. A rapid screening method was developed and the selectivity factors s = ka/kb for several 
catalysts were deduced from the ratios of the corresponding allyl intermediates 20a and 20b.  
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Figure 2. Mass spectrometric screening of chiral catalysts in the kinetic resolution of allylic esters. 
The method is fast and reliable, does not require workup of the reaction mixture, and in 
contrast to methods based on product analysis, allows for the simultaneous screening of 
several catalysts in one pot, as long as the catalysts have different molecular masses. The most 
selective ligand for this kinetic resolution to date (s > 100) was identified in this fashion, 
illustrating the potential of the approach. It was also demonstrated that mass spectrometric 
screening of quasienantiomeric substrates can considerably simplify the structural 
optimisation of chiral catalysts. Starting from a mixture of suitable building blocks libraries of 
modular ligands were prepared in a single batch and simultaneously evaluated by ESI-MS.[82] 
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Furthermore, a dinuclear allyl-bridged palladium(I) complex was discovered during the 
screening process, which is reversibly formed in substantial amounts in the course of the 
catalytic reaction.[53] 
However, screening a large number of catalysts revealed that the selectivity of a catalyst in 
the kinetic resolution step does not necessarily correlate with the enantioselectivity of the 
nucleophilic addition to the allyl intermediate 22, which determines the enantioselectivity of 
the overall reaction leading from racemic allyl ester 21 to the optically active substitution 
product 23 (Scheme 6). A range of palladium complexes that gave high enantioselectivities in 
the overall reaction were found to be inefficient in the kinetic resolution of allyl esters.  
 
Scheme 6. Allylic alkylation using a phox ligand.  
 
 
1.5 Objectives of this Work 
The main objective of this work was to develop an ESI-MS screening technique to evaluate 
the intrinsic enantioselectivity of chiral catalysts within asymmetric allylic substitution 
reactions. As described in the preceding Section 1.4.2, analysis of the kinetic resolution step 
(step II, Scheme 7) provides no information on the efficiency of the overall allylic substitution 
process leading from racemic allyl ester 14/ent-14 to the optically active substitution product 
18/ent-18. In order to determine the enantioselectivity of product formation, the nucleophilic 
addition (step II, Scheme 7) must be studied and thus we decided to monitor the back reaction 
leading from product 18/ent-18 to the corresponding allyl-palladium complex 16. According 
to the principle of microscopic reversibility, the transition states of the forward and the back 
reactions are identical and the enantioselectivity determined in this way is the same as the 
enantioselectivity of the forward reaction. 
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Scheme 7. General mechanism of the palladium-catalysed allylic substitution of racemic substrate 
14/ent-14.  
Monitoring the palladium-bound allyl intermediates 16 should directly provide the intrinsic 
selectivity of the catalyst when quasienantiomeric mass-labelled substrates are used. We 
decided to study substrates with leaving groups, which are normally applied as nucleophiles 
in the forward reaction. Linear diarylallyl derivatives, which are most often used in 
asymmetric allylic substitutions for the evaluation of new ligands, were chosen for the 
development of this screening method. 
After having proved the viability of this approach, it was planned to extend the methodology 
to more demanding carbocyclic substrates, including the mass spectrometric analysis of both 
the kinetic resolution step and the nucleophilic addition.  
A further goal of this thesis was to use the ESI-MS technique as an analytical tool for the 
evaluation of new ligands, such as bis(N-sulfonylamino)phosphine-oxazoline and pyridyl-
phosphite derivatives.  
In principle the method should also be applicable to the mass spectrometric evaluation of 
racemic catalysts. According to Lloyd-Jones[83] the use of a scalemic mixture of 
quasienantiomeric substrates allows to determine the enantioselectivity of a chiral complex by 
testing its racemate. In order to demonstrate the feasability of this approach, it was intended to 
synthesise racemic phosphinooxazoline ligands with stereogenic phosphorus atoms and to 
study them in asymmetric allylic substitutions.  
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2 ESI-MS Screening of Linear Diarylallyl Substrates 
We were interested in developing an ESI-MS screening technique to evaluate the intrinsic 
enantioselectivity of chiral catalysts within asymmetric allylic substitution reactions. In order 
to determine the enantioselectivity of the product formation, nucleophilic addition must be 
studied. This was accomplished by monitoring the back reaction based on the principle of 
microscopic reversibility. 
 
 
2.1 Leaving Group Ability of Selected Substrates 
In order to find a nucleophile with sufficient reactivity as leaving group, a range of allylation 
products 18 (R = Ph) derived from Meldrum’s acid, phthalimide, acetyl acetone and dimethyl 
malonate was initially screened. Substrates 23-26 were prepared by palladium-catalysed 
allylic alkylation (Scheme 8).[84]  
Benzoate 21 did not react with Meldrum’s acid under standard conditions to give the desired 
product 26. With 2 mol% of catalyst, prepared in situ from [Pd(C3H5)Cl]2 and chiral ligand 
27, N,O-bis(trimethylsilyl)acetamide and potassium acetate in both dichloromethane and 
tetrahydrofuran no product formation was observed. A NMR experiment showed that silyl 
transfer between N,O-bis(trimethylsilyl)acetamide and Meldrum’s acid takes place within a 
few minutes. This was overcome by variation of the base. Using 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) in dichloromethane at 50 °C was found to give the 
best result. However, product 26 was only obtained in 31% yield with an enantiomeric excess 
of 81% under these optimised conditions. 
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Scheme 8. Synthesis of substrates with different leaving groups.  
The leaving group ability was determined by screening the back reaction of these substitution 
products using ESI-MS (Scheme 9). In all cases allyl-palladium complexes, from the 
elimination of the nucleophile, were detected under the standard conditions usually applied in 
preparative allylic substitutions (2 mol% catalyst, toluene, r.t.).  
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Scheme 9. Back reaction screening of different substrates.  
From the relative intensities of the signals corresponding to the precatalyst [Pd(C3H5)L]+ and 
the substituted allyl complex 29 a qualitative order of leaving group ability was established 
for the four allylation products (Figure 3). As expected the reactivities correlate with the 
respective pKa values of the conjugated acids in the order Meldrum's acid (pKa = 4.97)[85] > 
phthalimide (pKa = 8.3)[86] > acetyl acetone (pKa = 8.95)[87] > dimethyl malonate (pKa = 
13.3).[87]  
The Meldrum’s acid-derived compound showed the highest reactivity, evident from a high 
consumption of the catalyst precursor. The dimethyl malonate derivative showed the lowest 
leaving group ability as demonstrated by an intense signal of the catalyst precursor.  
Based on these results a screening protocol for the reaction of quasienantiomeric allylation 
products derived from acetyl acetone was developed, which both is a sufficiently reactive 
leaving group and has similar properties as other widely used C-nucleophiles such as 
malonates. 
 
Ph Ph
X
Ph Ph
Pd
29
N
O
oTol2P
A) X = Meldrum's acid − H+: 26
B) X = phthalimide: 25
C) X = acetyl actetone − H+: 24
D) X = dimethyl malonate − H+: 23
N
O
oTol2P
2 mol% [Pd(C3H5)(MeCN)2]OTf, 
8 mol% [Na([15]crown-5)]CEt(CO2Et)2,
toluene, r.t.
28
(2 mol%)
CHAPTER 2 
 18 
Figure 3. Reactivity screening (Scheme 9) using substrates derived from Meldrum’s acid 26 (A), 
phthalimide 25 (B), acetyl acetone 24 (C) and dimethyl malonate 23 (D).  
 
 
2.2 Asymmetric Allylic Alkylations 
2.2.1 Synthesis of New Quasienantiomeric Substrates 
Enantiomerically pure quasienantiomers 30a and 30b derived from acetyl acetone were 
prepared by palladium-catalysed allylic alkylation as key step (Scheme 10). In contrast to 
previous studies they bear mass labels at the para-positions of both aryl substituents.[6] A 
double mass labelling strategy not only eases substrate synthesis, but also offers the advantage 
of providing symmetric allyl-palladium intermediates during the ESI-MS screening reaction.  
According to a literature procedure, aryl iodides 31 and 32 were reacted with acrolein diethyl 
acetal 33 in presence of Pd(OAc)2, followed by acidic workup to give products 34 and 35 
(Scheme 10).[88]  
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Scheme 10. Synthesis of quasienantiomeric substrates 30a and 30b.  
Cinnamaldehydes 34 and 35 were then converted to allylic alcohols 37a and 37b and after 
subsequent esterification, with benzoylchloride, 4-(dimethylamino)pyridine and triethylamine 
benzoates 38a and 38b, were produced in good yields.[89]  
Allylic alkylation with acetyl acetone in the presence of 2.5 mol% of the catalyst, prepared in 
situ from [Pd(C3H5)Cl]2 and phox ligand 27, a mixture of N,O-bis(trimethylsilyl)acetamide 
and catalytic amounts of potassium acetate as base smoothly afforded substitution products 
30a and 30b.[84] However, the reactions had to be carried out at 0 °C to obtain high 
enantioselectivities. Transformations using ligand (S)-27 provided the methyl-labelled 
quasienantiomer (S)-30a and the ethyl-substituted compound (S)-30b with an enantiomeric 
excess of > 99% in both cases. In the same way the (R)-alkylation products were obtained 
with ligand (R)-27 in high enantiomeric purity. 
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2.2.2 Mass Spectrometric Screening of Phosphinooxazoline Ligands 
Having prepared quasienantiomers 30a and 30b screening conditions for the back reaction 
were investigated to determine the selectivity of the nucleophilic addition step within these 
allylic substitutions. The influence of reaction temperature, solvent and the amount of 
nucleophile was studied to obtain the optimum conditions (Scheme 11). The catalysts were 
prepared in situ from [Pd(C3H5)(MeCN)2]OTf and stoichiometric amounts of the 
corresponding chiral ligands in toluene. An equimolar mixture of (R)-30a and (S)-30b 
(25 equivalents based on Pd each) was added and the reaction started by activation of the 
precatalyst with the crown ether sodium salt of diethyl ethylmalonate (4 equivalents based on 
Pd). A limited amount of nucleophile was required to ensure a defined conversion and obtain 
reproducible mass spectra. After 30 seconds at room temperature, a sample was taken, diluted 
with dichloromethane and directly injected into the mass spectrometer.  
 
Scheme 11. Back reaction screening of the nucleophilic addition step of allylic substitutions with acetyl 
acetone.  
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Table 1. ESI-MS screening of allylic alkylations using quasienantiomers (R)-30a and (S)-30b 
according to Scheme 11. 
Entry Ligand  Screening 
39a : 39b 
Preparative Reaction[a] 
(R)-24 : (S)-24 
1 
Ph2P
40
N
O
 
     3 : 97 
[742]
[714]
 
m/z
 
1 : 99 
t
 
2 
Ph2P
41
N
O
 
     2 : 98 
[762]
[734]
m/z
 
1 : 99 
t
 
3 
Ph2P
(S)-27
N
O
 
     4 : 96 
[728]
[700]
m/z
 
2 : 98 
t
 
4 
Ph2P
(R)-27
N
O
 
     96 : 4 
[728]
[700]
 
m/z
 
98 : 2 
t
 
5 
oTol2P
42
N
O
 
     20 : 80 
[756]
[728]
 
m/z
 
14 : 86 
t
 
6 
oTol2P
28
N
O
 
     17 : 83 
[770]
[742]
m/z
 
17 : 83 
t
 
[a] HPLC analysis (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 254 nm): 
tR = 16.3 (R), 17.9 (S) min. 
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Under these conditions the signals of the allyl complexes 39a and 39b, formed by elimination 
of acetyl acetonate, are clearly visible and show the characteristic isotope pattern of 
palladium.  
Screening results with a selection of phox ligands 27, 28 and 40-42 are depicted in Table 1. 
The selectivities, calculated from the ratios of the peak heights of the two signal clusters, 
correlate very well with the enantiomeric ratios of the products from the corresponding 
preparative reactions of racemic 1,3-diphenyl-2-propenyl benzoate with acetyl acetone, as 
measured by HPLC analysis (Scheme 12).  
 
Scheme 12. Preparative allylic alkylation reaction with acetyl acetone as nucleophile.  
Phox derivatives 40, 41 and 27 are clearly the most effective ligands whereas the analogous 
bis(ortho-tolyl)-substituted phosphanes 42 and 28 induce only moderate enantioselectivities. 
The two enantiomeric ligands (S)-27 and (R)-27 gave the exactly reverse peak ratios, 
confirming that quasienantiomers (R)-30a and (S)-30b perfectly behave as real enantiomers. 
This result was verified by an additional control experiment with inversely labelled 
quasienantiomers (S)-30a and (R)-30b bearing interchanged methyl and ethyl groups. The 
screening was carried out with ligands 40 and 42 under the conditions described in Scheme 11 
and in both cases a perfectly reverse peak ratio was obtained (Table 2). 
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Table 2. ESI-MS screening of quasiracemates (R)-30a + (S)-30b and (S)-30a + (R)-30b using ligands 
(S)-40 and (S)-42. 
Ligand (R)-30a : (S)-30b (S)-30a : (R)-30b 
Ph2P
40
N
O
 
3 : 97 
[743]
[714]
 
m/z
 
97 : 3 
[743]
[714]
m/z
 
oTol2P
42
N
O
 
20 : 80 
[756]
[728]
m/z
 
80 : 20 
[756]
[728]
 
m/z
 
 
The results obtained with phosphinooxazoline ligands 27, 28 and 40-42 prove that the ESI-
MS screening of the back reaction is a fast and reliable method for evaluating libraries of 
chiral catalysts. 
 
 
2.2.3 Reversibility of the Back Reaction  
During the investigations described above it became clear that the selectivity observed within 
the screening is time-dependent. As shown in Figure 4 the peak ratio slowly decreases when 
aliquots at differing reaction times are taken.  
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Figure 4. ESI-MS screening of ligand (S)-27 using quasiracemate (R)-30a + (S)-30b. Samples were 
taken after 30 s (A), 15 min (B) and 45 min (C).  
This is presumably caused by the reversibility of the reaction as the elimination of acetyl 
acetonate is an endergonic process. For clarification a substitution experiment was carried out. 
A precatalyst solution, prepared from [Pd(C3H5)(MeCN)2]OTf and an equimolar amount of 
ligand (S)-42 was mixed with the ethyl-labelled quasienantiomer (S)-30b and the reaction was 
initiated by addition of the crown ether sodium salt of diethyl ethylmalonate (Scheme 13). In 
contrast to standard screening conditions a substoichiometric amount of nucleophile, based on 
the palladium-precursor, was used (0.8 equivalents). The corresponding mass spectrum 
showed the allyl-palladium intermediate 39b as expected (Figure 5, A). After a reaction time 
of 25 minutes, when no initial nucleophile was assumed to be left, a solution of the methyl-
substituted quasienantiomer (R)-30a was added. The reaction mixture was analysed by ESI-
MS and allyl-palladium intermediate 39a was visible in small quantities indicating that the 
screening reaction is reversible (Figure 5, B).  
 
Scheme 13. Investigating the reversibility of the screening reaction.  
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Figure 5. ESI-MS experiment investigating the reversibility of the screening reaction. Mass spectrum 
obtained when using (S)-30b and ligand (S)-42 (A) and mass spectrum after the addition of (R)-30a 
(B).  
These findings indicate, that the peak ratio decreases slowly due to racemisation of 
quasienantiomers (R)-30a and (S)-30b through the reversible elimination-readdition of acetyl 
acetonate. However, at the initial stage of the reaction the concentration of acetyl acetonate is 
much lower than that of diethyl ethylmalonate and therefore the addition of acetyl acetonate 
to the allyl-palladium complexes negligible. The results of the screening are not affected if the 
samples are taken at the very beginning of the reaction. 
The equilibrium between the allylation products 30a and 30b and the corresponding allyl 
complexes 39a and 39b must lie almost entirely on the side of 30a and 30b, as these are 
known to be stable products. Nevertheless, due to the high sensitivity of ESI-MS both the 
reliable detection and the accurate quantification of the allyl intermediates is possible despite 
their low overall concentration.  
 
 
2.2.4 Influence of Palladium-Precursor and Solvent on the Selectivity in 
Preparative Allylic Alkylation Reactions 
The investigations also demonstrated that enantioselectivities of the preparative reactions 
under screening conditions ([Pd(C3H5)(MeCN)2]OTf in toluene, Scheme 12) are superior to 
those obtained under standard conditions ([Pd(C3H5)Cl]2 in CH2Cl2, Scheme 14). A 
comparison is shown in Table 3. With the most efficient catalysts 40, 41 and 27 only small 
deviations are observed, whereas the selectivity of bis(ortho-tolyl)-substituted phosphanes 42 
and 28 was found to be more sensitive to changes in reaction conditions. 
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Scheme 14. Allylic alkylation of benzoate 21 with acetyl acetone and ([Pd(C3H5)Cl]2 as catalyst 
precursor in CH2Cl2.  
Table 3. Comparison of different reaction conditions for the allylic alkylation of benzoate 21 with acetyl 
acetone.  
  [Pd(C3H5)(MeCN)2]OTf in toluene  
(Scheme 12) 
[Pd(C3H5)Cl]2 in CH2Cl2 
(Scheme 14) 
Entry Ligand Time [h] Yield [%] ee [%][a] Time [h] Yield [%] ee [%][a] 
1 40 14 92 > 99 16 96 94 
2 41 16 98 97 1 98 97 
3 27 17 100 96 16 98 92 
4 42 85 100 72 52 78 41 
5 28 71 100 66 17 98 21 
[a] HPLC analysis (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 254 nm): 
tR = 16.3 (R), 17.9 (S) min. 
 
2.2.5 Mass Spectrometric Screening of Other Chiral Ligands 
After having established a reliable ESI-MS screening protocol a series of other ligands was 
tested to investigate the scope of this new approach. It was not possible to determine the 
efficiency of all catalysts, as with a number of ligands only unreacted precatalyst 
[Pd(C3H5)L]+ was detected. With the majority of Walphos-, Mandyphos- and Taniaphos-type 
ligands from the Solvias ligand kit,[90] as well as the other ligands shown in Figure 6, no allyl-
palladium intermediates 39a and 39b were observed.  
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Figure 6. Selected ligands showing no allyl-palladium intermediates 39a and 39b in the back reaction 
screening according to Scheme 11.  
Exemplary, a preparative reaction with Walphos-type ligand 43 was carried out for 
comparison according to Scheme 12. After 19.5 hours the alkylation product 24 was obtained 
in high yield with 92% ee (R), showing that allylic alkylation proceeded smoothly. The 
preparative back reaction of 24 using ligand 43 was also analysed and no product formation 
was observed under ESI-MS screening conditions, indicating a high activation energy for the 
back reaction.  
 
Scheme 15. Preparative back reaction of substrate 24 using ligand 43.  
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When an analogous experiment was carried out with the sodium salt of dimethyl malonate in 
tetrahydrofuran product 23 was formed in small amounts according to NMR analysis (Scheme 
15). However, no allyl-palladium complex 16 (R = Ph) was detected in the mass spectrum 
under these conditions (for further discussions see Chapter 3.3). 
Results with Josiphos-type ligands 50-52 are depicted in Table 4.  
Table 4. ESI-MS screening of allylic alkylations with Josiphos-type ligands 50-52 using 
quasienantiomers (R)-30a and (S)-30b according to Scheme 11. 
Entry Ligand Screening 
39a : 39b 
Preparative Reaction[a] 
(R)-24 : (S)-24 
1 
FePh2P
PCy2
Me
50
(SL-J001-1)  
12 : 88 
[949]
[921]
m/z
 
7 : 93 
 
t
 
2 
FeCy2P
PCy2
Me
51
(SL-J003-1)  
44 : 56 
[961]
[933]
m/z
 
 
30 : 70 
t
 
3 
FePh2P
PXyl2
Me
52
(SL-J005-1)  
20 : 80 
[993]
[965]
m/z
 
 
23 : 77 
t
 
[a] HPLC analysis (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 254 nm): 
tR = 16.3 (R), 17.9 (S) min. 
The selectivities determined by ESI-MS correlate with the data from the HPLC analysis of the 
preparative reactions of racemic 1,3-diphenyl-2-propenyl benzoate 21 with acetyl acetonate. 
With ligand 51 only mass spetra of low quality were obtained, this presumably explains the 
poor correlation observed. However, enantioselectivity of the most selective ligand 50 was 
easily determined and the order of selectivity reliably reproduced. 
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Phox and phim ligands 53-57[91] were also analysed to evaluate their efficiency in the allylic 
alkylation of 21 with acetyl acetone (Table 5).  
Table 5. ESI-MS screening of allylic alkylations with phox and phim ligands 53-57 using 
quasienantiomers (R)-30a and (S)-30b according to Scheme 11. 
Entry Ligand  39a : 39b 
1 
N
O
OH
oTol2P
53  
86 : 14 
[772]
[744]
 
m/z
 
2 
N
O
O
oTol2P
54
O
 
82 : 18 
[876]
[848]
m/z
 
3 
N
O
O
oTol2P
55
O
 
72 : 28 
[856]
[828]
 
m/z
 
4 
N
N
Ph2P
56
 
97 : 3 
[927]
[899]
 
m/z
 
5 
N
N
Ph2P
57  
63 : 37 
[887]
[859]
 
m/z
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The majority of ligands exhibit only moderate selectivities, but phim 56 proved to be very 
efficient giving allyl-palladium intermediates 39a and 39b with a ratio of 97:3. This result 
was verified by comparison with the corresponding preparative reaction. Product 24 was 
thereby isolated with 96% ee (R), again validating the method.  
 
 
2.3 Asymmetric Allylic Aminations 
After having established a reliable screening protocol for the allylic alkylation reaction, we 
turned our attention to allylic aminations. The back reaction screening technique was 
successfully applied to the allylic amination using phthalimide. Quasienantiomers (R)-58a 
and (S)-58b were prepared from benzoates 38a and 38b according to Scheme 16. The 
respective reactions with potassium phthalimide gave the products in excellent yields and 
enantioselectivities of 97% ee each. 
Scheme 16. Synthesis of quasienantiomers (R)-58a and (S)-58b by palladium-catalysed allylic 
aminations.  
When quasienantiomeric N-allyl phthalimides (R)-58a and (S)-58b were reacted under the 
conditions used for screening reactions with acetyl acetonate as nucleophile, the 
corresponding allyl-palladium intermediates 39a and 39b were observed by ESI-MS and the 
selectivities were determined using the signal intensity ratios of the two signal clusters 
(Scheme 17).  
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Scheme 17. Back reaction screening of the nucleophilic addition step of allylic aminations with 
phthalimide.  
For comparison, the corresponding preparative reactions of racemic 1,3-diphenyl-2-propenyl 
benzoate with potassium phthalimide and 2 mol% of catalyst, prepared in situ from 
[Pd(C3H5)Cl]2 and the chiral ligand, were carried out in dichloromethane at room temperature 
(Scheme 18). Under the conditions used for the ESI-MS screening using toluene as the 
solvent no conversion was observed, presumably due to the insolubility of the potassium 
phthalimide in the reaction medium. 
Scheme 18. Preparative allylic aminations using potassium phthalimide as nucleophile.  
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Table 6. ESI-MS screening of allylic aminations using quasienantiomers (R)-58a and (S)-58b 
according to Scheme 17. 
Entry Ligand  Screening 
39a : 39b 
Preparative Reaction[a] 
(S)-25 : (R)-25 
1 
Ph2P
40
N
O
 
97 : 3 
[742]
[714]
m/z
 
< 1 : > 99 
t
 
2 
Ph2P
41
N
O
 
94 : 6 
[762]
[734]
m/z
 
1 : 99 
t
 
3 
Ph2P
(S)-27
N
O
 
96 : 4 
[728]
[700]
m/z
 
 
1 : 99 
t
 
4 
Ph2P
(R)-27
N
O
 
4 : 96 
[728]
[700]
m/z
 
99 :1 
t
 
5 
oTol2P
42
N
O
 
78 : 22 
[756]
[728]
m/z
 
 
19 : 81 
t
 
6 
oTol2P
28
N
O
 
78 : 22 
[770]
[742]
m/z
 
 
19 :81 
t
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Table 6. Continued. 
Entry Ligand  Screening 
39a : 39b 
Preparative Reaction[a] 
(S)-25 : (R)-25 
7 
O
O P O
59
N
O
 
95 : 5 
[1012]
[984]
m/z
 
1 : 99 
t
 
8 
FePh2P
PCy2
Me
50
(SL-J001-1)  
82 : 18 
[949]
[921]
m/z
 
 
18 : 82 
t
 
9 
FePh2P
PXyl2
Me
52
(SL-J005-1)  
86 : 14 
[993]
[965]
m/z
 
 
14 : 86 
m/z
 
[a] HPLC analysis (Daicel Chiracel OD-H, heptane/isopropanol 99:1, 0.5 mL*min−1, 20 °C, 254 nm): 
tR = 37.6 (S), 51.8 (R) min. 
It is evident from Table 6 that the enantioselectivities induced by ligands 27, 28 and 40-42 are 
very similar to those measured for the analogous reaction with acetyl acetonates (Table 1).  
Peak ratios determined by ESI-MS correlate well with the results of the preparative reactions. 
The somewhat lower selectivities obtained in the screening may be due to the different 
conditions applied in the preparative reactions and/or the reversibility of phthalimide 
elimination (see Chapter 2.2.3). However, despite these small deviations, the ESI-MS method 
reveals the correct selectivity order and therefore allows reliable identification of the most 
selective catalyst. With the Josiphos-type ligands the data from the screening correlate also 
very well with the results obtained by preparative allylic amination reactions.  
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2.4 Screening of Catalyst Mixtures 
The preceding results show that the developed ESI-MS screening technique provides data on 
the enantioselectivity of allylic alkylation and amination reactions with excellent agreement to 
the results obtained from preparative reactions. 
After establishing a reliable protocol for the screening of single catalysts the method was 
extended to analyse mixtures of several palladium catalysts in one reaction pot. Initial studies 
focused on the allylic amination as a test reaction (Scheme 17) because phthalimide shows a 
higher leaving group ability in the back reaction when compared to acetyl acetonate. Three 
different precatalysts were combined with the quasiracemate (S)-58a and (R)-58b in toluene 
at –20 °C and the reaction was started by the addition of the crown ether sodium salt of 
diethyl ethylmalonate. The control spectrum before activation of the precatalyst showed the 
corresponding three allyl-palladium complexes as expected.  
It was previously demonstrated that the screening of mixtures in the kinetic resolution of 
allylic esters has to be carried out at –78 °C in order to suppress ligand exchange.[6] In the 
back allylic amination we also experienced ligand exchange at room temperature, whereas at 
–78 °C unsufficient reactivity was observed. For this reason the reaction temperature had to 
be slightly increased. Initial results were obtained for different Phox, Josiphos-type and 
Claver-type ligands. It became clear that the analysis of these mixtures is hindered by the low 
reactivity of the back reaction in general. Possible ligand combinations are further limited due 
to similar molecular masses and differences in reactivity of the respective catalysts. Phox 
ligands, particularly with bis(ortho-tolyl)-substituted phosphorus atoms, were found to be 
much more reactive than the Josiphos or Claver-type derivatives and the signals of the latter 
become too small or unobservable. Provided that catalyst reactant complexes are detected in 
the mixture, it is possible to establish a qualitative selectivity order from the spectra. One 
example is shown in Figure 7, in which all precatalysts and catalyst reactant complexes are 
visible in the mass spectrum. Phosphinooxazoline 40, bearing a tert-butyl group on the 
oxazoline, was found to be the most selective ligand in this mixture with a ratio of 12:88, 
followed by 41 with 13:87 and commercially available 52 with 30:70. The same selectivity 
order was obtained by comparison of each individual screening result. In these experiments 
phox ligands 40 and 41 show similar selectivities as well.  
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Figure 7. Back reaction screening of a catalyst mixture using quasienantiomers (S)-58a and (R)-58b 
with P = [Pd(C3H5)L]+, A = 39a and B = 39b. 
A mixture screening procedure was also developed for the back allylic alkylation reaction of 
quasienatiomeric substrates (R)-30a and (S)-30b according to Scheme 11. As expected this 
transformation was even more hampered by the decreased reactivity at lower temperatures. 
However a better correlation with results from the single catalyst screening was obtained 
compared to analogous allylic aminations. The analysis of the mixture shown in Figure 7, 
containing catalysts derived from (S)-40, (S)-41 and 52 at −20 °C yielded ratios of 10:90, 8:92 
and 22:78, respectively, for the corresponding allyl complexes 39a and 39b, whereas 
selectivities of 3:97, 2:98 and 20:80 were obtained by screening the isolated catalysts. 
Although the efficiencies are lower in multicatalyst screening for both allylic aminations and 
alkylations the order of selectivity remains unchanged and the most efficient catalysts can 
easily be determined.  
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2.5 Conclusions and Outlook 
A fast and reliable method for the screening of chiral catalysts in palladium-catalysed 
asymmetric allylic substitutions of linear diarylallyl substrates, the most prominent model 
reaction in this field, has been developed. Based on the principle of microscopic reversibility 
the back reaction of the nucleophilic addition step was studied by electrospray mass 
spectrometry in order to evaluate the enantioselectivities of the respective catalysts. An 
equimolar mixture of mass-labelled quasienantiomeric allylation products was subjected to 
typical reaction conditions and the ratio of the resulting cationic allyl-palladium complexes, 
visible in the mass spectrum, determined with high accuracy. 
Initially several derivatives, with commonly used nucleophiles as leaving groups, were 
analysed with respect to their reactivity in the back reaction. As expected the leaving group 
ability and hence suitability for the screening of the allylation products correlated perfectly 
with the pKa values of the respective nucleophiles. 
Based on these observations an ESI-MS screening procedure was developed for determining 
the efficiency of chiral palladium catalysts in allylic alkylations and aminations using 
substrates derived from acetyl acetone and phthalimide. In both cases selectivities of the back 
reactions observed by the ESI-MS were in excellent agreement with the corresponding data 
from the analogous preparative nucleophilic substitution reaction, proving the utility of this 
novel approach. As only the intrinsic selectivity is measured in the screening the effects of 
unselective background reaction, catalytically active impurities and ligand dissociation do not 
alter the results, in contrast to product analysis. 
This methodology was extended to the simultaneous evaluation of several palladium 
complexes in a single reaction vessel. Although the selectivities obtained in this case were 
somewhat lower than the corresponding values measured for the single catalyst screening, the 
orders of selectivity remained the same. This allowed for a fast and reliable identification of 
the most powerful catalyst in the mixture.  
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3 ESI-MS Screening of Carbocyclic Substrates 
Asymmetric allylic substitution reactions of cyclic substrates remain a challenge. The 
enantioselectivities are usually more difficult to control due to the presence of less sterically 
demanding syn substituents.[80, 81]  
 
Scheme 19. Allylic substitution of cyclohex-2-enyl acetate 60.  
To date only a limited number of ligands, such as diphenylphosphino benzoic acid (DPPBA) 
based derivatives,[92, 93] phosphite-oxazolines,[94, 95] cymantrene-based systems and β-
phosphinocarboxylic acids[96] have been described to induce high selectivities in these 
transformations. Hence, the development of a rapid screening protocol based on ESI-MS for 
discovering highly selective palladium catalysts is of great interest.  
The allylic alkylation of cyclohex-2-enyl acetate 60 with dimethyl malonate is commonly 
used as model reaction for the evaluation of new chiral ligands (Scheme 19).[80, 81, 92] Inspired 
by the work of Trost for the palladium-catalysed deracemisations of cyclic allyl esters,[97] 
ester groups were introduced as mass labels allowing for a simple differentiation of the two 
allyl-palladium intermediates. The catalytic cycle for the allylic substitution process using 
mass-labelled quasienantiomeric substrates is shown in Scheme 20. Both reaction steps can be 
analysed by mass spectrometry, as with previously studied allylic substitutions (Chapter 2). 
By using an equimolar mixture of 62a and 62b, the selectivity factor s = ka/kb for the kinetic 
resolution (step I) can be deduced from the ratio of the corresponding allyl intermediates 63a 
and 63b. Furthermore the analysis of the back reaction of quasiracemate 64a/64b to the latter 
allows determination of the enantioselectivity of the nucleophilic addition step and thus the 
selectivity of the overall allylic substitution process (step II).  
AcO
cat. ML
Nu− ∗Nu
60 61
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Scheme 20. Mechanism of the palladium-catalysed allylic substitution of quasienantiomeric substrates 
62a and 62b.  
 
 
3.1 Kinetic Resolution of Racemic Allyl Esters 
3.1.1 Initial Experiments 
Initially an appropriate set of quasienantiomers 62a and 62b had to be identified for the 
screening of the kinetic resolution of cyclic allyl esters. Racemic methyl- and ethyl-labelled 
benzoates 65a and 65b were prepared (Scheme 21) and an equimolar mixture was analysed 
by ESI-MS. With phox ligand 28 the corresponding allyl complexes 63a and 63b were 
observed under the usual conditions applied in the back reaction screening for linear 
substrates (2 mol% catalyst, [Na([15]crown-5)]CEt(CO2Et)2, toluene, r.t., Chapter 2.2.2). The 
signals of 63a and 63b were detected with high intensity and a perfect 1:1 ratio, showing that 
quasienantiomeric substrates 65a and 65b behave like real enantiomers (Figure 8).  
X
CO2Me
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CO2Me
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+PdIIL
Nu
CO2Me
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 − X−
X
CO2Et
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Figure 8. Control experiment with racemic quasienantiomers 65a and 65b (Nu = [Na([15]crown-
5)]CEt(CO2Et)2).  
 
 
3.1.2 Synthesis of Quasienantiomeric Benzoates 
The preparation of benzoates (R,R)-65a and (S,S)-65b required enantiomerically pure 
cyclohex-3-enecarboxylic acid (66). Acid 66 was synthesised from from cyclohex-3-
enecarbaldehyde by oxidation[98] and resolved by re-crystallisations of the corresponding (+)-
and (−)-α-phenylethylamine salts.[99, 100] The free acid was obtained after acidic hydrolysis of 
the salts and both enantiomers were isolated with 97% ee. Iodolactonisation and DBU-
induced elimination of the resulting iodides 67 gave unsaturated lactones (R,R)- and (S,S)-68 
in good yields.[101, 102] Ring opening was accomplished using sodium hydrogen carbonate in 
methanol and ethanol respectively.[102] The alcohols (R,R)-69a and (S,S)-69b were then 
converted to the corresponding benzoates. Both quasienantiomers (R,R)-65a and (S,S)-65b 
were isolated as single diastereomers with an enantiomeric excesses of 97% and similar 
results were obtained for the inversely labelled quasienantiomers (S,S)-65a and (R,R)-65b. 
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Scheme 21. Synthesis of quasienantiomeric substrates (R,R)-65a and (S,S)-65b.  
 
 
3.1.3 Mass Spectrometric Evaluation of Chiral Ligands  
Applying the established screening protocol according to Scheme 22 several palladium 
complexes were subjected to ESI-MS analysis (Figure 9). The catalysts were prepared in situ 
from equimolar amounts of [Pd(C3H5)(MeCN)2]OTf and the corresponding chiral ligands. A 
1:1 mixture of (R,R)-65a and (S,S)-65b (25 equivalents based on Pd) was added and the 
reaction initiated by addition of the crown ether sodium salt of diethyl ethylmalonate 
(4 equivalents based on Pd). After 30 seconds at room temperature, an aliquot was taken and 
diluted with dichloromethane before direct injection into the mass spectrometer.  
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Scheme 22. Catalyst screening of the kinetic resolution using quasienantiomeric substrates (R,R)-65a 
and (S,S)-65b.  
Allyl-palladium intermediates 63a and 63b were easily detected by ESI-MS, except for 
Walphos-type and phosphoramidite ligands. However, phosphinooxazolines, phosphino-
imidazolines and most ligands of the Solvias ligand kit[90] were inefficient in the kinetic 
resolution of allylic esters (R,R)-65a and (S,S)-65b. Moderate results were obtained with 74 
(63:37), 75 (37:63) and 76 (22:78), whereas good selectivity was achieved with ligand 49 
(85:15).  
Claver recently described a new family of phosphite-oxazolines with a bulky biphenyl 
phosphite moiety, which gave excellent reaction rates and enantioselectivities for a broad 
number of substrates in palladium-catalysed asymmetric allylic substitution reactions.[94] 
Ligand 59 was synthesised following the literature procedure and applied in the screening as 
well. The intermediates 63a and 63b were obtained in a ratio of 8:92, the best result in the 
screening to date. 
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Figure 9. Screening results for the kinetic resolution of (R,R)-65a and (S,S)-65b.  
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Figure 9. Continued.  
 
 
3.1.4 Kinetic Analysis of Preparative Resolutions 
In order to confirm the ESI-MS screening results the kinetic analysis of corresponding 
preparative reactions was carried out. 
The kinetic resolution of benzoate 77 was initially studied using phosphite-oxazoline 59, as 
this was the most selective ligand in the screening with a selectivity factor of s = 11.5 ± 0.29 
(Figure 10).  
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Figure 10. ESI-MS spectrum for the kinetic resolution depicted in Scheme 22 using ligand 59.  
The reaction was performed in toluene at room temperature using 2 mol% of catalyst, 
prepared in situ by stirring a solution of [Pd(C3H5)(MeCN)2]OTf with 1.25 equivivalents of 
59 for three hours (Scheme 23). Three equivalents of both dimethyl malonate and N,O-bis(tri-
methylsilyl)acetamide were added, followed by a catalytic amount of potassium acetate.  
 
Scheme 23. Preparative kinetic resolution of 77.  
In the simplest case of a kinetic resolution the substrate enantiomers interact with the chiral 
catalyst to generate two diastereotopic transition states. The free energies of these transition 
states define the rate constants for converting the fast- and slow-reacting enantiomers and 
therefore determine the product distribution. Assuming first order kinetics in substrate, the 
selectivity factor s, which is equal to the ratio kfast/kslow, can be calculated from the conversion 
and the enantiomeric excess of the remaining substrate (Equation 1).[103]  
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The s factor of the resolution depicted in Scheme 23 was measured by taking aliquots over the 
reaction course. The conversions were analysed by GC and corrected for catalyst loading. 
This correction is necessary, because substrate bound to the catalyst as a η3-allyl fragment is 
removed during the workup.[104] The enantiomeric excesses of the remaining substrate were 
measured by chiral HPLC analysis. The experiment was repeated with consistent results and 
both sets of data points were analysed in one diagram (Figure 11).  
 
Figure 11. Kinetic resolution according to Scheme 23 using ligand 59. Plot of the enantiomeric excess 
of the remaining substrate 77 against conversion.  
The inverse function 2 of Equation 1 was used to calculate s by the least squares method.[104] 
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However, it was not possible to fit the data with this approach. After an initial induction 
period a nearly linear correlation was found. The Kagan model is not applicable in this case as 
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it requires the catalyst concentration to be stable.[103] The resolution catalysed by Claver-type 
ligand 59 seems not to fulfil this requirement. Within the first 15 minutes no conversion was 
observed and the reaction most likely suffers from catalyst decomposition after extended time. 
Even though it is more accurate to determine the s factor from multiple pairs of data points, it 
was not possible to evaluate the selectivity in this way. Therefore calculations from single 
point measurements were pursued. After conversions of 50% and 53% the remaining substrate 
was isolated with 71% and 75% ee, respectively. These pairs of data points correspond to s 
factors of 12.1 and 10.5. The 11.3 average of these two values matches the result from the 
screening very well.  
A complete kinetic analysis was carried out for the resolution of 77 using Mandyphos-type 
ligand 76, for which a s factor of 3.5 ± 0.31 was determined from the mass spectrum (Figure 
12). 
 
Figure 12. ESI-MS spectrum for the kinetic resolution depicted in Scheme 22 using ligand 76.  
The kinetic analysis was performed under analogous reaction conditions as described in 
Scheme 23. The experiment was repeated with consistent results and therefore both series of 
data points were plotted in one diagram (Figure 13). According to Equation 2 a value of 3.50 
± 0.08 was calculated using the least squares method, which exactly matches the s factor 
determined by ESI-MS. 
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Figure 13. Kinetic resolution according to Scheme 23 using ligand 76. Plot of the enantiomeric excess 
of the remaining substrate 77 against conversion. 
These results prove the ESI-MS screening to be a fast and reliable method for evaluating 
libraries of chiral catalysts in the palladium-catalysed kinetic resolution of cyclohexenyl 
esters. Like this it can be used as efficient tool for the development of new ligand systems.  
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3.2 Back Reaction of Carbocyclic Substrates 
3.2.1 Screening Method Development 
The next objective was to use the ESI-MS screening technique in palladium-catalysed 
asymmetric allylic substitutions of carbocyclic substrates. As already described in Chapter 2, 
the selectivity of product formation can be determined by monitoring the back reaction, i.e. 
formation of the corresponding allyl intermediates 63a and 63b from quasienantiomers 64a 
and 64b (Scheme 20). Again, we decided to use leaving groups that are usually applied as 
nucleophiles in the forward reaction.  
 
Scheme 24. Back reaction screening of the nucleophilic addition step in allylic substitutions yielding 
products 64a and 64b.  
A range of allylation products derived from dimethyl malonate, acetyl acetone and 
phthalimide were screened to find a nucleophile with sufficient reactivity as a leaving group 
(Scheme 25). Allyl-palladium complexes generated by elimination of these nucleophiles were 
successfully detected by ESI-MS for the corresponding linear substrates (Chapter 2.1). The 
analysis of a Meldrum’s acid-based substrate was initially discarded as synthesis proved 
difficult.  
Racemic products 79a-81a were obtained by palladium-catalysed allylic substitutions as 
shown in Scheme 25.  
Nu
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Scheme 25. Preparation of substrates 79a-81a by palladium-catalysed allylic substitutions.  
Alkylation of 65a using sodium dimethyl malonate, tetrakis(triphenylphosphine)palladium 
and an excess of triphenylphosphine in refluxing tetrahydrofuran afforded product 79a in 
quantitative yield.[105] The reaction proceeds with complete retention of configuration, 
whereas the corresponding transformation with acetyl acetone gives the product 80a as a 
cis/trans mixture in a ratio of 73:27. Benzoate 65a smoothly reacted with potassium 
phthalimide to produce the cis-diastereomer of 81a exclusively. 
No allyl-palladium complex 63a was detected employing substrates 79a-81a with several 
structurally different ligands under the standard conditions (Scheme 24). Variation of the 
reaction solvent, such as toluene, tetrahydrofuran, dichloromethane and dimethylformamide 
gave no observable back reaction. Increasing the reaction temperature had also no positive 
influence on the outcome of the screening.  
Preparative back reactions were carried out to confirm that no product formation occurs in 
this reaction. Phthalimide derived substrate 81a was treated with the sodium salt of dimethyl 
malonate in the presence of tetrakis(triphenylphosphine)palladium and an excess of 
triphenylphosphine in tetrahydrofuran (Scheme 26). The reaction mixture was analysed by 
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ESI-MS and no signals were detected. After two days either at room temperature or reflux no 
conversion was observed and aqueous workup gave a quantitative recovery of the starting 
material.  
 
Scheme 26. Preparative back reactions using racemic substrates 81a and 80a.  
The transformation was carried out under microwave conditions in tetrahydrofuran or 
acetonitril and no product formation observed in either case. The preparative back reaction of 
80a was also investigated using the same conditions described above (Scheme 26). After two 
days at either room temparature or reflux no conversion of the starting material was found and 
no allyl-palladium complex 63a detected by ESI-MS analysis over the course of the reaction. 
Interestingly the mass spectrum did show a single signal at m/z = 867 corresponding to the 
complex 82 (Figure 14).  
Figure 14. Detection of complex 82 by deprotonation of substrate 80a.  
This result suggests that substrate 80a is deprotonated under the described reaction conditions 
and afterwards acts as a ligand for palladium. The anionic acetyl acetone moiety can not serve 
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as a leaving group any longer. Furthermore, the catalytically active palladium is consumed 
and thus no back reaction is possible. Identical results were obtained, when the reaction 
mixture was heated under microwave irradiation using tetrahydrofuran or acetonitril as 
solvent. 
In order to prevent this undesired side reaction, substrate 83a, derived from 3-methyl-2,4-
pentanedione, was synthesised (Scheme 27). Under similar conditions as described earlier the 
product was obtained quantitatively as single cis-diastereomer. 
 
Scheme 27. Preparation of 83a by palladium-catalysed allylic substitution.  
The corresponding back reaction was investigated by mass spectrometry according to Scheme 
24, using various reaction conditions and structurally different ligands, but no allyl-palladium 
intermediate 63a was detected. A typical mass spectrum obtained when using phox ligand 40 
is shown in Figure 15. 
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Figure 15. Mass spectrum observed for the back reaction of substrate 83a using phox ligand 40.  
The dinuclear palladium complex 84 was observed as the main species. Presumably, this 
indicates a low reactivity of substrate 83a and as a consequence the activated palladium(0) 
species reacts with the precatalyst to form 84.[53]  
Furthermore, all mass spectra showed significant signals at m/z = Pd+L+113 corresponding to 
complexes of the type 85. These intermediates most likely result from a base-catalysed 
elimination of methyl acetyl acetonate. 
For the sake of completeness preparative back reactions of substrate 83a were analysed in 
analogy to Scheme 26 using various reaction conditions, but no product formation was 
observed in either case. ESI-MS analysis solely referred to the formation of complex 87, as 
depicted in Figure 16. 
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Figure 16. ESI-MS spectrum for the back reaction of substrate 83a with tetrakis(triphenylphosphine)-
palladium as catalyst.  
The introduction of more reactive leaving groups was necessary for the back reaction of 
quasienantiomers 64a and 64b to proceed. Meldrum’s acid was considered as a good leaving 
group as high reactivity was found for the corresponding diphenylallyl derivative 26 (Chapter 
2.1).  
During the synthesis of substrate 88a from benzaote 65a with the anion of Meldrum’s acid 
complex mixtures of aromatic compounds were produced, when weak bases, such as DBU, 
triethylamine and potassium acetate, were used in excess for the deprotonation. Methyl 
benzoate was formed as the main product presumably by oxidation of the diene, which is 
generated by the elimination of Meldrum’s acid. Benzoate 65a was treated with sodium 
hydride and Meldrum’s acid in presence of tetrakis(triphenylphosphine)palladium in 
tetrahydrofuran accordording to Scheme 25, but no conversion of the starting material was 
observed. However, when the reaction was carried out in dimethylformamide at 70 °C the 
desired product 88a was obtained in low yield as a mixture of the two diastereomers (Scheme 
28).  
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Scheme 28. Preparation of substrates 88a-90a by palladium-catalysed allylic substitution.   
Using these reaction conditions, substrates 89a and 90a derived from dimedone and 2-
methylcyclohexane-1,3-dione were prepared in high yields as well (Scheme 28). Thereby the 
latter was isolated as single cis-diastereomer, whereas the reaction with dimedone gave a 3:1 
mixture of diastereomers. 
In order to test their leaving group ability in the back reaction substrates 88a-90a were 
analysed by ESI-MS (Scheme 29). Meldrum´s acid-derivative 88a was treated with 2 mol% 
of the palladium catalyst and four equivalents (based on Pd) of nucleophile in toluene. The 
experiment was carried out at room temperature and analysed after 30 seconds, 5 and 15 
minutes by ESI-MS, but no allyl-palladium intermediate 63a was detectable in the mass 
spectra. 
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Scheme 29. Screening for reactivity using substrates 88a-90a.  
Therefore the reaction was repeated at 50 °C under otherwise identical conditions. After four 
minutes the mass spectrum was dominated by an intense signal of the catalyst precurser 91 
(Figure 17, A). Along with a significant amount of dinuclear palladium complex 84, a small 
quantity of allyl complex 92 was detected. During the course of the transformation the relative 
abundance of the dinuclear complex 84 increased considerably and the signal of intermediate 
92 remained near constant. This indicates a low reactivity of substrate 88a for this reaction in 
general (Figure 17, B). 
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Figure 17. Back reaction screening of substrate 88a at 50 °C using phox ligand 42. Mass spectra 
recorded after 4 min (A) and 50 min (B).  
When substrate 89a was subjected to ESI-MS analysis no allyl-palladium intermediate 92 was 
detected using a large set of conditions and ligands. 
The back reaction screening of compound 90a, derived from 2-methylcyclohexane-1,3-dione, 
was also carried out at both room temperature and 50 °C. The mass spectrum was dominated 
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by the precatalyst 91 at lower temperatures, whereas the allyl-palladium intermediate 92 was 
observed as the main signal after 30 seconds at 50 °C (Figure 18). However, a significant 
amount of the dinuclear complex 84 was also detected.  
 
Figure 18. Back reaction screening at 50 °C using substrate 90a and phox ligand 42.  
Compared to the Meldrum´s acid-based substrate 88a the methylated derivative 90a shows 
markedly higher reactivity. In the back reaction of 90a the allyl-palladium intermediate 92 
was clearly visible in the mass spectrum. Therefore a general screening method for 
cyclohexenyl carboxylates derived from 2-methylcyclohexane-1,3-dione was developed. For 
this an appropriate set of quasienantiomers was needed. The racemic ethyl ester 90b was 
prepared as a single cis-diastereomer in high yield by palladium-catalysed allylic alkylation 
(Scheme 30).  
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Scheme 30. Synthesis of ethyl-labelled substrate 90b.  
The back reaction of an equimolar mixture of racemic methyl- and ethyl-labelled substrates 
90a and 90b using phox ligand (S)-28 was then analysed (Figure 19). The corresponding 
allyl-palladium complexes 63a and 63b were clearly detectable in a perfect 1:1 ratio in the 
mass spectrum as the two main species, along with precatalyst [Pd(C3H5)L]+ and dinuclear 
complex 84. This result demonstrates that the mass labels have no influence on the ratio of 
63a and 63b and the reactivity of 62a and 62b is not affected. 
 
Figure 19. Back reaction using an equimolar mixture of racemic substrates 90a and 90b (L = (S)-28, 
Nu = [Na([15]crown-5)]CEt(CO2Et)2).  
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3.2.2 Synthesis of Quasienantiomeric Allylation Products 
To measure the intrinsic selectivity of a chiral catalyst directly by ESI-MS enantiomerically 
pure quasienantiomeric substrates 90a and 90b were needed. Palladium-catalysed asymmetric 
allylic alkylations of benzoate 65a were carried out in the presence of phosphite-oxazoline 59 
or Trost ligand 93 as these are known to induce high selectivities for carbocyclic substrates.[92-
95] 
The transformations were carried out using 2.6 equivalents of the sodium salt of 2-
methylcyclohexane-1,3-dione in presence of the 2.5 mol% of the respective palladium catalyst 
(Table 7).  
Table 7. Preparation of enantiomerically enriched quasienantiomer 90a. 
 
Entry Ligand  Additive Solvent Time [h] Yield [%] Product ee [%][a] 
1 59 − DMF 21 56 (R,R)-90a 78  
2 (S,S)-93 − DMF 39 65 (S,S)-90a 50 
3 (R,R)-93 − DMF 29 92 (R,R)-90a 50 
4 (S,S)-93 THAB CH2Cl2/DMF 24 65 (S,S)-90a 96 
5 (R,R)-93 THAB CH2Cl2/DMF 24 70 (R,R)-90a 96 
[a] HPLC analysis (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.5 mL*min−1, 30 °C, 220 nm): 
tR = 51.7 (S), 56.3 (R) min. 
(R,R)-90a was obtained with a moderate enantioselectivity of 78% when the reaction was 
accomplished with Claver-type ligand 59 in dimethylformamide (Table 7, entry 1). This 
selectivity is significantly lower compared to the established reaction between cyclohexenyl 
acetate and dimethyl malonate.[94] 
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Ligand 93 was less efficient when similar conditions were applied and product 90a was 
isolated with an enantiomeric excess of 50%  (Table 7, entries 2 and 3). Trost and coworkers 
discovered that in some cases the selectivity can be increased by adding tetrahexylammonium 
bromide (THAB) to the reaction mixture.[97, 106] The allylic alkylations were repeated using 
2.6 equivalents of THAB in a mixture of dichloromethane and dimethylformamide (Table 7, 
entries 4 and 5) with 93. Both ligand enantiomers gave the product in good yields and very 
high enantiomeric excesses of 96%. By applying these improved reaction conditions both 
enantiomers of the ethyl-labelled substrate (R,R)- and (S,S)-90b were prepared in 96% ee 
(Scheme 31). 
 
Scheme 31. Synthesis of enantiomerically enriched quasienantiomer 90b.  
 
 
3.2.3 Mass Spectrometric Evaluation of Chiral Ligands  
With quasienantiomers (R,R)-90a and (S,S)-90b a back reaction screening was performed to 
evaluate the intrinsic selectivities of several catalysts in the palladium-catalysed allylic 
alkylation of carbocyclic substrates (Scheme 32). The complexes were prepared in situ from 
stoichiometric amounts of [Pd(C3H5)(MeCN)2]OTf and the corresponding chiral ligands in 
toluene. An equimolar mixture of (R,R)-90a and (S,S)-90b (25 equivalents based on Pd each) 
was added and the reaction initiated by activation of the precatalyst with the crown ether 
sodium salt of diethyl ethylmalonate (4 equivalents based on Pd). Satisfactory results were 
obtained only with phox ligands 42 and 28, whereas most other derivatives gave no or very 
small quantities of allyl-palladium intermediates 63a and 63b under these conditions. 
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Scheme 32. Back reaction screening to determine the efficieny of chiral catalysts for cyclohexenyl 
benzoates as substrates.  
The synthesis of substrate 88a, derived from Meldrum’s acid, showed that dimethyl-
formamide is needed to achieve conversion of benzoate 65a to the product. For this reason the 
influence of dimethylformamide in the back reaction of quasienantiomers (R,R)-90a and 
(S,S)-90b using Josiphos-type ligand 50 was studied under identical conditions. Comparison 
of these results with those obtained in toluene showed a significant increase in reactivity when 
the reaction was carried out in dimethylformamide. Allyl-palladium complexes 63a and 63b 
were detected as the main signals after five minutes (Figure 20, A), whereas the mass 
spectrum of the reaction in toluene was dominated by the precatalyst [Pd(C3H5)L]+ (Figure 20, 
B). 
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Figure 20. Back reactions of quasienantiomers (R,R)-90a and (S,S)-90b using ligand 50 in 
dimethylformamide (A) or toluene (B).  
A new set of screenings was therefore carried out in dimethylformamide (Table 8). In all 
cases where allyl-palladium intermediates 63a and 63b could be detected, the calculated 
selectivities were compared with the results obtained from HPLC analyses of the 
corresponding preparative reactions, using cyclohexenyl benzoate 77 as substrate (Scheme 
33). These transformations were conducted in dimethylformamide with 2 mol% of the 
catalysts prepared in situ from [Pd(C3H5)]Cl]2 and the respective chiral ligands. In both 
dichloromethane and toluene no conversion of substrate 77 was achieved. 
 
Scheme 33. Preparative allylic substitutions of cyclohexenyl benzoate 77 with 2-methylcyclohexane-
1,3-dione.  
With entry 5 in Table 8 being the only exepction, the enantiomeric ratios measured by ESI-
MS correlate very well with the results of the product analysis for all the other preparative 
reactions. Importantly the screening reveals the correct selectivity order and therefore allows 
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reliable identification of the most efficient ligand. It is noteworthy that although intermediates 
63a and 63b are only visible in a small amount the correlation is not affected.  
Table 8. Results of the back reaction screening using quasienantiomers (R,R)-90a and (S,S)-90b. 
Entry Ligand Screening  
63a : 63b 
Preparative Reaction[a] 
(S)-94 : (R)-94 
1 
FeCy2P
44
(SL-M002-1)
PCy2
N
N
 
               52 : 48                               48 : 52 
 
[1103][1089]
m/z t
 
 
2 
FePh2P
PCy2
Me
50
(SL-J001-1)  
               82 : 18                               18 : 82 
 
[853]
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m/z t
 
3 
oTol2P
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N
O
 
               44 : 56                               56 : 44 
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Table 8. Continued. 
Entry Ligand Screening  
63a : 63b 
Preparative Reaction[a] 
(S)-94 : (R)-94 
5 
N
N
Ph2P
56  
               42 : 58                               51 : 49 
[831]
[817]
 
m/z
 
t
 
6 
N
N
Ph2P
57  
               45 : 55                               54 : 46 
t
[791]
[777]
m/z
 
[a] HPLC analysis (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.8 mL*min−1, 20 °C, 254 nm): 
tR = 10.9 ((S)-94), 13.2 ((R)-94) min. The absolute configuration of 94 was assigned by analogy. 
Low enantioselectivities were induced with phox and phim ligands (Table 8, entries 3-6) in 
the palladium-catalysed allylic alkylation of cyclohexenyl benzoates. Josiphos-type ligand 50 
was found to be the most efficient ligand so far, giving the allyl-palladium complexes 63a and 
63b in a ratio of 82:18. Although the obtained selectivities are rather low the results clearly 
show the viability of this approach. As long as some reactivity in the back reaction is 
observed, the screening method presented can be used as an efficient tool for the development 
of new ligand systems. 
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3.3 Back Reactions of 3-(1’,3’-Diphenylallyl)-pentane-2,4-dione 
Reinvestigated 
As described in Chapter 2.2.5 no back reaction was obtained with mass-labelled 3-(1’,3’-
diarylallyl)-pentane-2,4-diones 30a and 30b in the ESI-MS analysis of several ligands. After 
discovering the deprotonation of acetyl acetone-derived cyclohexenyl ester 80a under 
screening conditions, the mass spectra recorded with linear substrates were reinterpreted. No 
allyl-palladium intermediates 39a and 39b were detected for the Walphos-type ligands and 
formation of substrate palladium complexes, produced by the deprotonation of the acetyl 
acetone moiety, were observed in these cases, too. A preparative back reaction of substrate 24 
with sodium dimethyl malonate in the presence of tetrakis(triphenylphosphine)palladium and 
triphenylphosphine in tetrahydrofuran at room temperature was conducted and analysed by 
ESI-MS. 
 
Figure 21. Substrate deprotonation followed by complex formation observed in several cases.  
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The intense signal at m/z = 921 corresponding to complex 95 represented the main species 
whereas no conversion of the starting material was observed. This demonstrates that 
deprotonation of the acetyl acetonate moiety can presumably inhibit the back reaction of 
substrates 30a and 30b, depending on the reactivity of the ligand under investigation. 
 
 
3.4 Conclusion and Outlook 
After having established a reliable protocol for the evaluation of chiral palladium catalysts in 
allylic substitutions of linear diarylallyl substrates, the methodology was extended to 
carbocyclic derivatives. 
An efficient catalyst screening for the kinetic resolution of cyclohexenyl benzoate was 
developed by mass spectrometric monitoring of cyclic allyl esters. The data was compared 
with the corresponding results from kinetic analyses of the preparative reactions and an 
excellent correlation of the respective s values was found. 
Based on the principle of microscopic reversibility a method for determining the efficiency of 
the overall allylic substitution process was developed. After the extensive analysis of several 
substrates for reactivity in the back reaction, allylation products derived from 2-
methylcyclohexane-1,3-dione were identified as optimum quasienantiomers and a screening 
protocol was optimised. Although the applicability of this method is somewhat limited, the 
enantiomeric ratios determined by ESI-MS correlate very well with the results observed from 
the product analysis of the corresponding preparative reactions. 
  
 
 
 
CHAPTER 4  
DEVELOPMENT OF NEW CHIRAL LIGANDS USING ESI-MS AS 
ANALYTICAL TOOL 
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4 Development of New Chiral Ligands using ESI-MS as 
Analytical Tool 
After having established a fast and reliable protocol for the evaluation of chiral palladium 
catalysts for the allylic substitution of both linear diarylallyl and carbocyclic substrates, the 
screening method was used for the development of new ligand systems.  
 
 
4.1 Chiral Bis(N-sulfonylamino)phosphine-Oxazoline and Pyridyl-
Phosphite Ligands 
Within the scope of Franke’s master thesis new ligands were prepared and evaluated by ESI-
MS and conventional catalytic reactions.[107] 
As the phosphite-oxazolines 96 proved to be highly efficient in palladium-catalysed allylic 
substitutions of unhindered linear and cyclic substrates, their structural motive was used as a 
starting point for the development of new derivatives as shown in Figure 22.[94]  
 
Figure 22. Approach for new ligand structures.  
Previous work by Hilgraf and Kaiser demonstrated that ligands of the types 97 and 98 can 
induce high enantioselectivity in palladium-catalysed allylic alkylations and iridium-catalysed 
asymmetric hydrogenations, respectively.[108, 109] Therefore either the phosphite unit of 96 was 
replaced by sulfonyl-diazaphospholidines (Figure 22, A) or the oxazoline was substituted by a 
chiral pyridyl alcohol (Figure 22, B).  
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4.1.1 Ligand Synthesis 
For the preparation of chiral bis(N-sulfonylamino)phosphine-oxazoline ligands the respective 
phenolic precursors 99-101 were synthesised in high yields from 2-hydroxybenzonitrile 102 
and aminoalcohols 103-105 in the presence of catalytic amounts of zinc(II) chloride (Scheme 
34).[110]  
 
Scheme 34. Oxazoline synthesis.  
Sulfonyldiamines 106 and 107 were obtained under mild conditions as shown in Scheme 35. 
 
Scheme 35. Preparation of chiral sulfonyldiamines.  
Treatment of 108 or 109 with phosphorus trichloride in toluene at −78 °C gave the 
corresponding P-chlorodiazaphospholidines 110 and 111 as pale yellow solids (Scheme 36). 
These moisture- and air-sensitive intermediates were directly converted to the desired ligands 
112-118 by reaction with the respective oxazolines 99-101 and triethylamine. In contrast to 
similar derivatives reported in previous work, 112-118 are stable on deactivated silica gel and 
were obtained in good yields after column chromatography under argon.[108] 
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Scheme 36. Synthesis of bis(N-sulfonylamino)phosphine-oxazolines.  
Along with bis(N-sulfonylamino)phosphine-oxazolines 112-118 new pyridyl-phosphites were 
prepared. Oxidative coupling of 2,4-di-tert-butylphenol 119 in the presence of catalytic 
amounts of copper(II) chloride and N,N,N’,N’-tetramethylethylenediamine gave diol 120 
(Scheme 37).[111]  
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Scheme 37. Oxidative coupling of 2,4-di-tert-butylphenol.  
The ligands were prepared in similar manner to derivatives 112-118. Phosphorochloridite 121 
was synthesised from diol 120 and phosphorus trichloride in the presence of triethylamine.[111] 
This intermediate was directly reacted with the respective pyridyl alcohols 122 or 123 to give 
ligands 124 and 125 in very high yields after column chromatography on deactivated silica 
gel under argon.  
 
Scheme 38. Preparation of pyridyl-phosphite ligands.  
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4.1.2 ESI-MS Screening  
In order to evaluate the efficiency of ligands 112-118, 124 and 125 in palladium-catalysed 
allylic substitution reactions an ESI-MS analysis was carried out, in similar manner, as 
described in the two previous chapters. Allylic alkylations and aminations of diarylallyl 
substrates with acetyl acetone and phthalimide were investigated by studying the 
corresponding back reactions (Schemes 11 and 17, Chapter 2). However, no allyl-palladium 
complexes 39a and 39b were detected in the mass spectra using several conditions and it was 
not possible to initiate the back reaction. 
As previously described quasienantiomeric allyl benzoates and phenolates proved to be much 
more reactive and the corresponding allyl-palladium complexes therefore easier to detect, a 
screening with these substrates was carried out.[104] The kinetic resolution of mass-labelled 
benzoates (R)-19a and (S)-19b was investigated first (Scheme 39). 
 
Scheme 39. ESI-MS screening of palladium catalysts for the kinetic resolution of (R)-19a and (S)-19b.  
Even in this reaction the respective allyl-palladium complexes 20a and 20b were not observed 
for all ligands. The results for the more efficient derivatives are shown in Figure 23. 
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Figure 23. Screening results for the kinetic resolution according to Scheme 39.  
Bis(N-sulfonylamino)phosphine-oxazoline 112 proved to be the most efficient ligand. The 
intermediates 20a and 20b were observed in a ratio of 91:9, corresponding to a s factor of 
10.1, whereas only moderate selectivities were observed with the cyclohexyl derivatives 116 
and 118. These results compare favourably with those obtained with analogous ligands in 
earlier studies of this kinetic resolution.[104, 108] In case of derivatives 124 and 125, the 
compound with the six-membered ring was slightly better.  
Since palladium-catalysed allylic alkylations of unsymmetrical monosubstituted substrates are 
of particular interest, the ESI-MS analysis of such a reaction was performed.[104] 
As shown in Scheme 40 both quasienantiomeric benzoates (R)-126a/(S)-126b and phenolates 
(R)-127a/(S)-127b were tested. By analysing the former substrates the selectivity of the 
kinetic resolution can be estimated. The latter serve as model compounds for the allylic 
substitution with phenolate as nucleophile, since the process monitored by ESI-MS 
corresponds to the back reaction. 
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Scheme 40. Catalyst screening using mass-labelled arylallyl benzoates (R)-126a/(S)-126b or 
phenolates (R)-127a/(S)-127b.  
The results for this kinetic resolution are shown in Figure 24. Allyl-palladium complexes 
128a and 128b were only formed with the oxazoline derivatives 112, 116, 118 which also 
showed reactivity in the screening of diarylallyl benzoates (Scheme 39), but the selectivities 
were considerably lower. The selectivity order was reversed though and the cyclohexyl 
derivative 118 proved to be the best ligand. The selectivities for ligands 124 and 125 were 
also somewhat diminished, but the order remained the same.  
Markedly decreased reactivities were observed in the analysis of the back reaction of 
quasienantiomeric phenolates (R)-127a and (S)-127b as shown in Figure 25. Along with the 
pyridine derivatives 124 and 125, intermediates were only detected for 112 with rather low 
selectivities measured in all three cases. 
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Figure 24. Screening results for the kinetic resolution depicted in Scheme 40.  
 
Figure 25. Results of the back reaction screening depicted in Scheme 40.  
Finally, ligands 112-117, 124 and 125 were applied in the kinetic resolution of cyclic allyl 
esters 65a and 65b according to Scheme 22 (Chapter 3.1.3). As it is evident from Figure 26, 
no significant selectivities were induced with 115, 118 and 124. 
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Figure 26. Screening results for the kinetic resolution according to Scheme 22 (Chapter 3.1.3).  
In the following, both new ligand classes were evaluated in conventional catalytic reactions, 
as the ESI-MS screening did not provide sufficient data for estimating the efficiency of all 
derivatives.  
 
 
4.1.3 Preparative Allylic Alkylations 
All ligands were tested in three conventional preparative transformations. The substitutions 
were carried out using dimethyl malonate as the nucleophile, 2 mol% of the catalyst, prepared 
in situ from [Pd(C3H5)Cl]2 and the respective chiral ligand, N,O-bis(trimethylsilyl)acetamide 
and potassium acetate in dichloromethane at room temperature. 
With (E)-1,3-diphenyl-2-propenyl acetate (129) only moderate enantioselectivities were 
achieved (Table 9), which are worse than those obtained with Claver-type ligands 96.[94] The 
results of bis(N-sulfonylamino)phosphine-oxazolines 112-118 (entries 1-7) are similar to the 
corresponding data of previously described ligands derived from 2-[2’-(hydroxy)-prop-2’-yl]-
oxazolines.[108] Except for 115, the derivatives 112-114 with diphenyldiamine subunit (entries 
1-3) are more efficient than the ligands with an analogous dicyclohexanediamine moiety 116-
118 (entries 5-7). Catalysts prepared from 113 and 114 bearing a tert-butyl group on the 
oxazoline are the most selective (entries 2 and 3). In contrast to earlier studies, the 
diastereoisomer 114 derived from the (S,S)-diamine and the (S)-oxazoline is superior to the 
corresponding ligand 113 based on the (R,R)-diamine. Pyridyl-phosphites 124 and 125 
(entries 7 and 8) show only low selectivity in this transformation giving enantiomeric 
excesses of less than 50%. 
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Table 9. Enantioselective allylic alkylation of (E)-1,3-diphenyl-2-propen-1-yl acetate (129). 
 
Entry Ligand Time [h] Yield [%][a] ee [%][b] 
1 112 19 100 62 (S) 
2 113 24 100 83 (S) 
3 114 18 100 90 (R) 
4 115 18 100 17 (S) 
5 116 16 80 26 (S) 
6 117 24 100 50 (S) 
7 118 14 70 48 (S) 
8 124 20 100 47 (S) 
9 125 22 100 50 (S) 
[a] Isolated yields after column chromatography; [b] determined by chiral HPLC analysis (Daicel 
Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 220 nm): tR = 26.2 (R), 37.2 (S) min. 
Using (E)-3-phenyl-2-propen-1-yl acetate (130) as an unsymmetrical substrate, the new 
derivatives gave unsatisfactory results in comparison with previous work (Table 10).[94, 108] 
Formation of large amounts of the achiral linear substitution product 132 was observed with 
113 being the only exception (entry 2). Ligands with diphenyldiamine backbone (entries 1, 2, 
and 4) are more efficient than the analogous derivatives with dicyclohexanediamine moiety 
(entries 5-7). The best result was obtained with a tert-butyl substituent on the oxazoline, but 
in this case ligand 113 derived from the (R,R)-diamine and the (S)-oxazoline shows the 
matched configuration (entry 2). A branched to linear ratio of 73:27 was observed and 131 
isolated with 84% ee (S) whereas the diastereoisomer 114 based on the (S,S)-diamine only 
gave a low regioselectivity with 6% ee (R) (entry 3). Although 131 was obtained with 80% ee 
(S) using 124, this derivative gave the linear isomer 132 as the major product (entry 8). 
Compound 125 bearing a more flexible six-membered ring is not efficient in terms of enantio- 
and regioselectivity (entry 9). 
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Table 10. Asymmetric allylic alkylation of (E)-3-phenyl-2-propen-1-yl acetate (130). 
 
Entry Ligand Yield [%][a] ee [%][b] br/l[c] 
1 112 100 40 (S) 48 : 52 
2 113 100 84 (S) 73 : 27 
3 114 17 6 (R) 57 : 43 
4 115 100 80 (S) 37 : 63 
5 116 79 28 (S) 31 : 69 
6 117 99 72 (S) 56 : 44 
7 118 90 19 (S) 5 : 95 
8 124 100 80 (S) 11 : 88 
9 125 100 6 (S) 6 : 94 
[a] Isolated yields after column chromatography; [b] determined by chiral HPLC analysis (Daicel 
Chiracel OJ, heptane/ethanol 97:3, 0.5 mL*min−1, 20 °C, 210 nm): tR = 43.7 (S), 50.9 (R) min; [c] 
determined by GC (Restek Rtx-1701, 50/0/10/250/10): tR = 16.9 (br), 19.8 (l) min. 
Finally, the allylic alkylation of the more demanding cyclohex-2-enyl acetate 60 was 
investigated (Table 11). No product formation was observed with bis(N-sulfonylamino)-
phosphine-oxazolines 112-118. Ligands 124 and 125 catalysed the reaction in rather low 
selectivity. Derivative 124 was found to be more efficient yielding allylation product 78 in 
42% ee (R) (entry 1). 
Table 11. Enantioselective allylic alkylation of cyclohex-2-enyl acetate (60). 
 
Entry Ligand Yield [%][a] ee [%][b] 
1 124 76 42 
2 125 59 29 
[a] Isolated yields after column chromatography; [b] determined by chiral GC analysis (γ-CD, G-TA, 
95/0/0.1/120/0/15/180): tR(R) = 67.7 min, tR(S) = 69.0 min. 
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4.2 Cyclohexyl-Based Phosphite-Oxazoline Ligands 
Apart from the variations of Claver-type ligand 96, described in the preceding chapter, the 
influence of additional chirality elements in the backbone was also investigated. In order to 
keep rigidity of the original ligand 96 at the same time, the bridging aryl subunit was 
substituted by an aliphatic ring structure. As a first example ligand 133 with a cis-
disubstituted cyclohexane ring was prepared for the application in palladium-catalysed allylic 
alkylations (Figure 27). 
 
Figure 27. Development of new phosphite-oxazolines with aliphatic backbones.  
 
 
4.2.1 Ligand Synthesis 
Ligand 133 was prepared in seven steps from ethyl-2-oxocyclohexanecarboxylate (134) as 
shown in Scheme 41. Reduction of 134 with baker’s yeast yielded the enantioenriched 
secondary alcohol 135 in good yield.[112] After saponification of the ester the resulting 
carboxylic acid 136 was treated with tert-butyldimethylsilyl chloride to selectively protect the 
alcohol.[113] The following condensation of carboxylic acid 137 with tert-leucinol was carried 
out using established amide coupling conditions.[114] After cyclisation to the oxazoline, 139 
was deprotected with tetrabutylammonium fluoride without purification to yield oxazoline 
140.[115]  
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Scheme 41. Synthesis of phosphite-oxazoline 133.  
The phosphorylation was accomplished in analogy to the synthesis of derivatives 124 and 125 
with phosphorochloridite 121, which was prepared in situ from diol 120 and phosphorus 
trichloride.[111] Ligand 133 was isolated in moderate yield after column chromatography under 
argon. No conversion of the starting material was observed without the addition of 4-
(dimethylamino)pyridine. 
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4.2.2 Ligand Screening and Catalytic Reactions 
In order to evaluate the efficiency of ligand 133 in the palladium-catalysed allylic 
substitutions, it was subjected to ESI-MS analysis. Allylic alkylations and aminations of 
diarylallyl substrates were investigated by the analysis of the corresponding back reactions 
(Schemes 11 and 17, Chapter 2). The kinetic resolution of cyclic allyl esters was also studied 
(Scheme 22, Chapter 3). However, apart from the precatalyst [Pd(C3H5)L]+ no allyl-palladium 
complexes were observed in the corresponding mass spectra using a range of conditions. The 
ligand was therefore used in the conventional preparative allylic alkylations of both (E)-1,3-
diphenyl-2-propenyl benzoate (21) and cyclohex-2-enyl benzoate (77) (Scheme 42). The 
products 23 and 78 were isolated with promising enantiomeric excesses of 89% (S) and 
38% ee (R), respectively.  
 
Scheme 42. Preparative allylic alkylations using phosphite-oxazoline 133.  
 
 
4.3 Conclusions and Outlook 
In the course of Franke’s master thesis new bis(N-sulfonylamino)phosphine-oxazolines and 
pyridyl-phosphites were prepared and evaluated by ESI-MS and conventional catalytic 
reactions. It was observed, that these ligands exhibit a poor tendency to form allyl-palladium 
intermediates and therefore their analysis using ESI-MS was hampered. No back reactions 
were observed using quasienantiomeric substrates derived from acetyl acetone or phthalimide 
and a comparison with the corresponding preparative allylic alkylations and aminations was 
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not possible. By using more reactive mass-labelled benzoates and phenolates the formation of 
reaction intermediates was detected, but the selectivities were only moderate. 
All new ligands were further tested in conventional allylic alkylations with the main focus on 
unhindered linear and cyclic substrates. Low to moderate selectivities were obtained and the 
results can not compete with the values of previously developed derivatives.  
Finally a new phosphite-oxazoline with a chiral cyclohexyl backbone was synthesised. As 
first catalytic results are promising for this ligand the preparation of other diastereomeric 
derivatives, in particular with a trans-stereochemistry in the bridging ring, and compounds 
with different ring sizes in the backbone could be of interest to study the influence of the 
ligand geometry on its selectivity. 
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5 Screening of Racemic Catalysts  
5.1 Introduction 
In 2001, Lloyd-Jones introduced a method for estimating the efficiency of a chiral catalyst in 
a kinetic resolution by testing the racemic form of the ligand.[83] Qualitative information 
regarding the selectivity factor s can be obtained by employing a scalemic substrate (0 < ee < 
100) and monitoring the change in enantiomeric excess with conversion. In this fashion, 
racemic ligands 141 and 93 were screened in the palladium-catalysed substitution of 60 
(60% ee) with sodium dimethylmalonate (Scheme 43). 
 
Scheme 43. Evaluation of racemic catalysts in the kinetic resolution of cyclohex-2-enyl acetate (60).  
Several curves for the change in ee with conversion were calculated and then compared with 
the experimental data (Figure 28). The results clearly show that ligand 141 is more selective 
in this reaction than 93. 
Figure 28. Predicted enantiomeric excess of 60 for several s values as a function of conversion with 
eeinit = 60% (left) and experimental data (right).[83]  
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The ability to test for selectivity using racemic ligands is very useful, as no enantioselective 
ligand synthesis or resolution processes are required. In order to increase the scope of the 
back reaction screening, this methodology was adopted for mass spectrometric evaluation of 
chiral ligands. It was previously demonstrated that the selectivity of racemic catalysts in the 
kinetic resolution of allyl esters can be determined in this way using a scalemic mixture of 
quasienantiomers.[104] The two borderline cases are depicted in Scheme 44. 
 
Scheme 44. Concept for screening racemic ligands with ESI-MS.  
For an achiral or completely unselective chiral catalyst the relative rates of consumption of 
quasienantiomers are only dependent on the relative concentrations of the latter. Thus a 25:75 
ratio of allyl intermediates 39a and 39b is detected by ESI-MS. If the catalyst is perfectly 
selective, each enantiomer of the catalyst reacts exclusively with the corresponding substrate 
enantiomer and, consequently, the palladium complexes 39a and 39b are observed in 
equimolar amounts of 50:50. Since the majority of ligands exhibits properties in between, the 
ratio of intermediates 39a/39b is correlated with the selectivity factor s by Equation 3. This 
allows for the simple evaluation of the respective catalysts.[104] 
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5.2 Phox Ligands with Stereogenic Phosphorus 
Since the influence of stereogenic phosphorus atoms in phosphinooxazolines (Figure 29) has 
not intensely been investigated in allylic substitution reactions so far,[116-118] the method 
developed by Lloyd-Jones seemed promising to evaluate the selectivity of these ligands.  
 
Figure 29. Phox ligand with a stereogenic phosphorus atom.  
The synthesis of enantiomerically pure derivatives 143 with chiral phosphorus donors and 
achiral oxazoline moieties is not straightforward, but their racemates are easily accessible. 
Hence, the evaluation of the racemic catalysts by ESI-MS would be advantageous. 
 
 
5.2.1 Synthesis of Dialkyl- and Alkylaryl-Substituted Phosphinooxazolines 
The synthesis of phox ligands derived from dialkyl- or alkylarylchlorophosphines was 
pursued first.  
 
Scheme 45. Synthesis of chlorophosphines 144 and 145.  
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For this purpose, chlorophosphines 144 and 145 were synthesised in three steps starting from 
commercially available dichlorophenylphosphine 146 (Scheme 45).[119] Since clean 
monoalkylations of 146 are not possible, diethylamine was used as a surrogate for one of the 
chlorides and the obtained aminochlorophosphine 147 was reacted with the respective 
Grignard reagents. Treatment with anhydrous hydrogen chloride gave chlorophosphines 144 
and 145 in moderate yields after distillation. Because of its increased steric bulk, the tert-
butyl-chloro-isopropylphosphine 150 could be prepared directly from 151 and 
isopropylmagnesium chloride in good yield (Scheme 46).[117] 
 
Scheme 46. Preparation of tert-butyl-chloro-isopropylphosphine 150.  
Oxazolines 152 and 153 were obtained in high overall yields starting from amino alcohols 
154 and 155, by benzoylation and subsequent ring closure with tosyl chloride.[115, 120] 
 
Scheme 47. Synthesis of oxazolines 152 and 153.  
Racemic phox derivatives with stereogenic phosphorus atoms were prepared by 
ortholithiation of phenyl-substituted oxazolines 152 or 153 and subsequent reaction with 
chiral chlorophosphines 144, 145 or 150 (Table 12).[117] Sulfur was used to protect the air-
sensitive phosphine moiety.[117, 121] Racemic phosphine sulfides 158a-163a were isolated in 
20-90% yield after column chromatography.  
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Table 12. Synthesis of phosphinooxazolines with stereogenic phosphorus atoms. 
 
Entry R1 R2 R3 Phosphine 
Sulfide 
Yield [%] Free Ligand Yield [%] 
1 H Ph Me 158a 67 158 21 
2 H Ph iPr 159a 79 159 44 
3 H tBu iPr 160a 89 160 43 
4 Me Ph Me 161a 64 161 37 
5 Me Ph iPr 162a 31 162 33 
6 Me tBu iPr 163a 64 163 51 
 
The protecting groups were removed with hexachlorodisilane in benzene in order to avoid the 
racemisation of the stereogenic phosphorus atoms.[122, 123] Moderate yields were obtained and 
in some cases the procedure had to be repeated to achieve full conversions. The structures of 
all new derivatives are depicted in Figure 30. 
 
Figure 30. New phosphinooxazolines with stereogenic phosphorus atoms.  
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Due to the difficult removal of sulfur, borane was tested as alternative protecting group as 
well (Scheme 48).[124]  
 
Scheme 48. Synthesis of phosphinooxazolines using the borane protecting group.  
However, when the reaction was carried out with two equivalents of borane, partial protection 
of the nitrogen atom was observed. This took place even when substoichiometric amounts of 
protecting agent were used. The protected ligands 164 and 165 were obtained in high purity 
after column chromatography and the borane moiety was easily removed by treatment with an 
excess of diethylamine. However, separation of the enantiomers of the borane-protected 
ligands 164 and 165 by semipreparative HPLC was not possible, since the ligands partially 
decomposed. Therefore, the borane protection method was discarded. 
Portions of the racemic phosphine sulfides 158a-163a were separated into their enantiomers 
by semipreparative HPLC on a chiral column without difficulty. Single crystals suitable for 
X-ray analysis were obtained for the ligands 159a, 160a, and 162a (Figure 31) and the 
resulting crystal structure data enabled the assignment of configurations at phosphorus.  
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Figure 31. Crystal structures of the phosphine sulfides 159a, 160a and 162a.  
The sulfides were deprotected with hexachlorodisilane, as described above. This method is 
known to proceed with retention of configuration at phosphorus.[122, 123] 
During synthesis, it became clear that phox ligands possessing one or two alkyl-groups on the 
phosphorus donors are less stable than their aryl-substituted counterparts. Decomposition was 
observed, even when these derivatives were stored in an air- and moisture-free environment. 
Similar observations have previously been reported.[117]  
 
(S)-(−)-160a (R)-(+)-160a
(S)-(+)-162a
(R)-(+)-159a (S)-(−)-159a
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5.2.2 Ligand Screening  
After having prepared racemic ligands 158-163 a back reaction screening was carried out 
under the conditions described in Chapter 2, but a scalemic mixture of quasienantiomers (R)-
30a and (S)-30b was used (Scheme 49). The precatalysts were prepared in situ from 
[Pd(C3H5)(MeCN)2]OTf and the respective racemic ligands. In contrast to the established 
phosphinooxazolines 27, 28 and 40-42 only moderate precomplexation was achieved, as 
indicated by low signal intensities in the mass spectra. This might be attributed either to 
impurities from the reduction of the sulfides to the free ligands or to subsequent partial 
decomposition of the latter.  
 
Scheme 49. Back reaction screening of racemic ligands.  
After activation of the precatalysts with the crown ether sodium salt of diethyl ethylmalonate, 
allyl intermediates 39a and 39b were solely generated with the catalyst derived from ligand 
162 (Figure 32). The respective complexes 166a and 166b were detected in low intensity with 
a ratio of 25:75, indicating no selectivity of the catalyst at all.  
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Figure 32. Evaluation of phox ligand 162 in the back reaction according to Scheme 49.  
For comparison, the corresponding preparative reaction using the enantiomerically pure 
ligand 162 was carried out (Scheme 14, Chapter 2) and racemic product was isolated − a 
result consistent with the ESI-MS analysis. Similar results were obtained in the back reaction 
screening using phthalimide-based quasienantiomers (R)-58a and (S)-58b. 
Racemic ligands 158-163 were also studied in the kinetic resolution of quasienantiomeric 
allyl esters using a mixture of 19a and 19b in a ratio of 75:25 (Scheme 50). Although these 
more reactive substrates were employed, the palladium complexes 20a and 20b were detected 
only when the ligands 161-163 derived from dimethyl-substituted oxazoline 153 were used. 
As evident from Figure 33, the signal intensities were poor and the mass spectra of generally 
low quality, a result which confirms the decreased ability of these ligands to form allyl 
intermediates 20a and 20b. The latter were observed in a ratio of about 75:25 with the 
phosphines 161 and 162, again indicating that no resolution is taking place. Ligand 163 
proved to be more efficient, but an exact determination of the s value was complicated by 
signal overlap.  
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Scheme 50. Screening of racemic ligands in the kinetic resolution of (S)-19a and (R)-19b.  
 
Figure 33. Evaluation of phox derivatives 161-163 in the kinetic resolution depicted in Scheme 50.  
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Since the ESI-MS screening did not provide sufficient data to estimate the efficiency of all 
derivatives, conventional allylic alkylations of (E)-1,3-diphenyl-2-propenyl benzoate (21) 
with dimethyl malonate were conducted with the enantiomerically pure ligands (Table 13). 
The allylation product 23 was obtained in high yields with moderate to low enantiomeric 
excesses, except for phosphines 158 and 161 (entries 1 and 4), which showed no selectivity. 
Methyl substitution on the oxazoline moiety was found to give superior results and 163 was 
identified as the most selective derivative in this series with 66% ee (S) (entry 6). Overall, the 
data demonstrate that stereogenic phosphorus atoms have a significant influence on 
selectivity, but the new phox derivatives are not competitive with their already established 
counterparts.  
Table 13. Allylic alkylation of 21 with phox ligands 159-163. 
 
Entry Ligand Time [h] Yield [%] ee [%][a] 
1 (+)-158 17 86 rac 
2 (+)-(R)-159 19 80 24 (R) 
3 (+)-(R)-160 16 79 15 (S) 
4 (+)-161 63 100 6 (R) 
5 (+)-(S)-162 18 84 46 (S) 
6 (+)-163 41 100 66 (S) 
[a] determined by chiral HPLC analysis (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 
0.9 mL*min−1, 20 °C, 220 nm): tR = 26.2 (R), 37.2 (S) min. 
 
21
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∗
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5.2.3 Diaryl-Substituted Phosphinooxazolines 
The investigations described above demonstrate that phox ligands with dialkyl-substitution at 
the phosphorus donor generally exhibit poor ability to form allyl-palladium intermediates 39a 
and 39b. In contrast, excellent results in allylic alkylations and aminations were obtained with 
diaryl-phosphines 27, 28 and 40-42 (Chapter 2). Prompted by these findings, a series of phox 
ligands derived from chiral diarylphosphines was synthesised with the intent of improving 
efficiencies in the back reaction screening. 
For this purpose, chiral phosphines were prepared according to Scheme 51. The synthesis of 
phosphine 167 involved the reaction of diethylamino derivative 147 with one equivalent of 
Grignard reagent.[116] As described in Section 5.2.1, the diethylamino group was used to avoid 
product mixtures. Intermediate 168 was treated with anhydrous hydrogen chloride to give the 
desired product 167 in good yield. Similar procedures were employed to obtain the ortho-
anisyl-, 2-biphenyl- and 1-naphthylphenyl-derivatives 169, 170, and 171. Phosphines 170 and 
171 were isolated as mixtures of the corresponding chlorides and bromides, both of which are 
suitable electrophiles for ligand syntheses.  
Furyl-substituted phosphine 172 was prepared from furan by ortholithiation and subsequent 
reaction with 0.8 equivalents of dichlorophenylphosphine. The product was obtained in good 
yield, but was contaminated by 10% of di(2-furanyl)phenylphosphine.[125]  
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Scheme 51. Synthesis of diaryl-chlorophosphines.  
A phenyl-substituted oxazoline 176 was prepared from commercially available amino acid 
177 in three steps (Scheme 52). The product was obtained in good overall yield after 
reduction of the acid followed by benzoylation and ring closure with tosyl chloride.[115, 126] 
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Scheme 52. Preparation of oxazoline 176.  
The ligand syntheses were accomplished using ortholithiation of the achiral oxazolines 152, 
153 and 176 with sec-butyllithium and subsequent addition of the chiral chlorophosphines. 
Compounds 180-190 were isolated in variable yields ranging from 14% to 71% after column 
chromatography under argon (Table 14).  
Table 14. Synthesis of diarylphosphinooxazolines with stereogenic phosphorus atoms. 
 
Entry R1 R2 Ligand Yield [%] 
1 H oTol 180 25 
2 H oAn 181 62 
3 H 2-Bp 182 43 
4 H 1-Np 183 71 
5 H 1-Fu 184 42 
6 Me oTol 185 40 
7 Me oAn 186 28 
8 Me 2-Bp 187 37 
9 Me 1-Np 188 70 
10 Me 1-Fu 189 22 
11 Ph 2-Bp 190 14 
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In contrast to the alkylphosphine-based derivatives 158a-163a, sulfur protection was not 
necessary due to increased ligand stability.  
After their successful preparation, ligands 180-190 were evaluated by ESI-MS and the results 
are shown in Table 15. 
Table 15. Mass spectrometric evaluation of racemic phox ligands 180-190. 
Entry Ligand Back Reaction[a]  Kinetic Resolution[b] 
1 
N
O
P
180  
75 : 25 
[700]
[672]
m/z
 
25 : 75 
[672]
[658] 
m/z
 
2 
N
O
P
181
MeO
 
75 : 25 
[688] 
[716] 
m/z
 
28 : 72 
[688]
[674]
m/z
 
3 
N
O
P
182  
− 
30 : 70 
[734]
[720]
m/z
 
4 
N
O
P
183  
76 : 24 
[736]
[708]
 
m/z
 
25 : 75 
[694]
[708]
m/z
 
5 
N
O
P
184
O
 
− − 
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Table 15. Continued. 
Entry Ligand Back Reaction[a]   Kinetic Resolution[b] 
6 
N
O
P
185  
− − 
7 
N
O
P
186
MeO
 
75 : 25 
[744]
[716]
m/z
 
25 : 75  
[716]
[702]
m/z
 
8 
N
O
P
187  
75 : 25 
[790]
[762]
m/z
 
25 : 75 
[748]
[762]
m/z
 
9 
N
O
P
188  
− − 
10 
N
O
P
189
O
 
− 
28 : 72 
[676]
[662]
m/z
 
11 
N
O
P
190
Ph
Ph
 
− 
25 : 75 
[886]
[872]
m/z
 
[a] according to Scheme 49; [b] according to Scheme 50. 
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Both the back allylic alkylation (Scheme 49) and the kinetic resolution (Scheme 50), using 
scalemic mixtures of quasienantiomers in ratios of 75:25, were investigated. The ligands with 
diaryl-substituted phosphorus atoms showed increased reactivity relative to the analogous 
alkyl derivatives. In the kinetic resolution of allylic benzoates 19a and 19b, the desired allyl 
intermediates 20a and 20b were observed in all cases, except for ligands 184, 185, and 188 
(entries 5, 6, and 9). However, no or only weak asymmetric induction was observed in this 
reaction and intermediate ratios between 25:75 and 30:70 were obtained.  
In accordance with previous results, a lower efficiency for the formation of allyl-palladium 
complexes 39a and 39b was observed, when the back reaction was analysed; no selectivities 
were obtained either. 
In summary, the presented methodology for screening racemic catalysts efficiently 
demonstrates that phox derivatives with diaryl-substituted phosphorus atoms and achiral 
oxazoline moieties are unsuitable for allylic alkylation reactions, avoiding the time-
consuming and labour-intensive preparation of enantiomerically pure ligands. 
 
 
5.3 Conclusions and Outlook 
In this chapter, the ESI-MS screening protocol was extended to determine the selectivities of 
chiral catalysts in allylic substitution reactions by testing their racemates. Based on the work 
of Lloyd-Jones, scalemic mixtures of quasienantiomers were employed.[83, 104] The method 
was applied to investigate the efficiency of phox ligands with stereogenic phosphorus atoms, 
as the synthesis of enantiomerically pure derivatives with chiral phosphorus subunits and 
achiral oxazoline moieties is not straightforward. The advantage of this approach is that 
selective catalysts can be identified by testing their easily accessible racemates. 
First, ligands derived from dialkyl- and alkylaryl-chlorophosphines were successfully 
synthesised. However, the ESI-MS analysis of both kinetic resolution and the back allylic 
alkylation revealed a poor affinity for the formation of allyl-palladium intermediates and 
ligand evaluation was therefore not possible. For this reason conventional preparative allylic 
alkylations using the separated ligand enantiomers were carried out and the chiral phosphorus 
subunit was shown to have a significant influence on the reaction. However, the derivatives 
were not competitive with the easily accessible standard phox ligands derived from chiral 
amino alcohols. 
In order to favour the back reaction racemic phox ligands derived from chiral 
diarylchorophosphines were synthesised and subjected to ESI-MS analysis. In most cases 
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increased reactivities were observed for both the kinetic resolution and the back allylic 
alkylation. Without the time-consuming preparation of enantiomerically pure derivatives the 
results rapidly demonstrated that phox ligands with diaryl-substituted phosphine donors and 
achiral oxazolines are virtually unselective in allylic substitutions. Future work might be 
dedicated to the the evaluation of these ligands in other catalytic reactions, such as the 
iridium-catalysed asymmetric hydrogenations of unfunctionalised olefins. 
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6 Iridium-Catalysed Asymmetric Allylic Substitutions 
After having established a reliable ESI-MS based screening protocol for the evaluation of 
chiral palladium catalysts in allylic substitutions of both linear diarylallyl and carbocyclic 
substrates we became interested in reactions of monosubstituted allylic derivatives 191 
(Scheme 53).[80, 81, 92] In the last years more and more research has been directed on finding 
catalysts, which favour the formation of the chiral branched product 192 with high selectivity.  
 
Scheme 53. Allylic substitutions of monosubstituted allylic substrates 191.  
Palladium systems usually give the achiral linear product with few exceptions[94, 108, 127, 128] 
but iridium complexes of electron-poor ligands became the catalysts of choice for this 
purpose.[129] Precatalysts prepared from chloro-1,5-cyclooctadiene iridium(I) dimer and 
phosphoramidites derived from 2,2’-dihydroxybinaphtalene (BINOL) and 2-arylethylamines 
are the most efficient systems for allylic aminations,[130-135] etherifications[136] and 
alkylations.[137-139] The branched products are obtained in high yields with excellent regio- and 
enantioselectivities.  
During their investigations on allylic aminations Hartwig and coworkers discovered that the 
active catalyst 194 contains a metallacycle, which ist generated in situ by reaction of chloro-
1,5-cyclooctadiene iridium(I) dimer with the phosphoramidite ligand 195 in the presence of 
an amine base (Scheme 54).[140]  
 
Scheme 54. Preparation of the activated catalyst 194.  
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The transformation proceeds via the squareplanar iridium(I) complex 196, which was found to 
be inactive on the time scale of catalytic reactions. Apart from these findings mechanistic data 
are scarce.[141, 142]  
Due to the importance of iridium-catalysed allylic substitutions this reaction was investigated 
by ESI-MS in order to develop a screening method for the evaluation of alternative chiral 
ligands. Furthermore we hoped to get a closer insight into the catalytic cycle, whose 
intermediates have not been isolated or even detected to that date. 
 
 
6.1 Mass Spectrometric Analysis 
The evaluation of chiral catalysts by ESI-MS is only applicable to reactions, which proceed 
via charged intermediates that are related to the enantioselective step. Since no mechanistic 
data on iridium-catalysed allylic substitutions was available, it was unclear if the 
transformation would fulfil this criteria. Most assumptions on the mechanism were based on 
that for palladium, for which the identity of each species has been determined and the rate-
limiting step has been identified.  
The allylic amination of carbonate 197 with aniline was analysed, applying the conditions 
described in the literature (Scheme 55), to test if allyl-iridium intermediates analogous to the 
respective palladium species can be detected by ESI-MS.[131, 140] 
 
Scheme 55. Mass spectrometric analysis of the allylic amination of carbonate 197 with aniline.  
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The activated catalyst 194 was formed by the reaction of 1 mol% of chloro-1,5-
cyclooctadiene iridium(I) dimer with two equivalents of phosphoramidite 195 in a 1:1 mixture 
of propylamine and tetrahydrofuran at 50 °C. After 20 minutes an aliquot was diluted in 
methanol and analysed by ESI-MS (Figure 34, A).  
 
Figure 34. Mass spectra recorded during catalyst activation after 20 min (A) and 2 h (B).  
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The mass spectrum shows a major signal at m/z = 898 and a minor one at m/z = 1379 
corresponding to the sodium adduct of iridium(I) complex 196 and the protonated activated 
derivative 194. The spectra are of low quality, because 196 and 194 themselves are 
uncharged. The dilution in protic solvents like methanol or isopropanol was mandatory to 
detect these species by ESI-MS. After two hours another sample was analysed (Figure 34, B) 
and the signal of the cyclometallated derivative 194 was the most intensive one in the mass 
spectrum. Since a sodium adduct and a protonated species are compared a quantitative 
analysis is not possible, but the results clearly show the conversion of 196 to 194 over the 
course of the activation process. All volatiles were removed in high vacuum and the yellow 
residue was dissolved in tetrahydrofuran. The allylic carbonate 197 as well as aniline were 
added and the resulting mixture was stirred at room temperature. 
After five minutes the reaction was analysed by ESI-MS and a clean spectrum was obtained 
(Figure 35, A). Besides some activated catalyst 194, an intense signal at m/z = 956 
corresponding to the allyl complex 198 was detected. The structure of this species was 
confirmed by MS/MS experiments. The signal at m/z = 848 is attributed to the loss of 1,5-
cyclooctadiene. The mass spectrum recorded after 30 minutes indicated the complete 
consumption of the activated catalyst 194 (Figure 35, B).  
These results proved the existence of allyl intermediate 198 for the first time. It is assumed, 
that dissociation of ligand 195 creates a free coordination site at the activated catalyst species 
194 for oxidative addition of allylic carbonate 197.  
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Figure 35. ESI-MS analysis of the reaction mixture 5 min (A) and 30 min (B) after the addition of 197.  
Since allyl-iridium intermediates could be detected by ESI-MS, the question arose if a 
screening protocol in analogy to palladium-catalysed allylic substitutions would allow the 
determination of the enantioselectivity for the overall reaction. Applying the principle of 
microscopic reversibility, the back reaction of quasienantiomeric products leading to the 
corresponding mass-labelled allyl-iridium complexes should be monitored. The results should 
be compared with the selectivities determined from product analysis of the corresponding 
preparative reactions.  
The etherification of carbonate 197 with lithium phenolate 199 was tested first (Scheme 
56),[136] since the quasienantiomeric allylation products were readily available in the 
group.[104] 
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Scheme 56. Allylic etherification of carbonate 197 with lithium phenolate 199.  
The precatalyst solution was prepared from 1 mol% of chloro-1,5-cyclooctadiene iridium(I) 
dimer and two equivalents of phosphoramidite (R,R,R)-195 in tetrahydrofuran at 50 °C for 
four hours. Two equivalents lithium-para-methoxyphenolate (199) were used for generating 
the activated catalyst species 194 in this case. The metallacycle was added to an equimolar 
mixture of (R)-127a and (S)-127b (Scheme 57). After stirring the reaction mixture at room 
temperature for five minutes an aliquot was taken, diluted with methanol and analysed by 
ESI-MS.  
 
Scheme 57. Back reaction using quasienantiomeric phenolates (R)-127a and (S)-127b.  
As it is shown in Figure 36 the signals corresponding to the allyl intermediates 202a and 202b 
were detected at m/z = 970 and m/z = 984, respectively, with high intensities. However a ratio 
of 61:39 was observed, which is significantly lower compared to the product enantiomeric 
ratio of 98.5:1.5.[136]  
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Figure 36. Back reaction screening using iridium complex 194 derived from ligand (R,R,R)-195.  
 
Figure 37. Back reaction screening using iridium complex ent-194 derived from ligand (S,S,S)-195.  
 
Ir
Ph
N CH3
P O
O
Ph
202a
C6H4-Me
Ir
Ph
N CH3
P O
O
Ph
202b
C6H4-Et
69 : 31
940 960 980 1000 1020
0
20
40
60
80
100
Irel
m/z
[970]
[984]
Ir
Ph
N CH3
P O
O
Ph
ent-202a
C6H4-Me
Ir
Ph
N CH3
P O
O
Ph
ent-202b
C6H4-Et
31 : 69
940 960 980 1000 1020
0
20
40
60
80
100
Irel
m/z
[970]
[984]
CHAPTER 6 
 116 
The reaction was carried out with the catalyst ent-194 prepared from the enantiomeric 
phosphoramidite ligand (S,S,S)-195 under otherwise identical conditions and the allyl 
complexes ent-202a and ent-202b were detected with the exact reverse ratio of 39:61.  
It was reported in the literature that the base used for altering the catalyst can influence the 
enantioselectivity of this transformation.[136] Therefore the experiment was repeated in the 
presence of propylamine, but the same result was obtained. The ratio was not affected by the 
reaction temperature either and similar values were obtained at both 50 °C and −78 °C. 
Furthermore the ratio of intermediates remained constant for at least 50 minutes. 
The selectivity of the forward reaction using an equimolar mixture of quasienantiomeric 
benzoates (R)-126a and (S)-126b, lithium phenolate 199 and the catalyst 194 in 
tetrahydrofuran (Figure 38) was investigated as well.  
 
Figure 38. Forward reaction screening using quasienantiomeric benzoates (R)-126a and (S)-126b.  
However the allyl intermediates 202a and 202b were observed with a reversed selectivity 
compared to the back reaction screening (Figure 36) and a ratio of 35:65 in favour of the 
consumption of the (S)-benzoate was detected. The reason for this outcome remains unclear. 
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Furthermore and in contrast to the back reaction analysis the peak ratio decreased when 
aliquots were taken after different reaction times (202a/202b ~ 1:1 after 50 min).  
 
 
6.2 Combination of ESI-MS and NMR-Analysis 
In order to obtain a better understanding of the allylic substitution process, the amination of 
carbonate 197 with aniline in the presence of iridium complex 194 was simultaneously 
investigated by ESI-MS and NMR analysis (Scheme 58). In analogy to the well established 
mechanism of palladium-catalysed allylic substitutions, the acquisition of data on the 
corresponding intermediates in the iridium-catalysed process was envisaged. The former 
process proceeds by oxidative addition of an allylic ester to the palladium centre, followed by 
attack of the nucleophile on the allyl intermediate. 
 
Scheme 58. Allylic amination of carbonate 197 with aniline.  
In the course of this combined experiment the catalytic cycle should be passed step by step. 
The results are depicted in Figure 39. 
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Figure 39. Analysis of an allylic amination by 31P NMR spectroscopy and ESI-MS.  
By applying the exact stoichiometry for the preparation of the activated catalyst 194, a 
solution of a quarter equivalent of chloro-1,5-cyclooctadiene iridium(I) dimer and one 
equivalent of phosphoramidite ligand 195 was treated with propylamine in tetrahydrofuran-d8. 
The mixture was heated at 50 °C for one hour. After it had been cooled to room temperature a 
sample was taken and analysed by ESI-MS and 31P NMR (Figure 39, A). As it is described in 
the literature the catalyst activation proceeds via the squareplanar iridium(I) complex 196.[140] 
The addition of the amine base leads to the formation of species 194 by cyclometallation of 
the phosphoramidite ligand at one methyl group of the amino substituent and elimination of 
amine hydrochloride. Coordination of a second phosphoramidite 195 generates the trigonal 
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bipyramidal complex 194. The 31P NMR spectrum was dominated by a singlet at δ = 
116.0 ppm of 196 and two doublets at δ =153.9 ppm and δ = 128.9 ppm with 2JP,P = 46 Hz, 
which represent the cyclometallated complex 194, as reported in the literature.[140] The other 
diastereoisomer was also observed in low amount of approximately 5%. Signals at m/z = 898 
and m/z = 1379 for both iridium complexes were detected by ESI-MS as well, which 
correspond to the sodium adduct of 196 and protonated 194. 
After the activation process had been completed, all volatiles were removed in vacuo. The 
resulting orange solid was dissolved in tetrahydrofuran-d8 and one equivalent of carbonate 
197 was added. An aliquot of the reaction mixture was immediately taken and analysed by 
NMR spectroscopy and ESI-MS (Figure 39, B). However, the 31P NMR spectrum remained 
unchanged, whereas a new intense signal at m/z = 956 was observed in the mass spectrum, 
which corresponds to allyl intermediate 198. The 1H NMR spectrum was also analysed, but 
no allyl intermediates were found. Since the structural analysis of complex 194 is known to be 
complicated by conformational changes on the NMR time scale, it was assumed that this 
problem probably might also occur in the case of allyl intermediate 198.[140] Therefore the 
NMR spectra were recorded at both lower and higher temperatures, but no indication for the 
presence of an allyl intermediate was obtained.  
It is known, that additional chloro-1,5-cyclooctadiene iridium(I) dimer increases the rate of 
the catalysis,[140] because it facilitates the dissociation of the phosphoramidite 195 from the 
activated catalyst to generate a free coordination site. For this reason another quarter 
equivalent of chloro-1,5-cyclooctadiene iridium(I) dimer was added (Figure 39, C). The mass 
spectrum still showed a single signal at m/z = 956, but the catalytically inactive complex 196 
was detected by 31P NMR as the only major species and the signals for 194 had disappeared. 
This indicates that the activated complex had completely decomposed. Furthermore a new 
signal at δ = 103.9 ppm arose, but a characterisation of this entity was not possible. 
Finally aniline was added to the reaction mixture, but no product formation was observed in 
the 1H NMR spectrum (Figure 39, D). This can most likely be ascribed to the fact that no 
activated catalyst was present any longer at this stage.  
A similar experiment was carried out starting directly from half an equivalent of chloro-1,5-
cyclooctadiene iridium(I) dimer and one equivalent of the phosphoramidite ligand 195. After 
the catalyst activation both iridium complexes 196 and 194 were observed by 31P NMR 
spectroscopy and ESI-MS. When carbonate 197 was added, the NMR spectrum remained 
unchanged. Consistent with the previous experiment the allyl intermediate 198 was 
exclusively detected by ESI-MS. After addition of aniline the signals of the activated complex 
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194 disappeared and only the singlet at δ = 116.0 ppm for 196 was found in the NMR 
spectrum, whereas allyl intermediate 198 was still visible by ESI-MS.  
The results indicate that iridium-catalysed allylic substitutions do not proceed in exact 
analogy to the palladium-catalysed process. However with the data collected so far the poor 
correlation of the ESI-MS measurements and the results from the preparative reactions can 
not be explained. We assume that the allyl intermediates detected by ESI-MS are present only 
in very low concentration and the picture obtained by ESI-MS does not show the 
representative composition of the reaction mixture.  
After having finished these preliminary investigations, a detailed study towards the reaction 
mechanism was published by Hartwig and coworkers.[143] The allylamine complex 205 was 
claimed to be the resting state of the transformation. Based on the isolation of this complex 
205 and kinetic data for the process, a catalytic cycle was proposed (Scheme 59).  
 
Scheme 59. Mechanism for iridium-catalysed allylic substitutions as proposed by Hartwig.  
The catalytic cycle involves the formation of the proposed allyl complex 198 by an 
endothermic and reversible addition of the allylic carbonate 197 to the coordinatively 
unsaturated complex 206. This process is followed by an irreversible formation of the 
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allylamine complex 205. Furthermore it is assumed that the attack of the amine represents the 
‘enantio-determining’ step and the enantioselectivity is furthermore connected to the relative 
stabilities of the diastereomeric allylamine complexes of type 205, but no evidence is given. 
In this work we were able to confirm the existence of allyl complex 198, which was suggested 
by Hartwig and coworkers. The catalytic cycle shown in Scheme 59 allows the re-
interpretation of the combined ESI-MS and NMR investigations. In the course of the 
activation process, both catalyst species 196 and 194 were detected by 31P NMR as well as 
ESI-MS analysis (Figure 39, A). After the addition of allylcarbonate 197 the mass spectrum 
showed the clean formation of the allyl intermediate 198, whereas the NMR spectrum 
remained unchanged (Figure 39, B). It is now assumed that 198 is formed in such a small 
amount, that it can not be observed by NMR spectroscopy. However the sensitivity of ESI-
MS is much higher and enables the detection of charged species even in traces. This finding is 
consistent with Hartwig’s mechanism, involving an equilibrium between allyl complex 198 
and the substrate 197, which is on the side of 197. Since the activated catalyst 194 is only 
visible in its protonated form by ESI-MS, no quantitative information concerning the ratio of 
194 and 198 can be given.  
Chloro-1,5-cyclooctadiene iridium(I) dimer was added to activate the cyclometallated catalyst 
194 by removal of the phosphoramidite ligand 195. In the mass spectrum the signal of 198 
was still found exclusively (Figure 39, C). However, in the corresponding 31P NMR spectrum, 
only the catalytically inactive complex 196 was detected and the signals for 194 had 
disappeared. This can be explained with regard to the findings of Hartwig. The allyl complex 
198 is formed in negligible amounts and the equilibrium predominantly lies on the side of the 
starting material. The overall reaction proceeds only when intermediate 198 reacts irreversibly 
with the nucleophile. Since no amine was present, the activated catalyst 194, which is 
unstable after the removal of one phosphoramidite ligand, most likely decomposed before 
aniline was added after prolonged periods of reaction time (Figure 39, D). 
Taken together it was demonstrated that the mechanism of iridium-catalysed allylic 
substitutions is more complex in comparison to analogous reactions involving palladium 
complexes. Furthermore it became clear that it is more difficult to evaluate ligands by mass 
spectrometric monitoring of the allyl intermediates 202a and 202b in this case. If a screening 
method based on ESI-MS can be established in the future remains open at this stage. Closer 
mechanistic studies are required beforehand to reveal the exact process for enantioselection in 
this transformation. 
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6.2.1 Conclusions and Outlook 
After having established a fast and reliable ESI-MS screening method for the evaluation of 
palladium catalysts in asymmetric allylic substitutions, similar iridium-catalysed 
transformations were investigated. In this context it was oft special interest if an analogous 
protocol can be applied to determine the selectivity of chiral ligands in these reactions and 
preliminary experiments were carried out. 
The activation process of a catalyst derived from a phosphoramidite ligand was followed by 
ESI-MS and all involved species were detected. In addition mass spectrometric analysis of a 
related allylic amination revealed the existence of a previously postulated allyl-iridium 
species. 
Applying the principle of microscopic reversibility the back reaction of quasienantiomeric 
products leading to the corresponding mass-labelled allyl-iridium intermediates was 
monitored. However the selectivities calculated from the signal ratio do not correlate with the 
enantiomeric excesses determined from product analysis of the respective preparative 
reaction. In order to obtain a better understanding of the substitution process, the amination of 
an allylic carbonate with aniline was investigated by a combined ESI-MS and NMR 
experiment.  
In summary, it was found that the mechanism of iridium-catalysed allylic substitutions is 
quite different from the analogous reactions involving palladium catalysts. The mass 
spectrometric monitoring of allyl intermediates derived from quasienantiomeric substrates 
does not allow the evaluation of chiral ligands in an easy way. Before a screening method 
based on ESI-MS can be developed, further mechanistic studies will be indispensable to 
reveal the exact process for enantioselection. 
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7 Experimental 
7.1 Working Techniques and Reagents 
All reactions were performed in flame-dried glassware under argon using Schlenk techniques 
or under purified nitrogen in a glovebox (MBraun Labmaster 130). Air- or moisture-sensitive 
reagents were transferred with the help of oven-dried, gas-tight syringes or cannulas and 
introduced into the apparatus through septa. 
Solvents were distilled from calcium hydride (dichloromethane, triethylamine) or sodium 
(diethyl ether, pentane, tetrahydrofuran, toluene) and stored under nitrogen,[144] or were 
purchased from Fluka or Aldrich in septum-sealed bottles and kept under an inert atmosphere 
over molecular sieves. The solvents were degassed by three freeze-pump-thaw cycles, when 
necessary.  
Column chromatographic purifications were performed on Merck silica gel 60 (Darmstadt, 
particle size 40-63 nm) under 0.1-0.8 bar nitrogen or argon pressure. The eluents were 
technical grade and purified by distillation prior to use. In the case of air-sensitive compounds 
the solvents were degassed by a continuous stream of argon and the silica gel by three 
vacuum-argon cycles.  
All reagents were purchased from Acros, Aldrich, Fluka, Strem or Lancaster and used without 
further purification. Phosphorus trichloride and BzCl were distilled under argon prior to use. 
N,N,N’,N’-tetramethylethylenediamine (TMEDA) was distilled from n-butyllithium.[144] 
Racemic cyclohex-3-enecarboxylic acid was prepared according to a literature procedure.[98] 
 
 
7.2 Analytical Methods 
NMR-Spectroscopy (NMR): NMR spectra were measured either on a Bruker Avance 400 
(400 MHz) or a Bruker Avance DRX 500 (500 MHz) spectrometer, equipped with BBO 
broadband probe heads. The chemical shifts (δ) are given in ppm. 1H and 13C spectra are 
referenced relative to tetramethylsilane (δ = 0 ppm) using the solvent residual peaks (CDCl3 
7.26 ppm, CD2Cl2 5.32 ppm, C6D6 7.16 ppm and THF-d8 3.58 ppm) and the signals of the 
deuterated solvents (CDCl3 77.16 ppm, CD2Cl2 53.5 ppm, C6D6 128.1 ppm and THF-d8 
67.4 ppm), respectively as internal standards.[145] 31P spectra are calibrated relative to 85% 
phosphoric acid (δ = 0 ppm) as external standard. The assignment of 1H and 13C signals was 
accomplished with the help of DEPT experiments or, when needed by two-dimensional 
correlation experiments (COSY, HMQC and HMBC). Multiplets are assigned as s (singlet), d 
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(doublet), t (triplet), q (quartet), quint (quintet), sext (sextet), sept (septet), m (multiplet), mc 
(centred multiplet) and br (broad).  
 
Infrared Spectroscopy (IR): Infrared spectra were collected on a Perkin Elmer 1600 series 
FTIR spectrometer. The spectra of liquids and oils were measured as thin films between two 
sodium chloride plates, those of solid samples as potassium bromide discs. The absorption 
bands are given in wave numbers (ν~  [cm–1]). The peak intensity is described by s (strong), m 
(medium), w (weak) and br (broad).  
 
Mass Spectrometry (MS): Mass spectra were measured by Dr. H. Nadig (Department of 
Chemistry, University of Basel) on a VG70-250 spectrometer (electron ionisation (EI)) or on 
a MAR 312 spectrometer (fast atom bombardment (FAB)). FAB was performed with 3-
nitrobenzyl alcohol (NBA) as matrix.  
ESI-MS spectra were measured on a Finnigan MAT LCQ or on a Varian 1200L Quadrupol 
MS/MS spectrometer using mild desolvation conditions (39 psi nebulising gas, 4.9 kV spray 
voltage, 19 psi drying gas at 200 °C or 100 °C, 75 V capillary voltage, 1500 V detector 
voltage). Every spectrum consisted of at least 50 averaged scans. The samples were diluted 
immediately prior to their analysis and measured using direct injection. The signals are given 
in mass-to-charge ratios (m/z). The fragments and relative intensities are given in brackets. 
 
Elemental Analysis: Elemental analyses were measured by Mr. W. Kirsch (Department of 
Chemistry, University of Basel) on a Leco CHN-900 (C-, H-, N-detection) and Leco RO-478 
analysers (O-detection). The data are indicated in mass percent. 
 
Melting points (m.p.): Melting points were determined on a Büchi 535 apparatus and are 
uncorrected. 
 
Optical Rotations ( [ ]20Da ): Optical rotations were measured on a Perkin Elmer Polarimeter 
341 (in a cuvette (l = 1 dm)) at 20 °C. The concentration (c) is given in g/100 mL. 
 
Gas Chromatography (GC): Gas chromatograms were collected on Carlo Erba HRGC 
Mega2 Series 800 (HRGS Mega 2) instruments. Achiral separations were performed on a 
Restek Rtx-1701 column (30 m × 0.25 mm × 0.25 µm) and for chiral separations β- and γ-
cyclodextrine columns (30 m × 0.25 mm × 0.25 µm) were used. 
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High Performance Liquid Chromatography (HPLC): HPLC analyses were measured on 
Shimadzu systems with SLC-10A system controller, CTO-10AC column oven, LC10-AD 
pump system, DGU-14A degasser and SPD-M10A diode Array- or UV/VIS detector. Chiral 
columns Chiracel OD-H, OJ, or AD-H (4.6 × 250 mm) as well as Chiracel OD or AD (20 × 
300 mm) from Daicel Chemical Industries were used. 
 
Semipreparative High Performance Liquid Chromatography (HPLC): Separations by 
semipreparative HPLC were performed on Shimadzu systems with SIL 10 Advp autosampler, 
CTO 10 Asvp column oven, LC 10 Atvp pump system, FCV 10 Alvp degasser and SPD M10 
Avp diode array detector. Chiral columns Chiracel OD or AD (2 × 25 cm) from Daicel 
Chemical Industries were used in this case. 
 
Thin Layer Chromatography (TLC): TLC plates were obtained from Macherey-Nagel 
(Polygram SIL/UV254, 0.2 mm silica with fluorescence indicator). UV light (254 nm, 
366 nm), basic permanganate solution or ceric ammonium molybdate solution were used for 
the visualisation of the respective compounds. 
 
 
7.3 Quasienantiomeric Substrates 
7.3.1 Diarylallyl Substrates 
4-Methylcinnamaldehyde (34)[88] 
 
 
To a stirred solution of 4-iodotoluene (4.81 g, 22.3 mmol) in abs. DMF (85 mL) were added 
acrolein diethyl acetal (8.05 g, 61.8 mmol), [nBu4N]OAc (13.4 g, 44.5 mmol), K2CO3 (4.27 g, 
30.9 mmol), KCl (1.64 g, 22.0 mmol) and Pd(OAc)2 (111 mg, 0.500 mmol). The mixture was 
stirred at 90 °C for 3 h. After cooling the suspension to r.t. 2 M HCl (100 mL) was slowly 
added and the resulting mixture stirred for 10 min. It was then diluted with Et2O (250 mL) 
and ice-cold water (900 mL) and the aqueous phase extracted with Et2O (2 × 250 mL). The 
combined organic phases were dried over MgSO4 and concentrated under reduced pressure. 
H
O
Me
 34
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The residue was purified by column chromatography (silica gel, 5 × 20 cm, hexanes/EtOAc 
10:1, F32-60) to give aldehyde 34 as slightly yellow solid (2.57 g, 79%). 
 
C10H10O (146.19 g*mol−1): 
m.p. 40-42 °C. 
Rf = 0.44 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 2.39 (s, 3 H, CH3), 6.65 (ddd, J(H,H) = 16.0, 7.7, 0.7 Hz, 
1 H, ArCHCH), 7.22 (d, J(H,H) = 8.3 Hz, 2 H, Ar-m-H), 7.43 (d, J(H,H) = 16.0 Hz, 1 H, 
ArCHCH), 7.45 (d, J(H,H) = 7.9 Hz, 2 H, Ar-o-H), 9.67 (d, J(H,H) = 7.7, 0.9 Hz, 1 H, 
CHO) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.7 (CH3), 127.8 (ArCHCH), 128.7 (Ar-o-CH), 
129.9 (Ar-m-CH), 131.4 (Ar-i-C), 142.1 (Ar-p-C), 153.1 (ArCHCH), 194.0 (CHO) ppm. 
IR (KBr): ν~  = 3028m, 2967m, 2923w, 2841m, 2756w, 1932w, 1678s, 1608s, 1512m, 
1417m, 1298m, 1251m, 1181m, 1127s, 1010m, 979m, 805s cm–1. 
MS (EI, 70 eV): m/z (%) = 146 (21, M+), 131 (100, [M−CH3]+), 117 (29, [M−CHO]+), 115 
(34), 103 (21), 91 (30). 
Elemental analysis calcd. (%) for C10H10O: C 82.16, H 6.89; found: C 82.03, H 6.97. 
 
 
4-Ethylcinnamaldehyde (35)[88] 
 
 
To a stirred solution of 1-ethyl-4-iodobenzene (4.81 g, 20.7 mmol) in abs. DMF (85 mL) were 
added acrolein diethyl acetal (8.06 g, 61.9 mmol), [nBu4N]OAc (12.4 g, 41.3 mmol), K2CO3 
(4.28 g, 31.0 mmol), KCl (1.54 g, 20.7 mmol) and Pd(OAc)2 (139 mg, 0.600 mmol). The 
mixture was stirred at 90 °C for 15 h. After cooling the reaction mixture to r.t. 2 M HCl 
(100 mL) was slowly added and the black solution stirred for 10 min. It was then diluted with 
Et2O (250 mL) and ice-cold water (900 mL) and the aqueous phase extracted with Et2O 
(2 × 250 mL). The combined organic phases were dried over MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography (silica gel, 5 × 20 cm, 
H
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hexanes/EtOAc 10:1, F23-55) to give 4-ethylcinnamaldehyde (35) as yellow solid (2.04 g, 
88%). 
 
C11H12O (160.21 g*mol−1): 
m.p. 25 °C. 
Rf = 0.30 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.24 (t, J(H,H) = 7.7 Hz, 3 H, CH3), 2.65 (q, 
J(H,H) = 7.7 Hz, 2 H, CH2), 6.65 (dd, J(H,H) = 16.2, 7.9 Hz, 1 H, ArCHCH), 7.25 (d, 
J(H,H) = 8.1 Hz, 2 H, Ar-m-H), 7.43 (d, J(H,H) = 16.2 Hz, 1 H, ArCHCH), 7.47 (d, 
J(H,H) = 8.2 Hz, 2 H, Ar-o-H), 9.67 (d, J(H,H) = 7.9 Hz, 1 H, CHO) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 15.3 (CH3), 28.9 (CH2), 127.8 (ArCHCH), 128.7 (Ar-
o-CH), 128.8 (Ar-m-CH), 131.6 (Ar-i-C), 148.3 (Ar-p-C), 153.1 (ArCHCH), 193.9 
(CHO) ppm. 
IR (KBr): ν~  = 3028m, 2967s, 2932s, 2873m, 2818m, 2736w, 1913w, 1678s, 1621s, 1566m, 
1511m, 1456m, 1423m, 1389w, 1297m, 1249m, 1181m, 1056m, 1010m, 907s, 858w, 
752w cm–1. 
MS (EI, 70 eV): m/z (%) = 160 (12, M+), 131 (100, [M−C2H5]+), 115 (15), 103 (16), 91 (10). 
Elemental analysis calcd. (%) for C11H12O: C 82.46, H 7.55; found: C 82.35, H 7.53. 
 
 
1,3-Di-(4’-tolyl)-prop-2-en-1-ol (37a) 
 
 
At –78 °C 4-bromotoluene (3.05 g, 17.8 mmol) in abs. THF (36 mL) was treated with nBuLi 
in hexane (2.5 M, 9.70 mL, 24.3 mmol) resulting in the formation of a colourless solid. The 
mixture was warmed to –25 °C, until all the precipitate had dissolved, re-cooled to –78 °C and 
treated with a solution of aldehyde 34 (1.81 g, 12.4 mmol) in abs. THF (6.0 mL). The mixture 
was allowed to warm to r.t. overnight and then quenched with saturated aqueous NH4Cl 
solution (75 mL). The THF was removed under reduced pressure, the residue extracted with 
Et2O (3 × 80 mL) and the combined organic phases were washed with saturated aqueous 
OH
Me
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solutions of NH4Cl (200 mL) and NaCl (200 mL). After drying over MgSO4 the solvent was 
evaporated. The crude product was purified by column chromatography (silica gel, 5 × 20 cm, 
hexanes/EtOAc 5:1, F22-56) and 37a was obtained as a colourless solid (2.78 g, 94%). 
 
C17H18O (238.32 g*mol−1): 
m.p. 64 °C.  
Rf = 0.30 (hexanes/EtOAc 5:1). 
1H NMR (400 MHz, CDCl3): δ = 2.10 (br s, 1 H, OH), 2.35 (s, 3 H, CH3), 2.37 (s, 3 H, CH3), 
5.34 (d, J(H,H) = 6.5 Hz, 1 H, CHOH), 6.31 (dd, J(H,H) = 15.7, 6.5 Hz, 1 H, ArCHCH), 6.67 
(d, J(H,H) = 15.7 Hz, 1 H, ArCHCH), 7.10-7.25 (m, 4 H, Ar-H), 7.27-7.40 (m, 4 H, Ar-
H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.3 (CH3), 21.3 (CH3), 75.2 (CHOH), 126.4 (CH), 
126.6 (CH), 129.4 (CH), 129.4 (CH), 130.4 (CH), 130.8 (CH), 133.9 (3-Ar-i-C), 137.6 (Ar-p-
C), 137.8 (Ar-p-C), 140.1 (1-Ar-i-C) ppm. 
IR (KBr): ν~  = 3262br, 3022s, 2915s, 1905m, 1801w, 1716w, 1509s, 1417s, 1207m, 1087s, 
1021s, 966s, 805s, 743m, 713m, 656m, 512m cm–1. 
MS (EI, 70 eV): m/z (%) =  238 (21, M+), 223 (16, [M−CH3]+), 119 (100), 105 (20), 91 (21). 
Elemental analysis calcd. (%) for C17H18O: C 85.67, H 7.61, O 6.71; found: C 85.68, H 7.69, 
O 6.66. 
 
 
1,3-Di-(4’-ethylphenyl)-prop-2-en-1-ol (37b) 
 
 
At –78 °C 1-ethyl-4-iodobenzene (2.70 g, 11.6 mmol) in abs. THF (30 mL) was treated with 
nBuLi in hexane (2.5 M, 6.40 mL, 16.0 mmol). The resulting orange suspension was allowed 
to warm to –25 °C, re-cooled to –78 °C and treated with a solution of 35 (1.29 g, 8.10 mmol) 
in abs. THF (4.0 mL). The mixture was warmed to r.t. overnight and then quenched with 
saturated aqueous NH4Cl solution (30 mL). The THF was removed under reduced pressure, 
the residue extracted with Et2O (3 × 70 mL) and the combined organic phases were washed 
OH
Et
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with saturated aqueous solutions of NH4Cl (150 mL) and NaCl (150 mL). After drying over 
MgSO4 the solvent was evaporated. The crude product was purified by column 
chromatography (silica gel, 5 × 20 cm, pentanes/Et2O 5:1, F54-120) and alcohol 37b was 
obtained as a colourless solid (1.09 g, 51%). 
 
C19H22O (266.38 g*mol−1): 
m.p. 61-63 °C.  
Rf = 0.31 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.23 (mc, 6 H, CH3), 2.08 (d, J(H,H) = 3.7 Hz, 1 H, OH), 
2.68 (mc, 4 H, CH2), 5.36 (d, J(H,H) = 6.6 Hz, 1 H, CHOH), 6.32 (dd, J(H,H) = 15.8, 6.6 Hz, 
1 H, ArCHCH), 6.65 (d, J(H,H) = 15.8 Hz, 1 H, ArCHCH), 7.13-7.17 (m, 2 H, Ar-H), 7.19-
7.23 (m, 2 H, Ar-H), 7.30-7.36 (m, 4 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 15.7 (CH3), 15.7 (CH3), 28.7 (CH2), 28.7 (CH2), 75.2 
(CHOH), 126.5 (Ar-CH), 126.7 (Ar-CH), 128.2 (Ar-CH), 128.2 (Ar-CH), 130.4 (ArCHCH), 
130.8 (ArCHCH), 134.2 (3-Ar-i-C), 140.3 (Ar-p-C), 144.0 (Ar-p-C), 144.1 (1-Ar-i-C) ppm. 
IR (KBr): ν~  = 3392br, 3021s, 2963s, 2929m, 2871m, 1512s, 1457m, 1419m, 1179w, 1090m, 
967s, 832m cm–1. 
MS (EI, 70 eV): m/z (%) = 266 (16, M+), 237 (47, [M−C2H5]+), 133 (100), 119 (18, C8H7O+), 
91 (7). 
Elemental analysis calcd. (%) for C19H22O: C 85.67, H 8.32; found: C 85.48, H 8.38. 
 
 
1,3-Di-(4’-tolyl)-prop-2-enyl benzoate (38a) 
 
 
A solution of alcohol 37a (1.90 g, 7.90 mmol), abs. NEt3 (1.75 g, 17.3 mmol) and DMAP 
(25.0 mg, 0.205 mmol) in abs. CH2Cl2 (32 mL) was treated dropwise with BzCl (1.46 g, 
10.4 mmol) at –78 °C. The mixture was allowed to warm to r.t. overnight. After quenching 
the reaction with saturated aqueous NH4Cl solution (20 mL), the aqueous phase was extracted 
with CH2Cl2 (3 × 30 mL) and the combined organic phases were dried over MgSO4. The 
OBz
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solvent was removed under reduced pressure and the residue was purified by column 
chromatography (silica gel, 5 × 20 cm, hexanes/EtOAc/NEt3 18:1:1, F4-34) to yield benzoate 
38a as a colourless solid (2.48 g, 91%). 
 
C24H22O2 (342.43 g*mol−1): 
m.p. 58-59 °C.  
Rf = 0.56 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 2.33 (s, 3 H, CH3), 2.36 (s, 3 H, CH3), 6.40 (dd, 
J(H,H) = 16.0, 6.9 Hz, 1 H, ArCHCH), 6.66 (d, J(H,H) = 6.9 Hz, 1 H, CHOBz), 6.68 (d, 
J(H,H) = 16.0 Hz, 1 H, ArCHCH), 7.11 (d, J(H,H) = 7.8 Hz, 2 H, Ar-H), 7.21 (d, 
J(H,H) = 8.1 Hz, 2 H, Ar-H), 7.29 (d, J(H,H) = 8.1 Hz, 2 H, Ar-H), 7.39-7.49 (m, 4 H, Ar-H), 
7.55 (mc, 1 H, Bz-p-H), 8.12 (d, J(H,H) = 7.8 Hz, 2 H, Bz-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.3 (CH3), 21.4 (CH3), 76.8 (CHOBz), 126.8 (CH), 
126.8 (CH), 127.2 (CH), 128.4 (CH), 129.4 (CH), 129.5 (CH), 129.9 (CH), 130.3 (Bz-i-C), 
132.7 (CH), 133.1 (CH), 133.6 (3-pTol-i-C), 136.6 (pTol-p-C), 138.0 (pTol-p-C), 138.1 (1-
pTol-i-C), 166.8 (CO2) ppm. 
IR (KBr): ν~  = 3026s, 2920s, 1907w, 1716s, 1602m, 1512m, 1450m, 1312s, 1264s, 1176m, 
1103s, 1066m, 1025m, 968s, 805s, 709s, 578m cm–1. 
MS (EI, 70 eV): m/z (%) = 342 (12, M+), 237 (42, [M−C7H5O]+), 221 (61, [M−C7H5O2]+), 
220 (100), 205 (44), 129 (15), 105 (75), 77 (21, C6H5+). 
Elemental analysis calcd. (%) for C24H22O2: C 84.18, H 6.48; found: C 84.40, H 6.60. 
 
 
1,3-Di-(4’-ethylphenyl)-prop-2-enyl benzoate (38b) 
 
 
At –78 °C a solution of alcohol 37b (492 mg, 1.84 mmol), abs. NEt3 (379 mg, 3.80 mmol) 
and DMAP (6.00 mg, 49.0 µmol) in abs. CH2Cl2 (8.0 mL) was treated dropwise with BzCl 
(379 mg, 2.40 mmol). The mixture was allowed to warm to r.t. overnight. The reaction was 
quenched with saturated aqueous NH4Cl solution (5.0 mL). The aqueous phase was extracted 
OBz
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with CH2Cl2 (3 × 15 mL) and the combined organic phases were dried over MgSO4. The 
solvent was removed under reduced pressure and the residue was re-crystallised from 
hexanes/CH2Cl2 to yield benzoate 38b as a colourless solid (512 mg, 75%). 
 
C26H26O2 (370.48 g*mol−1): 
m.p. 79 °C. 
Rf = 0.53 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.21 (t, J(H,H) = 7.5 Hz, 3 H, CH3), 1.24 (t, 
J(H,H) = 7.6 Hz, 3 H, CH3), 2.62 (q, J(H,H) = 7.6 Hz, 2 H, CH2), 2.66 (q, J(H,H) = 7.5 Hz, 
2 H, CH2), 6.42 (dd, J(H,H) = 15.9, 6.7 Hz, 1 H, ArCHCH), 6.66 (d, J(H,H) = 6.7 Hz, 1 H, 
CHOBz), 6.71 (d, J(H,H) = 15.9 Hz, 1 H, ArCHCH), 7.12 (d, J(H,H) = 8.2 Hz, 2 H, Ar-H), 
7.21 (d, J(H,H) = 8.2 Hz, 2 H, Ar-H), 7.31 (d, J(H,H) = 8.0 Hz, 2 H, Ar-H), 7.40-7.48 (m, 
4 H, Ar-H), 7.54 (mc, 1 H, Bz-p-H), 8.11 (d, J(H,H) = 8.1 Hz, 2 H, Bz-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 15.6 (CH3), 15.7 (CH3), 28.7 (CH2), 28.7 (CH2), 76.8 
(CHOBz), 126.9 (CH), 127.2 (CH), 128.2 (CH), 128.3 (CH), 128.5 (CH), 129.9 (CH), 130.6 
(Bz-i-C), 132.7 (CH), 133.1 (CH), 133.9 (3-Ar-i-C), 136.8 (1-Ar-i-C), 144.4 (Ar-p-C), 144.5 
(Ar-p-C), 165.8 (CO2) ppm. 
IR (KBr): ν~  = 3027m, 2961s, 2868m, 1915w, 1710s, 1601m, 1512m, 1452s, 1312s, 1266s, 
1174m, 1103s, 1065m, 975m, 927m, 824s, 706s, 580m cm–1. 
MS (EI, 70 eV): m/z (%) = 370 (16, M+), 265 (56, [M−C7H5O]+), 249 (62, [M−C7H5O2]+), 
248 (100), 219 (52), 205 (21), 113 (29), 105 (96, C8H9+), 77 (25, C6H5+). 
Elemental analysis calcd. (%) for C26H26O2: C 84.29, H 7.07; found: C 84.27, H 7.30. 
 
 
(R)-3-[1’,3’-Di-(4’’-tolyl)-prop-2’-enyl]-pentane-2,4-dione ((R)-30a) 
 
 
In a Young tube a solution of [Pd(C3H5)Cl]2 (8.00 mg, 21.9 µmol) and ligand (R)-27 
(19.3 mg, 51.7 µmol) in CH2Cl2 (2.0 mL) was degassed by three freeze-pump-thaw cycles. 
Me Me
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The ampoule was sealed at 0.01 mbar and the solution stirred at 50 °C for 2 h. A solution of 
benzoate 38a (300 mg, 0.875 mmol) in CH2Cl2 (3.5 mL) in a Young tube was treated with 
acetyl acetone (263 mg, 2.63 mmol), followed by BSA (535 mg, 2.63 mmol) and catalytic 
amounts of dried KOAc (ca. 5.00 mg). After three freeze-pump-thaw cycles the catalyst 
solution was added by syringe and the resulting mixture stirred at 0 °C. After 40 h the orange 
solution was diluted with Et2O (50 mL) and ice-cold saturated aqueous NH4Cl solution 
(30 mL) was added. The aqueous phase was extracted with Et2O (3 × 30 mL) and the 
combined organic phases were dried over MgSO4. After evaporation of the solvent column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc/NEt3 18:1:1, F16-36) afforded the 
product (R)-30a as colourless solid with > 99.5 % ee (252 mg, 90%). 
 
C22H24O2 (320.42 g*mol−1): 
m.p. 95 °C. 
Rf = 0.47 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.93 (s, 3 H, COCH3), 2.24 (s, 3 H, COCH3), 2.30 (s, 6 H, 
CH3), 4.24-4.35 (m, 2 H, CHCH(COCH3)2 and CHCH(COCH3)2), 6.09 (dd, J(H,H) = 15.8, 
7.0 Hz, 1 H, ArCHCH), 6.36 (d, J(H,H) = 15.8 Hz, 1 H, ArCHCH), 7.02-7.21 (m, 8 H, Ar-
H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.2 (CH3), 21.3 (CH3), 29.9 (COCH3), 30.1 
(COCH3), 49.0 (CHCH(COCH3)2), 74.8 (CHCH(COCH3)2), 126.4 (CH), 127.9 (CH), 128.5 
(CH), 129.3 (CH), 129.8 (CH), 131.4 (CH), 134.0 (3’-Ar-i-C), 137.0 (Ar-C), 137.3 (Ar-C), 
137.6 (Ar-C), 203.1 (COCH3), 203.2 (COCH3) ppm. 
IR (KBr): ν~  = 3026m, 2929m, 2863m, 1914w, 1727s, 1512s, 1416s, 1359s, 1276s, 1139s, 
1065m, 1038w, 973s, 927m, 820s, 721w, 581w, 527m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 359 (24, [M+K]+), 302 (29, [M−C7H5O]+), 277 (100, 
C17H17+), 129 (19), 105 (22, C8H9+), 43 (36, CH3CO+). 
[ ]20Da = −11.0 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 254 nm): 
tR = 16.3 (R), 17.8 (S) min (> 99.5% ee). 
Elemental analysis calcd. (%) for C22H24O2: C 82.46, H 7.55; found: C 82.14, H 7.60. 
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(S)-3-[1’,3’-Di-(4’’-tolyl)-prop-2’-enyl]-pentane-2,4-dione ((S)-30a) 
 
 
The allylic alkylation was carried out in analogy to the preparation of (R)-30a using 
[Pd(C3H5)Cl]2 (8.01 mg, 21.9 µmol), ligand (S)-27 (19.6 mg, 52.5 µmol), benzoate 38a 
(300 mg, 0.875 mmol), acetyl acetone (275 mg, 2.74 mmol), BSA (534 mg, 2.63 mmol), and 
catalytic amounts of dried KOAc (ca. 5.00 mg) in CH2Cl2 (5.5 mL). Compound (S)-30a was 
obtained as colourless solid with > 99.5% ee (264 mg, 94%).  
 
[ ]20Da = +11.4 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 254 nm): 
tR = 16.3 (R), 17.8 (S) min (> 99.5% ee). 
 
 
(R)-3-[1’,3’-Di-(4’’-ethylphenyl)-prop-2’-enyl]-pentane-2,4-dione ((R)-30b) 
 
 
The allylic alkylation was carried out in analogy to the preparation of (R)-30a using 
[Pd(C3H5)Cl]2 (5.01 mg, 13.7 µmol), ligand (R)-27 (12.2 mg, 32.7 µmol), benzoate 38b 
(200 mg, 0.539 mmol), acetyl acetone (162 mg, 1.62 mmol), BSA (330 mg, 1.62 mmol), and 
catalytic amounts of dried KOAc (ca. 5.00 mg) in CH2Cl2 (4.1 mL). The crude product was 
purified by column chromatography (silica gel, 3 × 25 cm, hexanes/EtOAc/NEt3 18:1:1, F12-
29) and compound (R)-30b was obtained as colourless solid with > 99% ee (305 mg, quant.).  
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C24H28O2 (348.48 g*mol−1): 
m.p. 65 °C. 
Rf = 0.48 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.19 (t, J(H,H) = 7.7 Hz, 3 H, CH2CH3), 1.20 (t, 
J(H,H) = 7.7 Hz, 3 H, CH2CH3), 1.93 (s, 3 H, COCH3), 2.24 (s, 3 H, COCH3), 2.58 (q, 
J(H,H) = 7.7 Hz, 2 H, CH2), 2.59 (q, J(H,H) = 7.7 Hz, 2 H, CH2), 4.25-4.35 (m, 2 H, 
CHCH(COCH3)2 and CHCH(COCH3)2), 6.10 (ddd, J(H,H) = 15.8, 7.0, 1.0 Hz, 1 H, 
ArCHCH), 6.37 (d, J(H,H) = 15.8 Hz, 1 H, ArCHCH), 7.04-7.24 (m, 8 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 15.5 (CH2CH3), 15.7 (CH2CH3), 28.5 (CH2), 28.7 
(CH2), 29.9 (COCH3), 30.2 (COCH3), 49.0 (CHCH(COCH3)2), 74.8 (CHCH(COCH3)2), 
126.5 (CH), 127.9 (CH), 128.1 (CH), 128.6 (CH), 128.7 (CH), 131.4 (CH), 134.4 (3-Ar-i-C), 
137.5 (Ar-C), 143.3 (Ar-C), 144.0 (Ar-C), 203.1 (COCH3), 203.2 (COCH3) ppm. 
IR (KBr): ν~  = 3008m, 2962s, 2871m, 1914w, 1730s, 1510s, 1456m, 1417s, 1357s, 1277s, 
1239s, 1167m, 1140m, 1052w, 1016w, 969s, 821s, 620w, 532w, 491m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 387 (25, [M+K]+), 330 (26), 305 (22), 249 (100, C19H21+), 
119 (22), 57 (17), 43 (36, CH3CO+). 
[ ]20Da = −9.8 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 99:1, 0.9 mL*min−1, 30 °C, 254 nm): 
tR = 24.4 (R), 25.9 (S) min (> 99% ee). 
Elemental analysis calcd. (%) for C24H28O2: C 82.72, H 8.10, O 9.18; found: C 82.40, H 
8.05, O 9.35. 
 
 
(S)-3-[1’,3’-Di-(4’’-ethylphenyl)-prop-2’-enyl]-pentane-2,4-dione ((S)-30b) 
 
 
The allylic alkylation was carried out in analogy to the preparation of (R)-30a using 
[Pd(C3H5)Cl]2 (4.00 mg, 10.9 µmol), ligand (S)-27 (9.20 mg, 24.6 µmol), benzoate 38b 
(150 mg, 0.405 mmol), acetyl acetone (127 mg, 1.28 mmol), BSA (259 mg, 1.27 mmol), and 
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catalytic amounts of dried KOAc (ca. 5.00 mg) in CH2Cl2 (2.7 mL). Compound (S)-30b was 
obtained as colourless solid with > 99% ee (131 mg, 93%).  
 
[ ]20Da = +10.1 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 99:1, 0.9 mL*min−1, 30 °C, 254 nm): 
tR = 24.4 (R), 25.9 (S) min (> 99% ee). 
 
 
(R)-N-[1,3-Di-(4’-tolyl)-prop-2-enyl]-phthalimide ((R)-58a) 
 
 
In a Young tube a solution of [Pd(C3H5)Cl]2 (8.00 mg, 21.9 µmol) and ligand (S)-27 
(19.3 mg, 51.7 µmol) in CH2Cl2 (2.0 mL) was degassed by three freeze-pump-thaw cycles. 
The ampoule was sealed at 0.01 mbar and the solution stirred at 50 °C for 2 h. After the 
mixture had been cooled to r.t. it was added to a degassed solution of benzoate 38a (301 mg, 
0.875 µmol) and potassium phthalimide (194 mg, 1.05 mmol) in CH2Cl2 (4.0 mL) in a Young 
tube and the resulting yellow suspension was stirred at r.t. under argon. After 3 d the reaction 
was diluted with Et2O (50 mL) and ice-cold saturated aqueous NH4Cl solution (40 mL) was 
added. The organic phase was extracted with Et2O (3 × 30 mL) and the combined organic 
phases were dried over MgSO4. After evaporation of the solvent column chromatography 
(silica gel, 3 × 20 cm, hexanes/EtOAc/NEt3 18:1:1, F20-34) afforded the product (R)-58a as 
colourless oil with 97% ee (322 mg, quant.). 
 
C25H21NO2 (367.44 g*mol−1): 
Rf = 0.27 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 2.32 (s, 3 H, CH3), 2.33 (s, 3 H, CH3), 6.07 (d, 
J(H,H) = 8.7 Hz, 1 H, CHN), 6.65 (d, J(H,H) = 15.8 Hz, 1 H, ArCHCH), 6.97 (dd, 
N
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J(H,H) = 15.8, 8.7 Hz, 1 H, ArCHCH), 7.17 (mc, 4 H, Ar-H), 7.39 (mc, 4 H, Ar-H), 7.68-7.73 
(m, 2 H, Ar-H), 7.81-7.85 (m, 2 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.2 (CH3), 21.4 (CH3), 56.5 (CHN), 123.5 (CH), 
124.5 (CH), 126.8 (CH), 127.5 (CH), 129.4 (CH), 132.2 (Ar-C), 133.7 (Ar-C), 134.1 (CH), 
134.2 (CH), 136.2 (Ar-C), 137.6 (Ar-C), 138.0 (Ar-C), 168.0 (NCO) ppm. 
IR (KBr): ν~  = 3024m, 2923s, 1773m, 1712s, 1612s, 1513m, 1467m, 1381s, 1328m, 1232w, 
1180w, 1107m, 1080m, 971m, 802m, 718s, 630m cm–1. 
MS (EI, 70 eV): m/z (%) = 367 (10, M+), 352 (6, [M−CH3]+), 349 (5), 221 (21, 
[M−C8H4NO2]+), 220 (100), 205 (22), 129 (7).  
[ ]20Da = −11.2 (c = 0.500, CHCl3).  
HPLC (Daicel Chiracel OD-H, heptane/isopropanol 99:1, 0.5 mL*min−1, 20 °C, 254 nm): 
tR = 16.9 (R), 18.5 (S) min (97% ee). 
HRMS (EI) m/z calcd. (%) for C25H21NO2: 367.1560; found: 367.1572. 
 
 
(S)-N-[1,3-Di-(4’-ethylphenyl)-prop-2-enyl]-phthalimide ((S)-58b) 
 
 
The allylic amination was carried out in analogy to the preparation of (R)-58a using 
[Pd(C3H5)Cl]2 (11.4 mg, 31.2 µmol), ligand (R)-27 (28.0 mg, 75.0 µmol), benzoate 38b 
(465 mg, 1.24 mmol), and potassium phthalimide (277 mg, 1.49 mmol) in CH2Cl2 (8.5 mL). 
The crude product was purified by column chromatography (silica gel, 3  × 25 cm, 
hexanes/EtOAc/NEt3 18:1:1, F11-30) and (S)-58b was obtained as colourless oil with 97% ee 
(475 mg, 97%). 
 
C27H25NO2 (395.49 g*mol−1): 
Rf = 0.30 (hexanes/EtOAc 4:1). 
N
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1H NMR (400 MHz, CDCl3): δ = 1.19 (t, J(H,H) = 7.6 Hz, 3 H, CH3), 1.20 (t, 
J(H,H) = 7.6 Hz, 3 H, CH3), 2.61 (q, J(H,H) = 7.6 Hz, 2 H, CH2), 2.62 (q, J(H,H) = 7.6 Hz, 
2 H, CH2), 6.08 (d, J(H,H) = 8.5 Hz, 1 H, CHN), 6.66 (d, J(H,H) = 15.9 Hz, 1 H, ArCHCH), 
6.99 (dd, J(H,H) = 15.9, 8.5 Hz, 1 H, ArCHCH), 7.12 (mc, 4 H, Ar-H), 7.42 (mc, 4 H, Ar-H), 
7.68-7.72 (m, 2 H, Ar-H), 7.82-7.86 (m, 2 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 15.6 (CH3), 15.7 (CH3), 28.6 (CH2), 28.8 (CH2), 56.5 
(CHN), 123.5 (CH), 124.7 (CH), 126.9 (CH), 127.6 (CH), 128.2 (CH), 128.2 (CH), 132.2 
(Ar-C), 133.9 (Ar-C), 134.1 (CH), 134.2 (CH), 136.4 (Ar-C), 143.9 (Ar-C), 144.5 (Ar-C), 
168.0 (NCO) ppm.  
IR (KBr): ν~  = 2965s, 1772m, 1713s, 1611m, 1512m, 1466m, 1383s, 1326m, 1226w, 1181w, 
1121m, 973m cm–1. 
MS (EI, 70 eV): m/z (%) = 395 (10, M+), 366 (53, [M−C2H5]+), 249 (23, [M−C8H4NO2]+), 
248 (100), 219 (43), 104 (9).  
[ ]20Da = +10.8 (c = 0.500, CHCl3).  
HPLC (Daicel Chiracel OD-H, heptane/isopropanol 99:1, 0.5 mL*min−1, 25 °C, 254 nm): 
tR = 16.8 (S), 18.3 (R) min (97% ee). 
HRMS (EI) m/z calcd. (%) for C27H25NO2: 395.1897; found: 395.1885. 
 
 
(S)-2,2-Dimethyl-5-(1’,3’-diphenylprop-2’-enyl)-1,3-dioxane-4,6-dione (26) 
 
 
In a Young tube a solution of [Pd(C3H5)Cl]2 (8.10 mg, 22.2 µmol) and ligand (S)-27 
(16.6 mg, 44.4 µmol) in CH2Cl2 (2.5 mL) was degassed by three freeze-pump-thaw cycles. 
The ampoule was sealed at 0.01 mbar and the solution stirred at 50 °C for 2 h. After the 
mixture had been cooled to r.t. it was added to a degassed solution of benzoate 21 (349 mg, 
1.11 mmol), Meldrum’s acid (240 mg, 1.67 mmol) and DBU (338 mg, 1.67 mmol) in CH2Cl2 
(4.0 mL) in a Young tube. The resulting yellow mixture was stirred at 50 °C for 6 d. After 
cooling the solution to r.t. it was diluted with Et2O (30 mL) and ice-cold saturated aqueous 
26
OO
OO
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NH4Cl solution (50 mL) was added. The aqueous phase was extracted with Et2O (2 × 30 mL) 
and the combined organic phases were dried over MgSO4. After evaporation of the solvent 
column chromatography (3 × 20 cm, silica gel, hexanes/EtOAc 4:1) afforded product 26 as 
colourless solid with 81% ee (116 mg, 31%).  
 
C21H20O4 (336.38 g*mol−1): 
m.p. 141 °C. 
Rf = 0.32 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.48 (s, 3 H, CH3), 1.72 (s, 3 H, CH3), 3.97 (d, J(H,H) = 
2.7 Hz, 1 H, CHCH(CO2)2), 4.74 (dd, J(H,H) = 9.3, 2.7 Hz, 1 H, CHCH(CO2)2), 6.66 (d, 
J(H,H) = 15.8 Hz, 1 H, ArCHCH), 6.92 (dd, J(H,H) = 15.8, 9.3 Hz, 1 H, ArCHCH), 7.20-
7.50 (m, 10 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 27.8 (CH3), 28.4 (CH3), 47.6 (CHCH(CO2)2), 52.6 
(CHCH(CO2)2), 52.6 (C(CH3)2), 126.7 (Ar-CH), 127.5 (CH), 127.9 (CH), 128.0 (CH), 128.6 
(Ar-CH), 128.7 (Ar-CH), 128.8 (Ar-CH), 133.5 (CH), 136.8 (3-Ar-i-C), 139.9 (1-Ar-i-C), 
164.6 (CO2), 164.6 (CO2) ppm. 
IR (KBr): ν~  = 2895m, 1785s, 1744s, 1643s, 1495m, 1450m, 1385m, 1315s, 1270s, 1232m, 
1198m, 1118m, 1056m, 1011m, 975w, 926w, 897w, 852w, 797w, 752m, 700s cm–1. 
MS (FAB, NBA): m/z (%) = 250 (6), 221 (100), 193 (55, [M−C6H3O4]+), 115 (32). 
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 81:19, 0.5 mL*min−1, 20 °C, 254 nm): 
tR = 16.2 (R), 21.5 (S) min (81% ee). 
Elemental analysis calcd. (%) for C21H20O4: C 74.98, H 5.99; found: C 74.76, H 6.14. 
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7.3.2 Carbocyclic Substrates  
(R)-α-Phenylethylammonium (S)-cyclohex-3-enylcarboxylate (207a)[99, 100]  
 
 
A solution of cyclohex-3-enecarboxylic acid 66 (21.3 g, 169 mmol) in acetone (100 mL) was 
treated with (R)-α-phenylethylamine (23.6 g, 194 mmol) and the mixture was gently heated at 
70 °C. After all solids had been dissolved, the mixture was allowed to cool to r.t. and then 
kept in the refridgerator overnight. The precipitate was collected and seven further re-
crystallisations, carried out in the same manner as the first, gave the enantiomerically enriched 
salt 207a as colourless needles (7.41 g, 18%). 
 
C15H21NO2 (247.33 g*mol−1): 
m.p. 119-120 °C. 
1H NMR (400 MHz, CDCl3): δ = 1.30 (br s, 1 H, CH2), 1.52 (d, J(H,H) = 6.5 Hz, 3 H, CH3), 
1.69 (br s, 1 H, CH2), 1.93 (br s, 4 H, CH2), 2.04 (br s, 1 H, CH), 4.2 (q, J(H,H) = 6.5 Hz, 
1 H, CHN), 5.56 (br s, 2 H, CHCH and CHCH), 7.22-7.34 (m, 3 H, Ar-H), 7.36-7.44 (m, 2 H, 
Ar-H), 8.30 (br s, 3 H, NH3) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 22.3 (CH3), 25.1 (CH2), 25.9 (CH2), 28.5 (CH2), 41.8 
(CHCO2−), 51.1 (CHN), 126.2 (CHCH), 126.5 (Ph-o-CH), 126.8 (CHCH), 128.1 (Ph-p-CH), 
128.8 (Ph-m-CH), 141.0 (Ph-i-C), 183.0 (CO2−) ppm. 
IR (KBr): ν~  = 2909s, 2687s, 1573s, 1530s, 1452m, 1397s, 1338s, 1264s, 1196m, 1154m, 
1087w, 1023w, 920w, 822w, 764m, 696s, 675s, 646m cm–1.  
MS (EI, 70 eV): m/z (%) = 126 (8, C7H10O2+), 120 (6), 106 (100, C8H10N+), 81 (35, C6H9+), 
53 (11). 
[ ]20Da = −40.4 (c = 1.00, CHCl3); Lit.: −40.2 (c = 1.00, CHCl3).[99]  
Elemental analysis calcd. (%) for C15H21NO2: C 72.84, H 8.56, N 5.66; found: C 72.70, H 
7.97, N 4.42. 
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O
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(S)-α-Phenylethylammonium (R)-cyclohex-3-enylcarboxylate (207b)[99, 100] 
 
 
In analogy to the preparation of 207a resolution of cyclohex-3-enecarboxylic acid 66 (8.79 g, 
69.7 mmol) was effected by six re-crystallisations of the corresponding salt, from (S)-α-
phenylethylamine (10.1 g, 83.3 mmol). The product 207b was obtained as colourless needles 
(2.00 g, 12%). 
 
[ ]20Da = +40.2 (c = 1.00, CHCl3); Lit.: +40.5 (c = 1.00, CHCl3).[99] 
 
 
(S)-Cyclohex-3-enecarboxylic acid ((S)-66)[99, 100] 
 
 
(R)-α-Phenylethylammonium (S)-cyclohex-3-enylcarboxylate (207a, 988 mg, 3.99 mmol) 
was dissolved in ice water (100 mL) and treated with 1 M aqueous HCl (10 mL). The mixture 
was stirred for 5 min and then extracted with CH2Cl2 (3 × 100 mL). The combined organic 
phases were dried over MgSO4 and the solvent was removed under reduced pressure. The free 
carboxylic acid (S)-66 was isolated as colourless liquid with 96.5% ee (511 mg, quant.). 
 
C7H10O2 (126.15 g*mol−1): 
1H NMR (400 MHz, CDCl3): δ = 1.71 (mc, 1 H, 6-H), 1.99-2.16 (m, 3 H, 6-H and 5-H), 2.27 
(mc, 2 H, 2-H), 2.60 (mc, 1 H, 1-H), 5.66 (s, 2 H, 3-H and 4-H), 11.44 (br s, 1 H, CO2H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 24.4 (5-CH2), 24.9 (6-CH2), 27.3 (2-CH2), 39.3 (1-
CH), 125.1 (CHCH), 126.8 (CHCH), 182.8 (CO2H) ppm. 
IR (KBr): ν~  = 2928br, 1705s, 1423m, 1302m, 1238m, 1193m, 1089w, 1044w, 920m, 818w, 
747w, 651m cm–1.  
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MS (EI, 70 eV): m/z (%) = 126 (22, M+), 108 (29), 81 (100, C6H9+), 54 (29). 
[ ]20Da = −89.8 (c = 1.14, MeOH); Lit.: −95.9 (c = 1.00, CHCl3).[99] 
GC (γ-CD, DetTBuSil SE 54, 75/0/2/150/0/20/180): tR = 26.0 (S), 27.0 (R) min (96.5 % ee). 
Elemental analysis calcd. (%) for C7H10O2: C 66.65, H 7.99; found: C 66.38, H 7.97. 
 
 
(R)-Cyclohex-3-enecarboxylic acid ((R)-66)[99, 100] 
 
 
The synthesis of (R)-66 was accomplished in analogy to the preparation of (S)-66 starting 
from (S)-α-phenylethylammonium (R)-cyclohex-3-enylcarboxylate (207b, 696 mg, 
2.81 mmol) with 1 M aqueous HCl (10 mL). The free carboxylic acid (R)-66 was isolated as 
colourless liquid with 95.5% ee (410 mg, quant.). 
 
[ ]20Da = +95.6 (c = 1.00, CH3Cl); Lit.: +95.3 (c = 1.00, CHCl3).[99] 
GC (γ-CD, DetTBuSil SE 54, 75/0/2/150/0/20/180): tR = 26.0 (S), 27.0 (R) min (> 95.5% ee). 
 
 
4-Iodo-6-oxa-bicyclo[3.2.1]octan-7-one (67)[101]  
 
 
Cyclohex-3-enecarboxylic acid (66, 1.01 g, 8.43 mmol) was added to a solution of NaHCO3 
(2.02 g, 24.0 mmol) in water (20 mL) and the resulting mixture was stirred, until it was 
homogeneous. The flask was then protected from light and the mixture treated with a solution 
of KI (8.40 g, 50.6 mmol) and iodine (2.14 g, 8.41 mmol) in water (20 mL). The reaction 
mixture was stirred at r.t. for 20 h and then extracted with CHCl3 (3 × 50 mL). The organic 
OH
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phases were combined, washed with 10% aqueous Na2S2O3, 10% aqueous NaHCO3 and water 
and then dried over MgSO4. Removal of the solvent under reduced pressure gave 67 as off-
white solid (1.91 g, 95%). 
 
C7H9IO2 (252.0 g*mol−1): 
m.p. 138 °C. 
1H NMR (400 MHz, CDCl3): δ = 1.75-1.92 (m, 2 H), 2.03 (dd, J(H,H) = 16.6, 5.0 Hz, 1 H), 
2.34-2.49 (m, 2 H), 2.64-2.70 (m, 1 H), 2.77 (d, J(H,H) = 12.3 Hz, 1 H, 1-H), 4.49 (br t, 
J(H,H) = 4.6 Hz, 1 H, 4-H), 4.82 (br t, J(H,H) = 5.2 Hz, 1 H, 3-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 22.2 (2-CH2), 23.9 (4-CH), 29.8 (3-CH2), 34.6 (6-
CH2), 38.7 (1-CH), 80.3 (5-CH), 177.9 (7-CO) ppm. 
IR (KBr): ν~  = 2932m, 2853m, 1772s, 1442m, 1348m, 314m, 1269m, 1162s, 1076m, 1002s, 
953s, 897m, 830m cm–1.  
MS (EI, 70 eV): m/z (%) = 252 (3, M+), 125 (50, [M−I]+), 81 (100), 41 (29). 
Elemental analysis calcd. (%) for C7H9IO2: C 33.36, H 3.60; found: C 33.39, H 3.45. 
 
 
(1S,4S,5S)-4-Iodo-6-oxa-bicyclo[3.2.1]octan-7-one ((S,S,S)-67)[101] 
 
 
The iodolactonisation was carried out in analogy to the preparation of 67 using (S)-cyclohex-
3-enecarboxylic acid ((S)-66, 333 mg, 2.64 mmol), NaHCO3 (665 mg, 7.91 mmol), KI 
(2.62 g, 15.8 mmol) and iodine (701 mg, 2.77 mmol) in water (14 mL). Lactone (S,S,S)-67 
was isolated as off-white solid (594 mg, 90%). 
 
[ ]20Da = −41.3 (c = 2.00, CHCl3); Lit.: −43.2 (c = 2.00, CHCl3).[146]  
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(1R,4R,5R)-4-Iodo-6-oxa-bicyclo[3.2.1]octan-7-one ((R,R,R)-67)[101] 
 
 
The iodolactonisation was accomplished in analogy to the preparation of 67 using (R)-
cyclohex-3-enecarboxylic acid ((R)-66, 533 g, 4.22 mmol), NaHCO3 (1.06 g, 12.7 mmol), KI 
(4.21 g, 25.4 mmol) and iodine (1.13 g, 4.47 mmol) in water (20 mL). The lactone (R,R,R)-67 
was obtained as off-white solid (946 mg, 89%). 
 
[ ]20Da = +36.9 (c = 1.92, CHCl3); Lit.: +37.6 (c = 2.03, CHCl3).[147]  
 
 
6-Oxa-bicyclo[3.2.1]oct-3-en-7-one (68)[102] 
 
 
To a solution of iodolactone 67 (5.53 g, 21.9 mmol) in abs. THF (120 mL) DBU (4.90 mL, 
32.8 mmol) was added and the mixture was stirred at reflux for 8 h. After being cooled to r.t. 
the mixture was poured into 0.5 M HCl and the resulting emulsion extracted with Et2O (3 × 
50mL). The combined organic phases were washed with brine, dried over Mg2SO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (silica gel, 5 × 20 cm, hexanes/EtOAc 2:1, F37-62) to give alkene 68 as a 
colourless oil (2.60 g, 96%). 
 
C7H8O2 (124.14 g*mol−1): 
Rf = 0.23 (hexanes/EtOAc 2:1). 
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1H NMR (400 MHz, CDCl3): δ = 2.06 (d, J(H,H) =11.2 Hz, 1 H), 2.37-2.54 (m, 3 H), 2.89 
(br s, 1 H), 4.72 (t, J(H,H) = 5.4 Hz, 1 H, 5-CH), 5.82 (mc, 1 H, CHCH), 6.20 (mc, 1 H, 
CHCH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 29.2 (2-CH2), 34.5 (6-CH2), 38.1 (1-CH), 73.4 (5-
CH), 129.4 (CHCH), 130.4 (CHCH), 179.5 (7-CO) ppm. 
IR (NaCl): ν~  = 2986m, 2908m, 1774s, 1632w, 1448m, 1382m, 1238m, 1244m, 1137s, 
1055m, 981m cm–1. 
MS (EI, 70 eV): m/z (%) = 124 (3, M+), 95 (5), 80 (100), 79 (95, C6H7+), 39 (22). 
Elemental analysis calcd. (%) for C7H8O2: C 67.73, H 6.50; found: C 67.43. H 6.75. 
 
(1S,5S)-6-Oxa-bicyclo[3.2.1]oct-3-en-7-one ((S,S)-68)[102] 
 
 
The synthesis was accomplished in analogy to the preparation of 68 using iodolactone (S,S,S)-
67 (507 mg, 2.01 mmol) and DBU (450 µL, 3.01 mmol) in abs. THF (12 mL). Alkene (S,S)-
68 was isolated as colourless oil (215 mg, 86%).  
 
[ ]20Da = −197.0 (c = 1.08, CHCl3); Lit.: −201.2 (c = 4.00, CHCl3).[146] 
 
 
(1R,5R)-6-Oxa-bicyclo[3.2.1]oct-3-en-7-one ((R,R)-68)[102] 
 
 
The synthesis was accomplished in analogy to the preparation of 68 using iodolactone 
(R,R,R)-67 (624 mg, 2.47 mmol) and DBU (554 µL, 3.70 mmol) in abs. THF (15 mL). The 
alkene (R,R)-68 was obtained as colourless oil (245 mg, 80%). 
O
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[ ]20Da = +253.0 (c = 1.50, CHCl3); Lit.: +179.2 (c = 9.76, CHCl3).[147] 
 
 
cis-Methyl 5-hydroxycyclohex-3-enecarboxylate (69a)[102] 
 
 
To a solution of lactone 68 (497 mg, 4.00 mmol) in anhydrous MeOH (20 mL) was added 
NaHCO3 (347 mg, 4.13 mmol). The mixture was stirred at r.t. for 7 h and the solvent was 
removed under reduced pressure. The residue was re-dissolved in water (15 mL) and 
extracted with Et2O (3 × 20 mL). The combined organic phases were washed with brine, dried 
over MgSO4 and concentrated under reduced pressure. Purification by column 
chromatography (silica gel, 3 × 10 cm, hexanes/EtOAc 9:1, F4-13) afforded hydroxy ester 
69a as a colourless oil (556 mg, 89%). 
 
C8H12O2 (156.18 g*mol−1): 
Rf = 0.24 (Et2O/hexanes 9:1). 
1H NMR (400 MHz, CDCl3): δ = 1.69 (ddd, J(H,H) = 12.8, 11.0, 8.1 Hz, 1 H), 2.17 (mc, 
1 H), 2.25-2.32 (m, 3 H), 2.67 (mc, 1 H), 3.69 (s, 3 H, CH3), 4.27 (br d, J(H,H) = 7.1 Hz, 1 H, 
5-H), 5.70-5.79 (m, 2 H, 3-H and 4-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 27.5 (2-CH2), 34.3 (6-CH2), 37.8 (1-CH), 52.1 (CH3), 
66.1 (5-CH), 127.0 (CHCH), 130.9 (CHCH), 175.8 (CO2) ppm. 
IR (NaCl): ν~  = 3403br, 3028s, 2952s, 1734s, 1653m, 1437s, 1379m, 1245s, 1200s, 1115m, 
1045s, 1003s, 939w, 917m, 888w, 767m cm–1.  
MS (EI, 70 eV): m/z (%) = 156 (2, M+), 139 (63, [M−OH]+), 97 (29, [M−CO2CH3]+), 79 (100, 
C6H7+), 41 (9). 
Elemental analysis calcd. (%) for C8H12O2: C 61.52, H 7.74; found: C 61.18, H 7.84. 
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(1S,5S)-Methyl 5-hydroxycyclohex-3-enecarboxylate ((S,S)-69a)[102] 
 
 
The synthesis in analogy to the preparation of 69a using lactone (S,S)-68 (225 mg, 
1.81 mmol) and NaHCO3 (152 mg, 1.81 mmol) in anhydrous MeOH (9.0 mL) gave (S,S)-69a 
as colourless oil (246 mg, 87%). 
 
[ ]20Da = +3.5 (c = 1.46, CHCl3).  
 
 
(1R,5R)-Methyl 5-hydroxycyclohex-3-enecarboxylate ((R,R)-69a)[102] 
 
 
The synthesis in analogy to the preparation of 69a using lactone (R,R)-68 (300 mg, 
2.41 mmol) and NaHCO3 (206 mg, 2.45 mmol) in anhydrous MeOH (12 mL) gave (R,R)-69a 
as colourless oil (339 mg, 90%). 
 
[ ]20Da = −4.5 (c = 2.20, CHCl3); Lit.: −4.6 (c = 2.25, CHCl3).[102] 
 
 
cis-Ethyl 5-hydroxycyclohex-3-enecarboxylate (69b)[102]  
 
 
HO
OMe
O
(S,S)-69a
HO
OMe
O
(R,R)-69a
HO
OEt
O
69b
EXPERIMENTAL 
 149 
Lactone 68 (820 mg, 6.61 mmol) and NaHCO3 (610 mg, 7.27 mmol) were stirred in 
anhydrous EtOH (20 mL) at r.t. for 5 h. The solvent was removed under reduced pressure and 
the residue partitioned between Et2O (10 mL) and 1 M aqueous hydrochloric acid (10 mL). 
The aqueous phase was extracted with Et2O (2 × 20 mL) and the combined organic phases 
were washed with saturated aqueous solutions of NaHCO3 (40 mL) and NaCl (40 mL), dried 
over MgSO4 and concentrated under reduced pressure. Purification by column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 1:1, F17-28) afforded hydroxy ester 
69b as a colourless oil (864 mg, 77%). 
 
C9H14O3 (170.21 g*mol−1): 
Rf = 0.24 (Et2O/hexanes 9:1). 
1H NMR (400 MHz, CDCl3): δ = 1.26 (t, J(H,H) = 7.2 Hz, 3 H, CH3), 1.69 (J(H,H) = 12.8, 
11.1, 7.9 Hz, 1 H), 2.18 (br s, 1 H), 2.24-2.34 (m, 3 H), 2.66 (mc, 1 H), 4.12 (q, 
J(H,H) = 7.2 Hz, 2 H, CH2CH3), 4.27 (mc, 1 H), 5.71-5.80 (m, 2 H, 3-H and 4-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 14.3 (CH3), 27.6 (2-CH2), 34.3 (6-CH2), 38.0 (1-CH), 
60.9 (CH2CH3), 66.1 (5-CH), 127.1 (CHCH), 131.0 (CHCH), 175.4 (CO2) ppm. 
IR (NaCl): ν~  = 3035m, 2979m, 2936m, 1718s, 1653w, 1601m, 1584w, 1451s, 1378w, 
1273s, 1178s, 1111s, 1069s, 1026s, 998m, 955w, 927m, 858w, 806w cm–1.  
MS (EI, 70 eV): m/z (%) = 170 (1, M+), 153 (36, [M−OH]+), 97 (67, [M−CO2CH2CH3]+), 79 
(100, C6H7+), 41 (24). 
 
 
(1S,5S)-Ethyl 5-hydroxycyclohex-3-enecarboxylate ((S,S)-69b)[102] 
 
 
The synthesis in analogy to the preparation of 69b using lactone (S,S)-68 (209 mg, 
1.68 mmol) and NaHCO3 (161 mg, 1.92 mmol) in anhydrous EtOH (9.0 mL) gave (S,S)-69b 
as colourless oil (234 mg, 82%). 
 
[ ]20Da = −2.5 (c = 1.20, CHCl3). 
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(1R,5R)-Ethyl 5-hydroxycyclohex-3-enecarboxylate ((R,R)-69b)[102] 
 
 
The synthesis in analogy to the preparation of 69b using lactone (R,R)-68 (567 mg, 
4.64 mmol) and NaHCO3 (393 mg, 4.68 mmol) in anhydrous EtOH (30 mL) gave (R,R)-69b 
as colourless oil (749 mg, 95%). 
 
[ ]20Da = +2.8 (c = 1.20, CHCl3). 
 
 
cis-5-(Methoxycarbonyl)-cyclohex-2-enyl benzoate (65a) 
 
 
A solution of alcohol 69a (745 mg, 4.78 mmol), abs. NEt3 (1.33 mL, 9.55 mmol) and a 
spatula tip of DMAP (ca. 10 mg) in abs. CH2Cl2 (20 mL) was treated dropwise with BzCl 
(815 mg, 5.80 mmol) at –78 °C. The mixture was allowed to warm to r.t. overnight. After the 
reaction had been quenched with saturated aqueous NH4Cl solution (20 mL), the aqueous 
phase was extracted with CH2Cl2 (2 × 20 mL) and the combined organic phases were dried 
over MgSO4. The solvent was removed under reduced pressure and the residue purified by 
column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc/NEt3 18:1:1, F7-16) to yield 
benzoate 65a as a colourless solid (1.14 g, 92%). 
 
C15H16O4 (260.29 g*mol−1): 
m.p. 35 °C. 
Rf = 0.43 (hexanes/EtOAc 2:1). 
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1H NMR (400 MHz, CDCl3): δ = 1.96 (ddd, J(H,H) = 12.7, 10.8, 8.8 Hz, 1 H), 2.31-2.44 (m, 
2 H), 2.49 (mc, 1 H), 2.80 (mc, 1 H), 3.66 (s, 3 H, CH3), 5.64 (mc, 1 H, 1-H), 5.78 (mc, 1 H, 
CHCH), 5.93 (mc, 1 H, CHCH), 7.43 (t, J(H,H) = 7.6 Hz, 2 H, Bz-m-H), 7.55 (t, 
J(H,H) = 7.6 Hz, 1 H, Bz-p-H), 8.03 (mc, 2 H, Bz-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 27.3 (4-CH2), 30.7 (6-CH2), 37.8 (5-CH), 52.0 (CH3), 
69.6 (1-CH), 126.8 (3-CH), 128.4 (Bz-m-CH), 129.6 (Bz-o-CH), 129.8 (2-CH), 130.4 (Bz-i-
C), 133.1 (Bz-p-CH), 166.3 (CO2Ph), 174.8 (CO2CH3) ppm. 
IR (KBr): ν~  = 3030w, 2981m, 2940m, 1734s, 1686s, 1653m, 1617m, 1559m, 1507m, 
1457m, 1274m, 999m, 860w, 668m cm–1. 
MS (EI, 70 eV): m/z (%) = 260 (2, M+), 105 (100, C7H5O+), 77 (21, C6H5+). 
Elemental analysis calcd. (%) for C15H16O4: C 69.22, H 6.20; found: C 69.31, H 6.29. 
 
 
(1S,5S)-5-(Methoxycarbonyl)-cyclohex-2-enyl benzoate ((S,S)-65a) 
 
 
The synthesis in analogy to the preparation of 65a using alcohol (S,S)-69a (2.07 g, 
21.1 mmol), abs. NEt3 (5.90 mL, 42.4 mmol), DMAP (ca. 20 mg) and BzCl (468 mg, 
3.33 mmol) in abs. CH2Cl2 (12 mL) gave (S,S)-65a as colourless oil with 98% ee (632 mg, 
91%).  
 
[ ]20Da = −89.0 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 99.6:0.4, 0.9 mL*min−1, 35 °C, 220 nm): 
tR = 33.3 (S), 39.6 (R) min (98% ee). 
 
BzO
OMe
O
(S,S)-65a
CHAPTER 7 
 152 
(1R,5R)-5-(Methoxycarbonyl)-cyclohex-2-enyl benzoate ((R,R)-65a) 
 
 
The synthesis in analogy to the preparation of 65a using alcohol (R,R)-69a (235 mg, 
1.51 mmol), abs. NEt3 (420 µL, 3.01 mmol), DMAP (ca. 10 mg) and BzCl (253 mg, 
1.81 mmol) in abs. CH2Cl2 (7.0 mL) gave (R,R)-65a as colourless oil with 97% ee (350 mg, 
89%).  
 
[ ]20Da = +137.0 (c = 0.60, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 99.6:0.4, 0.9 mL*min−1, 35 °C, 220 nm): 
tR = 33.3 (S), 39.6 (R) min (97% ee). 
 
 
5-(Ethoxycarbonyl)-cyclohex-2-enyl benzoate (65b) 
 
 
A solution of alcohol 69b (500 mg, 2.94 mmol), abs. NEt3 (820 µL, 5.88 mmol) and a spatula 
tip of DMAP (ca. 10 mg) in abs. CH2Cl2 (13 mL) was treated dropwise with BzCl (500 mg, 
3.56 mmol) at –78 °C. The mixture was allowed to warm to r.t. overnight. After the reaction 
had been quenched with saturated aqueous NH4Cl solution (15 mL), the aqueous phase was 
extracted with CH2Cl2 (2 × 20 mL) and the combined organic phases were dried over MgSO4. 
The solvent was removed under reduced pressure and the residue purified by column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc/NEt3 18:1:1, F5-16) to yield benzoate 
65b as a colourless oil (661 mg, 82%). 
 
C16H18O4 (274.31 g*mol−1): 
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Rf = 0.32 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.22 (t, J(H,H) = 7.1 Hz, 3 H, CH3), 1.93 (ddd, 
J(H,H) = 12.3, 9.3 Hz, 1 H), 2.30-2.42 (m, 2 H), 2.48 (mc, 1 H), 2.78 (mc, 1 H), 4.12 (mc, 
2 H), 5.65 (mc, 1 H, 1-H), 5.77 (d, J(H,H) = 10.4 Hz, 1 H, CHCH), 5.93 (d, 
J(H,H) = 10.4 Hz, 1 H, CHCH), 7.43 (t, J(H,H) = 7.8 Hz, 2 H, Bz-m-H), 7.55 (t, 
J(H,H) = 7.7 Hz, 1 H, Bz-p-H), 8.03 (d, J(H,H) = 7.7 Hz, 2 H, Bz-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 14.3 (CH3), 27.3 (4-CH2), 30.7 (6-CH2), 38.0 (5-CH), 
60.7 (CH2CH3), 69.8 (1-CH), 126.9 (3-CH), 128.4 (Bz-m-CH), 129.6 (Bz-o-CH), 129.8 (2-
CH), 130.4 (Bz-i-C), 133.1 (Bz-p-CH), 166.3 (CO2Ph), 174.8 (CO2CH2CH3) ppm. 
IR (KBr): ν~  = 3035w, 2979m, 2936m, 1715s, 1601m, 1451s, 1378m, 1275s, 1178s, 1111s, 
1026s, 998m, 955m, 927m, 858w, 712s cm–1. 
MS (EI, 70 eV): m/z (%) = 274 (3, M+), 105 (100, C7H5O+), 77 (18, C6H5+). 
Elemental analysis calcd. (%) for C16H18O4: C 70.06, H 6.61; found: C 69.94, H 6.80. 
 
 
(1S,5S)-5-(Ethoxycarbonyl)-cyclohex-2-enyl benzoate ((S,S)-65b) 
 
 
The synthesis in analogy to the preparation of 65b using alcohol (S,S)-69b (234 mg, 
1.38 mmol), abs. NEt3 (395 µL, 2.84 mmol), DMAP (ca. 5 mg) and BzCl (235 mg, 
1.67 mmol) in abs. CH2Cl2 (6.0 mL) gave (S,S)-65b as colourless oil with 97% ee (302 mg, 
80%).  
 
[ ]20Da = −87.0 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel OD, heptane/isopropanol 99:1, 0.5 mL*min−1, 20 °C, 220 nm): 
tR = 19.3 (S), 20.8 (R) min (97% ee). 
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(1R,5R)-5-(Ethoxycarbonyl)-cyclohex-2-enyl benzoate ((R,R)-65b) 
 
 
The synthesis in analogy to the preparation of 65b using alcohol (R,R)-69b (532 mg, 
3.13 mmol), abs. NEt3 (870 µL, 6.26 mmol), DMAP (ca. 10 mg) and BzCl (541 mg, 
3.86 mmol) in abs. CH2Cl2 (14 mL) gave (R,R)-65b as colourless oil with 97% ee (712 mg, 
83%).  
 
[ ]20Da = +90.3 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel OD, heptane/isopropanol 99:1, 0.5 mL*min−1, 20 °C, 220 nm): 
tR = 19.3 (S), 20.8 (R) min (97% ee).  
 
 
Cyclohex-2-enyl benzoate (77) 
 
 
The synthesis in analogy to the preparation of 65a using cyclohex-2-enol (2.07 g, 21.1 mmol), 
abs. NEt3 (5.90 mL, 42.4 mmol), DMAP (ca. 10 mg) and BzCl (3.55 g, 25.3 mmol) in abs. 
CH2Cl2 (30 mL) gave benzoate 77 after column chromatography (silica gel, 5 × 20 cm, 
hexanes/EtOAc/NEt3 18:1:1, F8-19) as colourless oil (3.86 g, 90%). 
 
C13H14O2 (202.24 g*mol−1): 
Rf = 0.50 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.64-1.74 (m, 1 H, CH2), 1.78-1.93 (m, 2 H, CH2), 1.93-
2.21 (m, 3 H, CH2), 5.51 (mc, 1 H, 1-H), 5.84 (mc, 1 H, CHCH), 6.00 (mc, 1 H, CHCH), 7.43 
(mc, 2 H, Bz-m-H), 7.54 (mc, 1 H, Bz-p-H), 8.06 (mc, 2 H, Bz-o-H) ppm. 
BzO
OEt
O
(R,R)-65b
BzO
77
EXPERIMENTAL 
 155 
13C{1H} NMR (101 MHz, CDCl3): δ = 19.1 (CH2), 25.1 (CH2), 28.5 (CH2), 68.7 (1-CH), 
125.8 (CH), 128.4 (Bz-CH), 129.2 (Bz-CH), 130.9 (Bz-i-C), 132.9 (CH), 133.0 (CH), 166.3 
(CO2) ppm. 
IR (KBr): ν~  = 3033m, 2939m, 2869m, 1965w, 1915w, 1712s, 1602m, 1491w, 1450s, 1395w, 
1271s, 1171m, 1110s, 1062m, 1010m, 918s, 851w, 713s cm–1. 
MS (EI, 70 eV): m/z (%) = 202 (17, M+), 105 (100, C7H5O+), 81 (25, C6H9+), 41 (13). 
Elemental analysis calcd. (%) for C13H14O2: C 77.20, H 6.98; found: C 77.29, H 7.13. 
 
 
cis-Methyl 5-[di-(methoxycarbonyl)-methyl]-cyclohex-3-enecarboxylate (79a)[148] 
 
 
In a Young tube benzoate 65a (53.4 mg, 0.205 mmol), Pd(PPh3)4 (8.30 mg, 7.18 µmol) and 
PPh3 (19.0 mg, 7.24 µmol) were stirred in abs. THF (1.0 mL) at r.t. After 20 min the solution 
was treated with the nucleophile, freshly prepared from NaH (12.8 mg, 0.535 mmol) and 
dimethyl malonate (98.7 mg, 0.747 mmol) in abs. THF (1.5 mL). The reaction mixture was 
heated under reflux for 15 h, cooled to r.t. and then partitioned between Et2O (10 mL) and 
saturated aqueous NH4Cl solution (10 mL). The aqueous phase was extracted with Et2O (2 × 
20 mL) and the combined organic phases were dried over MgSO4. After evaporation of the 
solvent column chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 5:2, F9-13) afforded 
79a as colourless oil (55.4 mg, quant.). 
 
C13H18O6 (270.28 g*mol−1): 
Rf = 0.19 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.42 (q, J(H,H) = 12.1 Hz, 1 H, CH2), 2.07 (d, 
J(H,H) = 9.7 Hz, 1 H, CH2), 2.17 (mc, 1 H, CH2), 2.27 (mc, 1 H, CH2), 2.62 (mc, 1 H, 2-H), 
2.69 (mc, 1 H, CH(CO2CH3)2), 3.26 (d, J(H,H) = 8.6 Hz, 1 H, 5-H), 3.37 (s, 3 H, CO2CH3), 
3.71 (s, 6 H, CH(CO2CH3)2), 5.51 (d, J(H,H) = 10.4 Hz, 1 H, CHCH), 5.76 (mc, 1 H, 
CHCH) ppm. 
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13C{1H} NMR (101 MHz, CDCl3): δ = 27.7 (2-CH2), 29.4 (6-CH2), 36.1 (5-CH), 39.4 (1-
CH), 51.6 (CO2CH3), 52.4 (CH(CO2CH3)2), 52.4 (CH(CO2CH3)2), 55.4 (CH(CO2CH3)2), 
127.3 (CHCH), 127.4 (CHCH), 167.0 (CO2), 168.5 (CO2), 175.4 (CO2) ppm. 
IR (KBr): ν~  = 3004w, 2955w, 2849w, 1739s, 1439m, 1339m, 1255m, 1165m, 1023m, 850w, 
706w, 461s cm–1. 
MS (EI, 70 eV): m/z (%) = 270 (5, M+), 239 (21, [M−OCH3]+), 238 (24), 210 (90, C11H14O4+), 
148 (51), 178 (93), 150 (72), 119 (62), 91 (64), 79 (100). 
 
 
Methyl 5-(2’,4’-dioxopentan-3’-yl)-cyclohex-3-enecarboxylate (80a) 
 
 
A suspension of NaH (69.0 mg, 2.88 mmol) in abs. THF (4.0 mL) was carefully treated with 
acetyl acetone (671 mg, 6.64 mmol) at 0 °C. A solution of benzoate 65a (480 mg, 
1.85 mmol), Pd(PPh3)4 (70.0 mg, 60.5 µmol) and PPh3 (150 mg, 0.572 mmol) in abs. THF 
(6.0 mL) was stirred for 15 min at r.t. and then added to the sodium salt of acetyl acetone. The 
reaction mixture was stirred at r.t. for 26 h. The thick yellow slurry was partitioned between 
Et2O (20 mL) and saturated aqueous NH4Cl solution (20 mL). The aqueous phase was 
extracted with Et2O (2 × 20 mL) and the combined organic phases were dried over MgSO4. 
After evaporation of the solvent column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc 3:1, F25-45) afforded the product 80a as light-yellow solid (420 mg, 96%). 
This consisted of a mixture of the cis-diastereomer (major) and the trans-diastereomer 
(minor) with a ratio of 73:27 according to 1H NMR spectroscopy. 
 
C13H18O4 (238.28 g*mol−1): 
Rf = 0.54 (hexanes/EtOAc 2:1). 
1H NMR (400 MHz, CDCl3, major cis-diastereomer): δ = 1.23 (q, J(H,H) = 12.3 Hz, 1 H, 
CH2), 1.99 (mc, 1 H, CH2), 2.10-2.16 (m, 1 H, CH2), 2.16 (s, 6 H, COCH3), 2.25 (mc, 1 H, 
CH2), 2.61 (mc, 1 H, 5-H), 3.08 (mc, 1 H, 1-H), 3.57 (d, J(H,H) = 9.7 Hz, 1 H, 3’-H), 3.64 (s, 
3 H, OCH3), 5.35 (d, J(H,H) = 10.6 Hz, 1 H, CHCH), 5.76 (mc, 1 H, CHCH) ppm. 
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1H NMR (400 MHz, CDCl3, characteristic signals of the minor trans-diastereomer): δ = 2.17 
(s, 6 H, COCH3), 3.65 (s, 3 H, OCH3), 5.46 (mc, 1 H, CHCH) ppm. 
13C{1H} NMR (101 MHz, CDCl3, major cis-diastereomer): δ = 27.7 (CH2), 29.6 (CH2), 30.0 
(COCH3), 30.2 (COCH3), 36.1 (5-CH), 39.3 (1-CH), 51.6 (OCH3), 73.9 (3’-CH), 127.3 
(CHCH), 127.7 (CHCH), 175.3 (CO2), 203.1 (COCH3), 203.3 (COCH3) ppm. 
13C{1H} NMR (101 MHz, CDCl3, minor trans-diastereomer): δ = 27.2 (CH2), 28.1 (CH2), 
29.5 (COCH3), 30.5 (COCH3), 33.7 (5-CH), 35.7 (1-CH), 51.7 (OCH3), 73.6 (3’-CH), 126.7 
(CHCH), 127.9 (CHCH), 175.2 (CO2), 202.9 (COCH3), 203.1 (COCH3) ppm. 
IR (KBr): ν~  = 2950m, 1731s, 1434m, 1360s, 1252s, 1168s, 1060w, 1002w, 960w, 888w, 
701m, 624m cm–1. 
MS (EI, 70 eV): m/z (%) = 238 (2, M+), 195 (100, [M−COCH3]+), 135 (74), 117 (55), 79 (47). 
 
 
cis-Methyl 5-(1’,3’-dioxoisoindolin-2’-yl)-cyclohex-3-enecarboxylate (81a) 
 
 
In a Young tube benzoate 65a (75.0 mg, 0.288 mmol), Pd(PPh3)4 (7.00 mg, 6.06 µmol) and 
PPh3 (23.0 mg, 8.76 µmol) were stirred in abs. THF (2.0 mL) at r.t. After 20 min potassium 
phthalimide (152 mg, 0.820 mmol) was added and the mixture heated under reflux for 8 h. 
The thick yellow reaction mixture was cooled to r.t. and partitioned between Et2O (10 mL) 
and saturated aqueous NH4Cl solution (10 mL). The aqueous phase was extracted with Et2O 
(2 × 20 mL) and the combined organic phases were dried over MgSO4. After evaporation of 
the solvent column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 4:1, F24-36) 
afforded 81a as colourless solid (82.2 mg, quant.). 
 
C16H15NO4 (285.29 g*mol−1): 
m.p. 108-110 °C. 
Rf = 0.15 (hexanes/EtOAc 4:1). 
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1H NMR (400 MHz, CDCl3): δ = 2.15-2.24 (m, 1 H, 6-H), 2.34 (t, J(H,H) = 12.4 Hz, 1 H, 2-
H), 2.38-2.45 (m, 2 H, 2-H and 6-H), 2.81 (mc, 1 H, 1-H), 3.69 (s, 3 H, CH3), 4.98 (mc, 1 H, 
5-H), 5.59 (dt, J(H,H) = 10.1, 1.8 Hz, 1 H, CHCH), 5.80 (mc, 1 H, CHCH), 7.71 (dd, 
J(H,H) = 5.6, 3.0 Hz, 2 H, Ar-H), 7.83 (dd, J(H,H) = 5.5, 3.0 Hz, 2 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 27.3 (2-CH2), 29.2 (6-CH2), 39.5 (1-CH), 47.5 (5-
CH), 52.0 (CH3), 123.4 (4-CH), 125.8 (CH), 128.1 (CH), 132.1 (Ar-C), 134.1 (CH), 168.0 
(CON), 174.8 (CO2) ppm. 
IR (KBr): ν~  = 3195w, 3040w, 2995w, 1712s, 1462m, 1385s, 1306s, 1214s, 1136m, 1109m, 
1056m, 1006m, 934m, 864w, 797w, 718s, 642m, 528m cm–1. 
MS (EI, 70 eV): m/z (%) = 285 (5, M+), 254 (15, [M−OCH3]+), 226 (32, [M−COCH3]+), 225 
(90), 148 (51), 138 (100, [M−C8H4NO2]+), 104 (53), 78 (62). 
 
 
cis-Methyl 5-(3’-methyl-2’,4’-dioxopentan-3’-yl)-cyclohex-3-enecarboxylate (83a) 
 
 
In a Young tube NaH (78.8 mg, 3.29 mmol) in abs. THF (5.0 mL) was treated with 3-
methylpentane-2,4-dione (520 mg, 4.56 mmol) resulting in a thick colourless suspension. A 
solution of benzoate 65a (329 mg, 1.27 mmol), Pd(PPh3)4 (43.9 mg, 37.9 µmol) and PPh3 
(99.5 mg, 37.9 µmol) in abs. THF (5.0 mL) was stirred for 15 min at r.t. and then added to the 
sodium salt of 3-methylpentane-2,4-dione. The resulting mixture was heated at 75 °C for 
17 h. After the reaction had been cooled to r.t., the thick yellow slurry was partitioned 
between Et2O (20 mL) and saturated aqueous NH4Cl solution (20 mL). The aqueous phase 
was extracted with Et2O (2 × 20 mL) and the combined organic phases were dried over 
MgSO4. After evaporation of the solvent column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc 4:1, F15-25) afforded the product 83a as light-yellow solid (320 mg, quant.). 
 
C14H20O4 (252.31 g*mol−1): 
m.p. 54-55 °C. 
Rf = 0.16 (hexanes/EtOAc 4:1). 
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1H NMR (400 MHz, CDCl3): δ = 1.26 (s, 3 H, 3’-CH3), 1.75-1.84 (m, 1 H), 2.08 (s, 3 H, 
COCH3), 2.06-2.19 (m, 2 H), 2.10 (s, 3 H, COCH3), 2.22-2.32 (m, 1 H), 2.60 (mc, 1 H), 3.40 
(mc, 1 H), 3.66 (s, 3 H, OCH3), 5.22 (d, J(H,H) = 11.1 Hz, 1 H, CHCH), 5.77 (mc, 1 H, 
CHCH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 13.7 (3’-CH3), 26.8 (CH2), 27.0 (COCH3), 27.0 
(COCH3), 27.8 (CH2), 39.4 (CH), 39.7 (CH), 51.9 (OCH3), 70.7 (3’-C), 127.1 (CHCH), 128.3 
(CHCH), 175.7 (CO2), 206.2 (COCH3), 206.6 (COCH3) ppm. 
IR (KBr): ν~  = 3031s, 2939s, 2856s, 1737s, 1694s, 1445s, 1317m, 1221s, 1129s, 1092m, 
956m, 892w, 835m, 776w, 738m, 650m cm–1. 
MS (FAB, NBA): m/z (%) = 307 (24, [M+H]+), 209 (18, [M−COCH3]+), 154 (100), 79 (38, 
C6H7+). 
Elemental analysis calcd. (%) for C14H20O4: C 66.65, H 7.99; found: C 66.41, H 8.00. 
 
 
Methyl 5-(2’,2’-dimethyl-4’,6’-dioxo-1’,3’-dioxan-5’-yl)-cyclohex-3-enecarboxyl-
ate (88a) 
 
 
In a Young tube benzoate 65a (72.8 mg, 0.280 mmol), Pd(PPh3)4 (9.60 mg, 8.31 µmol) and 
PPh3 (34.0 mg, 0.129 mmol) in abs. DMF (4.0 mL) were stirred for 15 min at r.t. The solution 
was treated with the sodium salt of Meldrum’s acid in DMF (3.0 mL), which had been freshly 
prepared from NaH (20.0 mg, 0.835 mmol) and 2,2-dimethyl-1,3-dioxane-4,6-dione (144 mg, 
0.998 mmol) at 0 °C. The resulting mixture was stirred for 20 h at 70 °C. The thick yellow 
reaction mixture was cooled to r.t. and then partitioned between Et2O (15 mL) and saturated 
aqueous NH4Cl solution (15 mL). The aqueous phase was extracted with Et2O (2 × 20 mL) 
and the combined organic phases were dried over MgSO4. After evaporation of the solvent 
purification of the crude product by column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc 2:1, F19-30) afforded 88a as off-white solid (26.0 mg, 33%). This consisted 
of a mixture of the cis-diastereomer (major) and the trans-diastereomer  (minor) in a ratio of 
75:25 according to 1H NMR spectroscopy. 
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C14H18O6 (282.29 g*mol−1): 
m.p. 111-112 °C. 
Rf = 0.22 (hexanes/EtOAc 2:1). 
1H NMR (500 MHz, CDCl3, major cis-diastereomer): δ = 1.76 (s, 3 H, C(CH3)(CH3)), 1.78 
(s, 3 H, C(CH3)(CH3)), 1.96 (q, J(H,H) = 12.1 Hz, 1 H, CH2), 2.09 (mc, 1 H, CH2), 2.30-2.35 
(m, 2 H, CH2), 2.68 (mc, 1 H, 1-H), 3.38 (mc, 1 H, 5-H), 3.56 (d, J(H,H) = 3.2 Hz, 1 H, 5’-H), 
3.67 (s, 3 H, OCH3), 5.52 (d, J(H,H) = 10.3 Hz, 1 H, CHCH), 5.83 (mc, 1 H, CHCH) ppm. 
1H NMR (500 MHz, CDCl3, characteristic signals of the minor trans-diastereomer): δ = 1.73 
(s, 6 H, C(CH3)2), 2.92 (mc, 1 H, 5-H), 3.51 (d, J(H,H) = 3.6 Hz, 1 H, 5’-H), 3.71 (s, 3 H, 
OCH3) ppm. 
13C{1H} NMR (125 MHz, CDCl3, major cis-diastereomer): δ = 27.4 (C(CH3)(CH3)), 27.5 
(CH2), 28.0 (CH2), 28.4 (C(CH3)(CH3)), 36.4 (5-CH), 39.7 (1-CH), 50.0 (5’-CH), 51.9 
(OCH3), 105.0 (C(CH3)2), 127.1 (CHCH), 127.5 (CHCH), 164.3 (CO2), 164.3 (CO2), 175.4 
(CO2CH3) ppm. 
13C{1H} NMR (125 MHz, CDCl3, characteristic signals of the minor trans-diastereomer): 
δ = 26.1 (CH2), 27.4 (CH2), 27.8 (C(CH3)(CH3)), 28.5 (C(CH3)(CH3)), 37.1 (1-CH), 50.3 (5’-
CH), 52.1 (OCH3), 126.3 (CHCH), 127.9 (CHCH) ppm. 
IR (KBr): ν~  = 3007m, 2950m, 2875m, 1778s, 1735s, 1604w, 1429m, 1388m, 1301s, 1167s, 
1068m, 994m, 933m, 863m, 807w, 706s cm–1. 
MS (FAB, NBA): m/z (%) = 283 (33, [M+H]+), 225 (100), 137 (71), 79 (51, C6H7+), 39 (28). 
 
 
Methyl 5-(4’,4’-dimethyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate (89a) 
 
 
In a Young tube a suspension of NaH (74.0 mg, 3.09 mmol) in DMF (12 mL) was treated 
with 5,5-dimethylcyclohexane-1,3-dione (490 mg, 4.29 mmol) at r.t. To the resulting turbid 
mixture a solution of benzoate 65a (307 mg, 1.18 mmol), Pd(PPh3)4 (43.0 mg, 37.2 µmol) and 
PPh3 (93.0 mg, 35.5 µmol) in abs. DMF (10 mL) was added. The reaction mixture was stirred 
30 min at r.t. and then 20 h at 70 °C. The thick yellow reaction mixture was cooled to r.t. and 
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partitioned between Et2O (20 mL) and saturated aqueous NH4Cl solution (20 mL). The 
aqueous phase was extracted with Et2O (2 × 20 mL) and the combined organic phases were 
dried over MgSO4. After evaporation of the solvent column chromatography (silica gel, 3 × 
25 cm, hexanes/EtOAc 1:1, F8-18) gave 89a as off-white solid (325 mg, 98%). This consisted 
of a mixture of the cis-diastereomer (major) and the trans-diastereomer (minor) in a ratio of 
75:25 according to 1H NMR spectroscopy. 
 
C16H22O4 (278.34 g*mol−1): 
m.p. 154-155 °C. 
Rf = 0.36 (hexanes/EtOAc 1:1). 
1H NMR (500 MHz, CDCl3, major cis-diastereomer): δ = 1.05 (s, 3 H, C(CH3)(CH3)), 1.07 
(s, 3 H, C(CH3)(CH3)), 1.50 (q, J(H,H) = 12.5 Hz, 1 H, CH2), 1.97 (mc, 1 H), 2.19 (mc, 1 H, 
CH2), 2.26 (br s, 2 H), 2.30 (mc, 1 H), 2.34 (br s, 1 H, CH2), 2.37 (mc, 1 H, CH2), 2.64-2.78 
(m, 2 H, CH2), 3.69 (s, 3 H, OCH3), 3.85 (mc, 1 H, 5-H), 5.78 (d, J(H,H) = 10.3 Hz, 1 H, 
CHCH), 6.08 (mc, 1 H, CHCH) ppm. 
1H NMR (500 MHz, CDCl3, minor trans-diastereomer): δ = 0.99 (d, J(H,H) = 9.4 Hz, 1 H), 
1.09 (s, 3 H, C(CH3)(CH3)), 1.09 (s, 3 H, C(CH3)(CH3)), 1.85 (mc, 1 H, CH2), 2.26 (br s, 2 H), 
2.31 (mc, 1 H), 2.32 (br s, 1 H, CH2), 2.39 (mc, 1 H, CH2), 2.42 (mc, 1 H, CH2), 2.47 (mc, 2 H, 
CH2), 3.70 (s, 3 H, OCH3), 3.77 (mc, 1 H, 5-H), 6.08 (mc, 1 H, CHCH), 6.19 (mc, 1 H, 
CHCH) ppm. 
13C{1H} NMR (125 MHz, CDCl3, major cis-diastereomer): δ = 27.6 (CH2), 27.9 
(C(CH3)(CH3)), 28.7 (C(CH3)(CH3)), 30.5 (CH2), 30.7 (5-CH), 31.9 (C(CH3)2), 39.5 (CH), 
43.0 (CH2), 50.4 (CH2), 51.9 (OCH3), 130.4 (CHCH), 130.5 (CHCH), 171.0 (CO), 197.4 
(CO) ppm. 
13C{1H} NMR (125 MHz, CDCl3, minor trans-diastereomer): δ = 27.5 (CH2), 27.9 
(C(CH3)CH3), 28.7 (C(CH3)(CH3)), 29.6 (5-CH), 31.2 (CH2), 31.8 (C(CH3)2), 36.4 (CH), 43.4 
(CH2), 50.6 (CH2), 52.0 (OCH3), 130.3 (CHCH), 131.8 (CHCH), 171.9 (CO2), 197.7 
(CO) ppm. 
IR (KBr): ν~  = 2955m, 2612m, 1728s, 1564s, 1376s, 1342s, 1254m, 1169s, 1062m, 1023m, 
947w, 886w, 812w, 755w cm–1. 
MS (EI, 70 eV): m/z (%) = 278 (34, M+), 237 (7, [M−OCH3]+), 217 (100), 194 (17), 134 (21), 
117 (8), 79 (17). 
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cis-Methyl 5-(1’-methyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate 
(90a)[105] 
 
 
In a Young tube benzoate 65a (295 mg, 1.13 mmol), Pd(PPh3)4 (40.0 mg, 34.6 µmol) and 
PPh3 (90.0 mg, 34.3 µmol) in abs. DMF (10 mL) were stirred for 15 min at r.t. A solution of 
the sodium salt of 2-methylcyclohexane-1,3-dione in DMF (8.0 mL), which had freshly been 
prepared from NaH (70.8 mg, 2.96 mmol) and 2-methylcyclohexane-1,3-dione (515 mg, 
4.08 mmol) at 0 °C, was added and the resulting mixture stirred at 70 °C for 21 h. The thick 
yellow reaction mixture was cooled to r.t. and partitioned between Et2O (20 mL) and 
saturated aqueous NH4Cl solution (20 mL). The aqueous phase was extracted with Et2O (2 × 
20 mL) and the combined organic phases were dried over MgSO4. After evaporation of the 
solvent column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 1:1, F8-18) afforded 
90a as light-yellow oil, which solidified at 4 °C (287 mg, 96%). 
 
C15H20O4 (264.32 g*mol−1): 
m.p. 84-86 °C. 
Rf = 0.36 (hexanes/EtOAc 2:1). 
1H NMR (500 MHz, CDCl3): δ = 1.07 (s, 3 H, 1’-CH3), 1.44 (mc, 1 H, 6-H), 1.71-1.79 (m, 
2 H, 6-H and 4’-H), 2.09-2.16 (m, 1 H, 4’-H), 2.16-2.31 (m, 2 H, 2-H), 2.54-2.59 (m, 1 H, 1-
H), 2.61-2.66 (m, 2 H, 3’-H and 5’-H), 2.70-2.93 (m, 2 H, 3’-H and 5’-H), 3.01-3.12 (m, 1 H, 
5-H), 3.67 (s, 3 H, OCH3), 5.29 (d, J(H,H) = 9.8 Hz, 1 H, 4-H), 5.80 (mc, 1 H, 3-H) ppm.  
13C{1H} NMR (125 MHz, CDCl3): δ = 11.2 (1’-CH3), 18.3 (4’-CH2), 27.0 (6-CH2), 27.5 (2-
CH2), 37.8 (5’-CH2), 38.2 (3’-CH2), 39.9 (1-CH), 42.2 (5-CH), 52.0 (OCH3), 77.4 (1’-C), 
124.8 (4-CH), 128.6 (3-CH), 175.2 (CO2), 208.6 (CO), 209.2 (CO) ppm. 
IR (KBr): ν~  = 3010m, 2961s, 2844m, 1724s, 1436s, 1370m, 1319s, 1254s, 1209s, 1092m, 
961m, 889m, 825m, 738w, 683m cm–1. 
MS (FAB, NBA): m/z (%) = 265 (62, [M+H]+), 233 (15, [M−OCH3]+), 208 (18), 139 (78, 
[M−C7H9O2]+), 127 (94), 79 (100, C6H7+), 39 (71). 
Elemental analysis calcd. (%) for C15H20O4: C 68.16, H 7.63; found: C 68.07, H 7.40. 
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(1S,5S)-Methyl 5-(1’-methyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate 
((S,S)-90a))[97] 
 
 
[Pd(C3H5)Cl]2 (2.10 mg, 5.47 µmol) and ligand (S,S)-93 (811 mg, 16.4 µmol) were stirred in 
CH2Cl2 (1.0 mL) at r.t. for 30 min. 2-Methylcyclohexane-1,3-dione (109 mg, 0.863 mmol) 
was added to a suspension of NaH (18.0 mg, 0.769 mmol) and tetrahexylammonium bromide 
(334 mg, 0.769 mmol) in abs. CH2Cl2 (2.0 mL) and DMF (0.5 mL) and the resulting mixture 
was treated with the catalyst solution. After 15 min at r.t. benzoate 65a (60.0 mg, 
0.231 mmol) was added. The thick yellow solution was stirred at r.t. for 24 h, diluted with 
Et2O (10 mL) and ice-cold saturated aqueous NH4Cl solution (20 mL) was added. The 
aqueous phase was extracted with Et2O (2 × 30 mL) and the combined organic phases were 
dried over MgSO4. After evaporation of the solvent the residue was purified by column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 3:1, F15-27) to give (S,S)-90a as light-
yellow oil with 96% ee (39.7 mg, 65%). 
 
[ ]20Da = −30.0 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.5 mL*min−1, 30 °C, 220 nm): 
tR = 51.7 (S), 56.3 (R) min (96% ee). 
 
 
(1R,5R)-Methyl 5-(1’-methyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate 
((R,R)-90a)) 
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In analogy to the preparation of (S,S)-90a the reaction of benzoate 65a using ligand (R,R)-93 
gave (R,R)-90a as light-yellow oil with 96% ee (42.8 mg, 70%). 
 
[ ]20Da = +30.0 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.5 mL*min−1, 30 °C, 220 nm): 
tR = 51.7 (S), 56.3 (R) min (96% ee). 
 
 
cis-Ethyl 5-(1’-methyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate (90b) 
 
 
In analogy to the preparation of 90a a solution of benzoate 65b (149 mg, 0.543 mmol), 
Pd(PPh3)4 (20.0 mg, 17.3 µmol) and PPh3 (40.0 mg, 152 µmol) in abs. DMF (7.0 mL) was 
treated with the sodium salt of 2-methylcyclohexane-1,3-dione in DMF (5.0 mL), freshly 
prepared from NaH (33.8 mg, 1.41 mmol) and 2-methylcyclohexane-1,3-dione (247 mg, 
1.95 mmol). Purification of the crude product by column chromatography (silica gel, 3 × 
20 cm, hexanes/EtOAc 2:1, F19-30) afforded the product 90b as yellow oil (123 mg, 81%). 
 
C16H22O4 (278.34 g*mol−1): 
Rf = 0.63 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CDCl3): δ = 1.06 (s, 3 H, 1’-CH3), 1.24 (t, J(H,H) = 7.2 Hz, 3 H, 
CH2CH3), 1.38 (mc, 1 H, 6-H), 1.61-1.79 (m, 2 H, 6-H and 4’-H), 2.09-2.31 (m, 3 H, 2-H and 
4’-H), 2.50-2.66 (m, 3 H, 1-H, 3’-H and 5’-H), 2.71-2.93 (m, 2 H, 3’-H and 5’-H), 3.01-3.12 
(m, 1 H, 5-H), 4.07 (q, J(H,H) = 7.2 Hz, 2 H, CH2CH3), 5.28 (d, J(H,H) = 10.8 Hz, 1 H, 4-H), 
5.79 (mc, 1 H, 3-H) ppm.  
13C{1H} NMR (101 MHz, CDCl3): δ = 11.5 (1’-CH3), 14.3 (CH2CH3), 18.3 (4’-CH2), 27.0 (6-
CH2), 27.5 (2-CH2), 37.8 (5’-CH2), 38.2 (3’-CH2), 40.0 (1-CH), 42.3 (5-CH), 60.8 (CH2CH3), 
70.1 (1’-C), 124.8 (4-CH), 128.7 (3-CH), 174.8 (CO2), 208.6 (CO), 209.2 (CO) ppm. 
IR (KBr): ν~  = 3032m, 2945s, 1726s, 1693s, 1441m, 1381m, 1258m, 1223m, 1186s, 1102m, 
1062m, 1022s, 895m, 858m, 743w, 684m, 632m cm–1. 
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MS (FAB, NBA+KCl): m/z (%) = 317 (49, [M+K]+), 279 (85, [M+H]+), 233 (17, 
[M−OCH2CH3]+), 153 (78, [M−C7H9O2]+), 79 (48, C6H7+), 38 (100). 
Elemental analysis calcd. (%) for C16H22O4: C 69.04, H 7.97; found: C 68.87, H 7.97. 
 
 
(1S,5S)-Ethyl 5-(1’-methyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate 
((S,S)-90b) 
 
 
In analogy to the preparation of (S,S)-90a benzoate 65b (200 mg, 0.719 mmol) was reacted 
with [Pd(C3H5)Cl]2 (6.60 mg, 18.1 µmol), ligand (S,S)-93 (37.0 mg, 53.6 µmol), 2-
methylcyclohexane-1,3-dione (326 mg, 2.58 mmol), NaH (45.0 mg, 1.88 mmol) and 
tetrahexylammonium bromide (811 mg, 1.86 mmol) in abs. CH2Cl2 (10 mL) and DMF 
(0.5 mL). The crude product was purified by column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc 2:1, F10-18) to give (S,S)-90b as light-yellow oil with 96% ee (167 mg, 
83%). 
 
[ ]20Da = −30.4 (c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.8 mL*min−1, 30 °C, 220 nm): 
tR = 28.1 (S) , 34.8 (R) min (96% ee). 
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(1R,5R)-Ethyl 5-(1’-methyl-2’,6’-dioxocyclohexyl)-cyclohex-3-enecarboxylate 
((R,R)-90b) 
 
 
In analogy to the preparation of (S,S)-90a benzoate 65b (350 mg, 1.28 mmol) was reacted 
with [Pd(C3H5)Cl]2 (11.4 mg, 31.2 µmol), ligand (R,R)-93 (64.0 mg, 92.7 µmol), 2-
methylcyclohexane-1,3-dione (575 mg, 4.56 mmol), NaH (78.0 mg, 3.26 mmol) and 
tetrahexylammonium bromide (1.42 g, 3.27 mmol) in abs. CH2Cl2 (15 mL) and DMF 
(0.6 mL). The crude product was purified by column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc 2:1, F11-18) to give (R,R)-90b as light-yellow oil with 96% ee (310 mg, 
87%). 
 
[ ]20Da = +33.5 (c = 1.00, CHCl3). 
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.8 mL*min−1, 30 °C, 220 nm): 
tR = 28.1 (S), 34.8 (R) min (96% ee). 
 
 
7.4 Bis(N-sulfonylamino)phosphine-Oxazoline Ligands 
7.4.1 Oxazolines 
(S)-2-(4’-Isopropyl-4’,5’-dihydrooxazol-2’-yl)-phenol (99)[110] 
 
 
(S)-Valinol (103, 2.10 g, 20.4 mmol), 2-hydroxybenzonitrile (102, 2.02 g, 17.0 mmol) and 
ZnCl2 (28.5 mg, 0.210 mmol) were dissolved in abs. toluene (30 mL) and refluxed for 72 h. 
After the reaction mixture had been cooled to r.t. it was filtered and the filtrate was 
concentrated under reduced pressure. Purification of the residue by column chromatography 
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(silica gel, 3 × 20 cm, hexanes/EtOAc 7:1, F16-27) afforded 99 as colourless oil (3.25 g, 
93%). 
 
C12H15NO2 (205.35 g*mol−1): 
Rf = 0.70 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CD2Cl2): δ = 0.95 (d, J(H,H) = 6.8 Hz, 3 H, CH(CH3)(CH3)), 1.02 (d, 
J(H,H) = 6.8 Hz, 3 H, CH(CH3)(CH3)), 1.81 (q, J(H,H) = 6.8 Hz, 1 H, CH(CH3)2), 4.14 (mc, 
2 H, Ox-5’-H), 4.44 (mc, 1 H, Ox-4’-H), 6.87 (td, J(H,H) = 7.6, 1.1 Hz, 1 H, Ar-6-H), 6.97 (d, 
J(H,H) = 7.9 Hz, 1 H, Ar-4-H), 7.37 (td, J(H,H) = 7.9, 1.7 Hz, 1 H, Ar-5-H), 7.64 (dd, 
J(H,H) = 7.8, 1.6 Hz, 1 H, Ar-3-H), 12.31 (s, 1 H, OH) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ =18.4 (CH(CH3)(CH3)), 18.5 (CH(CH3)(CH3)), 33.1 
(CH(CH3)2), 70.0 (Ox-5’-CH2), 71.6 (Ox-4’-CH), 110.8 (Ar-2-C), 116.6 (Ar-6-CH), 118.5 
(Ar-4-CH), 128.0 (Ar-3-CH), 133.2 (Ar-5-CH), 160.0 (Ar-1-C), 165.1 (Ox-2’-C) ppm. 
IR (NaCl): ν~  = 3449s, 2962m, 1643s, 1492m, 1365m, 1310w, 1259m, 1232w, 1154w, 
1127w, 1067m, 959m, 755s cm–1. 
MS (EI, 70 eV): m/z (%) = 205 (58, M+), 162 (100, [M−C3H7]+), 134 (26), 107 (17). 
[ ]20Da = −33.0 (c = 1.20, CHCl3).  
Elemental analysis calcd. (%) for C12H15NO2: C 70.22, H 7.37, N 6.82, O 15.59; found: C 
70.36, H 7.40, N 7.07, O 15.52. 
 
 
(S)-2-(4’-tert-Butyl-4’,5’-dihydrooxazol-2’-yl)-phenol (100)[110] 
 
 
The oxazoline synthesis was accomplished in analogy to the preparation of 99 using (S)-tert-
leucinol (104, 2.67 g, 22.8 mmol), 2-hydroxybenzonitrile (102, 2.26 g, 19.0 mmol) and ZnCl2 
(64.0 mg, 0.480 mmol) in toluene (30 mL). Purification of the crude product by column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 15:1, F12-22) gave oxazoline 100 as 
colourless oil, which solidified at 4 °C (4.09 g, 98%).  
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C13H17NO2 (219.28 g*mol−1): 
m.p. 27 °C. 
Rf = 0.70 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 0.95 (s, 9 H, CH3), 4.12 (dd, J(H,H) = 10.0, 8.3 Hz, 1 H, 
Ox-5’-H), 4.22 (t, J(H,H) = 8.3 Hz, 1 H, Ox-4’-H), 4.35 (dd, J(H,H) = 10.0, 8.3 Hz, 1 H, Ox-
5’-H), 6.87 (t, J(H,H) = 8.3 Hz, 1 H, Ar-6-H), 7.01 (d, J(H,H) = 8.3 Hz, 1 H, Ar-4-H), 7.37 
(tt, J(H,H) = 7.8, 1.7 Hz, 1 H, Ar-5-H), 7.63 (dd, J(H,H) = 7.8, 1.7 Hz, 1 H, Ar-3-H), 12.41 (s, 
1 H, OH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 25.9 (C(CH3)3), 33.9 (C(CH3)3), 68.2 (Ox-4’-CH), 
75.1 (Ox-5’-CH2), 110.7 (Ar-2-C), 116.6 (Ar-6-CH), 118.5 (Ar-4-CH), 128.1 (Ar-3-CH), 
133.4 (Ar-5-CH), 160.0 (Ar-1-C), 165.0 (Ox-2’-C) ppm. 
IR (NaCl): ν~  = 3425s, 2961s, 2870s, 1643s, 1492s, 1365s, 1260s, 1234m, 1154w, 1127w, 
1073m, 1031m, 957m, 821m, 759s, 666m cm–1. 
MS (EI, 70 eV): m/z (%) = 219 (46, M+), 162 (100, [M−C4H9]+), 134 (30), 107 (20). 
[ ]20Da = −19.2 (c = 1.00, CHCl3).  
Elemental analysis calcd. (%) for C13H17NO2: C 71.21, H 7.81, N 6.39, O 14.59; found: C 
71.48, H 7.81, N 6.42, O 14.64. 
 
 
(S)-2-(4’-Phenyl-4’,5’-dihydrooxazol-2’-yl)-phenol (101)[110] 
 
 
The oxazoline synthesis was accomplished in analogy to the preparation of 99 using (S)-
phenylglycinol (105, 1.30 g, 10.2 mmol), 2-hydroxybenzonitrile (102, 1.01 g, 8.52 mmol) and 
ZnCl2 (28.5 mg, 0.210 mmol) in toluene (15 mL). Purification of the crude product by column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 7:1, F7-14) afforded product 101 as 
colourless oil, which solidified at 4 °C (1.94 g, 95%).  
 
C15H13NO2 (239.27 g*mol−1): 
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m.p. 29-33 °C. 
Rf = 0.66 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 4.25 (t, J(H,H) =  8.3 Hz, 1 H, Ox-4’-H), 4.80 (dd, 
J(H,H) = 10.1, 8.3 Hz, 1 H, Ox-5’-H), 5.47 (dd, J(H,H) = 10.1, 8.3 Hz, 1 H, Ox-5’-H), 6.29 
(t, J(H,H) = 7.8 Hz, 1 H, Ar-H), 7.06 (d, J(H,H) = 8.3 Hz, 1 H, Ar-H), 7.27-7.46 (m, 6 H, Ar-
H), 7.73 (d, J(H,H) = 8.1 Hz, 1 H, Ar-H), 12.16 (s, 1 H, OH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 69.0 (Ox-4’-CH), 74.2 (Ox-5’-CH2), 110.6 (Ar-2-C), 
117.0 (Ar-CH), 118.9 (Ar-CH), 126.6 (Ar-CH), 128.0 (Ar-CH), 128.4 (Ar-CH), 129.0 (Ar-
CH), 133.8 (Ar-CH), 141.7 (Ph-i-C), 160.2 (Ar-1-C), 166.4 (Ox-2’-C) ppm. 
IR (KBr): ν~  = 3266m, 3059m, 2917m, 1720w, 1640s, 1533s, 1485s, 1443s, 1313m, 1270m, 
1179w, 1104s, 1028s, 920w, 760m, 699s, 639m, 595m cm–1. 
MS (EI, 70 eV): m/z (%) = 239 (100, M+), 209 (21), 180 (16), 148 (45), 121 (44), 91 (35), 39 
(9). 
[ ]20Da = +85.5 (c = 1.00, CHCl3).  
Elemental analysis calcd. (%) for C15H13NO2: C 75.30, H 5.48, N 5.85, O 13.37; found: C 
77.29, H 5.42, N 6.04, O 13.37. 
 
 
7.4.2 Sulfonyldiamines  
(1R,2R)-1,2-N,N’-Bis-(4’-toluenesulfonylamino)-1,2-diphenylethane ((R,R)-
106)[108] 
 
 
A solution of (1R,2R)-1,2-diphenylethane-1,2-diamine ((R,R)-108, 300 mg, 1.42 mmol) in 
abs. CH2Cl2 (5.0 mL) was treated with NEt(iPr)2 (1.10 mL, 6.43 mmol) at 0 °C. After the 
mixture had been cooled to –40 °C and stirred for 15 min, p-TsCl (540 mg, 2.83 mmol) was 
added. The reaction was allowed to warm to r.t. and stirred for 3 h at this temperature. It was 
(R,R)-106
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then quenched by the addition of 1 M HCl (30 mL). The phases were separated and the 
aqueous phase was extracted with CH2Cl2 (3 × 30 mL). The combined organic phases were 
washed with brine and dried over Na2SO4. After evaporation of the solvent (R,R)-106 was 
obtained as colourless solid (689 mg, 94%). 
 
C28H28N2O4S2 (520.66 g*mol−1): 
m.p. 89 °C. 
1H NMR (400 MHz, CDCl3): δ = 2.33 (s, 6 H, CH3), 4.45 (dd, J(H,H) = 4.6, 2.5 Hz, 2 H, 
CH), 5.29 (mc, 2 H, NH), 6.63 (d, J(H,H) = 8.4 Hz, 4 H, Ar-H), 6.97 (t, J(H,H) = 7.6 Hz, 4 H, 
Ph-m-H), 7.03 (mc, 2 H, Ph-p-H), 7.08 (d, J(H,H) = 8.1 Hz, 4 H, Ar-H), 7.50 (d, J(H,H) = 
8.3 Hz, 4 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.6 (CH3), 62.3 (CH), 127.3 (Ar-CH), 127.7 (Ar-
CH), 127.9 (Ar-CH), 128.2 (Ar-CH), 129.5 (Ar-CH), 136.4 (pTol-i-C), 137.0 (pTol-p-C), 
143.4 (Ph-i-C) ppm. 
IR (KBr): ν~  = 3031w, 1597m, 1457s, 1328s, 1306m, 1221w, 1197m, 1159s, 1083s, 1063s, 
914m, 814s, 700s, 669s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 559 (50, [M+K]+), 521 (22, [M+H]+), 350 (100, 
[M−C7H8NO2S]+), 260 (42), 195 (24), 91 (61). 
[ ]20Da = +39.1 (c = 0.95, CHCl3). 
Elemental analysis calcd. (%) for C28H28N2O4S2: C 64.59, H 5.42, N 5.38; found: C 64.40, H 
5.30, N 5.27. 
 
 
(1S,2S)-1,2-N,N’-Bis-(4’-toluenesulfonylamino)-1,2-diphenylethane ((S,S)-
106)[108] 
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In analogy to the preparation of (R,R)-106 the reaction of (1S,2S)-1,2-diphenylethane-1,2-
diamine ((S,S)-108, 100 mg, 0.473 mmol), NEt(iPr)2 (364 µL, 2.13 mmol) and p-TsCl 
(180 mg, 946 µmol) in abs. CH2Cl2 (2.0 mL) gave (S,S)-106 as colourless solid (689 mg, 
94%). 
 
[ ]20Da = −38.5 (c = 0.42, CHCl3). 
 
 
(1R,2R)-1,2-N,N’-Bis-(4’-toluenesulfonylamino)-1,2-dicyclohexylethane ((R,R)-
107)[108] 
 
 
Diamide (R,R)-107 was prepared in analogy to the synthesis of (R,R)-106 from (1R,2R)-1,2-
dicyclohexylethane-1,2-diamine ((R,R)-109, 300 mg, 1.34 mmol), NEt(iPr)2 (1.10 mL, 
6.43 mmol) and p-TsCl (540 mg, 2.83 mmol) in abs. CH2Cl2 (7.0 mL). Purification of the 
crude product by column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 4:1, F12-18) 
yielded (R,R)-107 as colourless solid (245 mg, 34%). 
 
C28H40N2O4S2 (532.76 g*mol−1): 
Rf = 0.36 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 0.61-1.76 (m, 22 H, Cy-H), 2.42 (s, 6 H, CH3), 3.11 (m, 
2 H, CH), 4.72 (br s, 2 H, NH), 7.26 (d, J(H,H) = 7.0 Hz, 4 H, Ar-H), 7.73 (d, J(H,H) = 
7.0 Hz, 4 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.7 (CH2), 26.2 (CH3), 27.7 (CH2), 31.1 (CH2), 40.4 
(CH), 58.8 (CH), 127.5 (Ar-CH), 129.7 (Ar-CH), 138.1 (pTol-i-C), 143.6 (pTol-p-C) ppm. 
IR (KBr): ν~  = 2924s, 2848m, 1653w, 1598w, 1496w, 1448s, 1329s, 1152s, 1094s, 1050m, 
950m, 879w, 813m, 709m, 684m cm–1. 
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MS (FAB, NBA): m/z (%) = 533 (100, [M+H]+), 435 (6), 377 (7), 362 (13), 266 (79, 
C14H20NO2S+), 184 (24), 155 (14), 91 (34), 39 (24).  
[ ]20Da = +30.1 (c = 0.82, CHCl3). 
Elemental analysis calcd. (%) for C28H40N2O4S2: C 63.12, H 7.57, N 5.26; found: C 63.26, H 
7.56, N 5.18. 
 
 
7.4.3 Ligand Synthesis 
(4S,4’’R,5’’R)-4-Isopropyl-2-{2’-[4’’,5’’-diphenyl-1’’,3’’-bis(4’’’-
methylphenylsulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydro-
oxazole (112) 
 
 
A solution of abs. NEt3 (164 mg, 1.62 mmol) in abs. toluene (3.0 mL) was treated with PCl3 
(80.0 mg, 0.583 mmol) at –78 °C. A suspension of sulfonylated diamine (R,R)-106 (200 mg, 
0.384 mmol) in abs. toluene (5.0 mL) was slowly added and the reaction mixture was allowed 
to warm to r.t. overnight. After filtration over Celite under argon and concentration of the 
filtrate in high vacuum the residue was dissolved in abs. toluene (3.0 mL) and cooled to 
–78 °C. A solution of abs. NEt3 (392 mg, 3.87 mmol) in abs. toluene (4.0 mL) was added, 
followed after 15 min by azeotropically dried (3 × 1.5 mL abs. toluene) oxazoline alcohol 99 
(52.8 mg, 0.257 mmol) in abs. toluene (3.0 mL). The reaction mixture was allowed to warm 
to r.t. overnight and filtered over Celite under argon. After concentration of the filtrate in high 
vacuum the residue was purified by column chromatography (silica gel, 3 × 15 cm, 
hexanes/EtOAC 4:1, F10-13) under argon to give ligand 112 as colourless solid (140 mg, 
72%). 
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C40H40N3O6PS2 (753.87 g*mol−1): 
m.p. 64 °C. 
Rf = 0.15 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CD2Cl2): δ = 0.90 (d, J(H,H) = 6.7 Hz, 3 H, CH(CH3)(CH3)), 1.01 (d, 
J(H,H) = 6.7 Hz, 3 H, CH(CH3)(CH3)), 1.82 (q, J(H,H) = 6.7 Hz, 1 H, CH(CH3)2), 2.33 (s, 
3 H, pTol-CH3), 2.34 (s, 3 H, pTol-CH3), 3.99 (dd, J(H,H) = 12.6, 7.8 Hz, 1 H, Ox-5-H), 4.04 
(dd, J(H,H) = 12.6, 7.8 Hz, 1 H, Ox-5-H), 4.30 (t, J(H,H) = 7.8 Hz, 1 H, Ox-4-H), 4.62 (dd, 
J(H,H) = 6.1 Hz, J(P,H) = 2.8 Hz, 1 H, NCH), 5.15 (d, J(H,H) = 6.1 Hz, 1 H, NCH), 6.54 (d, 
J(H,H) = 7.8 Hz, 2 H, Ar-H), 6.67 (d, J(H,H) = 8.0 Hz, 2 H, Ar-H), 6.82-7.39 (m, 15 H, Ar-
H), 7.57 (mc, 1 H, Ar-H), 7.71 (d, J(H,H) = 8.4 Hz, 1 H, Ar-H), 7.97 (d, J(H,H) = 8.4 Hz, 1 H, 
Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 19.2 (CH(CH3)2), 21.5 (pTol-CH3), 32.8 (CH(CH3)2), 
70.4 (NCH), 72.0 (NCH), 73.5 (Ox-4-CH), 74.6 (Ox-5-CH2), 116.5 (Ar-CH), 120.0-129.9 
(diverse Ar-CH), 131.9 (Ar-CH), 132.3 (Ar-CH), 136.3 (Ar-C), 137.4 (Ar-C), 139.2 (Ar-C), 
143.8 (Ar-C), 144.2 (Ar-C), 161.7 (Ar-2’-C), 167.2 (Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 116.9 (s) ppm. 
IR (KBr): ν~  = 3032w, 2960m, 1734m, 1700m, 1653s, 1646m, 1599m, 1560w, 1496m, 
1457m, 1355s, 1212m, 1161s, 1089m, 955m, 855m, 765m, 675s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 792 (18, [M+K]+), 754 (60, [M+H]+), 549 (54, 
[M−C12H14NO2]+), 260 (43), 91 (100). 
[ ]20Da = +116.0 (c = 0.10, CHCl3). 
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(4S,4’’R,5’’R)-4-tert-Butyl-2-{2’-[4’’,5’’-diphenyl-1’’,3’’-bis(4’’’-
methylphenylsulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydro-
oxazole (113) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodiazaphospholidine was obtained from sulfonated diamine (R,R)-106 
(200 mg, 0.384 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in 
abs. toluene (8.0 mL). After filtration and removal of all volatiles in high vacuum, the reaction 
of the residue with oxazoline alcohol 100 (50.0 mg, 0.228 mmol) and abs. NEt3 (392 mg, 
3.87 mmol) in abs. toluene (11 mL) was carried out. Purification of the crude product by 
column chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 1:1, F11-15) under argon gave 
ligand 113 as colourless solid (80.0 mg, 46%). 
 
C41H42N3O6PS2 (767.89 g*mol−1): 
m.p. 76 °C. 
Rf = 0.44 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CDCl3): δ = 0.95 (s, 9 H, C(CH3)3), 2.33 (s, 3 H, pTol-CH3), 2.34 (s, 
3 H, pTol-CH3), 3.97 (dd, J(H,H) = 10.6, 8.1 Hz, 1 H, Ox-5-H), 4.16 (t, J(H,H) = 8.2 Hz, 1 H, 
Ox-4-H), 4.25 (dd, J(H,H) = 10.6, 8.1 Hz, 1 H, Ox-5-H), 4.77 (dd, J(H,H) = 5.9 Hz, J(P,H) = 
2.9 Hz, 1 H, NCH), 5.16 (d, J(H,H) = 6.0 Hz, 1 H, NCH), 6.12 (d, J(H,H) = 7.0 Hz, 2 H, Ar-
H), 6.84-7.26 (m, 15 H, Ar-H), 7.44-7.57 (m, 3 H, Ar-H), 7.73 (d, J(H,H) = 8.2 Hz, 1 H, Ar-
H), 8.02 (d, J(H,H) = 7.7 Hz, 1 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.4 (pTol-CH3), 26.0 (C(CH3)3), 34.0 (C(CH3)3), 
62.0 (NCH), 69.0 (NCH), 74.5 (Ox-4-CH), 75.3 (Ox-5-CH2), 121.0-129.5 (diverse Ar-CH), 
132.0 (Ar-CH), 132.2 (Ar-CH), 135.9 (Ar-C), 136.2 (Ar-C), 137.3 (Ar-C), 143.4 (Ar-C), 
143.7 (Ar-C), 163.0 (Ar-2’-C), 165.9 (Ox-2-C) ppm. 
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31P{1H} NMR (162 MHz, CDCl3): δ = 116.7 (s) ppm. 
IR (KBr): ν~  = 2952s, 1772m, 1734m, 1700m, 1675m, 1653s, 1635m, 1490m, 1457m, 1355s, 
1209m, 1160s, 1088m, 955m, 853m, 765m, 674s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 806 (11, [M+K]+), 768 (50, [M+H]+), 549 (41, 
[M−C13H16NO2]+), 350 (25), 260 (61), 91 (100), 57 (25).  
[ ]20Da = +48.0 (c = 0.15, CHCl3). 
Elemental analysis calcd. (%) for C41H42N3O6PS2: C 64.13, H 5.51, N 5.47; found: C 64.43, 
H.5.85, N 5.32. 
 
 
(4S,4’’S,5’’S)-4-tert-Butyl-2-{2’-[4’’,5’’-diphenyl-1’’,3’’-bis(4’’’-
methylphenylsulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydro-
oxazole (114) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodiazaphospholidine was obtained from sulfonated diamine (S,S)-106 
(200 mg, 0.384 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in 
abs. toluene (8.0 mL). After filtration and removal of all volatiles in high vacuum, reaction of 
the residue with oxazoline alcohol 100 (50.0 mg, 0.228 mmol) and abs. NEt3 (392 mg, 
3.87 mmol) in abs. toluene (10 mL) was carried out. Purification of the crude product by 
column chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 1:1, F11-15) under argon gave 
ligand 114 as colourless solid (140 mg, 80%). 
 
C41H42N3O6PS2 (767.89 g*mol−1): 
m.p. 65 °C. 
Rf = 0.31 (hexanes/EtOAc 1:1). 
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1H NMR (400 MHz, CDCl3): δ = 0.94 (s, 9 H, C(CH3)3), 2.32 (s, 3 H, pTol-CH3), 2.33 (s, 
3 H, pTol-CH3), 4.06 (dd, J(H,H) = 10.4, 8.3 Hz, 1 H, Ox-5-H), 4.15 (t, J(H,H) = 8.3 Hz, 1 H, 
Ox-4-H), 4.24 (dd, J(H,H) = 10.4, 8.3 Hz, 1 H, Ox-5-H), 4.82 (dd, J(H,H) = 6.4 Hz, J(P,H) = 
2.7 Hz, 1 H, NCH), 5.24 (d, J(H,H) = 6.4 Hz, 1 H, NCH), 6.65 (d, J(H,H) = 7.9 Hz, 2 H, Ar-
H), 6.89-7.28 (m, 15 H, Ar-H), 7.44 (d, J(H,H) = 8.2 Hz, 2 H, Ar-H), 7.52 (td, J(H,H) = 7.8, 
1.7 Hz, 1 H, Ar-H), 7.79 (d, J(H,H) = 8.4 Hz, 1 H, Ar-H), 7.99 (dd, J(H,H) = 7.9, 1.7 Hz, 1 H, 
Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.6 (pTol-CH3), 26.3 (C(CH3)3), 34.1 (C(CH3)3), 
63.9 (NCH), 68.8 (NCH), 73.6 (Ox-4-CH), 74.9 (Ox-5-CH2), 121.0-129.5 (diverse Ar-CH), 
131.8 (Ar-CH), 132.2 (Ar-CH), 135.8 (Ar-C), 136.5 (Ar-C), 137.1 (Ar-C), 137.9 (Ar-C), 
143.4 (Ar-C), 143.7 (Ar-C), 162.2 (Ar-2’-C), 169.5 (Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 115.9 (s) ppm. 
IR (KBr): ν~  = 3032w, 2958m, 1734w, 1700w, 1684w, 1653m, 1646m, 1601m, 1496m, 
1457m, 1355s, 1217m, 1159s, 1089m, 945m, 855m, 816w, 768m, 702m, 675s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 806 (7, [M+K]+), 768 (33, [M+H]+), 549 (33, 
[M−C13H16NO2]+), 350 (6), 260 (31), 91 (100).  
[ ]20Da = −81.0 (c = 0.21, CHCl3). 
 
 
(4S,4’’R,5’’R)-4-Phenyl-2-{2’-[4’’,5’’-diphenyl-1’’,3’’-bis(4’’’-
methylphenylsulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydro-
oxazole (115) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodiazaphospholidine was obtained from sulfonated diamine (R,R)-106 
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(200 mg, 0.384 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in 
abs. toluene (5.0 mL). After filtration and removal of all volatiles in high vacuum, the residue 
was reacted with oxazoline alcohol 101 (46.0 mg, 0.192 mmol) and abs. NEt3 (392 mg, 
3.87 mmol) in abs. toluene (12 mL). Purification of the crude product by column 
chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 1:1, F8-12) under argon gave ligand 
115 as colourless solid (73.0 mg, 48%). 
 
C43H38N3O6PS2 (787.88 g*mol−1): 
m.p. 81 °C. 
Rf = 0.44 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CDCl3): δ = 2.32 (s, 3 H, CH3), 2.33 (s, 3 H, CH3), 4.19 (t, J(H,H) = 
8.3 Hz, 1 H, Ox-4-H), 4.71 (dd, J(H,H) = 10.3, 8.3 Hz, 1 H, Ox-5-H), 4.78 (dd, J(H,H) = 
6.0 Hz, J(P,H) = 3.0 Hz, 1 H, NCH), 5.12 (d, J(H,H) = 6.0 Hz, 1 H, NCH), 5.31 (dd, 
J(H,H) = 10.3, 8.3 Hz, 1 H, Ox-5-H), 6.57 (d, J(H,H) = 8.5 Hz, 2 H, Ar-H), 6.82-7.62 (m, 
23 H, Ar-H), 7.78 (d, J(H,H) = 8.1 Hz, 1 H, Ar-H), 8.12 (dd, J(H,H) = 8.1, 1.8 Hz, 1 H, Ar-
H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.5 (CH3), 62.0 (NCH), 69.5 (NCH), 73.4 (Ox-4-
CH), 74.9 (Ox-5-CH2), 116.5 (Ar-CH), 121-129 (diverse Ar-CH), 132.0 (Ar-CH), 132.6 (Ar-
CH), 136.2 (Ar-C), 136.7 (Ar-C), 137.1 (Ar-C), 137.3 (Ar-C), 143.0 (Ar-C), 143.4 (Ar-C), 
143.7 (Ar-C), 160.4 (Ar-2’-C), 164.0 (Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 116.6 (s) ppm. 
IR (KBr): ν~  = 3032w, 2924w, 1700s, 1653s, 1617m, 1457m, 1350s, 1160s, 1088m, 951m, 
854m, 763m, 668s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 669 (7), 559 (32), 521 (20), 350 (100), 260 (65), 195 (21), 
91 (97), 57 (17).  
[ ]20Da = +84.0 (c = 0.33, CHCl3). 
Elemental analysis calcd. (%) for C43H38N3O6PS2: C 65.55, H 4.86, N 5.33; found: C 65.00, 
H 5.23, N 5.21. 
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(4S,4’’R,5’’R)-4-Isopropyl-2-{2’-[4’’,5’’-dicyclohexyl-1’’,3’’-bis(4’’’-methylphenyl-
sulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydrooxazole (116) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodiazaphospholidine was obtained from sulfonated diamine (R,R)-107 
(180 mg, 0.338 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in 
abs. toluene (8.0 mL). After filtration and removal of all volatiles in high vacuum, the residue 
was reacted with oxazoline alcohol 99 (52.0 mg, 0.253 mmol) and abs. NEt3 (392 mg, 
3.87 mmol) in abs. toluene (10 mL). Purification of the crude product by column 
chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 4:1, F16-23) under argon gave ligand 
116 as colourless solid (69.0 mg, 36%). 
 
C40H52N3O6PS2 (765.96 g*mol−1): 
m.p. 148 °C. 
Rf = 0.14 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = −0.74 (mc, 1 H, Cy-CH2), 0.07 (mc, 1 H, Cy-CH2), 0.41-
0.89 (m, 6 H, Cy-CH2), 0.93 (d, J(H,H) = 6.7 Hz, 3 H, CH(CH3)(CH3)), 0.96-1.03 (m, 2 H, 
Cy-CH2), 1.04 (d, J(H,H) = 6.7 Hz, 3 H, CH(CH3)(CH3)), 1.09-1.76 (m, 10 H, Cy-CH2), 1.87 
(sept, J(H,H) = 6.7 Hz, 1 H, CH(CH3)2), 1.87-1.94 (m, 1 H, Cy-CH), 2.15 (d, J(H,H) = 
13.1 Hz, 1 H, Cy-CH), 2.38 (s, 3 H, pTol-CH3), 2.39 (s, 3 H, pTol-CH3), 3.29 (t, J(P,H) = 
5.0 Hz, 1 H, NCH), 3.69 (d, J(H,H) = 3.3 Hz, 1 H, NCH), 3.99 (mc, 1 H, Ox-5-H), 4.21 (t, 
J(H,H) = 8.4 Hz, 1 H, Ox-4-H), 4.44 (dd, J(H,H) = 10.1, 8.4 Hz, 1 H, Ox-5-H), 7.15-7.33 (m, 
5 H, Ar-H), 7.49 (td, J(H,H) = 7.8, 1.8 Hz, 1 H, Ar-H), 7.68-7.80 (m, 5 H, Ar-H), 7.98 (dd, 
J(H,H) = 7.8, 1.8 Hz, 1 H, Ar-H) ppm. 
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13C{1H} NMR (101 MHz, CDCl3): δ = 18.5 (CH(CH3)(CH3)), 19.5 (CH(CH3)(CH3)), 21.6 
(pTol-CH3), 24.8 (Cy-CH2), 25.7 (Cy-CH2), 25.7 (Cy-CH2), 25.8 (Cy-CH2), 26.1 (Cy-CH2), 
26.3 (Cy-CH2), 26.4 (Cy-CH2), 26.5 (Cy-CH2), 29.3 (CH(CH3)2), 31.4 (Cy-CH2), 32.9 (Cy-
CH2), 39.7 (Cy-CH), 41.3 (Cy-CH), 66.0 (NCH), 67.5 (NCH), 70.7 (Ox-5-CH2), 72.1 (Ox-4-
CH), 121.9 (Ar-CH), 124.1 (Ar-CH), 127.9 (Ar-CH), 128.0 (Ar-CH), 128.1 (Ar-CH), 129.6 
(Ar-CH), 129.8 (Ar-CH), 132.0 (Ar-CH), 132.3 (Ar-1’-C), 137.2 (pTol-i-C), 137.3 (pTol-i-
C), 144.1 (pTol-p-C), 144.4 (pTol-p-C), 151.8 (Ar-2’-C), 163.6 (Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 119.2 (s) ppm. 
IR (KBr): ν~  = 2925s, 2853m, 1653m, 1635m, 1601m, 1490w, 1448m, 1355s, 1204m, 1159s, 
1086w, 1035w, 966s, 949m, 849m, 770m, 706m, 672s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 804 (10, [M+K]+), 766 (61, [M+H]+), 561 (100, 
[M−C12H14NO2]+), 361 (8), 139 (32), 91 (40).  
[ ]20Da = −96.0 (c = 0.26, CHCl3). 
 
 
(4S,4’’R,5’’R)-4-tert-Butyl-2-{2’-[4’’,5’’-dicyclohexyl-1’’,3’’-bis(4’’’-methylphenyl-
sulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydrooxazole (117) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodiazaphospholidine was obtained from sulfonated diamine (R,R)-107 
(180 mg, 0.338 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in 
abs. toluene (8.0 mL). After filtration and removal of all volatiles in high vacuum, the reaction 
of the residue with oxazoline alcohol 100 (50.0 mg, 0.228 mmol) and abs. NEt3 (392 mg, 
3.87 mmol) in abs. toluene (10 mL) was carried out. Purification of the crude product by 
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column chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 4:1, F16-23) under argon gave 
ligand 117 as colourless solid (69.0 mg, 39%). 
 
C41H54N3O6PS2 (779.99 g*mol−1): 
m.p. 176 °C. 
Rf = 0.15 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = −0.70 (mc, 1 H, Cy-CH2), 0.01 (mc, 1 H, Cy-CH2), 0.34-
1.00 (m, 10 H, Cy-CH2), 0.96 (s, 9 H, C(CH3)3), 1.09-1.50 (m, 7 H, Cy-CH2), 1.67 (mc, 1 H, 
Cy-CH2), 1.89 (mc, 1 H, Cy-CH), 2.13 (mc, 1 H, Cy-CH), 2.38 (s, 3 H, pTol-CH3), 2.39 (s, 
3 H, pTol-CH3), 3.31 (t, J(P,H) = 5.2 Hz, 1 H, NCH), 3.72 (d, J(H,H) = 3.4 Hz, 1 H, NCH), 
3.97 (dd, J(H,H) = 10.2, 8.4 Hz, 1 H, Ox-5-H), 4.28 (t, J(H,H) = 8.4 Hz, 1 H, Ox-4-H), 4.40 
(dd, J(H,H) = 10.2, 8.4 Hz, 1 H, Ox-5-H), 7.14-7.34 (m, 5 H, Ar-H), 7.48 (t, J(H,H) = 7.9 Hz, 
1 H, Ar-H), 7.66-7.81 (m, 5 H, Ar-H), 7.98 (dd, J(H,H) = 7.8, 1.8 Hz, 1 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.7 (pTol-CH3), 24.7 (Cy-CH2), 24.9 (Cy-CH2), 25.7 
(Cy-CH2), 25.8 (Cy-CH2), 25.9 (Cy-CH2), 26.1 (Cy-CH2), 26.3 (C(CH3)3), 26.5 (Cy-CH2), 
29.3 (Cy-CH2), 31.4 (Cy-CH2), 34.2 (Cy-CH2), 39.7 (Cy-CH), 39.8 (Cy-CH), 41.3 (C(CH3)3), 
67.5 (NCH), 67.6 (NCH), 69.4 (Ox-5-CH2), 75.4 (Ox-4-CH), 116.4 (Ar-CH), 124.1 (Ar-CH), 
127.9 (Ar-CH), 128.1 (Ar-CH), 129.6 (Ar-CH), 129.9 (Ar-CH), 132.1 (Ar-CH), 132.3 (Ar-1’-
C), 137.4 (pTol-i-C), 144.1 (pTol-p-C), 144.4 (pTol-p-C), 151.8 (Ar-2’-C), 163.6 (Ox-2-
C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 118.6 (s) ppm. 
IR (KBr): ν~  = 2924s, 1700w, 1653m, 1635m, 1599w, 1451m, 1354m, 1209m, 1162s, 964m, 
849m, 705m, 672s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 818 (8, [M+K]+), 780 (33, [M+H]+), 561 (86, 
[M−C13H16NO2]+), 139 (58), 91 (100).  
[ ]20Da = −85.0 (c = 0.21, CHCl3). 
Elemental analysis calcd. (%) for C41H54N3O6PS2: C 63.13, H 6.98, N 5.39; found: C 62.98, 
H 7.20, N 5.51. 
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(4S,4’’R,5’’R)-4-Phenyl-2-{2’-[4’’,5’’-dicyclohexyl-1’’,3’’-bis(4’’’-methylphenyl-
sulfonyl)-1’’,3’’-diazaphospholidine-2’’-yl]-oxyphenyl}-4,5-dihydrooxazole (118) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodiazaphospholidine was obtained from sulfonated diamine (R,R)-107 
(180 mg, 0.338 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in 
abs. toluene (8.0 mL). After filtration and removal of all volatiles in high vacuum, reaction of 
the residue with oxazoline alcohol 101 (53.0 mg, 0.222 mmol) and abs. NEt3 (392 mg, 
3.87 mmol) in abs. toluene (10 mL) was carried out. Purification of the crude product by 
column chromatography (silica gel, 3 × 15 cm, hexanes/EtOAc 4:1, F16-23) under argon gave 
ligand 118 as colourless solid (80.0 mg, 45%). 
 
C43H50N3O6PS2 (799.98 g*mol−1): 
m.p. 124 °C. 
Rf = 0.12 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = −0.69 (mc, 1 H, Cy-CH2), −0.06 (mc, 1 H, Cy-CH2), 0.46-
1.67 (m, 17 H, Cy-CH2), 1.86 (mc, 1 H, Cy-CH2), 2.20 (mc, 2 H, Cy-CH), 2.37 (s, 3 H, pTol-
CH3), 2.40 (s, 3 H, pTol-CH3), 3.31 (d, J(H,H) = 4.8 Hz, 1 H, NCH), 3.71 (d, J(H,H) = 
4.8 Hz, 1 H, NCH), 4.32 (t, J(H,H) = 8.4 Hz, 1 H, Ox-4-H), 4.83 (dd, J(H,H) = 10.4, 8.4 Hz, 
1 H, Ox-5-H), 5.35 (dd, J(H,H) = 10.4, 8.4 Hz, 1 H, Ox-5-H), 7.23 (mc, 3 H, Ar-H), 7.28 (d, 
J(H,H) = 9.3 Hz, 1 H, Ar-H), 7.32 (mc, 2 H, Ar-H), 7.36 (mc, 2 H, Ar-H), 7.53 (dd, J(H,H) = 
8.3, 7.4 Hz, 1 H, Ar-H), 7.77 (mc, 5 H, Ar-H), 7.90 (mc, 2 H, Ar-H), 8.10 (d, J(H,H) = 7.4 Hz, 
1 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 21.7 (pTol-CH3), 24.8 (Cy-CH2), 25.8 (Cy-CH2), 26.1 
(Cy-CH2), 26.2 (Cy-CH2), 26.3 (Cy-CH2), 26.5 (Cy-CH2), 31.4 (Cy-CH2), 34.2 (Cy-CH2), 
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39.8 (Cy-CH), 41.4 (Cy-CH), 67.5 (NCH), 67.8 (NCH), 69.8 (Ox-5-CH2), 76.4 (Ox-4-CH), 
113.2 (Ar-CH), 122.8-129.9 (diverse Ar-CH), 139.4 (Ar-C), 143.7 (Ar-C), 144.2 (Ar-C), 
154.8 (Ar-2’-C), 164.5 (Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 120.6 (s) ppm. 
IR (KBr): ν~  = 2925s, 2851m, 1653m, 1635m, 1599m, 1496w, 1451m, 1351s, 1209m, 1162s, 
1087m, 963s, 947m, 851w, 772w, 705m, 672s cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 838 (6, [M+K]+), 800 (21, [M+H]+), 561 (100, 
[M−C15H12NO2]+), 139 (44), 91 (68).  
[ ]20Da = −79.0 (c = 0.15, CHCl3). 
 
 
7.5 Pyridyl-Phosphite Ligands 
3,3',5,5'-Tetra-tert-butyl-(1,1'-biphenyl)-2,2'-diol (120)[111] 
 
 
To a solution of 2,4-di-tert-butylphenol (119, 20.0 g, 96.9 mmol) in MeOH (40 mL) was 
added CuCl2 (81.5 mg, 0.606 mmol) and TMEDA (129 µL, 0.860 mmol) at r.t. The resulting 
dark green solution was stirred for 48 h under a continuous flow of air. The colourless 
precipitate was filtered off, washed with MeOH (10 mL) and dried in high vacuum. The pure 
product 120 was obtained as colourless solid (13.6 g, 68%). 
 
C28H42O2 (410.63 g*mol−1): 
m.p. 190 °C. 
1H NMR (400 MHz, CDCl3): δ = 1.32 (s, 18 H, CH3), 1.45 (s, 18 H, CH3), 5.21 (br s, 2 H, 
OH), 7.11 (d, J(H,H) = 2.4 Hz, 2 H, Ar-4-H and Ar-4’-H), 7.39 (d, J(H,H) = 2.4 Hz, 2 H, Ar-
6-H and Ar-6’-H) ppm. 
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13C{1H} NMR (101 MHz, CDCl3): δ = 29.8 (CH3), 31.7 (CH3), 34.6 (C(CH3)3), 35.4 
(C(CH3)3), 122.4 (Ar-C), 125.0 (Ar-CH), 125.4 (Ar-CH), 136.4 (Ar-C), 143.1 (Ar-C), 149.9 
(Ar-C) ppm. 
IR (KBr): ν~  = 3524s, 2961s, 2868m, 2830m, 1476s, 1457m, 1436s, 1400m, 1362s, 1332m, 
1281m, 1237m, 1199m, 1169m, 1134w, 1094m, 880m cm–1. 
MS (EI, 70 eV): m/z (%) = 410 (94, M+), 395 (92, [M−CH3]+), 354 (18), 339 (75), 283 (31), 
227 (15), 190 (40), 176 (9), 57 (100). 
Elemental analysis calcd. (%) for C28H42O2: C 81.90, H 10.31; found: C 81.86, H 10.25. 
 
 
(R)-6-(6’,7’-Dihydro-2’-phenyl-5’H-cyclopenta[b]pyridine-7’-yloxy)-2,4,8,10-
tetrakis(tert-butyl)-dibenzo[d,f][1,3,2]dioxaphosphepin (124) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodioxaphospholidine was obtained from diol 120 (166 mg, 
0.405 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in abs. toluene 
(8.0 mL). After filtration and removal of all volatiles in high vacuum, the residue was reacted 
with pyridyl alcohol 122 (20.0 mg, 95.7 µmol) and abs. NEt3 (392 mg, 3.87 mmol) in abs. 
toluene (10 mL). Purification of the crude product by column chromatography (silica gel, 3 × 
15 cm, hexanes/EtOAc 4:1, F4-8) under argon gave product 124 as colourless solid (60 mg, 
97%). 
 
C42H52NO3P (649.84 g*mol−1): 
m.p. 91 °C. 
Rf = 0.66 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.30 (s, 9 H, CH3), 1.33 (s, 9 H, CH3), 1.34 (s, 9 H, CH3), 
1.53 (s, 9 H, CH3), 2.32 (mc, 2 H, CH2), 2.78 (mc, 1 H, CH2), 3.07 (mc, 1 H, CH2), 5.81 (mc, 
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1 H, 7’-CH), 7.16 (dd, J(H,H) = 6.2, 2.5 Hz, 2 H, Ar-H), 7.34-7.49 (m, 5 H, Ar-H), 7.61 (mc, 
2 H, Ar-H), 8.06 (d, J(H,H) = 8.2 Hz, 2 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 27.6 (CH2), 31.0 (C(CH3)3), 31.1 (C(CH3)3), 31.2 
(C(CH3)3), 31.3 (C(CH3)3), 31.5 (C(CH3)3), 32.5 (CH2), 34.6 (C(CH3)3), 35.3 (C(CH3)3), 35.4 
(C(CH3)3), 74.6 (7’-CH), 120.1 (Ar-CH), 124.1 (Ar-CH), 126.4 (Ar-CH), 126.5 (Ar-CH), 
127.1 (Ar-CH), 128.5 (Ar-CH), 128.6 (Ar-CH), 133.4 (Ar-C), 135.4 (Ar-C), 139.3 (Ar-C), 
140.4 (Ar-C), 146.1 (Ar-C), 146.3 (Ar-C), 156.6 (Ar-C), 161.9 (Ar-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 142.6 (s) ppm. 
IR (KBr): ν~  = 2958s, 1772w, 1734w, 1653w, 1590m, 1457m, 1437m, 1399m, 1362m, 
1323w, 1281w, 1228s, 1123w, 1090m, 1013m, 980m, 908w, 872s, 848m, 770m, 693m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 649 (6, M+), 194 (100, C14H12N+), 91 (4), 57 (70).  
[ ]20Da = −47.0 (c = 0.12, CHCl3). 
 
 
(R)-6-(5’,6’,7’,8’-Tetrahydro-2’-phenylquinolin-8’-yloxy)-2,4,8,10-tetrakis(tert-
butyl)-dibenzo[d,f][1,3,2]dioxaphosphepin (125) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 112. The 
corresponding P-chlorodioxaphospholidine was obtained from diol 120 (166 mg, 
0.405 mmol), PCl3 (80.0 mg, 0.583 mmol) and abs. NEt3 (164 mg, 1.62 mmol) in abs. toluene 
(8.0 mL). After filtration and removal of all volatiles in high vacuum, the residue was reacted 
with pyridyl alcohol 123 (30.0 mg, 0.133 mmol) and abs. NEt3 (392 mg, 3.87 mmol) in abs. 
toluene (10 mL). Purification of the crude product by column chromatography (silica gel, 
3 × 15 cm, hexanes/EtOAc/NEt3 8:1:1, F7-10) under argon gave ligand 125 as colourless 
solid (88.0 mg, 99%). 
 
C43H54NO3P (663.87 g*mol−1): 
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m.p. 96 °C. 
Rf = 0.65 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.13 (s, 9 H, CH3), 1.32 (s, 9 H, CH3), 1.35 (s, 9 H, CH3), 
1.51 (s, 9 H, CH3), 1.71 (mc, 1 H, CH2), 1.86 (mc, 1 H, CH2), 1.98 (mc, 1 H, CH2), 2.16 (mc, 
1 H, CH2), 2.64-2.90 (m, 2 H, CH2), 5.60 (mc, 1 H, 8’-CH), 7.08-7.51 (m, 8 H, Ar-H), 7.62 (d, 
J(H,H) = 8.1 Hz, 1 H, Ar-H), 8.09 (d, J(H,H) = 8.5 Hz, 2 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 18.7 (CH2), 28.0 (CH2), 29.7 (CH2), 30.8 (CH3), 31.2 
(CH3), 31.5 (CH3), 31.6 (CH3), 34.5 (C(CH3)3), 34.6 (C(CH3)3), 35.1 (C(CH3)3), 35.4 
(C(CH3)3), 73.3 (8’-CH), 119.6 (Ar-CH), 124.0 (Ar-CH), 125.3 (Ar-CH), 126.4 (Ar-CH), 
127.0 (Ar-CH), 128.2 (Ar-CH), 128.5 (Ar-CH), 128.6 (Ar-CH), 129.0 (Ar-CH), 131.2 (Ar-C), 
137.7 (Ar-C), 139.1 (Ar-C), 140.2 (Ar-C), 140.3 (Ar-C), 145.6 (Ar-C), 145.8 (Ar-C), 146.2 
(Ar-C), 154.1 (Ar-C), 155.0 (Ar-C) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 143.2 (s) ppm. 
IR (KBr): ν~  = 2961s, 1734w, 1653w, 1600m, 1465m, 1399m, 1361m, 1229s, 1090m, 970m, 
926w, 878s, 761m, 695m cm–1. 
MS (EI, 70 eV): m/z (%) = 663 (54, M+), 606 (57, [M−C4H9]+), 441 (58), 208 (100, 
C15H14N+), 57 (73).  
[ ]20Da = +105.0 (c = 0.13, CHCl3). 
 
 
7.6 Phosphite-Oxazoline Ligands 
(S)-4-(tert-Butyl)-2-{2’-[(2’’,4’’,8’’,10’’-tetrakis(tert-butyl)-dibenzo[d,f][1’’’,3’’’,2’’’]-
dioxaphosphepin-6’’’-yl)oxy]-phenyl}-4,5-dihydrooxazole (59)[94] 
 
 
A solution of abs. NEt3 (525 µL, 3.77 mmol) in abs. THF (3.0 mL) was treated with PCl3 
(200 µL, 2.29 mmol) at –78 °C. Azeotropically dried (3 × 1.5 mL toluene) diol 120 (700 mg, 
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1.71 mmol) in abs. THF (5.0 mL) was slowly added at –60 °C and the reaction mixture was 
allowed to warm to r.t. overnight. After filtration over Celite under argon and concentration of 
the filtrate in high vacuum, the residue was re-dissolved in abs. toluene (4.0 mL) and cooled 
to –78 °C. Abs. pyridine (500 µL, 6.12 mmol) was added, followed by a solution of 
azeotropically dried (3 × 1.5 mL toluene) oxazoline alcohol 100 (180 mg, 0.821 mmol) and 
abs. pyridine (200 µL, 2.47 mmol) in abs. toluene (8.0 mL). The reaction mixture was 
allowed to warm to r.t. overnight. After filtration over Celite under argon and removal of the 
solvent in high vacuum, the crude product was purified by column chromatography (silica gel, 
3 × 15 cm, hexanes/EtOAc 15:3:1, F2-3) under argon to give product 59 as colourless solid 
(162 mg, 30%). 
 
C41H56NO4P (657.86 g*mol−1): 
Rf = 0.82 (hexanes/EtOAc 4:1).  
1H NMR (400 MHz, C6D6): δ = 0.87 (s, 9 H, Ox-4-C(CH3)3), 1.24 (s, 9 H, CH3), 1.29 (s, 9 H, 
CH3), 1.30 (s, 9 H, CH3), 1.39 (s, 9 H, CH3), 3.99 (dd, J(H,H) = 10.0, 8.2 Hz, 1 H, Ox-5-H), 
4.06 (t, J(H,H) = 8.2 Hz, 1 H, Ox-4-H), 4.20 (dd, J(H,H) = 10.0, 8.2 Hz, 1 H, Ox-5-H), 5.78 
(br s, 1 H, Ar-H), 6.84 (mc, 2 H, Ar-H), 7.02 (d, J(H,H) = 2.5 Hz, 1 H, Ar-H), 7.06 (d, 
J(H,H) = 2.5 Hz, 1 H, Ar-H), 7.30 (d, J(H,H) = 2.4 Hz, 1 H, Ar-H), 7.42 (d, J(H,H) = 2.4 Hz, 
1 H, Ar-H), 7.64 (mc 1 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, C6D6): δ = 25.5 (Ox-4-C(CH3)3), 30.7 (CH3), 31.2 (CH3), 33.7 
(C(CH3)3), 34.0 (C(CH3)3), 34.8 (Ox-4-C(CH3)3), 35.2 (C(CH3)3), 35.6 (C(CH3)3), 68.2 (Ox-
5-CH2), 75.1 (Ox-4-CH), 123.7 (Ar-CH), 124.5 (Ar-CH), 125.2 (Ar-CH), 126.5 (Ar-CH), 
126.7 (Ar-CH), 127.9 (Ar-CH), 130.1 (Ar-C), 131.5 (Ar-CH), 133.3 (Ar-CH), 140.2 (Ar-C), 
140.6 (Ar-C), 146.8 (Ar-C), 147.1 (Ar-C), 148.5 (Ar-C), 161.1 (Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 132.4 (s) ppm. 
IR (KBr): ν~  = 2958s, 1655s, 1595w, 1465s, 1396s, 1359s, 1281m, 1234s, 1200s, 1122m, 
1049m, 971m, 910m, 864m, 842m, 766m, 698m, 657w, 615m, 541w, 479w cm–1. 
MS (EI, 70 eV): m/z (%) = 657 (9, M+), 573 (100, [M−C6H12]+), 441 (55), 376 (14, C28H40+). 
Elemental analysis calcd. (%) for C41H56NO4P: C 74.86, H 8.58, N 2.13; found: C 75.15, H 
8.65, N 1.83. 
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7.7 Cyclohexyl-Based Phosphite-Oxazolines  
(1R,2S)-Ethyl 2-hydroxycyclohexanecarboxylate (135)[112] 
 
 
A suspension of baker’s yeast (126 g) in water (1.0 L) was mechanically stirred at 30 °C for 
30 min. Ethyl 2-oxocyclohexanecarboxylate (134, 5.00 g, 29.4 mmol) was added and the 
brown suspension was stirred for another 24 h at 30 °C. After centrifugation and decanting the 
supernatant was extracted with Et2O (7 × 100 mL) and the combined organic phases were 
dried over MgSO4. Evaporation of the solvent and purification by column chromatography 
(silica gel, 3 × 20 cm, hexanes/EtOAc 7:1, F12-19) yielded carboxylate 135 as colourless oil 
(2.20 g, 43%). 
 
C9H16O3 (172.22 g*mol−1): 
Rf = 0.34 (hexanes/EtOAc 7:1). 
1H NMR (400 MHz, CDCl3): δ = 1.26 (t, J(H,H) = 7.0 Hz, 3 H, CH3), 1.31 (mc, 1 H, CH2), 
1.36-1.52 (m, 2 H, CH2), 1.67 (mc, 3 H, CH2), 1.86 (mc, 2 H, CH2), 2.45 (d, J(H,H) = 11.4 Hz, 
1 H, 1-H), 3.21 (d, J(H,H) = 3.6 Hz, 1 H, 2-H), 4.15 (q, J(H,H) = 7.0 Hz, 2 H, CH2CH3), 4.12 
(mc, 1 H, OH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 14.3 (CH3), 21.2 (CH2), 24.2 (CH2), 24.9 (CH2), 31.9 
(CH2), 46.8 (1-CH), 60.7 (CH2CH3), 66.8 (2-CH), 176.1 (CO2) ppm. 
IR (NaCl): ν~  = 3514m, 2935s, 1713s, 1447m, 1373m, 1308w, 1249m, 1186s, 1119m, 
1040m, 976m, 894w cm–1. 
MS (EI, 70 eV): m/z (%) = 172 (2, M+), 154 (5, [M−H2O]+), 144 (57, [M−C2H4]+), 101 (100), 
73 (54), 55 (11). 
[ ]20Da = +26.4 (c = 0.850, CHCl3); Lit.: +26.4 (c = 1.99, CHCl3).[112] 
Elemental analysis calcd. (%) for C9H16O3: C 62.77, H 9.36; found: C 62.37, H 9.10. 
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(1R,2S)-2-Hydroxycyclohexanecarboxylic acid (136)[112] 
 
 
An aqueous solution of LiOH (1 M, 80.0 mL, 80.0 mmol) was added to ethyl carboxylate 135 
(2.00 g, 11.6 mmol) in THF (160 mL) and the resulting solution was stirred at r.t. for 1 h. The 
reaction mixture was acidified with 6 M HCl to pH 2 at 0 °C, saturated with NaCl and 
continuously extracted with Et2O (300 mL) at reflux for 36 h. The organic phase was dried 
over MgSO4 and the solvent removed under reduced pressure. Purification of the residue by 
column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 1:1, F9-15) gave carboxylic 
acid 136 as colourless oil (1.25 g, 75%). 
 
C7H12O3 (144.17 g*mol−1): 
Rf = 0.34 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CDCl3): δ = 1.15-2.07 (m, 9 H, CH2 and OH), 2.55 (dt, J(H,H) = 10.5, 
3.4 Hz, 1 H, 1-H), 4.19 (mc, 1 H, 2-H), 6.59 (br s, 1 H, CO2H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 20.4 (CH2), 24.0 (CH2), 24.6 (CH2), 31.9 (CH2), 46.6 
(1-CH), 66.9 (2-CH), 180.3 (CO2H) ppm. 
IR (NaCl): ν~  = 3514br, 2937s, 1706s, 1448m, 1185m, 1063w, 972m, 926m cm–1. 
MS (EI, 70 eV): m/z (%) = 126 (34, [M−H2O]+), 98 (42, [M−CH2O2]+), 73 (100), 55 (31). 
[ ]20Da = +23.1 (c = 0.91, CHCl3). 
Elemental analysis calcd. (%) for C7H12O3: C 58.32, H 8.39; found: C 57.92, H 8.45. 
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(1R,2S)-2-(tert-Butyldimethylsilyloxy)-cyclohexanecarboxylic acid (137)[113] 
 
 
A solution of carboxylic acid 136 (1.25 g, 8.68 mmol), DMAP (20.0 mg, 0.164 µmol) and 
abs. NEt3 (3.90 mL, 26.0 mmol) in abs. CH2Cl2 (50 mL) was treated with TBDMSCl (2.83 g, 
17.4 mmol) at 0 °C. The reaction mixture was allowed to warm to r.t. within 60 min. It was 
then washed with saturated aqueous solutions of NH4Cl (50 mL), NaHCO3 (50 mL) as well as 
NaCl (50 mL) and dried over MgSO4. After evaporation of the solvent, purification of the 
crude product by column chromatography (silica gel, 3 × 22 cm, hexanes/EtOAc 10:1, F9-15) 
gave silyl ether 137 as colourless oil (1.13 g, 75%). 
 
C13H26O3Si (258.43 g*mol−1): 
Rf = 0.41 (hexanes/EtOAc 10:1). 
1H NMR (400 MHz, CDCl3): δ = 0.27 (s, 6 H, Si(CH3)2), 0.94 (s, 9 H, C(CH3)3), 1.39 (mc, 
3 H, CH2), 1.67 (mc, 3 H, CH2), 1.87 (mc, 2 H, CH2), 2.49 (ddd, J(H,H) = 10.6, 4.0, 2.8 Hz, 
1 H, 1-H), 3.25 (br s, 1 H, CO2H), 4.10 (td, 1 H, J(H,H) = 5.1, 2.5 Hz, 2-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = −3.4 (Si(CH3)2), 17.8 (C(CH3)3), 24.9 (CH2), 25.8 
(CH2), 25.9 (C(CH3)3), 26.0 (CH2), 31.9 (CH2), 48.1 (1-CH), 67.2 (2-CH), 176.6 
(CO2H) ppm. 
MS (FAB, NBA): m/z (%) = 259 (61, [M+H]+), 183 (13), 115 (23), 73 (100). 
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(1R,2S,2’S)-2-(tert-Butyldimethylsilyloxy)-N-(1’-hydroxy-3’,3’-dimethylbutan-2’-
yl)-cyclohexanecarboxamide (138) 
 
 
EDC (595 mg, 3.10 mmol) and HOBt (475 mg, 3.10 mmol) were added to a solution of 
carboxylic acid 137 (600 mg, 2.32 mmol) in CH2Cl2 (6.0 mL) at 0 °C. The reaction mixture 
was allowed to warm to r.t. and then stirred for 10 min. (S)-tert-Leucinol (578 mg, 
2.44 mmol) and NEt(iPr)2 (1.60 ml, 9.35 mmol) in CH2Cl2 (6.0 mL) were added then. After 
16 h the mixture was washed with saturated aqueous solutions of NH4Cl (30 mL), NaCl 
(30 mL), NaHCO3 (2 × 30 mL) and again NaCl (30 mL). The organic phase was dried over 
MgSO4 and the solvent removed under reduced pressure. Purification of the residue by 
column chromatography (silica gel, 3 × 30 cm, hexanes/EtOAc 2:1, F6-18) gave amide 138 as 
colourless solid (510 mg, 61%).  
 
C19H39NO3Si (357.27 g*mol−1): 
m.p. 100-101 °C. 
Rf = 0.48 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CDCl3): δ = 0.12 (s, 3 H, Si(CH3)(CH3)), 0.12 (s, 3 H, Si(CH3)(CH3)), 
0.92 (s, 9 H, SiC(CH3)3), 0.97 (s, 9 H, C(CH3)3), 1.22-1.49 (m, 4 H, CH2), 1.64-1.80 (m, 3 H, 
CH2), 2.33 (mc, 1 H, CH2), 2.63 (mc, 1 H), 2.98 (dd, J(H,H) = 6.5, 4.1 Hz, 1 H), 3.50 (mc, 
1 H), 3.89 (mc, 2 H), 4.03 (mc, 1 H), 7.44 (br s, 1 H, NH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = −3.4 (Si(CH3)2), 18.1 (SiC(CH3)3), 19.9 (CH2), 24.4 
(CH2), 25.1 (C(CH3)3), 25.6 (SiC(CH3)3), 26.9 (CH2), 32.4 (C(CH3)3), 33.5 (CH2), 49.1 (1-
CH), 59.5 (CH2OH), 63.1 (NCH), 67.3 (2-CH), 177.0 (CONH) ppm. 
MS (FAB, NBA+KCl): m/z (%) = 396 (27, [M+K]+), 358 (100, [M+H]+), 300 (26, 
[M−C4H9]+), 136 (11), 73 (69). 
[ ]20Da = −56.5 (c = 0.31, CHCl3). 
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(1S,2R,4’S)-2-(4’-tert-Butyl-4’,5’-dihydrooxazol-2’-yl)-cyclohexanol (140) 
 
 
To a solution of 138 (200 mg, 0.560 mmol) and abs. NEt3 (400 µL, 2.87 mmol) in CH2Cl2 
(4.0 mL) was added p-TsCl (134 mg, 0.953 mmol) at r.t. The resulting mixture was stirred 
under reflux for 24 h. After the addition of some H2O (200 µL) the solution was heated under 
reflux for another 60 min. The mixture was cooled to r.t. and then washed with H2O 
(3 × 10 mL). The organic phase was dried over Na2SO4 and evaporated under reduced 
pressure. 1H NMR analysis of the residue indicated the complete conversion of amide 138 to 
the silyl-protected oxazoline 139. The crude product was dissolved in THF (4.0 mL) without 
further purification and treated with TBAF × 3 H2O (1.10 g, 3.48 mmol) at 0 °C. The mixture 
was allowed to warm to r.t., stirred for 16 h, then poured into H2O (10 mL) and extracted with 
CH2Cl2 (3 × 20 mL). The combined organic phases were washed with brine (40 mL) and 
dried over MgSO4. Evaporation of the solvent under reduced pressure gave a yellow oil, 
which was purified by column chromatography (silica gel, 3 × 30 cm, hexanes/EtOAc 4:1, 
F8-16) to yield oxazoline 140 as colourless solid (68.0 mg, 54%). 
 
C13H23NO2 (225.33 g*mol−1): 
m.p. 44-45 °C. 
Rf = 0.35 (hexanes/EtOAc 4:1). 
1H NMR (500 MHz, CDCl3): δ = 0.86 (s, 9 H, CH3), 1.29 (mc, 1 H, 5-H), 1.36-1.48 (m, 2 H, 
3-H and 6-H), 1.59-1.70 (m, 3 H, 3-H, 4-H and 5-H), 1.76 (mc, 1 H, 4-H), 1.84 (mc, 1 H, 6-H), 
2.37 (d, J(H,H) =11.2 Hz, 1 H, 2-H), 3.84 (dd, J(H,H) =10.4, 7.9 Hz, 1 H, Ox-4’-H), 3.98-
4.02 (m, 2 H, Ox-5’-H and 1-H), 4.11 (dd, J(H,H) =10.4, 8.8 Hz, 1 H, Ox-5’-H), 4.77 (br s, 
1 H, OH) ppm. 
13C{1H} NMR (162 MHz, CDCl3): δ = 20.3 (3-CH2), 25.1 (5-CH2), 25.1 (4-CH2), 25.4 (CH3), 
31.6 (6-CH2), 33.4 (C(CH3)3), 40.8 (2-CH), 66.5 (1-CH), 67.9 (Ox-5’-CH2), 75.2 (Ox-4’-
CH) ppm; despite prolonged data acquisition time the signal for Ox-2’-C was not detected. 
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IR (KBr): ν~  = 3369m, 2935s, 1700w, 1653s, 1560m, 1448m, 1365m, 1182m, 1118w, 
1055m, 1029m, 979m, 937m cm–1. 
MS (EI, 70 eV): m/z (%) = 225 (2, M+), 197 (9), 182 (16), 168 (100, [M−C4H9]+), 154 (42), 
96 (7), 81 (14), 43 (13). 
[ ]20Da = −22.0 (c = 0.25, CHCl3). 
 
 
(1’S,2’R,4’’S)-2-[2’-(4’’-tert-Butyl-4’’,5’’-dihydrooxazol-2’’-yl)-cyclohexyloxy]-
2,4,8,10-tetrakis(tert-butyl)-dibenzo[d,f][1,3,2]dioxaphosphepin (133) 
 
 
A solution of abs. NEt3 (192 mg, 1.89 mmol) in abs. THF (2.0 mL) was treated with PCl3 
(147 mg, 1.07 mmol) at –78 °C. Azeotropically dried (3 × 1.5 mL toluene) diol 120 (304 mg, 
0.740 mmol) in abs. THF (2.0 mL) was slowly added at –60 °C and the reaction mixture was 
allowed to warm to r.t. overnight. The reaction was filtered over Celite under argon, which 
was washed with abs. THF (10 mL). After concentration of the filtrate in high vacuum the 
residue was re-dissolved in abs. toluene (4.0 mL) and cooled to –78 °C. This solution was 
then slowly added to azeotropically dried (3 × 1.5 mL abs. toluene) oxazoline alcohol 140 
(39.0 mg, 0.173 mmol), DMAP (20.0 mg, 0.163 mmol) and abs. NEt3 (70.0 mg, 0.692 mmol) 
in abs. toluene (4.0 mL) at –78 °C. The pink reaction mixture was allowed to slowly warm to 
r.t. overnight. After filtration over Celite under argon and removal of the solvent in high 
vacuum, the crude product was purified by column chromatography (silica gel, 3 × 18 cm, 
hexanes/EtOAc 10:1, F11-19) under argon to give ligand 133 as colourless solid (85.0 mg, 
30%). 
 
C41H62NO4P (663.91 g*mol−1): 
Rf = 0.27 (hexanes/EtOAc 10:1). 
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1H NMR (500 MHz, CD2Cl2): δ = 0.79 (s, 9 H, Ox-4’’-C(CH3)3), 0.86 (br s, 1 H, 2’-H) 1.35 
(s, 18 H, CH3), 1.47 (s, 9 H, CH3), 1.49 (s, 9 H, CH3), 1.59 (mc, 2 H, CH2), 1.70 (mc, 2 H, 
CH2), 1.83 (mc, 2 H, CH2), 1.91 (mc, 2 H, CH2), 2.53 (d, J(H,H) = 10.7 Hz, 1 H, 1’-H), 3.75 
(t, J(H,H) = 9.3 Hz, 1 H, Ox-4’’-H), 3.90 (t, J(H,H) = 8.7 Hz, 1 H, Ox-5’’-H), 4.03 (d, 
J(H,H) = 9.0 Hz, 1 H, Ox-5’’-H), 7.15 (s, 2 H, Ar-H), 7.43 (t, J(P,H) = 3.0 Hz, 2 H, Ar-H) 
ppm. 
13C{1H} NMR (162 MHz, CD2Cl2): δ = 24.0 (3’-CH2), 25.1 (5’-CH2), 25.2 (4’-CH2), 25.6 
(2’-CH), 25.7 (Ox-4’’-C(CH3)3), 30.9 (CH3), 30.9 (CH3), 31.3 (CH3), 31.3 (CH3), 31.6 (6’-
CH2) 33.4 (Ox-4’’-C(CH3)3), 33.4 (C(CH3)3), 34.6 (C(CH3)3), 34.6 (C(CH3)3), 35.3 
(C(CH3)3), 41.5 (1’-CH), 67.0 (Ox-5’’-CH2), 75.8 (Ox-4’’-CH), 124.2 (Ar-CH), 126.5 (Ar-
CH), 140.3 (Ar-C), 140.3 (Ar-C), 146.3 (Ar-C), 146.4 (Ar-C), 166.5 (Ox-2’’-C) ppm. 
31P{1H} NMR (202 MHz, CDCl3): δ = 146.2 (s) ppm. 
IR (KBr): ν~  = 2957s, 2866s, 1678s, 1620w, 1595w, 1475m, 1435m, 1414w, 1397m, 1361s, 
1258w, 1225s, 1176m, 1089m, 1019w, 978m, 926m, 881s, 839s, 777m, 702m, 616w, 527w 
cm–1. 
MS (EI, 70 eV): m/z (%) = 663 (3, M+), 606 (15, [M−C4H9]+), 456 (45, C28H41O3P+), 441 
(100), 208 (14, C13H22NO+), 150 (44), 57 (34). 
 
 
7.8 Phosphinooxazolines with Stereogenic Phosphorus Atoms  
7.8.1 Amino- and Chlorophosphines 
Chloro-diethylamino-phenylphosphine (147)[119] 
 
 
At 0 °C abs. HNEt2 (10.8 g, 148 mmol) in abs. Et2O (10 mL) was added over 30 min to a 
solution of PhPCl2 (146, 13.2 g, 73.7 mmol) in abs. Et2O (100 mL). The reaction mixture was 
allowed to warm to r.t. and then stirred for 15 h. The resulting suspension was filtered over 
Celite under argon, which was washed with abs. Et2O (3 × 10 mL) afterwards. The filtrate 
was concentrated under reduced pressure and the crude product purified by distillation in high 
vacuum to give the phosphine 147 as a colourless liquid (13.4 g, 83%). 
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C10H15ClNP (215.67 g*mol−1): 
b.p. 79 °C/0.09 mbar. 
1H NMR (400 MHz, C6D6): δ = 1.10 (t, J(H,H) = 7.1 Hz, 6 H, CH3), 3.09 (dq, J(H,H) = 
7.1 Hz, J(P,H) = 12.0 Hz, 4 H, CH2), 7.40-7.52 (m, 3 H, Ar-H), 7.72-7.80 (m, 2 H, Ar-
H) ppm. 
13C{1H} NMR (101 MHz, C6D6): δ = 14.0 (d, J(C,P) = 6 Hz, CH3), 44.0 (d, J(C,P) = 13 Hz, 
CH2), 128.5 (d, J(C,P) = 4 Hz, Ar-m-CH), 129.8 (d, J(C,P) = 1 Hz, Ar-p-CH), 130.7 (d, 
J(C,P) = 20 Hz, Ar-o-CH), 139.6 (d, J(C,P) = 29 Hz, Ar-i-C) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 139.4 (s) ppm. 
 
 
Diethylamino-methyl-phenylphosphine (148)[119] 
 
 
A solution of chlorophosphine 147 (1.32 g, 6.12 mmol) in abs. Et2O (36 mL) was cooled to  
–18 °C in an ice/NaCl bath and methylmagnesium bromide in Et2O (3.0 M, 2.04 mL, 
6.12 mmol) was slowly added within 15 min. After the mixture had been stirred 2 h at r.t. and 
1 h at reflux, the colourless precipitate was filtered off with the help of Celite under argon. 
Concentration of the filtrate under reduced pressure was followed by vacuum distillation to 
give product 148 as colourless liquid (720 mg, 60%). 
 
C11H18NP (195.24 g*mol−1): 
b.p. 85 °C/0.2 mbar. 
1H NMR (400 MHz, CDCl3): δ = 1.06 (t, J(H,H) = 7.0 Hz, 6 H, CH2CH3), 1.47 (d, J(P,H) = 
5.6 Hz, 3 H, PCH3), 2.99 (dq, J(H,H) = 7.0 Hz, J(P,H) = 9.5 Hz, 4 H, CH2CH3), 7.21-7.27 
(m, 2 H, Ar-H), 7.30-7.42 (m, 3 H, Ar-H) ppm. 
31P{1H} NMR (162 MHz, CDCl3): δ = 45.7 (s) ppm. 
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Diethylamino-isopropyl-phenylphosphine (149)[119] 
 
 
A solution of chlorophosphine 147 (3.19 g, 14.8 mmol) in abs. Et2O (70 mL) was cooled to  
–18 °C in an ice/NaCl bath and isopropylmagnesium chloride in Et2O (2.0 M, 7.40 mL, 
14.8 mmol) was slowly added within 10 min. After the mixture had been stirred 1 h at r.t. and 
1 h at reflux, the colourless precipitate was filtered off with the help of Celite under argon. 
Concentration of the filtrate under reduced pressure was followed by vacuum distillation to 
give the product 149 as colourless liquid (2.50 g, 76%). 
 
C13H22NP (223.29 g*mol−1). 
b.p. 79 °C/0.09 mbar. 
1H NMR (400 MHz, C6D6): δ = 0.97 (t, J(H,H) = 7.1 Hz, 6 H, CH2CH3), 1.06 (dd, J(H,H) = 
7.1 Hz, J(P,H) = 17.9 Hz, 3 H, CH(CH3)(CH3)), 1.29 (dd, J(H,H) = 7.1 Hz, J(P,H) = 
14.2 Hz, 3 H, CH(CH3)(CH3)), 2.42 (dsept, J(H,H) = 6.8 Hz, J(P,H) = 6.8 Hz, 1 H, 
CH(CH3)2), 2.95 (mc, 4 H, CH2CH3), 7.25 (mc, 3 H, Ar-H), 7.64 (mc, 2 H, Ar-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 66.0 (s) ppm. 
 
 
Chloro-methyl-phenylphosphine (144)[117] 
 
 
Diethylaminophosphine 148 (712 mg, 3.65 mmol) was dissolved in abs. pentane (15 mL) and 
HCl in abs. Et2O (2.0 M, 3.70 mL, 7.40 mmol) was added at 0 °C within 15 min. The mixture 
was allowed to warm to r.t. and stirred for 15 h. The colourless suspension was filtered over 
Celite under argon, which was washed with abs. pentane (10 mL) afterwards. The filtrate was 
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concentrated under reduced pressure and the crude product distilled under vacuum to give 144 
as colourless liquid (336 mg, 58%). 
 
C7H8ClP (158.57 g*mol−1): 
b.p. 55 °C/0.025 mbar. 
1H NMR (400 MHz, C6D6): δ = 1.44 (d, J(P,H) = 10.0 Hz, 3 H, CH3), 7.03 (mc, 3 H, Ar-H), 
7.51 (mc, 2 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, C6D6): δ = 21.9 (d, J(C,P) = 31 Hz, CH3), 128.9 (d, J(C,P) = 7 Hz, 
Ar-m-CH), 130.8 (d, J(C,P) = 8 Hz, Ar-o-CH), 131.1 (s, Ar-p-CH), 140.6 (d, J(C,P) = 34 Hz, 
Ar-i-C) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 83.7 (s) ppm. 
 
 
Chloro-isopropyl-phenylphosphine (145)[119] 
 
 
Diethylaminophosphine 149 (2.42 g, 10.8 mmol) was dissolved in abs. pentane (60 mL) and 
HCl in abs. Et2O (2.0 M, 10.8 mL, 21.6 mmol) was added at 0 °C within 15 min. The mixture 
was allowed to warm to r.t. and stirred for 2 h. The colourless suspension was filtered over 
Celite under argon, which was washed with abs. pentane (10 mL) afterwards. The filtrate was 
concentrated under reduced pressure and the crude product distilled under vacuum to give 145 
as colourless liquid (1.59 g, 79%). 
 
C9H12ClP (186.61 g*mol−1): 
b.p. 58 °C/0.1 mbar. 
1H NMR (400 MHz, C6D6): δ = 0.75 (dd, J(H,H) = 6.9 Hz, J(P,H) = 16.9 Hz, 3 H, 
CH(CH3)(CH3)), 1.01 (dd, J(H,H) = 6.9 Hz, J(P,H) = 14.2 Hz, 3 H, CH(CH3)(CH3)), 1.90 
(mc, 1 H, CH(CH3)2), 7.06 (mc, 3 H, Ar-H), 7.55 (mc, 2 H, Ar-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 98.9 (s) ppm. 
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tert-Butyl-chloro-isopropylphosphine (150)[117] 
 
 
A solution of tBuPCl2 (151, 3.69 g, 23.2 mmol) in abs. Et2O (130 mL) was treated with 
isopropylmagnesium chloride in Et2O (2.0 M, 11.6 mL, 23.2 mmol) at 0 °C within 30 min. 
After warming the colourless suspension to r.t. it was stirred for 16 h and filtered over Celite 
under argon, which was washed with abs. Et2O (2 × 15 mL) afterwards. The filtrate was 
concentrated and the crude product distilled under reduced pressure to give 150 as colourless 
liquid (2.76 g, 71%). 
 
C7H16ClP (166.63 g*mol−1). 
b.p. 60 °C/20 mbar. 
1H NMR (400 MHz, C6D6): δ = 0.91 (dd, J(H,H) = 7.1 Hz, J(P,H) = 17.5 Hz, 3 H, 
CH(CH3)(CH3)), 1.03 (d, J(P,H) = 12.1 Hz, 9 H, C(CH3)3), 1.15 (dd, J(H,H) = 7.1 Hz, 
J(P,H) = 11.4 Hz, 3 H, CH(CH3)(CH3)), 1.78 (sept, J(H,H) = 7.1 Hz, 1 H, CH(CH3)2) ppm. 
13C{1H} NMR (101 MHz, C6D6): δ = 20.2 (d, J(C,P) = 19 Hz, CH(CH3)(CH3)), 20.4 (s, 
CH(CH3)(CH3)), 26.5 (d, J(C,P) = 17 Hz, C(CH3)3), 29.1 (d, J(C,P) = 37 Hz, CH(CH3)2), 
33.4 (d, J(C,P) = 33 Hz, C(CH3)3) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 137.6 (s) ppm. 
 
 
Chloro-phenyl-(ortho-tolyl)phosphine (167) 
 
 
The Grignard reagent, which had been prepared from 2-bromotoluene (2.95 g, 17.2 mmol) 
and oven-dried magnesium turnings (450 mg, 18.5 mmol) in abs. Et2O (20 mL), was added at 
–5 °C to a solution of chlorophosphine 147 (3.00 g, 13.9 mmol) in abs. Et2O (15 mL). The 
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brown suspension was stirred at r.t. for 16 h and filtered over Celite under argon, which was 
washed with abs. Et2O (2 × 10 mL) afterwards. HCl in abs. Et2O (2.0 M, 14.0 mL, 28.0 mmol) 
was added at –15 °C within 15 min. The mixture was allowed to warm to r.t. and stirred for 
15 h. The yellow suspension was filtered over Celite under argon, which was washed then 
with abs. Et2O (10 mL). The filtrate was concentrated under reduced pressure and the crude 
product was distilled in high vacuum to give 167 as yellow oil (2.09 g, 64%). 
 
C13H12ClP (234.66 g*mol−1): 
b.p. 140 °C/1.1 mbar. 
1H NMR (400 MHz, C6D6): δ = 2.50 (d, J(P,H) = 2.4 Hz, 3 H, CH3), 7.21-7.33 (m, 2 H, Ar-
H), 7.38 (t, J(H,H) = 7.7 Hz, 1 H, Ar-H), 7.42-7.48 (m, 3 H, Ar-H), 7.61 (mc, 3 H, Ar-
H) ppm. 
13C{1H} NMR (101 MHz, C6D6): δ = 20.5 (d, J(C,P) = 24 Hz, CH3), 126.5 (d, J(C,P) = 1 Hz, 
Ar-CH), 128.5 (d, J(C,P) = 7 Hz, Ar-CH), 130.5 (d, J(C,P) = 4 Hz, Ar-CH), 130.5 (d, 
J(C,P) = 6 Hz, Ar-CH), 131.3 (d, J(C,P) = 5 Hz, Ar-CH), 132.0 (d, J(C,P) = 25 Hz, Ar-CH), 
136.2 (d, J(C,P) = 35 Hz, oTol-i-C), 138.0 (d, J(C,P) = 33 Hz, oTol-o-C), 141.5 (d, 
J(C,P) = 29 Hz, Ph-i-C) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 75.5 (s) ppm. 
 
 
Chloro-(2-methoxyphenyl)-phenylphosphine (169) 
 
 
The Grignard reagent, which had been prepared from 2-bromoanisole (3.18 g, 17.0 mmol) and 
oven-dried magnesium turnings (440 mg, 18.1 mmol) in abs. Et2O (20 mL) was treated with 
chlorophosphine 147 (3.00 g, 13.9 mmol) in abs. Et2O (15 mL) at 0 °C. The reaction mixture 
was stirred at r.t. for 16 h, filtered over Celite under argon and washed with abs. Et2O (3 × 
10 mL). HCl in abs. Et2O (2.0 M, 14.5 mL, 29.0 mmol) was added at –15 °C within 15 min. 
The mixture was allowed to warm to r.t. and stirred for 15 h. The yellow suspension was 
filtered over Celite under argon, which was washed with abs. Et2O (10 mL) afterwards. The 
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filtrate was concentrated under reduced pressure and the crude product distilled in high 
vacuum to give 169 as colourless solid (500 mg, 14%). 
 
C13H12ClOP (250.66 g*mol−1): 
b.p. 138 °C/0.13 mbar. 
1H NMR (400 MHz, C6D6): δ = 3.79 (s, 3 H, CH3), 6.80-7.95 (m, 9 H, Ar-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 16.1 (s) ppm. 
 
 
(2-Biphenyl)-chloro-phenylphosphine (170a)/(2-Biphenyl)-bromo-phenyl-
phosphine (170b) 
 
 
The phosphine synthesis was accomplished in analogy to the preparation of 167 using 2-
bromobiphenyl (1.03 g, 4.42 mmol) and magnesium turnings (120 mg, 4.43 mmol) in abs. 
Et2O (5.0 mL), chlorophosphine 147 (639 mg, 3.57 mmol) in abs. Et2O (5.0 mL) and HCl in 
Et2O (2.0 M, 3.60 mL, 7.20 mmol). The product was obtained as yellow oil in quantitative 
yield, representing a 3:2 mixture of 170a and 170b, and used without further purification. 
 
C18H14ClP (296.73 g*mol−1) and C18H14BrP (341.18 g*mol−1): 
1H NMR (400 MHz, C6D6): δ = 6.97-7.03 (m, 3 H, Ar-H), 7.10-7.33 (m, 8 H, Ar-H), 7.42-
7.54 (m, 2 H, Ar-H), 8.12-8.23 (m, 1 H, Ar-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 67.1 (s, X = Cl), 75.0 (s, X = Br) ppm (in a ratio of 3:2). 
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Chloro-(1-naphthalenyl)-phenylphosphine (171a)/Bromo-(1-naphthalenyl)-
phenylphosphine (171b) 
 
 
The Grignard reagent, which had been prepared from 1-bromonaphthalene (6.40 g, 
30.9 mmol) and oven-dried magnesium turnings (817 mg, 33.6 mmol) in abs. Et2O (40 mL) 
was cooled to 0 °C and chlorophosphine 147 (5.50 g, 25.5 mmol) in abs. Et2O (30 mL) was 
added. The greenish solution was stirred at r.t. for 16 h and the resulting brown suspension 
filtered over Celite under argon, which was washed with abs. Et2O (3 × 15 mL) afterwards. 
HCl in abs. Et2O (1.0 M, 54.0 mL, 54.0 mmol) was added at –15 °C within 15 min. The 
mixture was allowed to warm to r.t. and then stirred for 15 h. The yellow suspension was 
filtered over Celite under argon, which was washed with abs. Et2O (10 mL). The filtrate was 
concentrated under reduced pressure and the crude product distilled in high vacuum to give a 
9:2 mixture of 171a and 171b as yellow liquid (4.40 g, 64%). 
 
C16H12ClP (270.69 g*mol−1) and C16H12BrP (313.14 g*mol−1): 
b.p. 211-213 °C/0.8 mbar. 
1H NMR (400 MHz, CD2Cl2): δ = 7.05 (mc, 2 H, Ar-H), 7.11-7.34 (m, 4 H, Ar-H), 7.53-7.75 
(m, 4 H, Ar-H), 7.77-7.92 (m, 1 H, Ar-H), 8.56-8.75 (m, 1 H, Ar-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 77.1 (s, X = Cl), 66.5 (s, X = Br) ppm (in a ratio of 9:2). 
 
 
Chloro-(2-furanyl)-phenylphosphine (172)[125] 
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nBuLi in hexane (2.5 M, 14.0 mL, 35.0 mmol) was slowly added to a solution of furan 
(2.42 g, 35.5 mmol) in abs. Et2O (20 mL) at –40 °C. The mixture was allowed to warm to 
10 °C and then stirred for 2 h at this temperature, resulting in the formation of a yellow 
suspension. PhPCl2 (146, 5.29 g, 29.5 mmol) in abs. Et2O (230 mL) was cooled to –78 °C and 
the 2-furyllithium slurry was added over the course of 60 min using a wide teflon cannula. 
The mixture was allowed to warm to r.t. overnight and the slightly yellow suspension was 
filterd over Celite under argon. The filtrate was concentrated under reduced pressure and the 
crude product purified by distillation in high vacuum to yield 172 as colourless solid (4.50 g, 
65%). 
 
C10H8ClOP (210.59 g*mol−1): 
b.p. 120-125 °C/0.06 mbar. 
1H NMR (400 MHz, C6D6): δ = 5.96 (mc, 1 H, Fur-H), 6.61 (mc, 1 H, Fur-H), 7.10-7.16 (m, 
3 H, Ph-H), 7.17 (mc, 1 H, Fur-H), 7.76 (mc, 2 H, Ph-H) ppm. 
13C{1H} NMR (101 MHz, C6D6): δ = 111.7 (d, J(C,P) = 6 Hz, Fur-CH), 123.2 (d, J(C,P) = 
1 Hz, Fur-CH), 128.9 (d, J(C,P) = 8 Hz, Ph-m-CH), 130.8 (s, Ar-CH), 132.1 (d, J(C,P) = 
26 Hz, Ph-o-CH), 136.4 (d, J(C,P) = 25 Hz, Ar-i-C), 149.1 (d, J(C,P) = 3 Hz, Ar-CH), 153.3 
(d, J(C,P) = 45 Hz, Ar-i-C) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 46.2 (s) ppm. 
 
 
7.8.2 Oxazolines 
N-(2-Hydroxyethyl)-benzamide (156)[120] 
 
 
BzCl (16.8 g, 120 mmol) in THF (120 mL) was added dropwise within 20 min to a solution of 
2-aminoethanol (154, 31.5 g, 457 mmol) in THF (260 mL) at 4 °C. The reaction mixture was 
stirred for 2.5 h at r.t. After evaporation of the solvent the residue was dissolved in ice water 
(250 mL). The solution was acidified to pH 6 with concentrated HCl and extracted with 
EtOAc (4 × 150 mL). The combined organic phases were washed with brine (350 mL), dried 
N
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over Na2SO4 and evaporated. The crude product was re-crystallised from hexanes/EtOAc, 
which yielded the product 156 as colourless needles (15.9 g, 81%). 
 
C9H11NO2 (165.19 g*mol−1): 
m.p. 62 °C. 
1H NMR (400 MHz, CDCl3): δ = 3.52 (mc, 2 H, HNCH2), 3.72 (mc, 2 H, HOCH2), 4.06 (br s, 
1 H, OH), 7.24 (br s, 1 H, NH), 7.32 (t, J(H,H) = 8.1 Hz, 2 H, Bz-m-H), 7.42 (t, 
J(H,H) = 8.6 Hz, 1 H, Bz-p-H), 7.72 (d, J(H,H) = 8.5 Hz, 2 H, Bz-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 42.9 (HNCH2), 61.8 (HOCH2), 127.1 (Bz-o-CH), 
128.6 (Bz-m-CH), 131.7 (Bz-p-CH), 134.1 (Bz-i-C), 168.9 (CONH) ppm. 
IR (KBr): ν~  = 3306s, 2937m, 2874m, 1637s, 1539s, 1327m, 1297s, 1205m, 1040s, 865m, 
802w, 695s, 554m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 204 (24, [M+K]+), 166 (100, [M+H]+), 105 (32, C7H5O+), 
44 (10). 
Elemental analysis calcd. (%) for C9H11NO2: C 65.44, H 6.71, N 8.48, O 19.37; found: C 
65.55, H 6.66, N 8.33, O 19.44. 
 
 
N-(1-Hydroxy-2-methylpropan-2-yl)-benzamide (157)[120] 
 
 
The synthesis in analogy to the preparation of 156 using BzCl (12.4 g, 88.2 mmol) and 2-
amino-2-methylpropan-1-ol (155, 31.5 g, 353 mmol) in THF (300 mL) gave amide 157 as 
colourless solid after re-crystallisation from hexanes/EtOAc (13.7 g, 79%). 
 
C11H15NO2 (193.24 g*mol−1): 
m.p. 93 °C. 
1H NMR (400 MHz, CDCl3): δ = 1.39 (s, 6 H, CH3), 3.68 (mc, 2 H, CH2), 4.88 (br s, 1 H, 
OH), 6.31 (br s, 1 H, NH), 7.37-7.45 (m, 2 H, Bz-m-H), 7.45-7.52 (m, 1 H, Bz-p-H), 7.72 (mc, 
2 H, Bz-o-H) ppm. 
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13C{1H} NMR (101 MHz, CDCl3): δ = 24.7 (CH3), 56.5 (C(CH3)2), 70.8 (CH2), 127.0 (Bz-o-
CH), 128.7 (Bz-m-CH), 131.7 (Bz-p-CH), 134.9 (Bz-i-C), 168.6 (CONH) ppm. 
IR (KBr): ν~  = 3188s, 2980s, 2895s, 1628s, 1543s, 1491s, 1388m, 1367m, 1315m, 1263s, 
1177s, 1066s, 1021m, 932w, 873w, 806w, 776w, 691s, 518m, 471w, 421m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 232 (19, [M+K]+), 194 (100, [M+H]+), 162 (16), 122 (23), 
105 (35, C7H5O+). 
Elemental analysis calcd. (%) for C11H15NO2: C 68.37, H 7.82, N 7.25, O 16.56; found: C 
68.40, H 7.84, N 7.20, O 16.56. 
 
 
2-Amino-2,2-diphenylethanol (178)[126, 149] 
 
 
To a suspension of LiAlH4 (670 mg, 17.7 mmol) in abs. THF (16 mL) was added 
diphenylglycine (2.04 g, 8.95 mmol) at 0 °C and the mixture was refluxed for 5 h. After the 
reaction had been cooled to r.t. water (1.0 mL), 15% aqueous NaOH solution (2.0 mL), and 
water (1.0 mL) were successively added. The mixture was dried over K2CO3 and filtered. The 
solvent was removed under reduced pressure and the crude product was re-crystallised from 
EtOAc/MeOH to give aminoalcohol 178 as colourless needles (1.23 g, 64%). 
 
C14H15NO (213.28 g*mol−1): 
m.p. 127-129 °C. 
Rf = 0.08 (hexanes/EtOAc 2:1). 
1H NMR (400 MHz, CDCl3): δ = 2.23 (br s, 3 H, OH and NH2), 4.12 (s, 2 H, CH2), 7.20-7.38 
(m, 10 H, Ph-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 62.4 (C(C6H5)2), 70.2 (CH2), 126.7 (Ph-CH), 126.9 
(Ph-CH), 128.3 (Ph-CH), 145.9 (Ph-i-C) ppm. 
IR (KBr): ν~  = 3424m, 3285m, 3147m, 2885m, 2822m, 1961w, 1894w, 1824w, 1587s, 
1488m, 1442s, 1285m, 1254m, 1101m, 1068s, 1001s, 935s, 908m, 857w, 766m, 703s, 645m, 
593m, 535w, 494w cm–1. 
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MS (FAB, NBA+KCl): m/z (%) = 252 (10, [M+K]+), 214 (41, [M+H]+), 197 (84, [M−NH2]+), 
182 (100, [M−CH2OH]+), 105 (30). 
Elemental analysis calcd. (%) for C14H15NO: C 78.84, H 7.09, N 6.57, O 7.50; found: C 
78.88, H 7.08, N 6.54, O 7.43. 
 
 
N-(2-Hydroxy-1,1-diphenylethyl)-benzamide (179) 
 
 
A solution of diphenylglycinol (178, 1.23 g, 5.76 mmol) and abs. NEt3 (1.16 g, 11.5 mmol) in 
dioxane (10 mL) and CH2Cl2 (6.0 mL) was cooled to 0 °C and BzCl (810 mg, 5.76 mmol) 
was slowly added. The mixture was stirred for 7 h at r.t. and the solvents were removed under 
reduced pressure. The residue was re-dissolved in EtOAc (150 mL) and filtered over silica gel 
(3 × 4 cm). Concentration of the filtrate and re-crystallisation of the crude product from 
EtOAc gave 179 as colourless solid (1.10 g, 40%). 
 
C21H19NO2 (317.38 g*mol−1): 
m.p. 186-187 °C. 
1H NMR (400 MHz, CDCl3): δ = 4.50 (d, J(H,H) = 6.5 Hz, 2 H, CH2), 5.73 (t, J(H,H) = 
6.5 Hz, 1 H, OH), 7.02 (br s, 1 H, NH), 7.29-7.59 (m, 12 H, Ar-H), 7.81-7.85 (m, 3 H, Ar-
H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 69.5 (C(C6H5)2), 70.2 (CH2), 127.2 (Ar-CH), 127.4 
(Ar-CH), 128.0 (Ar-CH), 129.9 (Ar-CH), 130.0 (Ar-CH), 132.3 (Ar-CH), 134.3 (Bz-i-C), 
142.0 (Ph-i-C), 168.5 (CONH) ppm. 
IR (KBr): ν~  = 3058m, 2919m, 2861m, 1962w, 1890w, 1815w, 1718s, 1641s, 1598m, 1529s, 
1486s, 1445s, 1377w, 1313m, 1268s, 1216m, 1179m, 1109m, 1052s, 979m, 934w, 914w, 
844w, 760s, 699s, 569m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 356 (15, [M+K]+), 318 (48, [M+H]+), 197 (40), 122 (32), 
105 (100, C7H5O+). 
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Elemental analysis calcd. (%) for C21H19NO2: C 79.47, H 6.03, N 4.41, O 10.08; found: C 
79.20, H 6.02, N 4.39, O 10.14. 
 
 
2-Phenyl-4,5-dihydrooxazole (152)[116]  
 
 
To hydroxyamide 156 (6.42 g, 38.9 mmol) and abs. NEt3 (27.0 mL, 194 mmol) in abs. 
CH2Cl2 (120 mL) was added p-TsCl (8.16 g, 42.8 mmol) at r.t. The resulting solution was 
stirred under reflux for 24 h. After the addition of H2O (2.0 mL) the solution was heated under 
reflux for another 60 min. The mixture was cooled to r.t. and then washed with H2O 
(3 × 100 mL). The organic phase was dried over Na2SO4 and evaporated under reduced 
pressure. The crude product was purified by means of a Kugelrohr distillation in high vacuum 
yielding 152 as colourless oil (4.86 g, 85%). 
 
C9H9NO (147.17 g*mol−1): 
b.p. 120 °C/6.0 mbar. 
Rf = 0.33 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 3.98 (t, J(H,H) = 9.6 Hz, 2 H, Ox-4-H), 4.33 (t, 
J(H,H) = 9.6 Hz, 2 H, Ox-5-H), 7.29-7.46 (m, 3 H, Ph-m-H and Ph-p-H), 7.90 (d, 
J(H,H) = 7.6 Hz, 2 H, Ph-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 54.9 (Ox-4-CH2), 67.5 (Ox-5-CH2), 127.7 (Ph-i-C), 
128.1 (Ph-m-CH), 128.2 (Ph-o-CH), 131.2 (Ph-p-CH), 164.5 (Ox-2-C) ppm. 
IR (NaCl): ν~  = 3061m, 2964m, 2900m, 1966w, 1910w, 1822w, 1648s, 1576m, 1487m, 
1447m, 1366s, 1266s, 1192w, 1062s, 1021w, 940m, 893m, 776m, 694s cm–1. 
MS (EI, 70 eV): m/z (%) = 147 (64, M+), 117 (100, [M−CH2O]+), 77 (35, C6H5+), 51 (12). 
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4,4-Dimethyl-2-phenyl-4,5-dihydrooxazole (153)[116] 
 
 
The synthesis in analogy to the preparation of 152 using hydroxy amide 157 (3.80 g, 
19.7 mmol), abs. NEt3 (14.0 mL, 100 mmol) and p-TsCl (4.10 g, 21.5 mmol) in abs. CH2Cl2 
(60 mL) yielded oxazoline 153 as colourless oil after Kugelrohr distillation under reduced 
pressure (3.51 g, 70%). 
 
C11H13NO (175.23 g*mol−1): 
b.p. 125 °C/20.0 mbar. 
Rf = 0.44 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.38 (s, 6 H, CH3), 4.10 (s, 2 H, Ox-5-H), 7.39 (mc, 2 H, 
Ph-m-H), 7.46 (mc, 1 H, Ph-p-H), 7.93 (d, J(H,H) = 8.5 Hz, 2 H, Ph-o-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 28.5 (CH3), 67.7 (Ox-4-C), 79.2 (Ox-5-CH2), 128.1 
(Ph-i-C), 128.3 (Ph-m-CH), 128.4 (Ph-o-CH), 131.3 (Ph-p-CH), 162.2 (Ox-2-C) ppm. 
IR (NaCl): ν~  = 2964m, 1650s, 1455s, 1354s, 1313s, 1185s, 1062s, 968s, 924m, 781w, 
693s cm–1. 
MS (EI, 70 eV): m/z (%) = 175 (12, M+), 160 (100, [M−CH3]+), 145 (18, [M−2×CH3]+), 132 
(16), 104 (51), 77 (21, C6H5+). 
Elemental analysis calcd. (%) for C11H13NO: C 75.40, H 7.48, N 7.99; found: C 75.76, H 
7.66, N 8.04. 
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2,4,4-Triphenyl-4,5-dihydrooxazole (176) 
 
 
The synthesis in analogy to the preparation of 152 using hydroxy amide 179 (222 mg, 
0.700 mmol), abs. NEt3 (326 mg, 3.22 mmol) and p-TsCl (147 mg, 0.771 mmol) in abs. 
CH2Cl2 (3.5 mL) gave oxazoline 176 after column chromatography (silica gel, 3 × 15 cm, 
hexanes/EtOAc 4:1, F6-19) as colourless solid (142 mg, 68%). 
 
C21H17NO (299.13 g*mol−1): 
m.p. 92-93 °C. 
Rf = 0.59 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 4.96 (s, 2 H, Ox-5-H), 7.20-7.55 (m, 13 H, Ph-H), 8.07-
8.14 (m, 2 H, Ph-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 79.7 (Ox-4-C), 80.0 (Ox-5-CH2), 126.8 (Ph-CH), 
127.3 (Ph-CH), 127.9 (2-Ph-i-C), 128.5 (Ph-CH), 128.6 (Ph-CH), 128.7 (Ph-CH), 131.6 (Ph-
CH), 146.3 (4-Ph-i-C), 163.0 (Ox-2-C) ppm. 
IR (KBr): ν~  = 3056m, 2898m, 1636s, 1486m, 1444m, 1356m, 1317m, 1280s, 1212m, 
1170m, 1066s, 1023s, 901m, 853w, 752m, 694s, 560m, 532m cm–1. 
MS (EI, 70 eV): m/z (%) = 299 (18, M+), 269 (100), 222 (76, [M−C6H5]+), 156 (86), 91 (25). 
Elemental analysis calcd. (%) for C21H17NO: C 84.25, H 5.72, N 4.68; found: C 84.22, H 
5.89, N 4.54. 
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7.8.3 Dialkyl- and Alkylaryl-Substituted Phosphinooxazolines  
2-[2’-(Methyl-phenyl-thiophosphino)-phenyl]-4,5-dihydrooxazole (158a) 
 
 
A solution of azeotropically dried (2 × 2.0 mL toluene) phenyloxazoline 152 (321 mg, 
2.18 mmol) and TMEDA (279 mg, 2.40 mmol) in abs. pentane (20 mL) was cooled to –78 °C 
and sBuLi in cyclohexane (1.3 M, 1.80 mL, 2.34 mmol) was added dropwise. After the 
reaction mixture had been stirred for 30 min at –78 °C and then 15 min at 0 °C, the orange 
suspension was re-cooled to –78 °C and treated with chlorophosphine 144 (500 mg, 
3.15 mmol). The yellow mixture was allowed to slowly reach r.t. overnight. After removal of 
all volatiles in high vacuum the crude product was dissolved in abs. toluene (20 mL) and 
sulfur powder (101 mg, 3.15 mmol) was added. After 16 h at r.t. the reaction was filtered over 
Celite and the filtrate was concentrated under reduced pressure. Column chromatography 
(silica gel, 3 × 20 cm, hexanes/EtOAc 7:3, F60-73) of the crude product gave ligand 158a as 
colourless solid (440 mg, 67%). A portion of the racemic ligand was separated into its 
enantiomers by semipreparative HPLC on a chiral column.  
 
C16H16NOPS (301.34 g*mol−1): 
m.p. 100-101 °C. 
Rf = 0.20 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CD2Cl2): δ = 2.49 (d, J(P,H) = 13.3 Hz, 3 H, CH3), 3.48 (ddd, 
J(H,H) = 14.0, 10.5, 8.8 Hz, 1 H, Ox-4-H), 3.72 (mc, 2 H, Ox-5-H), 3.99 (ddd, J(H,H) = 10.2, 
8.8, 7.6 Hz, 1 H, Ox-4-H), 7.40-7.50 (m, 3 H, Ar-H), 7.55-7.68 (m, 5 H, Ar-H), 8.45 (mc, 1 H, 
Ar-3’-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 23.0 (d, J(C,P) = 61 Hz, CH3), 54.7 (s, Ox-4-CH2), 
67.2 (s, Ox-5-CH2), 128.3 (d, J(C,P) = 13 Hz, Ar-CH), 129.5 (d, J(C,P) = 11 Hz, Ar-CH), 
130.1 (d, J(C,P) = 6 Hz, Ar-CH), 130.2 (d, J(C,P) = 2 Hz, Ar-CH), 130.6 (d, J(C,P) = 3 Hz, 
Ar-CH), 131.3 (d, J(C,P) = 3 Hz, Ar-CH), 131.4 (s, Ar-1’-C), 132.2 (d, J(C,P) = 77 Hz, Ar-
2’-C), 134.6 (d, J(C,P) = 13 Hz, Ar-3’-CH), 135.6 (d, J(C,P) = 87 Hz, Ph-1’’-C), 163.3 (d, 
J(C,P) = 3 Hz, Ox-2-C) ppm. 
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31P{1H} NMR (162 MHz, CD2Cl2): δ = 36.8 (s) ppm. 
IR (KBr): ν~  = 2973m, 2928m, 2868m, 1657s, 1583w, 1573w, 1471m, 1431m, 1352s, 1322s, 
1279m, 1242s, 1091m, 1043m, 977w, 938s, 891m, 750s, 699s, 603s, 486m cm–1. 
MS (EI, 70 eV): m/z (%) = 301 (22, M+), 286 (28), 259 (81), 192 (100, [M−C6H5]+), 183 (13). 
[ ]20Da = −45.8 ((−)-158a, c = 0.61, CHCl3); +44.0 ((+)-158a, c = 0.61, CHCl3).  
HPLC (Daicel Chiracel OD, heptane/isopropanol 90:10, 6.0 mL*min−1, 20 °C, 254 nm): 
tR = 72.5 ((−)-158a), 93.5 ((+)-158a) min. 
Elemental analysis calcd. (%) for C16H16NOPS: C 63.77, H 5.35, N 4.65; found: C 63.78, H 
5.50, N 4.52. 
 
 
2-[2’-(Methyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (158) 
 
 
A solution of phosphine sulfide 158a (150 mg, 0.497 mmol) in abs. benzene (20 mL) was 
treated with Si2Cl6 (410 mg, 1.52 mmol) at r.t. and heated under reflux for 60 min. More 
Si2Cl6 (432 mg, 1.61 mmol) was added then and the mixture was refluxed for another 60 min. 
A yellow-brownish suspension was obtained, which was cooled to 10 °C and hydrolysed with 
30% degassed, aqueous NaOH solution (8.3 mL). The colourless biphasic mixture was 
vigorously stirred for ten minutes and the two phases were separated under argon. The organic 
layer was washed with degassed water (3 × 8 mL) and the solvent removed under reduced 
pressure afterwards. The residue was re-dissolved with degassed CH2Cl2 (25 mL) and the 
solution filtered through a teflon cannula equipped with a glass fibre filter. Removal of the 
solvent gave ligand 158 as colourless oil (28.1 mg, 21%).  
 
C16H16NOP (269.28 g*mol−1): 
31P{1H} NMR (162 MHz, CD2Cl2): δ = −30.9 (s) ppm. 
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2-[2’-(Isopropyl-phenyl-thiophosphino)-phenyl]-4,5-dihydrooxazole (159a) 
 
 
In analogy to the preparation of 158a phenyloxazoline 152 (256 mg, 1.74 mmol), TMEDA 
(228 mg, 1.96 mmol), sBuLi in cyclohexane (1.3 M, 1.80 mL, 2.34 mmol) and chloro-
phosphine 145 (422 mg, 2.26 mmol) were reacted in abs. pentane (15 mL). Protection of the 
residue was accomplished with sulfur powder (76.0 mg, 2.37 mmol) in abs. toluene (15 mL) 
and column chromatography (silica gel, 4 × 15 cm, hexanes/EtOAc 7:3, F38-62) of the crude 
product gave phosphine sufide 159a as colourless solid (261 mg, 79%). A portion of the 
racemic ligand was separated into its enantiomers by semipreparative HPLC on a chiral 
column. Some of the isolated crystals were suitable for structure determination by X-ray 
analysis. 
 
C18H20NOPS (329.40 g*mol−1): 
m.p. 108 °C. 
Rf = 0.16 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CD2Cl2): δ = 1.03 (dd, J(H,H) = 6.9 Hz, J(P,H) = 19.4 Hz, 3 H, 
CH(CH3)(CH3)), 1.26 (dd, J(H,H) = 6.9 Hz, J(P,H) = 19.4 Hz, 3 H, CH(CH3)(CH3)), 3.56 
(septd, J(H,H) = 6.9 Hz, J(P,H) = 14.4 Hz, 1 H, CH(CH3)2), 3.67 (ddd, J(H,H) = 11.2, 11.0, 
8.9 Hz, 1 H, Ox-4-H), 3.77 (mc, 2 H, Ox-5-H), 4.11 (mc, 1 H, Ox-4-H), 7.36-7.48 (m, 3 H, Ar-
H), 7.56 (mc, 2 H, Ar-H), 7.59-7.68 (mc, 3 H, Ar-H), 8.50 (dd, J(H,H) = 7.9 Hz, J(P,H) = 
14.2 Hz, 1 H, Ar-3’-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 16.2 (s, CH(CH3)(CH3)), 17.2 (s, CH(CH3)(CH3)), 
27.8 (d, J(C,P) = 57 Hz, CH(CH3)2), 55.0 (s, Ox-4-CH2), 67.4 (s, Ox-5-CH2), 128.1 (d, 
J(C,P) = 14 Hz, Ar-CH), 129.8 (d, J(C,P) = 12 Hz, Ar-CH), 130.5 (d, J(C,P) = 9 Hz, Ar-CH), 
130.6 (d, J(C,P) = 3 Hz, Ar-CH), 130.9 (d, J(C,P) = 10 Hz, Ar-CH), 131.1 (d, J(C,P) = 6 Hz, 
Ar-1’-C), 131.3 (d, J(C,P) = 70 Hz, Ar-C), 131.9 (d, J(C,P) = 44 Hz, Ar-CH), 134.2 (d, 
J(C,P) = 80 Hz, Ar-C), 134.8 (d, J(C,P) = 10 Hz, Ar-CH), 161.2 (d, J(C,P) = 3 Hz, Ox-2-
C) ppm. 
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31P{1H} NMR (162 MHz, CD2Cl2): δ = 53.9 (s) ppm. 
IR (KBr): ν~  = 2968m, 2872m, 1656s, 1587m, 1466m, 1432m, 1357s, 1247m, 1099s, 1056m, 
937m, 847w, 692s cm–1. 
MS (EI, 70 eV): m/z (%) = 329 (12, M+), 296 (38), 286 (65, [M−C3H7]+), 254 (100), 220 (68), 
212 (11), 178 (15), 139 (6). 
[ ]20Da = +91.3 ((R)-159a, c = 0.50, CHCl3); −90.0 ((S)-159a, c = 0.50, CHCl3).  
HPLC (Daicel Chiracel AD, heptane/isopropanol 85:15, 6.0 mL*min−1, 20 °C, 254 nm): 
tR = 35.2 ((R)-159a), 40.3 ((S)-159a) min. 
Elemental analysis calcd. (%) for C18H20NOPS: C 65.63, H 6.12, N 4.25; found: C 65.46, H 
6.08, N 4.30. 
 
 
2-[2’-(Isopropyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (159) 
 
 
The deprotection was accomplished in analogy to the preparation of 158 using phosphine 
sulfide 159a (164 mg, 0.497 mmol) and Si2Cl6 (349 mg, 1.29 mmol) in abs. benzene (20 mL), 
followed by the treatment with 30% degassed aqueous NaOH solution (3.5 mL). The free 
ligand 159 was isolated as colourless oil (65 mg, 44%). 
 
C18H20NOP (297.33 g*mol−1): 
31P{1H} NMR (162 MHz, C6D6): δ = −8.1 (s) ppm. 
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2-[2’-(tert-Butyl-isopropyl-thiophosphino)-phenyl]-4,5-dihydrooxazole (160a) 
 
 
In analogy to the preparation of 158a phenyloxazoline 152 (284 mg, 1.93 mmol), TMEDA 
(251 mg, 2.16 mmol), sBuLi in cyclohexane (1.3 M, 1.90 mL, 2.47 mmol) and 
chlorophosphine 150 (412 mg, 2.47 mmol) were reacted in abs. pentane (15 mL). Protection 
of the residue was accomplished with sulfur powder (79.2 mg, 2.46 mmol) in abs. toluene 
(15 mL) and column chromatography (silica gel, 3  × 20 cm, hexanes/EtOAc 7:3, F80-105) of 
the crude product gave phoshine sufide 160a as colourless solid (529 mg, 89%). A portion of 
the racemic ligand was separated into its enantiomers by semipreparative HPLC on a chiral 
column. Some of the isolated crystals were suitable for structure determination by X-ray 
analysis. 
 
 
C16H24NOPS (309.41 g*mol−1): 
m.p. 158-159 °C. 
Rf = 0.21 (hexanes/EtOAc 1:1). 
1H NMR (400 MHz, CD2Cl2): δ = 0.92 (dd, J(H,H) = 6.8 Hz, J(P,H) = 17.5 Hz, 3 H, 
CH(CH3)(CH3)), 1.02 (d, J(P,H) = 16.4 Hz, 9 H, C(CH3)3) 1.31 (dd, J(H,H) = 6.8 Hz, 
J(P,H) = 17.5 Hz, 3 H, CH(CH3)(CH3)), 3.05 (mc, 1 H, CH(CH3)2), 3.99 (mc, 2 H, Ox-4-H), 
4.39 (mc, 2 H, Ox-5-H), 7.47-7.50 (m, 3 H, Ar-3’-H, Ar-4’-H and Ar-5’-H), 8.08 (br s, 1 H, 
Ar-6’-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 17.3 (s, CH(CH3)(CH3)), 17.9 (s, CH(CH3)(CH3)), 
26.7 (d, J(C,P) = 47 Hz, CH(CH3)2), 26.9 (d, J(C,P) = 2 Hz, C(CH3)3), 36.2 (s, C(CH3)3), 
55.5 (s, Ox-4-CH2), 67.5 (s, Ox-5-CH2), 129.1 (d, J(C,P) = 10 Hz, Ar-CH), 130.7 (d, J(C,P) = 
5 Hz, Ar-CH), 131.5 (s, Ar-CH), 131.6 (s, Ar-CH), 134.1 (s, Ar-1’-C), 164.3 (s, Ox-2-
C) ppm; despite prolonged data acquisition time the signal for Ph-2’-C was not detected. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = 77.4 (s) ppm. 
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IR (KBr): ν~  = 2900s, 1673s, 1582w, 1470s, 1353s, 1238s, 1187w, 1127w, 1093m, 1043m, 
969m, 936s, 780s, 692s, 627s, 561m, 487m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 348 (12, [M+K]+), 310 (100, [M+H]+), 252 (16), 220 (47), 
57 (50). 
[ ]20Da = −33.3 ((R)-160a, c = 0.50, CHCl3); +30.3 ((S)-160a, c = 0.50, CHCl3).  
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 85:15, 6.0 mL*min−1, 20 °C, 254 nm): 
tR = 19.2 ((R)-160a), 20.8 ((S)-160a) min.  
Elemental analysis calcd. (%) for C16H24NOPS: C 62.11, H 7.82, N 4.53; found: C 62.04, H 
7.85, N 4.53. 
 
 
2-[2’-(tert-Butyl-isopropylphosphino)-phenyl]-4,5-dihydrooxazole (160) 
 
 
The deprotection was accomplished in analogy to the preparation of 158 using phosphine 
sulfide 160a (112 mg, 0.362 mmol), Si2Cl6 (304 mg, 1.13 mmol) in abs. benzene (14 mL), 
followed by the treatment with 30% degassed aqueous NaOH solution (3.0 mL). The free 
ligand 160 was isolated as colourless oil (42.5 mg, 43%). 
 
C16H24NOPS (277.34 g*mol−1): 
31P{1H} NMR (162 MHz, C6D6): δ = 9.1 (s) ppm. 
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4,4-Dimethyl-2-[2’-(methyl-phenyl-thiophosphino)-phenyl]-4,5-dihydrooxazole 
(161a) 
 
 
In analogy to the preparation of 158a phenyloxazoline 153 (429 mg, 2.45 mmol), TMEDA 
(343 mg, 2.95 mmol), sBuLi in cyclohexane (1.3 M, 2.50 mL, 3.25 mmol) and 
chlorophosphine 144 (505 mg, 3.18 mmol) were reacted in abs. pentane (20 mL). Protection 
of the residue was accomplished with sulfur powder (102 mg, 3.18 mmol) in abs. toluene 
(20 mL) and column chromatography (silica gel, 4 × 20 cm, hexanes/EtOAc 7:3, F29-55) of 
the crude product gave phosphine sufide 161a as colourless solid (514 mg, 64%). A portion of 
the racemic ligand was separated into its enantiomers by semipreparative HPLC on a chiral 
column. 
 
C18H20NOPS (329.40 g*mol−1): 
m.p. 130 °C. 
Rf = 0.17 (hexanes/EtOAc 7:3). 
1H NMR (500 MHz, CD2Cl2): δ =1.01 (s, 3 H, Ox-4-CH3), 1.13 (s, 3 H, Ox-4-CH3), 2.48 (d, 
J(P,H) = 13.6 Hz, 3 H, PCH3), 3.65 (d, J(H,H) = 7.8 Hz, 1 H, Ox-5-H), 3.70 (d, 
J(H,H) = 7.8 Hz, 1 H, Ox-5-H), 7.45 (mc, 3 H, Ar-H), 7.61 (mc, 4 H, Ar-H), 7.80 (mc, 1 H, 
Ar-6’-H), 8.35 (ddd, J(H,H) = 7.6, 1.5 Hz, J(P,H) = 16.0 Hz, 1 H, Ar-3’-H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 23.5 (d, J(C,P) = 64 Hz, PCH3), 27.5 (s, Ox-4-
C(CH3)(CH3)), 27.6 (s, Ox-4-C(CH3)(CH3)), 67.9 (s, Ox-4-C(CH3)2), 78.7 (s, Ox-5-CH2), 
128.7 (d, J(C,P) = 13 Hz, Ar-CH), 129.5 (d, J(C,P) = 11 Hz, Ar-CH), 130.3 (d, 
J(C,P) = 13 Hz, Ar-CH), 130.8 (d, J(C,P) = 3 Hz, Ar-CH), 131.1 (d, J(C,P) = 8 Hz, Ar-6’-
CH), 131.5 (d, J(C,P) = 3 Hz, Ar-CH), 131.6 (d, J(C,P) = 7 Hz, Ar-1’-C), 131.7 (d, 
J(C,P) = 75 Hz, Ar-2’-C), 134.8 (d, J(C,P) = 14 Hz, Ar-3’-CH), 136.8 (d, J(C,P) = 88 Hz, 
Ph-1’’-C), 161.2 (d, J(C,P) = 2 Hz, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = 37.4 (s) ppm. 
IR (KBr): ν~  = 2973m, 2900m, 1650s, 1578m, 1460m, 1439s, 1352m, 1306m, 1252m, 
1212m, 1169s, 1102m, 1045s, 961m, 887s, 820w, 767m, 747s, 712m, 610m cm–1. 
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MS (FAB, NBA+KCl): m/z (%) = 368 (16, [M+K]+), 330 (100, [M+H]+), 258 (59), 220 (31), 
55 (9). 
[ ]20Da = −58.0 ((−)-161a, c = 0.50, CHCl3); +58.7 ((+)-161a, c = 0.50, CHCl3).  
HPLC (Daicel Chiracel AD, heptane/isopropanol 85:15, 6.0 mL*min−1, 20 °C, 254 nm): 
tR = 49.1 ((−)-161a), 58.6 ((+)-161a) min. 
Elemental analysis calcd. (%) for C18H20NOPS: C 65.63, H 6.12, N 4.25; found: C 65.30, H 
6.17, N 4.28. 
 
 
4,4-Dimethyl-2-[2’-(methyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (161) 
 
 
The deprotection was accomplished in analogy to the preparation of 158 using phosphine 
sulfide 161a (103 mg, 0.313 mmol) and Si2Cl6 (259 mg, 0.963 mmol) in abs. benzene 
(13 mL), followed by the treatment with 30% degassed aqueous NaOH solution (2.6 mL). 
Ligand 161 was isolated as colourless oil (34.4 mg, 37%). 
 
C18H20NOP (297.33 g*mol−1): 
1H NMR (400 MHz, C6D6): δ = 1.17 (s, 6 H, Ox-4-CH3), 1.60 (d, J(P,H) = 5.1 Hz, 3 H, 
PCH3), 3.65 (d, J(H,H) = 8.0 Hz, 1 H, Ox-5-H), 3.70 (d, J(H,H) = 8.0 Hz, 1 H, Ox-5-H), 
6.96-7.14 (m, 5 H, Ar-H), 7.22 (mc, 1 H, Ar-6’-H), 7.46 (mc, 2 H, Ar-H), 8.01 (mc, 1 H, Ar-
3’-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 31.3 (s) ppm. 
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4,4-Dimethyl-2-[2’-(isopropyl-phenyl-thiophosphino)-phenyl]-4,5-dihydro-
oxazole (162a) 
 
 
In analogy to the preparation of 158a phenyloxazoline 153 (305 mg, 1.73 mmol), TMEDA 
(223 mg, 1.92 mmol), sBuLi in cyclohexane (1.3 M, 1.80 mL, 2.34 mmol) and chloro-
phosphine 145 (469 mg, 2.51 mmol) were reacted in abs. pentane (15 mL). Protection of the 
residue was accomplished with sulfur powder (73.0 mg, 2.27 mmol) in abs. toluene (15 mL) 
and column chromatography (silica gel, 4 × 15 cm, hexanes/EtOAc 7:3, F36-72) of the crude 
product gave phosphine sufide 162a as colourless solid (195 mg, 31%). A portion of the 
racemic ligand was separated into its enantiomers by semipreparative HPLC on a chiral 
column. Some of the isolated crystals were suitable for structure determination by X-ray 
analysis. 
 
C20H24NOPS (357.45 g*mol−1): 
m.p. 122 °C. 
Rf = 0.13 (hexanes/EtOAc 7:3). 
1H NMR (500 MHz, C6D6): δ = 1.03 (s, 3 H, Ox-4-CH3), 1.14 (dd, J(H,H) = 6.8 Hz, J(P,H) = 
18.6 Hz, 3 H, CH(CH3)(CH3)), 1.15 (s, 3 H, Ox-4-CH3), 1.21 (dd, J(H,H) = 6.8 Hz, 
J(P,H) = 18.6 Hz, 3 H, CH(CH3)(CH3)), 3.14 (mc, 1 H, CH(CH3)2), 3.39 (d, J(H,H) = 7.7 Hz, 
1 H, Ox-5-H), 3.72 (d, J(H,H) = 7.7 Hz, 1 H, Ox-5-H), 6.96-7.10 (m, 5 H, Ar-H), 7.74-7.82 
(m, 3 H, Ar-H), 8.28 (dd, J(H,H) = 7.9 Hz, J(P,H) = 13.2 Hz, 1 H, Ar-3’-H) ppm. 
13C{1H} NMR (126 MHz, C6D6): δ = 17.1 (d, J(C,P) = 41 Hz, CH(CH3)2), 27.9 (s, Ox-4-
C(CH3)(CH3)), 28.0 (s, Ox-4-C(CH3)(CH3)), 28.9 (d, J(C,P) = 56 Hz, CH(CH3)2), 68.9 (s, 
Ox-4-C(CH3)2), 78.7 (s, Ox-5-CH2), 128.5 (d, J(C,P) = 14 Hz, Ar-CH), 129.7 (d, 
J(C,P) = 11 Hz, Ar-CH), 130.4 (d, J(C,P) = 2 Hz, Ar-CH), 130.9 (d, J(C,P) = 3 Hz, Ar-CH), 
131.3 (d, J(C,P) = 11 Hz, Ar-CH), 131.9 (d, J(C,P) = 8 Hz, Ar-CH), 132.1 (d, 
J(C,P) = 71 Hz, Ar-2’-C), 133.5 (d, J(C,P) = 6 Hz, Ar-1’-C), 134.3 (d, J(C,P) = 10 Hz, Ar-
3’-CH), 135.7 (d, J(C,P) = 80 Hz, Ph-1’’-C), 161.2 (d, J(C,P) = 4 Hz, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, C6D6): δ = 70.0 (s) ppm. 
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IR (KBr): ν~  = 2967m, 1653s, 1578m, 1457m, 1436s, 1349m, 1310m, 1103m, 1056m, 962m, 
716s, 696s, 594m, 501m cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 396 (15, [M+K]+), 358 (100, [M+H]+), 314 (17), 286 (55), 
282 (46), 248 (23), 210 (20), 55 (17). 
[ ]20Da = −57.0 ((R)-162a, c = 1.10, CHCl3); +61.0 ((S)-162a, c = 1.00, CHCl3).  
HPLC (Daicel Chiracel AD, heptane/isopropanol 85:15, 6.0 mL*min−1, 20 °C, 254 nm): 
tR = 20.5 ((R)-162a), 24.9 ((S)-162a) min. 
Elemental analysis calcd. (%) for C20H24NOPS: C 67.20, H 6.77, N 3.92; found: C 67.00, H 
6.75, N 3.95. 
 
 
4,4-Dimethyl-2-[2’-(isopropyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole 
(162) 
 
 
The deprotection was accomplished in analogy to the preparation of 158 using phosphine 
sulfide 162a (160 mg, 0.447 mmol) and Si2Cl6 (313 mg, 1.16 mmol) in abs. benzene (20 mL), 
followed by the treatment with 30% degassed aqueous NaOH solution (3.1 mL). Ligand 162 
was isolated as colourless oil (48.1 mg, 33%). 
 
C20H24NOPS (325.28 g*mol−1): 
31P{1H} NMR (162 MHz, C6D6): δ = −8.2 (s) ppm. 
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4,4-Dimethyl-2-[2’-(tert-butyl-isopropyl-thiophosphino)-phenyl]-4,5-dihydro-
oxazole (163a) 
 
 
In analogy to the preparation of 158a phenyloxazoline 153 (294 mg, 1.68 mmol), TMEDA 
(214 mg, 1.83 mmol), sBuLi in cyclohexane (1.3 M, 1.70 mL, 2.21 mmol) and chloro-
phosphine 150 (440 mg, 2.64 mmol) were reacted in abs. pentane (20 mL). Protection of the 
residue was accomplished with sulfur powder (95.0 mg, 2.96 mmol) in abs. toluene (20 mL) 
and column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 7:3, F35-65) of the crude 
product gave phosphine sufide 163a as colourless solid (361 mg, 64%). A portion of the 
racemic ligand was separated into its enantiomers by semipreparative HPLC on a chiral 
column. 
 
C18H28NOPS (337.46 g*mol−1): 
m.p. 162 °C. 
Rf = 0.21 (hexanes/EtOAc 2:1). 
1H NMR (500 MHz, CD2Cl2): δ = 0.95 (dd, J(H,H) = 6.7 Hz, J(P,H) = 17.4 Hz, 3 H, 
CH(CH3)(CH3)), 1.21 (d, J(P,H) = 15.8 Hz, 9 H, C(CH3)3), 1.31 (dd, J(H,H) = 6.6 Hz, 
J(P,H) = 17.4 Hz, 3 H, CH(CH3)(CH3)), 1.37 (s, 3 H, Ox-4-CH3), 1.38 (s, 3 H, Ox-4-CH3), 
3.06 (mc, 1 H, CH(CH3)2), 4.09 (d, J(H,H) = 8.0 Hz, 1 H, Ox-5-H), 4.14 (d, J(H,H) = 8.0 Hz, 
1 H, Ox-5-H), 7.47-7.35 (m, 3 H, Ar-3’-H, Ar-4’-H and Ar-5’-H), 8.10 (br s, 1 H, Ar-6’-
H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 17.1 (s, CH(CH3)(CH3)), 18.1 (s, CH(CH3)(CH3)), 
26.7 (d, J(C,P) = 48 Hz, CH(CH3)2), 26.9 (d, J(C,P) = 2 Hz, C(CH3)3), 27.6 (s, Ox-4-
C(CH3)2), 36.4 (d, J(C,P) = 47 Hz, C(CH3)3), 68.3 (s, Ox-4-C(CH3)2), 79.0 (s, Ox-5-CH2), 
128.9 (d, J(C,P) = 10 Hz, Ar-CH), 129.2 (d, J(C,P) = 61 Hz, Ar-2’-C), 130.6 (d, J(C,P) = 
4 Hz, Ar-CH), 131.9 (d, J(C,P) = 10 Hz, Ar-CH), 134.3 (s, Ar-6’-CH), 134.6 (s, Ar-1’-C), 
162.7 (s, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = 77.9 (s) ppm. 
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IR (KBr): ν~  = 2973s, 1734m, 1695m, 1663s, 1559m, 1457m, 1362m, 1305m, 1096w, 
1045m, 963m, 774s, 729m, 697s, 668m, 634m, 566w cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 376 (13, [M+K]+), 338 (100, [M+H]+), 248 (48), 210 (28), 
150 (7), 57 (42). 
[ ]20Da = +15.0 ((+)-163a, c = 0.50, CHCl3); −17.0 ((−)-163a, c = 0.50, CHCl3).  
HPLC (Daicel Chiracel OD, heptane/isopropanol 98:2, 6.0 mL*min−1, 25 °C, 254 nm): 
tR = 28.2 ((+)-163a), 37.0 ((−)-163a) min.  
Elemental analysis calcd. (%) for C18H28NOPS: C 64.06, H 8.36, N 4.15, O 4.74; found: C 
64.05, H 8.12, N 4.26, O 4.67. 
 
 
4,4-Dimethyl-2-[2’-(tert-butyl-isopropylphosphino)-phenyl]-4,5-dihydrooxazole 
(163) 
 
 
The deprotection was accomplished in analogy to the preparation of 158 using phosphine 
sulfide 163a (105 mg, 0.311 mmol) and Si2Cl6 (320 mg, 1.19 mmol) in abs. benzene (13 mL), 
followed by the treatment with 30% degassed aqueous NaOH solution (3.2 mL). Ligand 163 
was isolated as colourless oil (48.0 mg, 51%). 
 
C18H28NOPS (305.39 g*mol−1): 
1H NMR (400 MHz, C6D6): δ = 0.91 (dd, J(H,H) = 6.9 Hz, J(P,H) = 14.0 Hz, 3 H, 
CH(CH3)(CH3)), 1.15 (d, J(P,H) = 11.1 Hz, 9 H, C(CH3)3), 1.20 (dd, J(H,H) = 6.8 Hz, 
J(P,H) = 14.1 Hz, 3 H, CH(CH3)(CH3)), 1.30 (s, 3 H, Ox-4-CH3), 1.36 (s, 3 H, Ox-4-CH3), 
2.13 (mc, 1 H, CH(CH3)2), 3.86 (d, J(H,H) = 7.9 Hz, 1 H, Ox-5-H), 3.92 (d, J(H,H) = 7.9 Hz, 
1 H, Ox-5-H), 7.01-7.12 (m, 2 H, Ar-H), 7.41 (td, J(H,H) = 7.5 Hz, J(P,H) = 1.7 Hz, 1 H, Ar-
H), 7.60 (mc, 1 H, Ar-6’-H) ppm. 
31P{1H} NMR (162 MHz, C6D6): δ = 8.5 (s) ppm. 
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2-[2’-(tert-Butyl-isopropylphosphino)-phenyl]-4,5-dihydrooxazole borane (164a) 
 
 
A solution of azeotropically dried (2 × 2.0 mL toluene) phenyloxazoline 152 (181 mg, 
1.23 mmol) and TMEDA (159 mg, 1.37 mmol) in abs. pentane (10 mL) was cooled to –78 °C 
and sBuLi in cyclohexane (1.3 M, 1.20 mL, 2.34 mmol) was added dropwise. After the 
reaction mixture had been stirred for 30 min at –78 °C and then 15 min at 0 °C, the orange 
suspension was re-cooled to –78 °C and treated with chlorophosphine 150 (273 mg, 
1.64 mmol). The resulting yellow mixture was allowed to warm to r.t. overnight and then 
filtered over Celite under argon. Afterwards BH3 in THF (1.0 M, 2.50 mL, 2.50 mmol) was 
added to the filtrate at 0 °C. After 16 h at r.t. the solvent was evaporated. Column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 1:1, F20-29) of the residue yielded a 
colourless solid (125 mg, 35%). According to mass spectrometric analysis this consisted of a 
mixture of 164a and and the bis(borane) adduct 164b. 
 
C16H27BNOP (291.18 g*mol-1): 
Rf = 0.19 (pentane/Et2O 1:1). 
1H NMR (400 MHz, CD2Cl2): δ = 0.09-0.77 (br m, 3 H, BH3), 0.92 (dd, J(H,H) = 6.9 Hz, 
J(P,H) = 15.7 Hz, 3 H, CH(CH3)(CH3)), 1.18 (d, J(P,H) = 13.5 Hz, 9 H, C(CH3)3), 1.38 (dd, 
J(H,H) = 6.9 Hz, J(P,H) = 14.9 Hz, 3 H, CH(CH3)(CH3)), 2.68 (sept, J(H,H) = 6.9 Hz, 1 H, 
CH(CH3)2), 4.10 (t, J(H,H) = 10.2 Hz, 2 H, Ox-4-H), 4.67 (mc, 1 H, Ox-5-H), 4.84 (mc, 1 H, 
Ox-5-H), 7.47-7.51 (m, 1 H, Ar-H), 7.64 (mc, 2 H, Ar-H), 7.80 (mc, 1 H, Ar-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 17.8 (d, J(C,P) = 3 Hz, CH(CH3)(CH3)), 18.6 (s, 
CH(CH3)(CH3)), 24.1 (d, J(C,P) = 33 Hz, CH(CH3)2), 27.1 (d, J(C,P) = 2 Hz, C(CH3)3), 31.2 
(d, J(C,P) = 28 Hz, C(CH3)3), 55.6 (s, Ox-4-CH2), 68.7 (s, Ox-5-CH2), 128.2 (d, J(C,P) = 
48 Hz, Ar-C), 130.5 (d, J(C,P) = 6 Hz, Ar-CH), 130.7 (d, J(C,P) = 2 Hz, Ar-CH), 131.4 (d, 
J(C,P) = 8 Hz, Ar-CH), 132.0 (d, J(C,P) = 9 Hz, Ar-C), 132.6 (s, Ar-CH) ppm; despite 
prolonged data acquisition time the signal for Ox-2-C was not detected. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = 40.1 (d, J(P,B) = 60 Hz) ppm. 
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IR (KBr): ν~  = 2979s, 2930s, 2067m, 1839s, 1671s, 1588m, 1468s, 1389s, 1272s, 1167s, 
1076s, 921s, 809s, 765m, 616m, 551m cm–1. 
MS (FAB, NBA): m/z (%) = 304 (25, [M+BH2]+), 290 (100, [M−H]+), 234 (17, [M−C4H9]+), 
190 (20), 57 (31). 
 
 
2-[2’-(tert-Butyl-isopropylphosphino)-phenyl]-4,5-dihydrooxazole (160) 
 
 
The BH3 protecting group was removed by stirring 164a (107 mg, 0.368 mmol) in abs. HNEt2 
(2.0 mL) at r.t. for 12 h. After all volatiles had been removed under reduced pressure, the free 
ligand 160 was isolated as colourless oil (103 mg, quant.). 
 
C16H24NOPS (277.34 g*mol−1): 
31P{1H} NMR (162 MHz, C6D6): δ = 9.1 (s) ppm. 
 
 
2-[2’-(Isopropyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole borane (165a) 
 
 
In analogy to the preparation of 164a phenyloxazoline 152 (189 mg, 1.28 mmol), TMEDA 
(187 mg, 1.61 mmol), sBuLi in cyclohexane (1.3 M, 1.30 mL, 1.69 mmol) and chloro-
phosphine 145 (311 mg, 1.67 mmol) were reacted in abs. pentane (10 mL). Protection of the 
residue was accomplished with BH3 in THF (1.0 M, 5.00 mL, 5.00 mmol) and column 
chromatography (silica gel, 4 × 15 cm, pentane/Et2O 1:2, F34-49) of the crude product gave a 
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colourless solid (266 mg, 67%). According to mass spectrometric analysis this consisted of a 
mixture of 165a and bis(borane) adduct 165b.  
 
C18H23BNOP (311.17 g*mol−1):  
Rf = 0.14 (pentane/Et2O 1:1). 
1H NMR (400 MHz, CD2Cl2): δ = 0.29-2.91 (br m, 3 H, BH3), 1.07 (dd, J(H,H) = 7.1 Hz, 
J(P,H) = 16.8 Hz, 3 H, CH(CH3)(CH3)), 1.17 (dd, J(H,H) = 6.9 Hz, J(P,H) = 15.6 Hz, 3 H, 
CH(CH3)(CH3)), 3.88 (mc, 1 H, CH(CH3)2), 3.62 (mc, 1 H, Ox-4-H), 3.76 (mc, 1 H, Ox-4-H), 
3.91 (mc, 1 H, Ox-5-H), 4.33 (mc, 1 H, Ox-5-H), 7.49-7.57 (m, 3 H, Ar-H), 7.60-7.73 (m, 5 H, 
Ar-H), 7.96 (mc, 1 H, Ar-3’-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 17.2 (d, J(C,P) = 2 Hz, CH(CH3)(CH3)), 17.4 (s, 
CH(CH3)(CH3)), 24.6 (d, J(C,P) = 35 Hz, CH(CH3)2), 55.8 (s, Ox-4-CH2), 68.2 (s, Ox-5-
CH2), 127.4 (d, J(C,P) = 54 Hz, Ar-C), 128.8 (d, J(C,P) = 4 Hz, Ar-1’-C), 129.1 (d, J(C,P) = 
10 Hz, Ar-CH), 129.5 (d, J(C,P) = 45 Hz, Ar-C), 130.8 (d, J(C,P) = 2 Hz, Ar-CH), 131.7 (d, 
J(C,P) = 3 Hz, Ar-CH), 131.9 (d, J(C,P) = 9 Hz, Ar-CH), 132.8 (d, J(C,P) = 6 Hz, Ar-CH), 
132.9 (d, J(C,P) = 9 Hz, Ar-CH), 134.5 (d, J(C,P) = 8 Hz, Ar-CH), 167.6 (d, J(C,P) = 3 Hz, 
Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = 26.6 (d, J(P,B) = 64 Hz) ppm. 
IR (KBr): ν~  = 3023m, 2955m, 2067m, 1645s, 1470s, 1399s, 1351m, 1308m, 1249m, 1163s, 
1009s, 872s, 795m, 685m, 633w, 593w cm–1. 
MS (FAB, NBA): m/z (%) = 324 (29, [M+BH2]+), 310 (100, [M−H]+), 266 (11), 129 (45), 58 
(29). 
 
 
2-[2’-(Isopropyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (159) 
 
 
N
O
P
159
EXPERIMENTAL 
 223 
The BH3 protecting group was removed by stirring 165a (100 mg, 0.322 mmol) in degassed 
abs. HNEt2 (2.0 mL) at r.t. for 12 h. After all volatiles had been removed under reduced 
pressure the free ligand 159 was isolated as colourless oil (98.0 mg, quant.). 
 
C18H20NOP (297.33 g*mol−1):  
31P{1H} NMR (162 MHz, C6D6): δ = −8.1 (s) ppm. 
 
 
7.8.4 Diaryl-Substituted Phosphinooxazolines  
2-{2’-[Phenyl-(2’’-tolyl)-phosphino]-phenyl}-4,5-dihydrooxazole (180) 
 
 
A solution of azeotropically dried (2 × 2.0 mL toluene) phenyloxazoline 152 (180 mg, 
1.22 mmol) and TMEDA (156 mg, 1.34 mmol) in abs. pentane (10 mL) was cooled to –78 °C 
and sBuLi in cyclohexane (1.3 M, 1.00 mL, 1.30 mmol) was added dropwise. After the 
reaction mixture had been stirred for 30 min at –78 °C and then 15 min at 0 °C, the yellow-
orange suspension was re-cooled to –78 °C and treated with chlorophosphine 167 (375 mg, 
1.59 mmol). The yellow mixture was allowed to slowly reach r.t. overnight. The suspension 
was diluted with abs. CH2Cl2 (30 mL) and filtered over Celite, which was washed with abs. 
CH2Cl2 (2 × 10 mL). After removal of all volatiles in high vacuum the crude product was 
purified by column chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 4:1, F30-35) under 
argon. Ligand 180 was obtained as colourless foam (105 mg, 25%). 
 
C22H20NOP (345.37 g*mol−1): 
Rf = 0.42 (hexanes/EtOAc 4:1).  
1H NMR (500 MHz, CD2Cl2): δ = 2.42 (s, 3 H, CH3), 3.81 (mc, 2 H, Ox-4-H), 4.14 (t, 
J(H,H) = 9.3 Hz, 2 H, Ox-5-H), 6.81 (dd, J(H,H) = 7.7 Hz, J(P,H) = 4.1 Hz, 1 H, Ar-H), 6.93 
(ddd, J(H,H) = 7.7, 1.0 Hz, J(P,H) = 4.2 Hz, 1 H, Ar-H), 7.06 (t, J(H,H) = 7.0 Hz, 1 H, Ar-
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H), 7.19-7.40 (m, 9 H, Ar-H), 7.83 (dd, J(H,H) = 7.6 Hz, J(P,H) = 3.7 Hz, 1 H, Ar-6’-
H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 21.1 (d, J(C,P) = 23 Hz, CH3), 55.2 (s, Ox-4-CH2), 
67.3 (s, Ox-5-CH2), 125.9 (s, Ar-CH), 128.1 (s, Ar-CH), 128.5 (d, J(C,P) = 7 Hz, Ar-CH), 
128.6 (d, J(C,P) = 8 Hz, Ar-CH), 129.8 (d, J(C,P) = 3 Hz, Ar-CH), 129.9 (d, J(C,P) = 5 Hz, 
Ar-6’-CH), 130.4 (s, Ar-CH), 132.6 (s, Ar-1’-C), 133.3 (s, Ar-CH), 134.1 (s, Ar-CH), 134.3 
(d, J(C,P) = 21 Hz, Ar-CH), 137.2 (d, J(C,P) = 12 Hz, Ar-C), 137.6 (d, J(C,P) = 12 Hz, Ph-i-
C), 138.6 (d, J(C,P) = 25 Hz, Ar-2’-C), 142.3 (d, J(C,P) = 27 Hz, oTol-2’’-C), 164.0 (d, 
J(C,P) = 2 Hz, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −15.3 (s) ppm. 
IR (KBr): ν~  = 3046m, 2963m, 2892m, 1956w, 1737w, 1643s, 1582m, 1465s, 1430s, 1346s, 
1245s, 1194m, 1128m, 1086m, 1036m, 970m, 938s, 894m, 802w, 750s, 693s, 549w cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 384 (8, [M+K]+), 346 (100, [M+H]+), 254 (39), 165 (28), 
77 (33). 
 
 
2-[2’-(2’’-Methoxyphenyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (181) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 152 (84.0 mg, 0.571 mmol), TMEDA (72.0 mg, 0.620 mmol) in abs. pentane 
(5.0 mL), sBuLi in cyclohexane (1.3 M, 480 µL, 0.624 mmol) and chlorophosphine 169 
(180 mg, 0.718 µmol). Purification of the crude product by column chromatography (silica 
gel, 3 × 20 cm, hexanes/EtOAc 2:1, F29-37) under argon gave ligand 181 as colourless solid 
(128 mg, 62%). 
 
C22H20NO2P (361.37 g*mol−1). 
Rf = 0.32 (hexanes/EtOAc 2:1).  
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1H NMR (500 MHz, CD2Cl2): δ = 3.71 (s, 3 H, OCH3), 3.83 (t, J(H,H) = 9.5 Hz, 2 H, Ox-4-
H), 4.16 (t, J(H,H) = 9.5 Hz, 2 H, Ox-5-H), 6.67 (mc, 1 H, Ar-H), 6.84 (t, J(H,H) = 7.6 Hz, 
1 H, Ar-H), 6.91 (dd, J(H,H) = 8.3 Hz, J(P,H) = 4.7 Hz, 1 H, Ar-H), 6.96 (dd, J(H,H) = 
7.8 Hz, J(P,H) = 3.8 Hz,1 H, Ar-H), 7.22-7.39 (m, 8 H, Ar-H), 7.82 (ddd, J(H,H) = 7.7, 
3.7 Hz, J(P,H) = 4.1 Hz, 1 H, Ar-H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 55.2 (s, Ox-4-CH2), 55.7 (s, OCH3), 67.3 (s, Ox-5-
CH2), 110.5 (s, Ar-CH), 120.9 (s, Ar-CH), 126.8 (d, J(C,P) = 14 Hz, Ar-C), 128.0 (s, Ar-CH), 
128.3 (s, Ar-CH), 128.3 (s, Ar-CH), 125.5 (s, Ar-CH), 129.6 (d, J(C,P) = 45 Hz, Ar-CH), 
130.2 (s, Ar-CH), 132.6 (d, J(C,P) = 22 Hz, Ar-C), 134.0 (s, Ar-CH), 134.0 (d, 
J(C,P) = 3 Hz, Ar-CH), 134.2 (d, J(C,P) = 22 Hz, Ar-CH), 138.0 (d, J(C,P) = 12 Hz, Ar-C), 
138.6 (d, J(C,P) = 27 Hz, Ar-C), 161.3 (d, J(C,P) = 17 Hz, Ar-2’’-C), 164.1 (s, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −17.4 (s) ppm. 
IR (KBr): ν~  = 3055m, 2963m, 2891m, 1971w, 1732w, 1640s, 1575s, 1463s, 1429s, 1349m, 
1239s, 1180m, 1125w, 1088m, 1018s, 972m, 938m, 896w, 778m, 747s, 691s, 483w cm–1. 
MS (EI, 70 eV): m/z (%) = 361 (16, M+), 332 (100), 302 (23), 270 (41), 227 (34), 183 (20), 77 
(8). 
 
 
2-[2’-(2’’-Biphenylyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (182) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 152 (115 mg, 0.781 mmol), TMEDA (107 mg, 0.921 mmol), sBuLi in 
cyclohexane (1.3 M, 660 µL, 0.858 mmol) and chlorophosphine 170 (270 mg, 0.910 mmol) in 
abs. pentane (6.0 mL). Purification of the crude product by column chromatography (silica 
gel, 3 × 20 cm, pentane/Et2O/NEt3 10:20:1, F9-17) under argon gave ligand 182 as colourless 
solid (136 mg, 43%). 
 
C27H22NOP (407.44 g*mol−1): 
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Rf = 0.33 (hexanes/EtOAc 2:1).  
1H NMR (500 MHz, CD2Cl2): δ = 3.75 (t, J(H,H) = 9.7 Hz, 2 H, Ox-4-H), 4.08 (mc, 2 H, Ox-
5-H), 6.95 (dd, J(H,H) = 7.7 Hz, J(P,H) = 3.5 Hz, 1 H, Ar-H), 7.07 (dd, J(H,H) = 7.6 Hz, 
J(P,H) = 3.4 Hz, 1 H, Ar-H), 7.17-7.43 (m, 15 H, Ar-H), 7.81 (ddd, J(H,H) = 7.7, 1.3 Hz, 
J(P,H) = 3.7 Hz, 1 H, Ar-6’-H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 55.2 (s, Ox-4-CH2), 67.3 (s, Ox-5-CH2), 127.1 (s, Ar-
CH), 127.3 (s, Ar-CH), 127.5 (s, Ar-CH), 127.9 (s, Ar-CH), 128.4 (d, J(C,P) = 4 Hz, Ar-CH), 
128.5 (s, Ar-CH), 129.6 (s, Ar-CH), 129.7 (d, J(C,P) = 4 Hz, Ar-CH), 130.0 (d, 
J(C,P) = 4 Hz, Ar-CH), 130.2 (s, Ar-CH), 131.9 (d, J(C,P) = 22 Hz, Ar-1’-C), 133.8 (d, 
J(C,P) = 2 Hz, Ar-CH), 134.2 (s, Ar-CH), 134.3 (s, Ar-CH), 134.5 (s, Ar-CH), 136.8 (d, 
J(C,P) = 12 Hz, Ar-C), 138.9 (d, J(C,P) = 16 Hz, Ar-C), 140.1 (d, J(C,P) = 28 Hz, Ar-C), 
142.3 (d, J(C,P) = 8 Hz, Ar-C), 147.9 (d, J(C,P) = 31 Hz, Ar-C), 164.0 (d, J(C,P) = 2 Hz, 
Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −14.2 (s) ppm. 
IR (KBr): ν~  = 3047m, 2968m, 1951w, 1816w, 1765w, 1733w, 1642s, 1581m, 1462s, 1428s, 
1347m, 1242m, 1180w, 1084m, 1036s, 970m, 938s, 747s, 697s, 613m, 499s cm–1. 
MS (EI, 70 eV): m/z (%) = 407 (35, M+), 378 (100), 316 (27), 302 (27), 254 (34), 240 (18), 
183 (31). 
 
 
2-[2’-(1’’-Naphthalenyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (183) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 152 (212 mg, 1.40 mmol), TMEDA (184 mg, 1.58 mmol), sBuLi in 
cyclohexane (1.3 M, 1.20 mL, 1.56 mmol) and chlorophosphine 171 (506 mg, 1.87 mmol) in 
abs. pentane (10 mL). Purification of the crude product by column chromatography (silica gel, 
3 × 25 cm, hexanes/EtOAc/NEt3 10:1:1, F9-15) under argon gave ligand 183 as colourless 
solid (362 mg, 71%). 
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C25H20NOP (381.41 g*mol−1): 
Rf = 0.49 (hexanes/EtOAc 1:1).  
1H NMR (600 MHz, C6D6): δ = 3.38 (mc, 2 H, Ox-4-H), 3.45 (mc, 2 H, Ox-5-H), 6.85 (td, 
J(H,H) = 7.6, 1.2 Hz, 1 H, Ar-4’-H), 6.95-7.24 (m, 8 H, Ar-H), 7.33 (dd, J(H,H) = 7.3 Hz, 
J(P,H) =4.6 Hz, 1 H, Ar-2’’-H), 7.46 (mc, 2 H, Ph-o’-H), 7.60 (d, J(H,H) = 8.3 Hz, 1 H, Ar-
4’’-H), 7.62 (d, J(H,H) = 8.1 Hz, 1 H, Ar-5’’-H), 8.12 (ddd, J(H,H) = 7.8, 1.1 Hz, J(P,H) = 
3.5 Hz, 1 H, Ar-6’-H), 8.90 (mc, 1 H, Ar-4a’’-H) ppm. 
13C{1H} NMR (151 MHz, C6D6): δ = 55.3 (s, Ox-4-CH2), 66.6 (s, Ox-5-CH2), 125.7 (s, Ar-
3’’-CH), 125.9 (d, J(C,P) = 1 Hz, Ar-6’’-CH), 126.2 (d, J(C,P) = 1 Hz, Ar-7’’-CH), 126.8 (d, 
J(C,P) = 25 Hz, Ar-8’’-CH), 128.1 (s, Ar-5’-CH), 128.5 (s, Ph-m-CH and Ph-p-CH), 128.7 (s, 
Ar-5’’-CH), 129.0 (s, Ar-4’’-CH), 129.9 (d, J(C,P) = 3 Hz, Ar-6’-CH), 130.3 (s, Ar-4’-CH), 
132.3 (s, Ar-2’’-CH), 133.0 (d, J(C,P) = 21 Hz, Ar-8a’’-C), 133.8 (d, J(C,P) = 6 Hz, Ar-1’-
C), 134.6 (d, J(C,P) = 12 Hz, Ph-o-CH), 135.1 (s, Ar-3’-CH), 136.0 (d, J(C,P) = 24 Hz, Ar-
4a’’-C), 136.2 (d, J(C,P) = 14 Hz, Ph-i-C), 137.0 (d, J(C,P) = 14 Hz, Ar-1’’-C), 139.3 (d, 
J(C,P) = 24 Hz, Ar-2’-C), 163.5 (s, Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = −19.6 (s) ppm. 
IR (KBr): ν~  = 3050m, 2966m, 2874m, 1730m, 1636s, 1499m, 1471s, 1427m, 1354s, 1320s, 
1245m, 1132m, 1090m, 1040s, 970m, 938s, 749s, 700s, 675s cm–1. 
MS (EI, 70 eV): m/z (%) = 381 (19, M+), 352 (100), 290 (21), 240 (40), 227 (54). 
Elemental analysis calcd. (%) for C25H20NOP: C 78.73, H 5.29, N 3.67; found: C 78.18, H 
5.45, N 3.42. 
 
 
2-[2’-(2’’-Furanyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole (184) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 152 (232 mg, 1.58 mmol), TMEDA (201 mg, 1.73 mmol), sBuLi in 
cyclohexane (1.3 M, 1.30 mL, 1.69 mmol) and chlorophosphine 172 (480 mg, 2.28 mmol) in 
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abs. pentane (12 mL). Purification of the crude product by column chromatography (silica gel, 
3 cm × 20 cm, hexanes/EtOAc 2:1, F23-30) under argon gave ligand 184 as colourless solid 
(215 mg, 42%). 
 
C19H16NO2P (321.30 g*mol−1): 
Rf = 0.39 (hexanes/EtOAc 4:1).  
1H NMR (500 MHz, CD2Cl2): δ = 3.75 (t, J(H,H) = 9.7 Hz, 1 H, Ox-4-H), 3.83 (t, J(H,H) = 
9.7 Hz, 1 H, Ox-4-H), 4.14 (t, J(H,H) = 9.7 Hz, 2 H, Ox-5-H), 6.42 (mc, 1 H, Fu-4’’-H), 6.61 
(mc, 1 H, Fu-3’’-H), 7.05 (mc, 1 H, Ar-H), 7.28-7.43 (m, 8 H, Ar-H), 7.81 (mc, 1 H, Ar-6’-
H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 55.0 (s, Ox-4-CH2), 67.3 (s, Ox-5-CH2), 110.8 (d, 
J(C,P) = 6 Hz, Fu-4’’-CH), 121.8 (d, J(C,P) = 23 Hz, Fu-3’’-CH), 128.3 (d, J(C,P) = 15 Hz, 
Ar-CH), 128.7 (s, Ar-CH), 129.6 (d, J(C,P) = 2 Hz, Ar-CH), 130.4 (s, Ar-CH), 131.6 (d, 
J(C,P) = 18 Hz, Ar-C), 133.4 (s, Ar-CH), 133.5 (s, Ar-CH), 133.6 (s, Ar-CH), 137.1 (d, 
J(C,P) = 2 Hz, Ar-C), 138.3 (d, J(C,P) = 24 Hz, Ar-C), 147.4 (s, Fu-5’’-CH), 154.0 (d, 
J(C,P) = 22 Hz, Fu-2’’-C), 161.5 (dd, J(C,P) = 4 Hz, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −27.9 (s) ppm. 
IR (KBr): ν~  = 3063m, 2963m, 2909m, 1726m, 1646s, 1469s, 1431s, 1355m, 1250m, 1207m, 
1136m, 1090m, 1038s, 1003m, 972m, 938m, 896m, 745s, 694s, 670m, 596w cm–1. 
MS (EI, 70 eV): m/z (%) = 321 (5, M+), 292 (100), 240 (67), 227 (72), 202 (15), 183 (19). 
Elemental analysis calcd. (%) for C19H16NO2P: C 71.02, H 5.02, N 4.36; found: C 70.93, H 
5.26, N 3.98. 
 
 
4,4-Dimethyl-2-{2’-[Phenyl-(2’’-tolyl)-phosphino]-phenyl}-4,5-dihydrooxazole 
(185) 
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The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 153 (196 mg, 1.12 mmol), TMEDA (150 mg, 1.29 mmol), sBuLi in 
cyclohexane (1.3 M, 970 µL, 1.24 mmol), and chlorophosphine 167 (340 mg, 1.45 mmol) in 
abs. pentane (10 mL). Purification of the crude product by column chromatography (silica gel, 
3 × 20 cm, hexanes/EtOAc 4:1, F16-23) under argon gave ligand 185 as colourless oil 
(168 mg, 40%). 
 
C24H24NOP (373.43 g*mol−1): 
Rf = 0.20 (hexanes/EtOAc 4:1).  
1H NMR (500 MHz, CD2Cl2): δ = 0.99 (s, 3 H, Ox-4-CH3), 1.10 (s, 3 H, Ox-4-CH3), 2.44 (d, 
J(P,H) = 2.6 Hz, 3 H, oTol-CH3), 3.77 (mc, 2 H, Ox-5-H), 6.81 (dd, J(H,H) = 7.7 Hz, 
J(P,H) = 4.1 Hz, 1 H, Ar-H), 6.86 (ddd, J(H,H) = 7.7, 1.0 Hz, J(P,H) = 3.9 Hz, 1 H, Ar-H), 
7.05 (td, J(H,H) = 7.1, 1.7 Hz, 1 H, Ar-H), 7.21 (mc, 2 H, Ar-H), 7.25-7.39 (m, 7 H, Ar-H), 
7.83 (ddd, J(H,H) = 7.7, 1.2 Hz, J(P,H) = 3.7 Hz, 1 H, Ar-6’-H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 21.1 (d, J(C,P) = 23 Hz, oTol-CH3), 27.6 (s, Ox-4-
C(CH3)(CH3)), 27.8 (s, Ox-4-C(CH3)(CH3)), 68.0 (s, Ox-4-C(CH3)2), 78.6 (s, Ox-5-CH2), 
125.9 (s, Ar-CH), 127.9 (s, Ar-CH), 128.5 (d, J(C,P) = 4 Hz, Ar-CH), 128.6 (d, 
J(C,P) = 19 Hz, Ar-CH), 128.8 (d, J(C,P) = 3 Hz, Ar-CH), 130.0 (d, J(C,P) = 5 Hz, Ar-6’-
CH), 130.3 (s, Ar-CH), 132.4 (s, Ar-1’-C), 132.7 (s, Ar-CH), 133.6 (d, J(C,P) = 2 Hz, Ar-
CH), 134.7 (d, J(C,P) = 22 Hz, Ar-CH), 137.4 (d, J(C,P) = 11 Hz, oTol-1’’-C), 137.5 (d, 
J(C,P) = 14 Hz, Ph-i-C), 138.7 (d, J(C,P) = 26 Hz, Ar-2’-C), 142.3 (d, J(C,P) = 28 Hz, oTol-
2’’-C), 161.5 (d, J(C,P) = 3 Hz, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −14.3 (s) ppm. 
IR (KBr): ν~  = 3053m, 2963m, 2883m, 1971w, 1936w, 1735w, 1639s, 1585m, 1437s, 
1348m, 1309s, 1249m, 1184m, 1125m, 1087m, 1029m, 961s, 919m, 871m, 815w, 754s, 696s, 
613w, 549w cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 412 (8, [M+K]+), 374 (100, [M+H]+), 318 (81), 302 (43), 
183 (21), 165 (22), 77 (20), 55 (52). 
Elemental analysis calcd. (%) for C24H24NOP: C 77.19, H 6.48, N 3.75; found: C 77.13, H 
6.50, N 3.65. 
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4,4-Dimethyl-2-[2’-(2’’-methoxyphenyl-phenylphosphino)-phenyl]-4,5-dihydro-
oxazole (186) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 153 (135 mg, 0.771 mmol), TMEDA (100 mg, 0.861 mmol), sBuLi in 
cyclohexane (1.3 M, 650 µL, 0.845 mmol) and chlorophosphine 169 (250 mg, 0.998 mmol) in 
abs. pentane (6.0 mL). Purification of the crude product by column chromatography (silica 
gel, 3 × 20 cm, hexanes/EtOAc 4:1, F20-30) under argon gave ligand 186 as colourless oil 
(85.2 mg, 28%). 
 
C24H24NO2P (389.43 g*mol−1): 
Rf = 0.37 (hexanes/EtOAc 1:1). 
1H NMR (500 MHz, CD2Cl2): δ = 1.06 (s, 3 H, Ox-4-CH3), 1.07 (s, 3 H, Ox-4-CH3), 3.74 (s, 
3 H, OCH3), 3.79 (mc, 2 H, Ox-5-H), 6.69 (ddd, J(H,H) = 7.5, 1.7 Hz, J(P,H) = 4.3 Hz, 1 H, 
Ar-H), 6.82 (t, J(H,H) = 7.0 Hz, 1 H, Ar-H), 6.87-6.94 (m, 2 H, Ar-H), 7.24-7.83 (m, 8 H, Ar-
H), 7.78 (mc, 1 H, Ar-6’-H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 27.7 (s, Ox-4-C(CH3)(CH3)), 27.7 (s, Ox-4-
C(CH3)(CH3)), 55.7 (s, OCH3), 68.2 (s, Ox-4-C(CH3)2), 78.6 (s, Ox-5-CH2), 110.5 (d, 
J(C,P) = 2 Hz, Ar-CH), 121.0 (s, Ar-CH), 123.3 (s, Ar-CH), 127.8 (s, Ar-CH), 128.5 (d, 
J(C,P) = 22 Hz, Ar-CH), 130.0 (d, J(C,P) = 49 Hz, Ar-CH), 130.3 (s, Ar-6’-CH), 130.5 (d, 
J(C,P) = 15 Hz, Ar-CH), 133.7 (d, J(C,P) = 63 Hz, Ar-CH), 134.5 (d, J(C,P) = 15 Hz, Ar-
CH), 134.8 (s, Ar-CH), 135.8 (s, Ar-CH), 137.7 (d, J(C,P) = 13 Hz, Ar-C), 137.9 (d, 
J(C,P) = 16 Hz, Ar-C), 138.7 (d, J(C,P) = 27 Hz, Ar-C), 161.4 (d, J(C,P) = 16 Hz, Ar-2’’-
C) ppm; despite prolonged data acquisition time the signal for Ox-2-C was not detected. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −19.8 (s) ppm. 
IR (KBr): ν~  = 3054m, 2962m, 1971w, 1953w, 1735w, 1648s, 1577m, 1463s, 1429s, 1350m, 
1306s, 1240m, 1180m, 1127m, 1083m, 1030s, 962s, 919m, 871w, 817w, 746s, 693s, 613w, 
482w cm–1. 
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MS (FAB, NBA+KCl): m/z (%) = 412 (8, [M+K]+), 374 (100, [M+H]+), 318 (81), 302 (43), 
183 (21), 165 (22), 77 (20), 55 (52). 
 
 
4,4-Dimethyl-2-[2’-(2’’-biphenylyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole 
(187) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 153 (94.4 mg, 0.539 mmol), TMEDA (86.0 mg, 0.740 mmol), sBuLi in 
cyclohexane (1.3 M, 460 µL, 0.598 mmol) and chlorophosphine 170 (188 mg, 0.634 mmol) in 
abs. pentane (5.0 mL). Purification of the crude product by column chromatography (silica 
gel, 3 × 15 cm, pentane/Et2O/NEt3 20:10:1, F6-14) under argon gave ligand 187 as colourless 
solid (86.0 mg, 37%). 
 
C29H26NOP (435.49 g*mol−1): 
Rf = 0.13 (pentane/Et2O 1:2).  
1H NMR (500 MHz, CD2Cl2): δ = 0.97 (s, 3 H, Ox-4-CH3), 1.05 (s, 3 H, Ox-4-CH3), 3.72 
(mc, 2 H, Ox-5-H), 6.87 (dd, J(H,H) = 7.8 Hz, J(P,H) = 3.5 Hz, 1 H, Ar-H), 7.06 (dd, 
J(H,H) = 7.9 Hz, J(P,H) = 3.3 Hz, 1 H, Ar-H), 7.16-7.44 (m, 15 H, Ar-H), 7.85 (dd, 
J(H,H) = 7.7 Hz, J(P,H) = 3.7 Hz, 1 H, Ar-6’-H) ppm. 
13C{1H} NMR (126 MHz, CD2Cl2): δ = 27.6 (s, Ox-4-C(CH3)(CH3)), 27.7 (s, Ox-4-
C(CH3)(CH3)), 67.9 (s, Ox-4-C(CH3)2), 78.6 (s, Ox-5-CH2), 127.2 (d, J(C,P) = 30 Hz, Ar-
CH), 127.5 (s, Ar-CH), 127.7 (s, Ar-CH), 128.4 (s, Ar-CH), 128.5 (d, J(C,P) = 7 Hz, Ar-CH), 
128.6 (s, Ar-CH), 129.6 (s, Ar-CH), 129.8 (d, J(C,P) = 4 Hz, Ar-CH), 130.0 (d, 
J(C,P) = 2 Hz, Ar-CH), 130.2 (d, J(C,P) = 7 Hz, Ar-CH), 130.3 (s, Ar-CH), 131.9 (d, 
J(C,P) = 21 Hz, Ar-1’-C), 133.6 (s, Ar-CH), 134.2 (d, J(C,P) = 3 Hz, Ar-CH), 134.5 (d, 
J(C,P) = 22 Hz, Ar-CH), 136.9 (d, J(C,P) = 15 Hz, Ar-C), 138.8 (d, J(C,P) = 15 Hz, Ar-C), 
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139.7 (d, J(C,P) = 28 Hz, Ar-C), 142.1 (d, J(C,P) = 7 Hz, Ar-C), 147.5 (d, J(C,P) = 33 Hz, 
Ar-C), 161.5 (s, Ox-2-C) ppm. 
31P{1H} NMR (202 MHz, CD2Cl2): δ = −12.0 (s) ppm. 
IR (KBr): ν~  = 2961m, 1651s, 1462s, 1430s, 1347m, 1305m, 1177w, 1129w, 1081m, 1031s, 
961m, 776m, 742s, 696s, 519m, 485m cm–1. 
MS (EI, 70 eV): m/z (%) = 435 (15, M+), 378 (100), 350 (11), 282 (37), 228 (12), 183 (21). 
 
 
4,4-Dimethyl-2-[2’-(1’’’-naphthalenyl-phenylphosphino)-phenyl]-4,5-dihydro-
oxazole (188) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 153 (205 mg, 1.17 mmol), TMEDA (159 mg, 1.37 mmol), sBuLi in 
cyclohexane (1.3 M, 900 µL, 1.17 mmol), chlorophosphine 171 (428 mg, 1.58 mmol) in abs. 
pentane (10 mL). Purification of the crude product by column chromatography (silica gel, 
3 × 15 cm, hexanes/EtOAc/NEt3 18:1:1, F5-9) under argon gave ligand 188 as colourless 
foam (334 mg, 70%). 
 
C27H24NOP (409.46 g*mol−1): 
Rf = 0.55 (hexanes/EtOAc 4:1).  
1H NMR (400 MHz, CD2Cl2): δ = 0.70 (s, 3 H, Ox-4-CH3), 0.96 (s, 3 H, Ox-4-CH3), 3.46 
(mc, 2 H, Ox-5-H), 6.87 (t, J(H,H) = 7.8 Hz, 1 H, Ar-H), 6.99-7.14 (m, 6 H, Ar-H), 7.23 (mc, 
2 H, Ar-H), 7.35 (mc, 1 H, Ar-H), 7.48 (mc, 2 H, Ar-H), 7.57-7.67 (m, 2 H, Ar-H), 8.15 (ddd, 
J(H,H) = 7.8, 1.2 Hz, J(P,H) = 3.7 Hz, 1 H, Ar-6’-H), 9.02 (mc, 1 H, Ar-2’’-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 27.9 (s, Ox-4-C(CH3)(CH3)), 28.3 (s, Ox-4-
C(CH3)(CH3)), 68.3 (s, Ox-4-C(CH3)2), 78.6 (s, Ox-5-CH2), 126.0 (s, Ar-CH), 126.2 (d, 
J(C,P) = 2 Hz, Ar-CH), 126.4 (d, J(C,P) = 3 Hz, Ar-CH), 127.1 (d, J(C,P) = 30 Hz, Ar-CH), 
128.1 (s, Ar-CH), 128.8 (d, J(C,P) = 7 Hz, Ar-CH), 128.9 (s, Ar-CH), 129.3 (s, Ar-CH), 
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130.2 (s, Ar-CH), 130.5 (s, Ar-CH), 132.0 (s, Ar-C), 132.6 (s, Ar-CH), 132.8 (s, Ar-CH), 
134.1 (d, J(C,P) = 5 Hz, Ar-C), 134.9 (d, J(C,P) = 2 Hz, Ar-CH), 135.1 (s, Ar-CH), 136.5 (d, 
J(C,P) = 25 Hz, Ar-C), 137.6 (d, J(C,P) = 13 Hz, Ar-C), 138.9 (d, J(C,P) = 15 Hz, Ar-C), 
140.1 (d, J(C,P) = 27 Hz, Ar-8a’’-C), 161.0 (d, J(C,P) = 3 Hz, Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = −18.5 (s) ppm. 
IR (KBr): ν~  = 3051m, 2964m, 1942w, 1827w, 1736m, 1656s, 1585s, 1501m, 1461s, 1432s, 
1381m, 1348m, 1307s, 1250m, 1187m, 1084m, 1031s, 959s, 918m, 869w, 797m, 773s, 743s, 
694s cm–1. 
MS (EI, 70 eV): m/z (%) = 409 (8, M+), 352 (100), 282 (17), 233 (13), 127 (5). 
 
 
4,4-Dimethyl-2-[2’-(2’’-furanyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole 
(189) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180, using 
phenyloxazoline 153 (262 mg, 1.50 mmol), TMEDA (193 mg, 1.66 mmol), sBuLi in 
cyclohexane (1.3 M, 1.30 mL, 1.69 mmol), and chlorophosphine 172 (460 mg, 2.18 mmol) in 
abs. pentane (12 mL). Purification of the crude product by column chromatography (silica gel, 
3 × 15 cm, hexanes/EtOAc 3:1, F18-25) under argon gave ligand 189 as colourless solid 
(115 mg, 22%). 
 
C21H20NO2P (349.36 g*mol−1): 
Rf = 0.48 (hexanes/EtOAc 1:1).  
1H NMR (400 MHz, CD2Cl2): δ = 1.01 (s, 3 H, Ox-4-CH3), 1.13 (s, 3 H, Ox-4-CH3), 3.77 (d, 
J(H,H) = 8.0 Hz, 1 H, Ox-5-H), 3.83 (d, J(H,H) = 8.0 Hz, 1 H, Ox-5-H), 6.44 (mc, 1 H, Fu-
4’’-H), 6.59 (mc, 1 H, Fu-3’’-H), 6.98 (mc, 1 H, Ar-H), 7.27-7.41 (m, 8 H, Ar-H), 7.83 (mc, 
1 H, Ar-6’-H) ppm. 
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13C{1H} NMR (101 MHz, CD2Cl2): δ = 27.7 (s, Ox-4-C(CH3)(CH3)), 28.1 (s, Ox-4-
C(CH3)(CH3)), 68.1 (s, Ox-4-C(CH3)3), 78.7 (s, Ox-5-CH2), 110.8 (d, J(C,P) = 6 Hz, Fu-4’’-
CH), 121.8 (d, J(C,P) = 27 Hz, Fu-3’’-CH), 128.2 (s, Ar-CH), 128.5 (d, J(C,P) = 30 Hz, Ar-
CH), 129.0 (s, Ar-CH), 129.7 (d, J(C,P) = 3 Hz, Ar-CH), 130.3 (s, Ar-CH), 131.6 (d, 
J(C,P) = 18 Hz, Ar-C), 133.4 (s, Ar-CH), 133.6 (s, Ar-CH), 137.2 (d, J(C,P) = 3 Hz, Ar-C), 
138.2 (d, J(C,P) = 21 Hz, Ar-C), 147.3 (d, J(C,P) = 2 Hz, Fu-5’’-CH), 154.2 (d, J(C,P) = 
21 Hz, Fu-2’’-C), 161.1 (d, J(C,P) = 3 Hz, Ox-2-C) ppm. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = −30.7 (s) ppm. 
IR (KBr): ν~  = 3058m, 2968m, 2909m, 1956w, 1816w, 1735w, 1709w, 1650s, 1586m, 1461s, 
1353m, 1310m, 1209m, 1163w, 1089w, 1038m, 1005m, 963m, 902w, 745s, 693s, 674w cm–1. 
MS (FAB, NBA+KCl): m/z (%) = 388 (9, [M+K]+), 350 (100, [M+H]+), 294 (53), 240 (32), 
122 (54). 
Elemental analysis calcd. (%) for C21H20NO2P: C 72.20, H 5.77, N 4.01; found: C 72.55, H 
5.99, N 3.68. 
 
 
4,4-Diphenyl-2-[2’-(2’’-biphenylyl-phenylphosphino)-phenyl]-4,5-dihydrooxazole 
(190) 
 
 
The ligand synthesis was accomplished in analogy to the preparation of 180 using 
phenyloxazoline 176 (130 mg, 0.434 mmol), TMEDA (60.7 mg, 0.522 mmol), sBuLi in 
cyclohexane (1.3 M, 400 µL, 0.520 mmol), chlorophosphine 170 (176 mg, 0.593 mmol) in 
abs. pentane (6.0 mL). Purification of the crude product by column chromatography (silica 
gel, 3 cm × 15 cm, pentane/Et2O/NEt3 5:1:0.5, F6-19) under argon gave ligand 190 as 
colourless solid (34.2 mg, 14%). 
 
C39H30NOP (559.63 g*mol−1): 
Rf = 0.38 (pentane/Et2O 2:1).  
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1H NMR (400 MHz, CD2Cl2): δ = 4.59 (d, J(H,H) = 8.4 Hz, 1 H, Ox-5-H), 4.66 (d, J(H,H) = 
8.4 Hz, 1 H, Ox-5-H), 6.94-7.63 (m, 26 H, Ar-H), 7.82 (dd, J(H,H) = 7.7 Hz, J(P,H) = 
4.0 Hz, 1 H, Ar-H), 8.08 (d, J(H,H) = 8.5 Hz, 1 H, Ar-6’-H) ppm. 
13C{1H} NMR (101 MHz, CD2Cl2): δ = 79.6 (s, Ox-CH2), 125.4-130.1 (diverse Ar-CH), 
130.6 (Ar-C), 131.6 (Ar-C), 132.6 (d, J(C,P) = 9 Hz, Ar-CH), 133.4 (d, J(C,P) = 12 Hz, Ar-
C), 140.5 (Ar-C), 146.1 (Ar-C), 146.3 (Ar-C), 146.5 (Ar-C) ppm; despite prolonged data 
acquisition time the signal for Ox-2-C was not detected. 
31P{1H} NMR (162 MHz, CD2Cl2): δ = −14.4 (s) ppm. 
IR (KBr): ν~  = 3053m, 2960m, 1953w, 1645s, 1488s, 1442s, 1354m, 1296m, 1185m, 1105m, 
1059m, 1026m, 901w, 750s, 696s, 617m, 537s cm–1. 
MS (EI, 70 eV): m/z (%) = 559 (6, M+), 395 (28), 378 (100), 362 (19), 302 (18), 165 (26). 
 
 
7.9 Evaluation of Chiral Ligands by ESI-MS and Preparative 
Catalyses 
7.9.1 General Procedure for ESI-MS Screenings 
In the glovebox a solution of the precatalyst under investigation was prepared by stirring 
stoichiometric quantities of [Pd(C3H5)(MeCN)2]OTf and the respective chiral ligand in abs. 
toluene (ccat = 2.50 mM) at r.t. for 30 min. Furthermore equimolar amounts of the methyl- and 
ethyl-labelled quasienantiomers were dissolved in abs. toluene (cs = 62.5 mM each) and a 
solution of [Na([15]crown-5)]CEt(CO2Et)2 in abs. toluene (cnu = 10.0 mM) was freshly 
prepared.1 All stock solutions were then filtered through syringe filters. In a typical ESI-MS 
screening experiment the precatalyst solution (50.0 µL) was treated with the solution of 
quasienantiomers (50.0 µL, 2 × 25.0 equiv. substrate per Pd) and the catalysis was initiated by 
the addition of the nucleophile (50.0 µL, 4 equiv. per Pd). The reaction was carried out in an 
oven-dried 2 mL screw-thread-vial with septum and cut-out top cap under nitrogen and the 
stock solutions were transferred with Hamilton 1700RN syringes.  
After the mixture had been stirred for 30 s at r.t., an aliquot was taken (ca. 4 µL), diluted to 
10-5 M (1.0 mL abs. CH2Cl2) and directly analysed by ESI-MS using mild desolvation 
conditions. The mass spectra were acquired in the centroid mode and the selectivities were 
calculated from the ratios of the peak heights of the two signal clusters.  
                                                 
1 For the back reaction screening using carbocyclic substrates (R,R)-90a and (S,S)-90b the precatalyst and 
substrate solutions were prepared in abs. DMF under elsewise identical conditions. 
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7.9.2 General Procedure for Preparative Allylic Alkylations of 1,3-Diphenyl-2-
propen-1-yl benzoate  
 
 
In a Young tube a solution of [Pd(C3H5)(MeCN)2]OTf (2.00 mg, 5.28 µmol) and the 
respective chiral ligand (5.28 µmol) in abs. toluene (2.0 mL) was degassed by three freeze-
pump-thaw cycles and stirred for 60 min at r.t. In a second Young tube benzoate 21 (83.0 mg, 
0.264 mmol) in abs. toluene (1.3 mL) was subsequently treated with acetyl acetone (79.3 mg, 
0.792 mmol), BSA (161 mg, 0.792 mmol) and catalytic amounts of dried KOAc (ca. 
2.00 mg). After three freeze-pump-thaw cycles the catalyst solution was added and the 
resulting mixture stirred at r.t., until all starting material was consumed according to TLC 
analysis. The reaction was diluted with Et2O (30 mL) and ice-cold saturated aqueous NH4Cl 
solution (30 mL) was added. The aqueous phase was extracted with Et2O (2 × 30 mL) and the 
combined organic phases were dried over MgSO4. After evaporation of the solvent column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc/NEt3 18:1:1, F14-20) afforded the 
product 24 as colourless solid, whose enantiomeric excess was determined by HPLC analysis. 
 
C20H20O2 (292.37 g*mol−1): 
m.p. 76 °C. 
Rf = 0.42 (hexanes/EtOAc 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1.93 (s, 3 H, CH3), 2.23 (s, 3 H, CH3), 4.31 (dd, J(H,H) = 
11.6, 8.5 Hz, 1 H, CHCH(COCH3)2), 4.39 (d, J(H,H) = 11.6 Hz, 1 H, CHCH(COCH3)2), 6.22 
(dd, J(H,H) = 15.7, 8.2 Hz, 1 H, PhCHCH), 6.44 (d, J(H,H) = 15.7 Hz, 1 H, PhCHCH), 7.16-
7.38 (m, 10 H, Ph-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 29.9 (CH3), 30.1 (CH3), 49.3 (CHCH(COCH3)2), 74.0 
(CHCH(COCH3)2), 126.3 (Ph-CH), 127.2 (CH), 127.7 (CH), 128.0 (Ph -CH), 128.5 (Ph-CH), 
128.9 (Ph-CH), 129.6 (CH), 131.5 (CH), 136.7 (3-Ph-i-C), 140.5 (1-Ph-i-C), 202.3 (COCH3), 
202.4 (COCH3) ppm. 
IR (KBr): ν~  = 3059w, 3024w, 2925w, 1723s, 1492m, 1417m, 1369s, 1273m, 1175m, 970s, 
743s, 697s cm–1. 
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MS (FAB, NBA+KCl): m/z (%) = 331 (28, [M+K]+), 274 (26), 249 (27, [M−COCH3]+), 193 
(100, [M−C5H7O2]+), 115 (23). 
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 97:3, 0.9 mL*min−1, 20 °C, 254 nm): 
tR = 16.3 (R), 17.9 (S) min.  
Elemental analysis calcd. (%) for C20H20O2 (292.37): C 82.16, H 6.89; found: C 81.82, H 
7.01. 
 
 
7.9.3 General Procedure for Preparative Allylic Aminations of 1,3-Diphenyl-2-
propen-1-yl benzoate 
 
 
In a Young tube a solution of [Pd(C3H5)Cl]2 (1.00 mg, 2.74 µmol) and the respective chiral 
ligand (5.48 µmol) in CH2Cl2 (0.6 mL) was degassed by three freeze-pump-thaw cycles. The 
ampoule was sealed at 0.01 mbar and the solution stirred at 50 °C for 2 h. After the mixture 
had been cooled to r.t. the catalyst was added to a degassed solution of benzoate 21 (85.9 mg, 
0.273 mmol) and potassium phthalimide (60.7 mg, 0.328 mmol) in CH2Cl2 (1.0 mL) in a 
Young tube. The resulting mixture was stirred at r.t. under argon, until all starting material 
was consumed according to TLC analysis. The reaction was diluted with Et2O (30 mL) and 
ice-cold saturated aqueous NH4Cl solution (30 mL) was added. The aqueous phase was 
extracted with Et2O (2 × 30 mL) and the combined organic phases were dried over MgSO4. 
After evaporation of the solvent column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc/NEt3 18:1:1, F18-30) afforded 25 as colourless solid, whose enantiomeric 
excess was determined by HPLC analysis.  
 
C23H17NO2 (339.39 g*mol−1): 
m.p. 118-119 °C. 
Rf = 0.22 (hexanes/EtOAc 4:1). 
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1H NMR (400 MHz, CDCl3): δ = 6.13 (d, J(H,H) = 8.8 Hz, 1 H, CHN), 6.72 (d, J(H,H) = 
16.0 Hz, 1 H, PhCHCH), 7.07 (dd, J(H,H) = 16.0, 8.8 Hz, 1 H, PhCHCH), 7.20-7.39 (m, 6 H, 
Ph-H), 7.41-7.52 (m, 4 H, Ph-H), 7.71 (mc, 2 H, Phth-H), 7.85 (mc, 2 H, Phth-H) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 56.6 (CHN), 123.5 (Ar-CH), 125.4 (CHCH), 126.9 
(Ar-CH), 127.6 (Ar-CH), 127.9 (Ar-CH), 128.2 (Ar-CH), 128.7 (Ar-CH), 128.8 (Ar-CH), 
132.1 (Ptht-C), 134.2 (Ar-CH), 134.5 (CHCH), 136.4 (3-Ph-i-C), 139.0 (1-Ph-i-C), 167.9 
(CON) ppm. 
IR (KBr): ν~  = 3064w, 1713s, 1644m, 1492m, 1451m, 1382s, 1114m, 971m, 763s,  
718m cm–1. 
MS (EI, 70 eV): m/z (%) = 339 (10, M+), 321 (7), 193 (100, [M−C8H4NO2]+), 115 (14). 
HPLC (Daicel Chiracel OD-H, heptane/iPrOH 99:1, 0.5 mL*min−1, 20 °C, 254 nm): tR = 37.6 
(S), 51.8 (R) min. 
 
 
7.9.4 Analyses of Preparative Kinetic Resolutions 
Ligand 76 
 
In a Young tube a solution of [Pd(C3H5)(MeCN)2]OTf (7.40 mg, 19.6 µmol) and ligand 76 
(19.3 mg, 23.5 µmol) in abs. toluene (4.0 mL) was stirred for 3 h at r.t. In a second Young 
tube benzoate 77 (194 mg, 0.958 mmol) and catalytic amounts of dried KOAc (ca. 2.00 mg) 
in abs. toluene (2.0 mL) were treated with dimethyl malonate (378 mg, 2.86 mmol) and BSA 
(582 mg, 2.86 mmol) in abs. toluene (2.0 mL) and the reaction was immediately started by the 
addition of the catalyst (t = 0 min). The resulting mixture was stirred at r.t., while the reaction 
course was analysed by taking small aliquots of 100 µL. The respective sample was poured 
into brine (4.0 mL) and the resulting mixture extracted with hexanes/EtOAc (2:1, 
2 × 4.0 mL). The combined organic phases were dried over MgSO4 and filtered over a pad of 
silica gel (0.5 × 4 cm). After evaporation of the solvent the residue was re-dissolved in 
heptane (1.0 mL). The enantiomeric excess of each sample was determined by HPLC analysis 
on a chiral column (Daicel Chiracel AD-H, heptane/isopropanol 99.8:0.2, 0.5 mL*min−1, 
BzO BzO ∗+
2.0 mol% [Pd(C3H5)(MeCN)2]OTf,
2.5 mol% 76
DMMA, BSA, KOAc, 
toluene, r.t.
77 (R)-77 78
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20 °C, 220 nm: tR = 18.0 ((R)-77), 20.0 ((S)-77 min). The conversions were measured by GC 
analysis (Restek Rtx-1701, 110/0/1/180/0/20/250): tR= 39.0 (78), 54.2 (77) min and calculated 
with the help of Equation [4].  
 
[ ] 


+⋅
⋅⋅+=
)()(
)(100[%]%
substrateAQproductA
QproductAloadingcatalystconversion  [4] 
 
The conversion was corrected for the catalyst loading of 2 mol% (Chapter 3.1.4). A Q factor 
of 0.834 was calculated by GC analysis of several known product substrate mixtures and the 
correlation of the given ratios with the respective peak areas. 
 
Q
substrateA
productA
substraten
productn ⋅=
)(
)(
)(
)(   [5] 
 
The kinetic analysis of the resolution using ligand 76 was repeated with consistent results and 
both sets of data points were analysed in one diagram (Chapter 3.1.4). 
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1. Series of measurements  
Time t [min] Area (78) [%] Area (77) [%] Conv. corr. [%] ee (77) [%] 
0.5 0.00 100.00 2.00 0.72 
1.0 1.41 98.86 2.95 0.86 
1.3 2.29 97.61 3.99 2.04 
2.3 3.59 96.41 5.01 3.28 
3.3 5.49 94.51 6.62 4.42 
4.2 6.78 93.22 7.72 5.12 
5.0 7.94 92.06 8.71 5.94 
6.0 11.90 88.10 12.13 7.72 
7.3 12.79 87.21 12.89 9.28 
9.0 15.67 84.33 15.41 10.40 
10.0 17.69 82.31 17.20 11.74 
11.0 19.02 80.98 18.39 12.50 
12.0 21.06 78.94 20.20 12.89 
13.0 23.00 77.00 21.94 14.96 
14.0 25.01 74.99 23.75 16.80 
15.0 27.36 72.63 25.91 16.52 
16.0 29.89 70.11 28.23 17.76 
17.0 32.28 67.72 32.05 23.00 
22.0 43.56 57.44 40.19 28.76 
25.0 49.07 50.93 46.56 24.78 
27.0 54.65 45.35 52.04 28.20 
30.0 59.82 40.18 57.39 28.22 
38.0 72.78 27.20 71.06 31.78 
41.0 78.76 21.77 77.11 33.02 
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2. Series of measurements  
Time t [min] Area (78) [%] Area (77) [%] Conv. corr. [%] ee (77) [%] 
0.5 0.00 100.00 2.00 1.50 
1.3 4.19 95.81 5.52 3.90 
2.5 5.82 94.18 6.89 4.76 
4.0 8.27 91.73 8.99 5.42 
5.0 9.86 90.14 10.36 6.78 
6.0 11.01 88.99 11.35 9.18 
8.0 14.96 85.04 14.79 8.08 
10.0 17.81 82.19 17.31 12.36 
12.0 20.82 79.18 19.98 15.58 
14.0 23.13 76.87 22.07 16.88 
18.0 28.88 71.12 27.30 20.66 
20.0 31.07 68.93 29.32 20.36 
22.0 33.19 66.81 31.29 22.96 
24.0 36.04 63.96 33.97 23.60 
26.0 37.71 62.29 35.54 20.66 
30.0 42.14 57.86 39.78 26.68 
32.0 44.74 55.26 42.31 29.54 
35.0 47.11 52.89 44.63 34.04 
37.0 48.71 51.29 46.14 33.38 
39.0 50.74 49.26 48.21 33.82 
42.0 52.81 47.18 50.28 39.12 
 
The enantiomeric excess was plotted against the corrected conversion and a s factor of 3.50 ± 
0.08 was calculated with Equation [2] using the least squares method.  
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Ligand 59 
 
The kinetic resolution of benzoate 77 (194 mg, 0.958 mmol) using ligand 59 (15.5 mg, 
23.5 µmol) was performed under identical conditions with [Pd(C3H5)(MeCN)2]OTf (7.40 mg, 
19.6 µmol), dimethyl malonate (378 mg, 2.86 mmol), BSA (582 mg, 2.86 mmol) and dried 
KOAc (ca. 2.00 mg) in abs. toluene (8.0 mL). The reaction was repeated with consistent 
results and both sets of data points were analysed in one diagram. As described in Chapter 
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3.1.4 it is not possible to fit these data using Equation [2] and the s factor was calculated from 
single point measurements. 
1. Series of measurements  
Time t [min] Area (78) [%] Area (77) [%] Conv. corr. [%] ee (77) [%] 
0.5 0.00 100.00 2.00 2.01 
3.0 0.00 100.00 2.00 0.54 
6.0 0.00 100.00 2.00 1.80 
10.0 0.51 99.41 2.42 2.60 
16.0 2.21 97.79 3.85 4.80 
31.0 8.07 91.93 8.82 11.60 
60.0 27.53 72.47 26.06 43.80 
85.0 52.75 47.25 50.22 71.08 
105.0 65.75 34.25 63.55 82.80 
 
2. Series of measurements  
Time t [min] Area (78) [%] Area (77) [%] Conv. corr. [%] ee (77) [%] 
1.0 0.00 100.00 2.00 0.60 
3.0 0.00 100.00 2.00 1.00 
5.0 0.00 100.00 2.00 1.12 
11.0 0.00 100.00 2.00 3.10 
16.0 0.75 99.25 2.63 4.14 
20.0 1.57 98.43 3.31 4.90 
25.0 3.84 96.16 5.22 6.34 
31.0 7.81 92.19 8.59 14.80 
35.0 12.93 87.07 13.02 20.42 
40.0 17.62 82.38 17.14 25.94 
45.0 23.40 76.60 22.31 33.60 
51.0 32.36 67.64 30.52 43.28 
59.0 47.04 52.96 44.56 62.06 
65.0 55.89 44.11 53.38 74.90 
70.0 65.18 34.82 62.96 79.02 
75.0 75.24 24.76 73.71 87.34 
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7.9.5 General Procedure for Preparative Allylic Alkylations of Cyclohex-2-
enyl benzoate 
2-(Cyclohex-2'-enyl)-2-methylcyclohexane-1,3-dione (94) 
 
 
In a Young tube a solution of [Pd(C3H5)Cl]2 (1.08 mg, 2.97 µmol) and the respective chiral 
ligand (5.94 µmol) was stirred in abs. DMF (1.0 mL) at r.t. for 2 h. NaH (18.5 mg, 
0.772 mmol) was suspended in a second Young tube in abs. DMF (2.0 mL) and treated with 
2-methylcyclohexane-1,3-dione (135 mg, 1.07 mmol). After 15 min at r.t. benzoate 77 
(60.0 mg, 0.297 mmol) was added followed by the catalyst solution and the resulting mixture 
was stirred at r.t., until all starting material was consumed according to TLC analysis. The 
reaction was diluted with Et2O (20 mL) and ice-cold saturated aqueous NH4Cl solution 
(20 mL) was added. The aqueous phase was extracted with Et2O (3 × 15 mL) and the 
combined organic phases were dried over MgSO4. After evaporation of the solvent column 
chromatography (silica gel, 3 × 20 cm, hexanes/EtOAc 4:1) afforded 94 as colourless solid, 
whose enantiomeric excess was determined by HPLC analysis.  
 
C13H18O2 (206.28 g*mol−1): 
m.p. 77-78 °C. 
Rf = 0.50 (hexanes/EtOAc 2:1). 
1H NMR (400 MHz, CDCl3): δ = 1.04 (s, 3 H, CH3), 1.28 (mc, 1 H), 1.41-1.56 (m, 2 H), 1.67 
(mc, 1 H), 1.79 (mc, 1 H), 1.95 (mc, 2 H), 2.11 (mc, 1 H), 2.57 (mc, 2 H), 2.76 (dt, 
J(H,H) = 14.3, 6.4 Hz, 1 H), 2.89 (dt, J(H,H) = 14.3, 6.6 Hz, 1 H), 2.97 (mc, 1 H), 5.23 (d, 
J(H,H) = 10.0 Hz, 1 H, CHCH), 5.81 (mc, 1 H, CHCH) ppm. 
13C{1H} NMR (101 MHz, CDCl3): δ = 10.8 (CH3), 18.5 (5’-CH2), 22.3 (5-CH2), 24.2 (6-
CH2), 24.7 (4-CH2), 37.7 (4’-CH2), 38.1 (6’-CH2), 42.4 (1’-CH), 71.0 (2-C), 124.7 (3-CH), 
130.9 (2-CH), 209.0 (CO), 209.5 (CO) ppm. 
IR (KBr): ν~  = 3024w, 2952m, 2900m, 1722s, 1689s, 1432s, 1371w, 1320s, 1266m, 1225m, 
1141w, 1094m, 1064m, 1024s, 986w, 884m, 844m, 808m, 719m, 628m, 564m, 473w cm–1. 
∗
94
O
O
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MS (EI. 70 eV): m/z (%) = 206 (18, M+), 178 (33), 150 (98), 135 (82), 122 (42), 81 (100, 
C6H9+). 
HPLC (Daicel Chiracel AD-H, heptane/isopropanol 98:2, 0.8 mL*min−1, 30 °C, 254 nm): 
tR = 11.1 (S), 13.5 (R) min. 
 
 
7.9.6 Ligand Evaluation by Conventional Preparative Allylic Alkylations 
A solution of [Pd(C3H5)Cl]2 (0.01 equiv.) and the respective chiral ligand (0.025 equiv.) in 
CH2Cl2 (1.2 mL/mmol substrate) in a Young tube was degassed by three freeze-pump-thaw 
cycles. The ampoule was sealed at 0.01 mbar and the mixture stirred at 50 °C for 2 h. The 
substrate (1.00 equiv.) in CH2Cl2 (4.0 mL/mmol substrate) was treated with dimethyl 
malonate (3.00 equiv.), BSA (3.00 equiv.) and catalytic amounts of dried KOAc. After three 
freeze-pump-thaw cycles the catalyst solution was added and the resulting mixture stirred at 
r.t., while the course of the transformation was analysed by TLC. The reaction was diluted 
with Et2O (100 mL/mmol substrate) and ice-cold saturated aqueous NH4Cl solution 
(100 mL/mmol substrate) was added. The aqueous phase was extracted with Et2O (2 × 
100 mL/mmol substrate) and the combined organic phases were dried over MgSO4. After 
evaporation of the solvent column chromatography (silica gel, 3 × 20 cm, 
hexanes/EtOAc/NEt3 18:1:1) afforded the product. The enantiomeric excesses were 
determined on chiral HPLC or GC columns and the spectroscopic properties of all products 
were in agreement with published data.[150]  
 
 
7.10 Iridium-Catalysed Asymmetric Allylic Substitutions 
7.10.1 Mass Spectrometric Analysis of Allylic Aminations[131, 140] 
In a Young Tube [Ir(COD)Cl]2 (4.50 mg, 6.70 µmol) and (R,R,R)-195 (7.20 mg, 13.4 µmol) 
in abs. THF (200 µL) and propylamine (30 µL, 0.365 mmol) were heated to 50 °C. After 
20 min and 2 h respectively aliquots (ca. 6 µL) were taken and diluted with MeOH (1.0 mL) 
using oven-dried 2 mL glass screw-thread-vials with septum cut-out top caps. The samples 
were filtered through syringe filters and directly analysed by ESI-MS using mild desolvation 
conditions. Afterwards all volatiles were removed under reduced pressure and the yellow 
residue was re-dissolved in THF (400 µL). Carbonate 197 (123 mg, 0.639 mmol) and aniline 
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(77.0 mg, 0.827 mmol) were added and the resulting mixture was stirred at r.t. After 5 min 
and 30 min respectively the reaction was analysed by ESI-MS as described above.  
 
 
7.10.2 General Procedures for Screening Allylic Substitutions using 
Quasienantiomeric Substrates 
The activated catalyst 194 was prepared by heating a solution of [Ir(COD)Cl]2 (1.06 mg, 
1.57 µmol) and 195 (1.69 mg, 3.15 µmol) and lithium phenolate 199 (20.5 mg, 0.157 mmol) 
in abs. THF (200 µL) at 50 °C for 4 h. After the catalyst solution had been cooled to r.t. 
quasienantiomeric phenolates (R)-127a and (S)-127b (or benzoates (R)-126a and (S)-126a) 
(78.7 µmol each) in abs. THF (100 µL) were added and the resulting mixture was stirred at r.t. 
After 5 min and 30 min respectively aliquots (ca. 6 µL) were taken, diluted with MeOH 
(1.0 mL) and analysed by ESI-MS as described in Section 7.10.1.  
 
 
7.10.3 Investigation of Allylic Aminations using ESI-MS and NMR Analysis[140] 
In a Young tube [Ir(COD)Cl]2 (4.00 mg, 5.98 µmol) and (S,S,S)-195 (12.8 mg, 23.9 µmol) 
were dissolved in abs. THF-d8 (800 µL) and propylamine (75 µL, 0.912 mmol). After this 
solution had been heated at 50 °C for 60 min, an aliquot was taken (sample A) and analysed 
by NMR (140 µL diluted with 560 µL THF-d8) and ESI-MS (20 µL diluted with 1.0 mL 
MeOH). After the reaction mixture had been stirred for another 50 min at 50 °C, all volatiles 
were removed in high vacuum. The yellow solid was re-dissolved in THF-d8 (600 µL) and the 
solution transferred to a NMR tube. Carbonate 197 (4.30 mg, 22.4 µmol) was added and the 
reaction mixture analysed by NMR (sample B). An aliquot was taken (10 µL diluted with 
0.5 mL MeOH) and analysed by ESI-MS as well. After 60 min at r.t. additional [Ir(COD)Cl]2 
(2.50 mg, 3.73 µmol) was added and the resulting solution (sample C) analysed by NMR and 
ESI-MS (10 µL diluted with 0.5 mL MeOH). After 3.5 h aniline (3.00 µL, 32.9 µmol) was 
added and the reaction immediately analysed by NMR and ESI-MS (10 µL diluted with 
0.5 mL MeOH), once again. 
 
Sample A: 
ESI-MS (100 °C, MeOH): m/z = 898 (15, [196+Na]+), 1379 (100, [194+H]+).  
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31P{1H} NMR (202 MHz, THF-d8): δ = 116.0 (s, 196), 128.9 (d, J(P,P) = 46 Hz, 194), 153.9 
(d, J(P,P) = 46 Hz, 194) ppm.  
Sample B: 
ESI-MS (100 °C, MeOH): m/z = 956 (100, 198), 1379 (4, [194+H]+).  
31P{1H} NMR (202 MHz, THF-d8): δ = 116.0 (s, 196), 128.9 (d, J(P,P) = 46 Hz, 194), 153.9 
(d, J(P,P) = 46 Hz, 194) ppm.  
Sample C: 
ESI-MS (100 °C, MeOH): m/z = 956 (100, 198).  
31P{1H} NMR (202 MHz, THF-d8): δ = 103.9 (s), 116.0 (s, 196) ppm.  
Sample D: 
ESI-MS (100 °C, MeOH): m/z = 956 (100, 198).  
31P{1H} NMR (202 MHz, THF-d8): δ = 103.9 (s), 116.0 (s, 196) ppm.  
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8 Appendix 
8.1 X-Ray Crystal Structures 
X-ray data analyses were carried out and crystal structures were solved by Markus Neuburger 
and Dr. Sylvia Schaffner at the Department of Chemistry of the University of Basel. Data 
collection was performed with a Nonius KappaCCD diffractometer. Measurements were 
recorded at 173 K. The structure was solved with SIR92[151] or SIR97[152] and refined with 
crystals.[153] Chebychev polynomial weights were used to complete the refinement.[154] 
Hydrogen atoms were calculated and refined as rigidifying atoms. The absolute configuration 
and enantiopurity was determined by refinement of the flack parameter.[155] 
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 (+)-(R)-159a (−)-(S)-159a 
molecular formula C18H20NOPS C18H20NOPS 
molecular weight 329.40 329.40 
shape  plate block 
colour colourless colourless 
temperature [K] 173 173 
radiation MoKα MoKα 
wavelength [Å] 0.71073 0.71073 
crystal size [mm3] 0.14 ⋅ 0.17 ⋅ 0.27 0.16 ⋅ 0.20 ⋅ 0.20 
crystal system trigonal trigonal 
space group P 32 P 31 
a [Å] 9.13950(10) 9.13950(10) 
b [Å] 9.13950(10) 9.13950(10) 
c [Å] 17.4359(3) 17.4359(3) 
α [°] 90 90 
β [°] 90 90 
γ [°] 120 120 
unit cell volume [Å3] 1261.30(3) 1260.44(3) 
Z 3 3 
calcd. density [g*cm−3] 1.301 1.302 
adsorption coeff. µ [mm−1] 0.289 0.289 
F(000) 522 522 
Θ range for data collection  2.573-30.053 2.574-30.012 
collected reflections 10735 13665 
independent reflections 4910 (Rint = 0.056) 4886 (Rint = 0.146)  
observed reflections 3707 3306 
refinded parameters 200 200 
R 0.0321 0.0299 
Rw 0.0486 0.0484 
goodness of fit 1.1054 1.1199 
Flack parameter 0.07(6) 0.03(6) 
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 (−)-(R)-160a (+)-(S)-160a 
molecular formula C16H24NOPS C16H24NOPS 
molecular weight 309.41 309.41 
shape  plate plate 
colour colourless colourless 
temperature [K] 173 173 
radiation MoKα MoKα 
wavelength [Å] 0.71073 0.71073 
crystal size [mm3] 0.08 ⋅ 0.09 ⋅ 0.19 0.08 ⋅ 0.12 ⋅ 0.32 
crystal system monoclinic monoclinic 
space group P 1 21 1 P 21  
a [Å] 8.80250(10) 8.80020(10) 
b [Å] 10.3357(2) 10.32970(10) 
c [Å] 9.37570(10) 9.37770(10) 
α [°] 90 90 
β [°] 92.2969(10) 92.3064(7) 
γ [°] 90 90 
unit cell volume [Å3] 852.32(2) 851.775(16) 
Z 2 2 
calcd. density [g*cm−3] 1.206 1.206 
adsorption coeff. µ [mm−1] 0.280 0.280 
F(000) 332.000 332.00 
Θ range for data collection [°] 2.174-30.006 2.173-30.043 
collected reflections 9136 9368 
independent reflections 4976 (Rint = 0.110) 4923 (Rint = 0.028) 
observed reflections 4250 4398 
refinded parameters 183 183 
R 0.0287 0.0318 
Rw 0.0368 0.0484 
goodness of fit 1.1183 1.0034 
Flack parameter 0.00(5) 0.03(5) 
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 (+)-(S)-162a  
molecular formula C20H24NOPS   
molecular weight 325.28  
shape  plate  
colour colourless  
temperature [K] 173  
radiation MoKα  
wavelength [Å] 0.71073  
crystal size [mm3] 0.02 ⋅ 0.12 ⋅ 0.20  
crystal system orthorhombic   
space group P 21 21 21  
a [Å] 8.2162(2)  
b [Å] 12.3226(3)  
c [Å] 19.0837(5)  
α [°] 90  
β [°] 90  
γ [°] 90  
unit cell volume [Å3] 1932.13  
Z 4  
calcd. density [g*cm−3] 1.229  
adsorption coeff. µ [mm−1] 0.257  
F(000) 760  
Θ range for data collection [°] 1.967-27.169  
collected reflections 15624  
independent reflections 4259 (Rint =0.039)  
observed reflections 2551  
refinded parameters 218  
R 0.0256  
Rw 0.0512  
goodness of fit 1.0037  
Flack parameter 0.01(8)  
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8.2 List of Abbreviations
Å Ångström (10−10 m) 
abs. absolute 
Ac acetyl 
acac acetyl acetone 
An anisyl 
Ar aryl 
aq. aqueous 
BINOL 2,2’-dihydroxy-1,1’-binaphtyl 
Bn benzyl 
Bp biphenyl 
b.p. boiling point 
bpy bipyridyl 
BSA N,O-bis(trimethylsilyl)-
acetamide 
nBu 1-butyl 
sBu sec-butyl, 2-butyl 
tBu tert-butyl, 2-methyl-2-propyl 
Bz benzoyl 
c concentration 
calcd. calculated 
cat.  catalytic 
CID collision induced dissociation 
COD 1,5-cyclooctadiene 
conv. conversion 
COSY correlation spectroscopy 
(NMR) 
Cy cyclohexyl 
δ chemical shift  
DBU 1,8-diazabicyclo[5.4.0]undec-7-
ene  
DEPT distortionless enhancement by 
polarisation transfer (NMR) 
DMAP 4-(dimethylamino)pyridine 
DMF dimethylformamide 
DMMA dimethyl malonate 
DMSO dimethyl sulfoxide 
DPPBA diphenylphosphino benzoic 
acid 
EDC N-(3-Dimethylaminopropyl)-
N’-ethylcarbodiimide  
ee enantiomeric excess 
EI electron impact 
ent enantiomer 
ESI electrospray ionisation 
Et ethyl 
equiv. equivalent 
F fraction 
FAB fast atom bombardement 
Fu furyl 
GC gas chromatograpy 
HMBC heteronuclear multiple bond 
correlation (NMR) 
HMQC heteronuclear multiple quantum 
coherence (NMR) 
HOBt 1-hydroxybenzotriazole 
HPLC high performance liquid 
chromatography 
Hz Hertz 
i ipso 
init initial 
Irel relative intensity 
J coupling constant 
k rate constant 
L ligand 
m meta 
M metal 
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M molar [mol*L−1] 
Me methyl 
MS mass spectrometry 
m/z mass-to-charge ratio 
NMR nuclear magnetic resonance 
Np naphtyl 
Nu nucleophile 
o ortho 
Ox oxazolinyl 
p para 
Piv pivaloyl 
Ph phenyl 
Phim phosphinoimidazoline 
Phox phosphinooxazoline 
Phth phthalimide 
ppm parts per million (10−6) 
iPr isopropyl, 2-propyl 
quant. quantitative 
rac racemic 
Rf retention factor 
r.t. room temperature 
s selectivity factor 
sec secondary 
t time 
TBAF tetrabutylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
tert tertiary 
Tf trifluoromethanesulfonyl 
THAB tetrahexylammonium bromide 
THF tetrahydrofuran 
TMEDA N,N,N’,N’-tetramethyl-
ethylenediamine 
TMS trimethylsilyl 
Tol tolyl 
tR retention time 
Ts tosyl, 4-toluenesulfonyl 
Xyl xylyl
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